Query 011628
Match_columns 481
No_of_seqs 414 out of 2606
Neff 8.4
Searched_HMMs 46136
Date Fri Mar 29 03:28:37 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/011628.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/011628hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 KOG0583 Serine/threonine prote 100.0 2.1E-61 4.5E-66 489.1 30.1 261 22-284 13-280 (370)
2 KOG0615 Serine/threonine prote 100.0 1.9E-62 4E-67 475.7 17.4 261 22-285 168-443 (475)
3 KOG0588 Serine/threonine prote 100.0 2.5E-61 5.3E-66 490.7 20.9 260 23-285 9-269 (786)
4 KOG0575 Polo-like serine/threo 100.0 2E-60 4.3E-65 482.6 25.9 260 26-288 18-278 (592)
5 KOG0598 Ribosomal protein S6 k 100.0 1.3E-57 2.8E-62 439.0 24.6 259 23-284 22-286 (357)
6 KOG0616 cAMP-dependent protein 100.0 2.4E-57 5.2E-62 423.7 20.7 255 24-284 42-302 (355)
7 KOG0581 Mitogen-activated prot 100.0 5.4E-57 1.2E-61 434.8 23.2 255 24-285 77-341 (364)
8 KOG0592 3-phosphoinositide-dep 100.0 3.2E-56 7E-61 445.2 21.0 260 24-284 71-343 (604)
9 KOG0595 Serine/threonine-prote 100.0 2.7E-55 5.9E-60 426.3 23.4 260 21-285 5-274 (429)
10 KOG0611 Predicted serine/threo 100.0 1.7E-55 3.8E-60 425.0 17.4 262 22-287 49-311 (668)
11 KOG0605 NDR and related serine 100.0 1.9E-53 4.2E-58 425.6 25.6 261 22-284 137-450 (550)
12 KOG0591 NIMA (never in mitosis 100.0 1E-54 2.2E-59 403.1 9.8 249 21-273 14-275 (375)
13 KOG0585 Ca2+/calmodulin-depend 100.0 2.9E-53 6.2E-58 417.6 19.1 265 23-287 94-380 (576)
14 KOG0694 Serine/threonine prote 100.0 2.2E-52 4.8E-57 428.5 25.0 258 25-285 367-630 (694)
15 KOG0593 Predicted protein kina 100.0 2.8E-53 6.1E-58 397.1 14.7 256 25-283 1-288 (396)
16 KOG0033 Ca2+/calmodulin-depend 100.0 2.3E-54 5E-59 393.6 7.1 258 23-285 8-273 (355)
17 KOG0198 MEKK and related serin 100.0 2.2E-52 4.8E-57 408.5 19.6 258 25-285 16-282 (313)
18 KOG0597 Serine-threonine prote 100.0 9.6E-53 2.1E-57 420.5 16.6 257 25-286 1-258 (808)
19 KOG0580 Serine/threonine prote 100.0 1.5E-52 3.2E-57 381.2 13.9 255 25-284 21-278 (281)
20 KOG0600 Cdc2-related protein k 100.0 1.7E-51 3.6E-56 408.4 20.1 256 25-283 116-404 (560)
21 KOG0661 MAPK related serine/th 100.0 2.5E-52 5.5E-57 411.5 14.0 260 21-286 5-298 (538)
22 PTZ00263 protein kinase A cata 100.0 1.2E-50 2.5E-55 408.0 26.2 255 24-284 16-276 (329)
23 KOG0582 Ste20-like serine/thre 100.0 3.4E-50 7.3E-55 393.7 27.3 260 23-285 23-299 (516)
24 KOG4717 Serine/threonine prote 100.0 1.5E-51 3.2E-56 407.5 17.8 262 21-286 13-277 (864)
25 cd05612 STKc_PRKX_like Catalyt 100.0 2.8E-50 6E-55 398.1 24.5 253 26-284 1-259 (291)
26 KOG0032 Ca2+/calmodulin-depend 100.0 8.4E-50 1.8E-54 404.4 28.1 260 22-285 31-299 (382)
27 PTZ00426 cAMP-dependent protei 100.0 1.8E-49 3.8E-54 401.2 27.2 258 21-284 25-289 (340)
28 cd05571 STKc_PKB Catalytic dom 100.0 1.1E-49 2.3E-54 399.9 25.2 251 32-285 1-257 (323)
29 KOG0659 Cdk activating kinase 100.0 3.6E-50 7.8E-55 370.5 19.7 255 26-284 2-286 (318)
30 KOG0578 p21-activated serine/t 100.0 1.4E-50 3E-55 407.9 18.4 254 25-284 272-528 (550)
31 KOG0599 Phosphorylase kinase g 100.0 6.9E-51 1.5E-55 376.0 13.2 258 23-284 14-288 (411)
32 KOG0610 Putative serine/threon 100.0 1.1E-49 2.4E-54 387.3 21.5 259 25-284 76-397 (459)
33 KOG0586 Serine/threonine prote 100.0 7E-50 1.5E-54 406.1 19.8 263 22-288 52-315 (596)
34 cd05589 STKc_PKN Catalytic dom 100.0 1.5E-48 3.4E-53 391.6 28.8 254 28-284 1-262 (324)
35 cd05585 STKc_YPK1_like Catalyt 100.0 5.5E-49 1.2E-53 392.8 25.2 249 34-285 1-253 (312)
36 cd05628 STKc_NDR1 Catalytic do 100.0 1.6E-48 3.4E-53 397.7 27.5 257 26-284 1-298 (363)
37 cd05593 STKc_PKB_gamma Catalyt 100.0 1.4E-48 3.1E-53 392.7 25.9 250 32-284 1-256 (328)
38 cd05600 STKc_Sid2p_Dbf2p Catal 100.0 2.1E-48 4.5E-53 392.0 26.3 253 26-284 1-262 (333)
39 cd05595 STKc_PKB_beta Catalyti 100.0 1.9E-48 4.2E-53 390.9 25.6 250 32-284 1-256 (323)
40 KOG0660 Mitogen-activated prot 100.0 2.9E-49 6.3E-54 379.8 18.5 260 24-285 20-316 (359)
41 cd05599 STKc_NDR_like Catalyti 100.0 4.3E-48 9.4E-53 394.4 28.0 257 26-284 1-301 (364)
42 cd05587 STKc_cPKC Catalytic do 100.0 4E-48 8.7E-53 388.6 27.3 255 27-284 1-262 (324)
43 cd05590 STKc_nPKC_eta Catalyti 100.0 2.5E-48 5.3E-53 389.6 25.2 250 32-284 1-258 (320)
44 cd05626 STKc_LATS2 Catalytic d 100.0 3.7E-48 8E-53 397.6 27.1 258 26-284 1-310 (381)
45 KOG0201 Serine/threonine prote 100.0 1.8E-50 3.8E-55 395.5 8.5 256 25-285 12-269 (467)
46 cd05596 STKc_ROCK Catalytic do 100.0 4.1E-48 8.9E-53 395.7 26.3 259 25-284 42-309 (370)
47 cd05620 STKc_nPKC_delta Cataly 100.0 6.6E-48 1.4E-52 385.8 27.1 250 32-284 1-253 (316)
48 cd05631 STKc_GRK4 Catalytic do 100.0 5.7E-48 1.2E-52 380.3 26.1 253 28-284 2-266 (285)
49 cd05591 STKc_nPKC_epsilon Cata 100.0 3.9E-48 8.4E-53 388.2 25.1 250 32-284 1-259 (321)
50 cd05625 STKc_LATS1 Catalytic d 100.0 4.9E-48 1.1E-52 396.8 26.3 257 26-284 1-310 (382)
51 cd05614 STKc_MSK2_N N-terminal 100.0 1.7E-47 3.8E-52 385.0 29.0 257 27-284 1-272 (332)
52 cd05629 STKc_NDR_like_fungal C 100.0 4.8E-48 1E-52 396.1 25.3 257 26-284 1-310 (377)
53 cd07871 STKc_PCTAIRE3 Catalyti 100.0 9.3E-48 2E-52 379.4 26.1 253 25-282 4-288 (288)
54 cd05594 STKc_PKB_alpha Catalyt 100.0 3.6E-48 7.8E-53 389.1 23.5 250 32-284 1-257 (325)
55 cd07848 STKc_CDKL5 Catalytic d 100.0 9.6E-48 2.1E-52 378.2 25.9 254 26-282 1-287 (287)
56 cd05573 STKc_ROCK_NDR_like Cat 100.0 3.8E-48 8.2E-53 392.3 23.4 257 26-284 1-290 (350)
57 KOG0663 Protein kinase PITSLRE 100.0 1.4E-48 3E-53 370.0 18.7 257 25-285 75-367 (419)
58 cd05616 STKc_cPKC_beta Catalyt 100.0 1.2E-47 2.6E-52 384.9 26.6 255 27-284 1-262 (323)
59 cd05598 STKc_LATS Catalytic do 100.0 5.7E-48 1.2E-52 395.4 24.4 257 26-284 1-306 (376)
60 cd05621 STKc_ROCK2 Catalytic d 100.0 9.6E-48 2.1E-52 392.9 25.7 260 24-284 41-309 (370)
61 cd05575 STKc_SGK Catalytic dom 100.0 1.7E-47 3.6E-52 383.9 26.9 250 32-284 1-256 (323)
62 cd05592 STKc_nPKC_theta_delta 100.0 1.4E-47 3E-52 383.5 25.6 250 32-284 1-253 (316)
63 cd05588 STKc_aPKC Catalytic do 100.0 1.7E-47 3.6E-52 385.0 25.6 250 32-284 1-267 (329)
64 cd05604 STKc_SGK3 Catalytic do 100.0 2.2E-47 4.8E-52 383.4 26.1 250 32-284 1-256 (325)
65 cd05584 STKc_p70S6K Catalytic 100.0 2E-47 4.4E-52 383.4 25.8 252 31-285 1-262 (323)
66 cd07869 STKc_PFTAIRE1 Catalyti 100.0 2.5E-47 5.5E-52 378.9 25.9 255 25-284 4-293 (303)
67 cd05601 STKc_CRIK Catalytic do 100.0 2.5E-47 5.4E-52 383.6 25.4 257 26-284 1-268 (330)
68 cd05570 STKc_PKC Catalytic dom 100.0 2.8E-47 6E-52 381.6 25.3 250 32-284 1-257 (318)
69 KOG0690 Serine/threonine prote 100.0 6.9E-49 1.5E-53 370.3 12.8 260 22-284 164-429 (516)
70 cd05615 STKc_cPKC_alpha Cataly 100.0 4.9E-47 1.1E-51 380.6 27.0 255 27-284 1-262 (323)
71 cd05627 STKc_NDR2 Catalytic do 100.0 1.9E-47 4.1E-52 389.3 24.2 257 26-284 1-298 (360)
72 cd05619 STKc_nPKC_theta Cataly 100.0 4E-47 8.8E-52 380.2 26.0 250 32-284 1-253 (316)
73 cd05622 STKc_ROCK1 Catalytic d 100.0 4.5E-47 9.7E-52 388.2 26.6 259 25-284 42-309 (371)
74 KOG0192 Tyrosine kinase specif 100.0 2.8E-47 6E-52 383.0 24.3 248 25-278 40-298 (362)
75 cd05618 STKc_aPKC_iota Catalyt 100.0 4.9E-47 1.1E-51 381.7 25.8 250 32-284 1-267 (329)
76 PLN00034 mitogen-activated pro 100.0 1.4E-46 3.1E-51 381.9 27.1 256 23-285 71-334 (353)
77 cd05602 STKc_SGK1 Catalytic do 100.0 1.5E-46 3.2E-51 377.4 26.7 250 32-284 1-256 (325)
78 KOG0589 Serine/threonine prote 100.0 6.7E-48 1.5E-52 386.3 16.4 257 25-285 3-264 (426)
79 cd07859 STKc_TDY_MAPK_plant Ca 100.0 1.6E-46 3.4E-51 378.2 26.3 255 27-284 1-295 (338)
80 cd05608 STKc_GRK1 Catalytic do 100.0 1.5E-46 3.2E-51 369.3 25.0 248 34-284 1-262 (280)
81 KOG0594 Protein kinase PCTAIRE 100.0 4.4E-47 9.6E-52 365.7 20.4 257 25-285 10-308 (323)
82 cd05603 STKc_SGK2 Catalytic do 100.0 1.3E-46 2.7E-51 377.1 24.5 250 32-284 1-256 (321)
83 cd05586 STKc_Sck1_like Catalyt 100.0 4.6E-47 1E-51 381.7 21.4 249 34-284 1-258 (330)
84 cd06649 PKc_MEK2 Catalytic dom 100.0 4.9E-46 1.1E-50 374.6 28.9 254 25-285 4-307 (331)
85 cd05582 STKc_RSK_N N-terminal 100.0 5.6E-47 1.2E-51 379.2 21.8 249 32-284 2-259 (318)
86 cd05617 STKc_aPKC_zeta Catalyt 100.0 2.2E-46 4.8E-51 376.6 25.6 250 32-284 1-265 (327)
87 cd05605 STKc_GRK4_like Catalyt 100.0 3.3E-46 7.1E-51 367.8 26.3 254 27-284 1-266 (285)
88 cd05597 STKc_DMPK_like Catalyt 100.0 4.6E-46 1E-50 374.9 27.2 258 26-284 1-271 (331)
89 PTZ00283 serine/threonine prot 100.0 8.5E-46 1.8E-50 391.7 28.9 261 23-285 29-303 (496)
90 PTZ00267 NIMA-related protein 100.0 1.7E-45 3.8E-50 388.4 29.8 258 23-284 64-328 (478)
91 cd07862 STKc_CDK6 Catalytic do 100.0 1.1E-45 2.4E-50 364.2 26.1 251 26-282 1-290 (290)
92 PTZ00036 glycogen synthase kin 100.0 1.2E-45 2.5E-50 385.8 27.3 249 25-284 65-356 (440)
93 cd05623 STKc_MRCK_alpha Cataly 100.0 1.2E-45 2.6E-50 371.9 26.1 258 26-284 1-271 (332)
94 KOG0658 Glycogen synthase kina 100.0 9.5E-47 2.1E-51 363.1 17.0 251 24-285 22-312 (364)
95 cd07876 STKc_JNK2 Catalytic do 100.0 2.2E-45 4.7E-50 374.0 27.9 257 23-286 18-322 (359)
96 cd07872 STKc_PCTAIRE2 Catalyti 100.0 1.9E-45 4.1E-50 366.4 26.9 256 25-285 5-292 (309)
97 PHA03212 serine/threonine kina 100.0 1.8E-45 3.9E-50 378.6 27.0 250 24-285 90-382 (391)
98 cd05580 STKc_PKA Catalytic dom 100.0 3.6E-45 7.8E-50 361.0 27.9 253 26-284 1-259 (290)
99 cd05624 STKc_MRCK_beta Catalyt 100.0 1.7E-45 3.7E-50 370.7 25.2 258 26-284 1-271 (331)
100 cd07878 STKc_p38beta_MAPK11 Ca 100.0 1.1E-45 2.3E-50 373.7 23.4 255 23-284 12-303 (343)
101 PF00069 Pkinase: Protein kina 100.0 1.5E-45 3.2E-50 356.3 23.3 252 28-282 1-260 (260)
102 cd07853 STKc_NLK Catalytic dom 100.0 1.5E-45 3.2E-50 377.1 24.5 256 27-285 1-294 (372)
103 cd06625 STKc_MEKK3_like Cataly 100.0 7.6E-45 1.7E-49 352.4 27.7 256 26-282 2-263 (263)
104 cd06650 PKc_MEK1 Catalytic dom 100.0 7E-45 1.5E-49 366.6 27.8 255 24-285 3-305 (333)
105 PTZ00284 protein kinase; Provi 100.0 4.8E-45 1E-49 384.3 27.8 251 25-286 128-445 (467)
106 cd05102 PTKc_VEGFR3 Catalytic 100.0 3.3E-45 7.2E-50 369.2 24.1 251 25-278 6-329 (338)
107 cd07875 STKc_JNK1 Catalytic do 100.0 5.7E-45 1.2E-49 371.6 26.0 256 23-285 21-324 (364)
108 cd05630 STKc_GRK6 Catalytic do 100.0 9.9E-45 2.1E-49 357.3 26.6 254 27-284 1-266 (285)
109 cd07874 STKc_JNK3 Catalytic do 100.0 6.2E-45 1.4E-49 370.0 25.9 257 23-286 14-318 (355)
110 KOG0604 MAP kinase-activated p 100.0 1.3E-46 2.8E-51 351.8 12.3 253 20-284 55-327 (400)
111 cd07863 STKc_CDK4 Catalytic do 100.0 8E-45 1.7E-49 357.4 24.9 250 27-282 1-288 (288)
112 KOG0579 Ste20-like serine/thre 100.0 1E-46 2.2E-51 380.4 11.1 255 25-285 31-295 (1187)
113 cd07873 STKc_PCTAIRE1 Catalyti 100.0 1.8E-44 3.9E-49 357.9 26.9 256 25-285 5-292 (301)
114 cd05607 STKc_GRK7 Catalytic do 100.0 1.4E-44 3.1E-49 354.6 25.6 247 34-284 1-259 (277)
115 cd05632 STKc_GRK5 Catalytic do 100.0 2.6E-44 5.7E-49 354.2 27.4 255 27-285 1-267 (285)
116 KOG0667 Dual-specificity tyros 100.0 2.9E-45 6.2E-50 376.0 21.2 252 22-284 182-507 (586)
117 cd08223 STKc_Nek4 Catalytic do 100.0 7.2E-44 1.6E-48 344.4 28.4 252 27-282 1-257 (257)
118 cd06628 STKc_MAPKKK_Byr2_like 100.0 5.6E-44 1.2E-48 347.3 26.9 255 27-282 1-267 (267)
119 cd07861 STKc_CDK1_euk Catalyti 100.0 5.1E-44 1.1E-48 350.9 26.3 252 27-282 1-285 (285)
120 cd05574 STKc_phototropin_like 100.0 7.4E-44 1.6E-48 355.8 27.7 258 26-284 1-294 (316)
121 cd06615 PKc_MEK Catalytic doma 100.0 8.8E-44 1.9E-48 354.5 27.9 253 26-285 1-293 (308)
122 PHA03207 serine/threonine kina 100.0 7.4E-44 1.6E-48 367.1 27.6 253 23-285 89-381 (392)
123 cd06654 STKc_PAK1 Catalytic do 100.0 9.5E-44 2.1E-48 352.3 27.4 255 24-284 18-275 (296)
124 KOG0607 MAP kinase-interacting 100.0 1.3E-45 2.8E-50 347.5 13.1 262 21-285 72-367 (463)
125 cd08529 STKc_FA2-like Catalyti 100.0 2.2E-43 4.7E-48 340.6 28.2 252 27-282 1-256 (256)
126 KOG0696 Serine/threonine prote 100.0 3.3E-45 7.3E-50 354.4 15.1 261 21-284 344-611 (683)
127 cd07868 STKc_CDK8 Catalytic do 100.0 6.1E-44 1.3E-48 356.5 24.8 246 31-282 6-317 (317)
128 cd05609 STKc_MAST Catalytic do 100.0 1.9E-43 4.1E-48 351.3 28.2 258 26-284 1-278 (305)
129 cd06655 STKc_PAK2 Catalytic do 100.0 1.7E-43 3.6E-48 350.6 27.6 254 25-284 18-274 (296)
130 cd06610 STKc_OSR1_SPAK Catalyt 100.0 1.5E-43 3.3E-48 343.5 26.7 255 26-282 1-267 (267)
131 cd07832 STKc_CCRK Catalytic do 100.0 1.7E-43 3.6E-48 347.2 27.0 254 27-283 1-286 (286)
132 cd06609 STKc_MST3_like Catalyt 100.0 1.2E-43 2.5E-48 346.8 25.6 256 26-286 1-258 (274)
133 cd05578 STKc_Yank1 Catalytic d 100.0 5.2E-44 1.1E-48 346.0 22.8 252 27-282 1-258 (258)
134 cd07839 STKc_CDK5 Catalytic do 100.0 3.8E-44 8.2E-49 351.9 22.0 252 27-282 1-284 (284)
135 KOG0197 Tyrosine kinases [Sign 100.0 1.5E-44 3.2E-49 363.4 19.2 245 27-278 207-456 (468)
136 cd06611 STKc_SLK_like Catalyti 100.0 7.6E-44 1.7E-48 349.2 23.9 256 25-285 4-268 (280)
137 KOG0574 STE20-like serine/thre 100.0 6.7E-47 1.5E-51 353.5 2.0 253 25-285 32-289 (502)
138 cd06619 PKc_MKK5 Catalytic dom 100.0 3E-43 6.4E-48 345.4 27.8 250 26-285 1-259 (279)
139 PTZ00266 NIMA-related protein 100.0 1.4E-43 3.1E-48 388.4 28.3 265 17-285 4-301 (1021)
140 PHA03211 serine/threonine kina 100.0 1.7E-43 3.8E-48 369.4 27.7 249 25-284 168-460 (461)
141 cd06656 STKc_PAK3 Catalytic do 100.0 1E-43 2.3E-48 352.1 24.5 256 24-285 17-275 (297)
142 cd06631 STKc_YSK4 Catalytic do 100.0 2.1E-43 4.6E-48 343.1 26.2 254 27-282 1-265 (265)
143 cd07847 STKc_CDKL1_4 Catalytic 100.0 2.4E-43 5.3E-48 346.1 26.8 254 26-282 1-286 (286)
144 cd08227 PK_STRAD_alpha Pseudok 100.0 1.2E-43 2.5E-48 356.6 24.8 254 29-284 1-312 (327)
145 KOG0612 Rho-associated, coiled 100.0 3.4E-45 7.3E-50 390.8 14.1 258 25-284 74-343 (1317)
146 cd06637 STKc_TNIK Catalytic do 100.0 1.7E-43 3.7E-48 344.8 25.0 252 24-282 4-272 (272)
147 cd06645 STKc_MAP4K3 Catalytic 100.0 1.2E-43 2.5E-48 345.3 23.4 251 25-281 8-267 (267)
148 cd06644 STKc_STK10_LOK Catalyt 100.0 3.8E-43 8.2E-48 346.8 27.2 254 25-284 11-274 (292)
149 cd06646 STKc_MAP4K5 Catalytic 100.0 1.8E-43 4E-48 343.9 24.5 252 25-281 8-267 (267)
150 cd08218 STKc_Nek1 Catalytic do 100.0 4.5E-43 9.7E-48 338.8 26.9 252 27-282 1-256 (256)
151 cd08221 STKc_Nek9 Catalytic do 100.0 7E-43 1.5E-47 337.5 28.3 252 27-282 1-256 (256)
152 cd06622 PKc_MAPKK_PBS2_like Ca 100.0 1.8E-43 3.8E-48 347.7 24.3 254 26-285 1-268 (286)
153 cd06643 STKc_SLK Catalytic dom 100.0 3.8E-43 8.2E-48 344.8 26.4 254 27-285 6-268 (282)
154 cd06629 STKc_MAPKKK_Bck1_like 100.0 4.3E-43 9.2E-48 342.3 26.5 256 27-282 2-272 (272)
155 cd05048 PTKc_Ror Catalytic Dom 100.0 2.1E-43 4.5E-48 346.5 24.2 252 25-279 4-279 (283)
156 cd05106 PTKc_CSF-1R Catalytic 100.0 1.1E-43 2.5E-48 363.4 23.3 251 25-278 37-367 (374)
157 PHA02988 hypothetical protein; 100.0 3.3E-43 7.2E-48 346.4 25.5 239 32-278 26-274 (283)
158 cd05096 PTKc_DDR1 Catalytic do 100.0 3.9E-43 8.4E-48 348.8 25.7 251 25-278 4-300 (304)
159 cd05572 STKc_cGK_PKG Catalytic 100.0 4E-43 8.7E-48 340.5 25.3 247 34-284 1-257 (262)
160 cd06651 STKc_MEKK3 Catalytic d 100.0 6.5E-43 1.4E-47 340.3 26.7 256 26-283 2-265 (266)
161 cd06652 STKc_MEKK2 Catalytic d 100.0 1E-42 2.2E-47 338.5 27.9 256 26-283 2-265 (265)
162 cd07845 STKc_CDK10 Catalytic d 100.0 4.6E-43 9.9E-48 349.1 25.9 257 25-285 6-296 (309)
163 cd06630 STKc_MEKK1 Catalytic d 100.0 3E-43 6.4E-48 342.2 23.9 256 27-283 1-268 (268)
164 cd07846 STKc_CDKL2_3 Catalytic 100.0 2.7E-43 5.9E-48 345.9 23.5 254 26-282 1-286 (286)
165 cd05581 STKc_PDK1 Catalytic do 100.0 2.8E-43 6.1E-48 344.0 23.1 256 26-282 1-280 (280)
166 cd05064 PTKc_EphR_A10 Catalyti 100.0 7.3E-43 1.6E-47 340.2 25.9 250 25-278 4-260 (266)
167 cd08220 STKc_Nek8 Catalytic do 100.0 1.5E-42 3.2E-47 334.7 27.6 251 27-282 1-256 (256)
168 cd05633 STKc_GRK3 Catalytic do 100.0 6.9E-43 1.5E-47 343.1 25.6 248 33-284 1-260 (279)
169 cd07841 STKc_CDK7 Catalytic do 100.0 5.4E-43 1.2E-47 346.3 25.0 257 27-286 1-289 (298)
170 cd05104 PTKc_Kit Catalytic dom 100.0 2.8E-43 6.2E-48 360.6 23.8 252 25-279 34-370 (375)
171 cd06632 STKc_MEKK1_plant Catal 100.0 1.2E-42 2.5E-47 335.6 26.4 253 27-282 1-258 (258)
172 cd07849 STKc_ERK1_2_like Catal 100.0 5.7E-43 1.2E-47 352.9 25.2 259 24-285 3-298 (336)
173 cd08219 STKc_Nek3 Catalytic do 100.0 1.3E-42 2.9E-47 335.5 26.8 248 27-279 1-252 (255)
174 KOG0577 Serine/threonine prote 100.0 9.2E-45 2E-49 364.3 11.8 252 26-285 26-284 (948)
175 cd06917 STKc_NAK1_like Catalyt 100.0 6.5E-43 1.4E-47 341.9 24.6 255 27-285 2-261 (277)
176 cd06613 STKc_MAP4K3_like Catal 100.0 1.5E-42 3.2E-47 335.9 26.8 251 25-281 2-262 (262)
177 cd06640 STKc_MST4 Catalytic do 100.0 6.5E-43 1.4E-47 342.5 24.5 256 25-285 3-259 (277)
178 PHA03209 serine/threonine kina 100.0 5.6E-43 1.2E-47 356.2 24.9 246 25-284 65-356 (357)
179 cd07850 STKc_JNK Catalytic dom 100.0 8.7E-43 1.9E-47 354.0 25.8 258 23-287 13-319 (353)
180 cd07833 STKc_CDKL Catalytic do 100.0 1E-42 2.2E-47 342.0 25.5 255 26-282 1-288 (288)
181 cd06608 STKc_myosinIII_like Ca 100.0 1.1E-42 2.3E-47 338.7 25.4 252 25-282 5-275 (275)
182 cd06636 STKc_MAP4K4_6 Catalyti 100.0 9.1E-43 2E-47 341.9 25.0 252 24-282 14-282 (282)
183 cd06639 STKc_myosinIIIB Cataly 100.0 3E-42 6.4E-47 340.0 28.7 254 24-283 20-291 (291)
184 KOG0662 Cyclin-dependent kinas 100.0 5.6E-44 1.2E-48 312.1 14.3 255 26-284 2-288 (292)
185 cd07860 STKc_CDK2_3 Catalytic 100.0 8.5E-43 1.8E-47 342.3 24.5 252 27-282 1-284 (284)
186 cd07844 STKc_PCTAIRE_like Cata 100.0 1.3E-42 2.8E-47 342.4 25.9 253 25-282 4-291 (291)
187 cd07865 STKc_CDK9 Catalytic do 100.0 1.4E-42 3E-47 344.7 25.9 258 23-282 9-310 (310)
188 cd08217 STKc_Nek2 Catalytic do 100.0 2.6E-42 5.7E-47 333.9 27.2 252 27-282 1-265 (265)
189 KOG4279 Serine/threonine prote 100.0 2.6E-44 5.7E-49 366.2 13.7 250 32-287 581-840 (1226)
190 KOG0614 cGMP-dependent protein 100.0 8.1E-45 1.8E-49 359.6 9.7 258 22-283 416-681 (732)
191 cd05606 STKc_beta_ARK Catalyti 100.0 1.6E-42 3.5E-47 340.3 25.7 249 33-285 1-261 (278)
192 cd05577 STKc_GRK Catalytic dom 100.0 9.5E-43 2.1E-47 341.3 24.1 247 34-284 1-259 (277)
193 cd06612 STKc_MST1_2 Catalytic 100.0 1.1E-42 2.4E-47 335.5 23.9 249 26-282 3-256 (256)
194 cd06626 STKc_MEKK4 Catalytic d 100.0 4.2E-42 9.1E-47 333.1 28.0 255 27-282 1-264 (264)
195 cd05579 STKc_MAST_like Catalyt 100.0 9.6E-43 2.1E-47 336.9 23.3 250 34-284 1-262 (265)
196 cd06658 STKc_PAK5 Catalytic do 100.0 6.8E-43 1.5E-47 345.6 22.5 257 23-285 19-278 (292)
197 cd06641 STKc_MST3 Catalytic do 100.0 2.7E-42 5.9E-47 338.0 26.5 254 27-285 5-259 (277)
198 KOG4236 Serine/threonine prote 100.0 3.9E-44 8.4E-49 355.7 13.2 253 26-285 562-825 (888)
199 cd06642 STKc_STK25-YSK1 Cataly 100.0 3.6E-43 7.8E-48 344.1 19.9 255 26-285 4-259 (277)
200 cd07837 STKc_CdkB_plant Cataly 100.0 2.8E-42 6E-47 340.5 26.4 254 26-283 1-295 (295)
201 cd07880 STKc_p38gamma_MAPK12 C 100.0 3.6E-42 7.8E-47 348.3 27.2 256 23-285 12-304 (343)
202 cd07867 STKc_CDC2L6 Catalytic 100.0 1.3E-42 2.8E-47 346.6 23.7 246 31-282 6-317 (317)
203 KOG0986 G protein-coupled rece 100.0 7.4E-44 1.6E-48 349.1 14.3 256 25-284 184-451 (591)
204 cd07843 STKc_CDC2L1 Catalytic 100.0 1.4E-42 2.9E-47 342.8 23.5 254 25-282 4-293 (293)
205 cd07831 STKc_MOK Catalytic dom 100.0 3.3E-42 7.2E-47 337.3 26.1 248 28-282 1-282 (282)
206 cd07854 STKc_MAPK4_6 Catalytic 100.0 1.8E-42 3.8E-47 350.3 24.8 257 24-284 3-305 (342)
207 cd06605 PKc_MAPKK Catalytic do 100.0 1.2E-42 2.5E-47 337.4 22.6 252 26-284 1-262 (265)
208 cd06638 STKc_myosinIIIA Cataly 100.0 3E-42 6.4E-47 338.8 25.7 252 24-282 16-286 (286)
209 cd08228 STKc_Nek6 Catalytic do 100.0 4.6E-42 9.9E-47 333.9 26.8 252 25-279 1-261 (267)
210 cd05108 PTKc_EGFR Catalytic do 100.0 2.4E-42 5.2E-47 345.3 25.3 251 25-279 6-264 (316)
211 cd07836 STKc_Pho85 Catalytic d 100.0 3E-42 6.5E-47 338.2 25.3 251 27-282 1-284 (284)
212 cd06620 PKc_MAPKK_Byr1_like Ca 100.0 2.2E-42 4.7E-47 340.0 24.2 255 25-286 4-273 (284)
213 cd05090 PTKc_Ror1 Catalytic do 100.0 3.7E-42 8.1E-47 337.9 25.8 252 25-279 4-279 (283)
214 cd07870 STKc_PFTAIRE2 Catalyti 100.0 6.1E-42 1.3E-46 337.8 27.1 253 25-282 4-291 (291)
215 cd05049 PTKc_Trk Catalytic dom 100.0 2.3E-42 5E-47 338.3 23.7 251 25-278 4-276 (280)
216 cd05611 STKc_Rim15_like Cataly 100.0 3.6E-42 7.9E-47 333.5 24.9 246 32-284 2-256 (260)
217 cd05033 PTKc_EphR Catalytic do 100.0 6.5E-42 1.4E-46 333.0 26.6 252 25-279 3-261 (266)
218 KOG4645 MAPKKK (MAP kinase kin 100.0 7.7E-45 1.7E-49 392.5 6.6 259 23-283 1232-1498(1509)
219 cd05061 PTKc_InsR Catalytic do 100.0 5.9E-42 1.3E-46 337.7 26.4 256 25-283 5-284 (288)
220 cd05093 PTKc_TrkB Catalytic do 100.0 5.4E-42 1.2E-46 338.0 26.0 249 26-278 5-274 (288)
221 cd08225 STKc_Nek5 Catalytic do 100.0 5E-42 1.1E-46 331.2 25.2 252 27-282 1-257 (257)
222 cd05062 PTKc_IGF-1R Catalytic 100.0 4.7E-42 1E-46 336.2 25.3 253 24-279 4-274 (277)
223 cd05084 PTKc_Fes Catalytic dom 100.0 5E-42 1.1E-46 331.0 25.0 244 32-278 1-248 (252)
224 cd06647 STKc_PAK_I Catalytic d 100.0 2.4E-42 5.2E-47 341.7 23.4 255 25-285 18-275 (293)
225 cd08215 STKc_Nek Catalytic dom 100.0 1.2E-41 2.6E-46 327.6 27.3 252 27-282 1-258 (258)
226 cd07842 STKc_CDK8_like Catalyt 100.0 3.4E-42 7.3E-47 343.0 24.2 255 27-282 1-316 (316)
227 cd06607 STKc_TAO Catalytic dom 100.0 1E-41 2.3E-46 339.2 27.6 257 22-285 11-273 (307)
228 cd05035 PTKc_Axl_like Catalyti 100.0 5.9E-42 1.3E-46 333.7 25.3 250 28-279 1-268 (273)
229 cd06659 STKc_PAK6 Catalytic do 100.0 2.7E-42 5.8E-47 342.1 23.1 255 25-285 20-277 (297)
230 KOG1989 ARK protein kinase fam 100.0 5.2E-43 1.1E-47 369.8 19.0 247 25-279 36-307 (738)
231 cd07851 STKc_p38 Catalytic dom 100.0 3.1E-42 6.7E-47 348.7 23.8 257 22-285 11-304 (343)
232 cd05052 PTKc_Abl Catalytic dom 100.0 9.9E-42 2.1E-46 331.4 26.4 248 25-278 5-257 (263)
233 cd06648 STKc_PAK_II Catalytic 100.0 1E-41 2.2E-46 335.7 26.8 254 26-285 19-275 (285)
234 cd05091 PTKc_Ror2 Catalytic do 100.0 2.8E-42 6.1E-47 338.7 22.4 252 25-279 4-279 (283)
235 cd07835 STKc_CDK1_like Catalyt 100.0 6.5E-42 1.4E-46 335.9 24.8 251 28-282 1-283 (283)
236 cd06623 PKc_MAPKK_plant_like C 100.0 1.3E-41 2.7E-46 329.5 26.3 254 26-284 1-261 (264)
237 cd05114 PTKc_Tec_Rlk Catalytic 100.0 1.1E-41 2.3E-46 329.6 25.7 246 26-278 4-253 (256)
238 cd06606 STKc_MAPKKK Catalytic 100.0 2E-41 4.3E-46 325.8 27.4 254 27-282 1-260 (260)
239 cd06617 PKc_MKK3_6 Catalytic d 100.0 1.2E-41 2.6E-46 333.8 26.2 253 26-285 1-267 (283)
240 cd05032 PTKc_InsR_like Catalyt 100.0 1.1E-41 2.4E-46 333.0 25.8 251 25-278 5-273 (277)
241 cd05075 PTKc_Axl Catalytic dom 100.0 8.9E-42 1.9E-46 332.8 25.0 250 28-279 1-267 (272)
242 cd05036 PTKc_ALK_LTK Catalytic 100.0 1E-41 2.2E-46 334.0 25.5 252 25-279 5-274 (277)
243 PLN00009 cyclin-dependent kina 100.0 1.2E-41 2.7E-46 336.1 26.2 256 25-284 1-289 (294)
244 KOG0596 Dual specificity; seri 100.0 9.7E-43 2.1E-47 348.6 18.3 256 25-284 360-632 (677)
245 cd06653 STKc_MEKK3_like_1 Cata 100.0 2.9E-41 6.3E-46 328.2 28.3 255 26-282 2-264 (264)
246 cd07855 STKc_ERK5 Catalytic do 100.0 4E-42 8.7E-47 346.4 22.8 260 24-285 3-300 (334)
247 cd05105 PTKc_PDGFR_alpha Catal 100.0 7.6E-42 1.6E-46 352.3 25.3 251 25-278 36-392 (400)
248 cd06627 STKc_Cdc7_like Catalyt 100.0 3E-41 6.6E-46 324.6 27.9 252 27-282 1-254 (254)
249 cd05088 PTKc_Tie2 Catalytic do 100.0 8.6E-42 1.9E-46 339.4 24.8 249 25-279 6-276 (303)
250 PRK13184 pknD serine/threonine 100.0 1.1E-41 2.3E-46 372.3 27.5 253 25-278 1-284 (932)
251 cd05054 PTKc_VEGFR Catalytic d 100.0 4.8E-42 1.1E-46 346.5 23.0 252 25-279 6-329 (337)
252 cd08229 STKc_Nek7 Catalytic do 100.0 7.8E-42 1.7E-46 332.2 23.6 250 26-278 2-260 (267)
253 cd05053 PTKc_FGFR Catalytic do 100.0 1.1E-41 2.5E-46 336.0 24.9 252 25-279 11-287 (293)
254 cd07877 STKc_p38alpha_MAPK14 C 100.0 1.3E-41 2.8E-46 344.4 25.9 256 23-285 14-306 (345)
255 cd00192 PTKc Catalytic domain 100.0 1.6E-41 3.4E-46 327.6 25.1 245 32-279 1-260 (262)
256 cd07858 STKc_TEY_MAPK_plant Ca 100.0 8.4E-42 1.8E-46 344.6 24.1 257 24-284 3-296 (337)
257 cd08224 STKc_Nek6_Nek7 Catalyt 100.0 4.3E-41 9.4E-46 326.5 27.7 250 26-278 2-260 (267)
258 cd06624 STKc_ASK Catalytic dom 100.0 3.1E-41 6.8E-46 328.6 26.8 247 31-282 13-268 (268)
259 PHA03390 pk1 serine/threonine- 100.0 1.4E-41 2.9E-46 331.8 24.3 245 24-283 12-266 (267)
260 PHA03210 serine/threonine kina 100.0 8.6E-42 1.9E-46 362.0 24.8 260 23-285 145-460 (501)
261 KOG4721 Serine/threonine prote 100.0 2.6E-43 5.6E-48 352.6 12.3 233 31-279 129-364 (904)
262 cd07852 STKc_MAPK15 Catalytic 100.0 9.1E-42 2E-46 344.2 23.6 261 22-284 3-300 (337)
263 cd06621 PKc_MAPKK_Pek1_like Ca 100.0 4.7E-41 1E-45 331.1 28.1 253 26-285 1-272 (287)
264 cd05123 STKc_AGC Catalytic dom 100.0 1.8E-41 4E-46 325.9 24.4 246 34-282 1-250 (250)
265 cd05098 PTKc_FGFR1 Catalytic d 100.0 2.8E-41 6E-46 336.1 26.4 255 22-279 14-295 (307)
266 cd05109 PTKc_HER2 Catalytic do 100.0 3.2E-41 7E-46 330.6 26.4 250 25-278 6-263 (279)
267 cd05613 STKc_MSK1_N N-terminal 100.0 3.7E-41 8E-46 332.1 26.8 258 27-285 1-274 (290)
268 cd07864 STKc_CDK12 Catalytic d 100.0 1.7E-41 3.7E-46 336.0 24.4 258 22-282 3-302 (302)
269 cd05111 PTK_HER3 Pseudokinase 100.0 3.2E-41 7E-46 331.1 26.0 250 25-278 6-263 (279)
270 cd05072 PTKc_Lyn Catalytic dom 100.0 2.8E-41 6.1E-46 327.4 25.2 247 25-278 5-256 (261)
271 cd07840 STKc_CDK9_like Catalyt 100.0 3E-41 6.4E-46 330.9 25.5 252 28-282 1-287 (287)
272 cd05089 PTKc_Tie1 Catalytic do 100.0 3.4E-41 7.5E-46 333.9 26.2 248 26-279 2-271 (297)
273 cd05051 PTKc_DDR Catalytic dom 100.0 2.6E-41 5.6E-46 333.8 25.0 251 25-278 4-292 (296)
274 cd05101 PTKc_FGFR2 Catalytic d 100.0 4.8E-41 1E-45 333.8 26.6 254 23-279 12-292 (304)
275 PTZ00024 cyclin-dependent prot 100.0 2.5E-41 5.4E-46 340.6 24.9 261 24-285 6-319 (335)
276 cd05094 PTKc_TrkC Catalytic do 100.0 3.8E-41 8.3E-46 332.4 25.6 250 25-278 4-277 (291)
277 cd05045 PTKc_RET Catalytic dom 100.0 3.4E-41 7.3E-46 332.5 25.2 249 27-278 1-281 (290)
278 cd05068 PTKc_Frk_like Catalyti 100.0 6E-41 1.3E-45 325.3 26.5 247 25-278 5-256 (261)
279 cd05099 PTKc_FGFR4 Catalytic d 100.0 5.4E-41 1.2E-45 335.2 26.6 251 25-278 11-288 (314)
280 cd07866 STKc_BUR1 Catalytic do 100.0 2.7E-41 5.8E-46 335.6 24.3 257 24-282 6-311 (311)
281 KOG0603 Ribosomal protein S6 k 100.0 2.5E-42 5.4E-47 352.8 17.1 245 23-282 319-566 (612)
282 cd05113 PTKc_Btk_Bmx Catalytic 100.0 3.8E-41 8.3E-46 326.3 24.6 248 25-279 3-254 (256)
283 cd05103 PTKc_VEGFR2 Catalytic 100.0 2E-41 4.4E-46 342.8 23.6 252 25-279 6-335 (343)
284 cd05148 PTKc_Srm_Brk Catalytic 100.0 2.3E-41 4.9E-46 327.9 22.8 247 25-278 5-256 (261)
285 cd05116 PTKc_Syk Catalytic dom 100.0 4.7E-41 1E-45 325.5 25.0 243 33-278 2-250 (257)
286 cd06657 STKc_PAK4 Catalytic do 100.0 3.4E-41 7.4E-46 333.5 24.4 253 28-286 22-277 (292)
287 KOG0193 Serine/threonine prote 100.0 1.3E-42 2.9E-47 351.4 14.5 249 24-278 390-648 (678)
288 cd06633 STKc_TAO3 Catalytic do 100.0 1.4E-40 3E-45 332.3 29.0 255 24-285 19-279 (313)
289 cd05071 PTKc_Src Catalytic dom 100.0 5.6E-41 1.2E-45 326.2 25.4 247 24-278 4-255 (262)
290 cd05059 PTKc_Tec_like Catalyti 100.0 3.6E-41 7.8E-46 326.1 23.9 247 26-279 4-254 (256)
291 cd05055 PTKc_PDGFR Catalytic d 100.0 5.6E-41 1.2E-45 333.5 25.9 254 22-278 31-296 (302)
292 cd05610 STKc_MASTL Catalytic d 100.0 6.9E-41 1.5E-45 365.9 29.0 150 24-173 2-152 (669)
293 cd07834 STKc_MAPK Catalytic do 100.0 2.1E-41 4.5E-46 340.2 22.9 257 27-285 1-295 (330)
294 cd06635 STKc_TAO1 Catalytic do 100.0 1.5E-40 3.2E-45 332.6 28.8 256 23-285 22-283 (317)
295 cd05122 PKc_STE Catalytic doma 100.0 1.3E-40 2.9E-45 318.8 27.3 248 27-281 1-253 (253)
296 PF07714 Pkinase_Tyr: Protein 100.0 2E-41 4.3E-46 329.2 21.8 247 29-278 2-257 (259)
297 cd08530 STKc_CNK2-like Catalyt 100.0 6.6E-41 1.4E-45 322.9 25.3 250 27-282 1-256 (256)
298 cd07856 STKc_Sty1_Hog1 Catalyt 100.0 9.1E-41 2E-45 336.0 27.1 255 24-285 8-294 (328)
299 cd07879 STKc_p38delta_MAPK13 C 100.0 5.2E-41 1.1E-45 339.6 25.3 254 23-284 12-302 (342)
300 cd05092 PTKc_TrkA Catalytic do 100.0 6.2E-41 1.4E-45 329.1 25.0 250 25-278 4-276 (280)
301 cd06614 STKc_PAK Catalytic dom 100.0 7.3E-41 1.6E-45 329.3 25.4 254 24-284 17-275 (286)
302 cd05050 PTKc_Musk Catalytic do 100.0 5.9E-41 1.3E-45 330.3 24.7 251 25-278 4-284 (288)
303 cd05066 PTKc_EphR_A Catalytic 100.0 8.9E-41 1.9E-45 325.4 25.5 251 25-278 3-261 (267)
304 cd07857 STKc_MPK1 Catalytic do 100.0 1.6E-40 3.6E-45 334.4 28.2 257 27-285 1-298 (332)
305 KOG0983 Mitogen-activated prot 100.0 3.5E-42 7.7E-47 318.4 14.6 250 28-284 94-354 (391)
306 cd05065 PTKc_EphR_B Catalytic 100.0 9.8E-41 2.1E-45 325.3 25.6 251 25-278 3-263 (269)
307 cd08226 PK_STRAD_beta Pseudoki 100.0 4E-41 8.6E-46 338.3 23.6 254 32-286 4-315 (328)
308 cd05097 PTKc_DDR_like Catalyti 100.0 6E-41 1.3E-45 331.7 24.3 250 26-278 5-291 (295)
309 cd05100 PTKc_FGFR3 Catalytic d 100.0 9.6E-41 2.1E-45 336.4 26.1 253 24-279 10-289 (334)
310 cd05057 PTKc_EGFR_like Catalyt 100.0 1.6E-40 3.6E-45 325.6 26.7 250 25-278 6-263 (279)
311 cd05080 PTKc_Tyk2_rpt2 Catalyt 100.0 1.2E-40 2.6E-45 327.3 25.6 251 25-278 2-276 (283)
312 cd05070 PTKc_Fyn_Yrk Catalytic 100.0 9E-41 2E-45 323.9 24.2 247 24-278 4-255 (260)
313 cd05095 PTKc_DDR2 Catalytic do 100.0 9.7E-41 2.1E-45 330.4 24.9 251 25-278 4-292 (296)
314 cd05107 PTKc_PDGFR_beta Cataly 100.0 8.6E-41 1.9E-45 344.5 25.4 252 25-279 36-395 (401)
315 KOG0608 Warts/lats-like serine 100.0 5.1E-42 1.1E-46 346.7 15.6 257 26-284 629-933 (1034)
316 cd06616 PKc_MKK4 Catalytic dom 100.0 6.1E-41 1.3E-45 330.0 23.0 253 26-284 4-272 (288)
317 cd05069 PTKc_Yes Catalytic dom 100.0 1.8E-40 4E-45 321.9 25.6 247 24-278 4-255 (260)
318 cd05067 PTKc_Lck_Blk Catalytic 100.0 1.7E-40 3.6E-45 322.0 25.2 247 24-278 4-255 (260)
319 cd05060 PTKc_Syk_like Catalyti 100.0 2.3E-40 4.9E-45 320.5 26.0 243 32-278 1-250 (257)
320 cd05118 STKc_CMGC Catalytic do 100.0 7.1E-41 1.5E-45 327.8 22.4 251 28-282 1-283 (283)
321 cd05039 PTKc_Csk_like Catalyti 100.0 2.4E-40 5.3E-45 319.9 25.9 242 25-278 5-251 (256)
322 cd05115 PTKc_Zap-70 Catalytic 100.0 2.3E-40 5E-45 321.1 25.6 242 33-278 2-250 (257)
323 cd08222 STKc_Nek11 Catalytic d 100.0 7.5E-41 1.6E-45 324.2 22.0 252 27-282 1-260 (260)
324 KOG0666 Cyclin C-dependent kin 100.0 4.1E-42 8.8E-47 323.0 12.5 260 24-285 22-343 (438)
325 cd05043 PTK_Ryk Pseudokinase d 100.0 2.4E-40 5.2E-45 324.4 25.6 251 25-278 5-271 (280)
326 cd05583 STKc_MSK_N N-terminal 100.0 2.4E-40 5.2E-45 325.9 25.7 258 27-285 1-272 (288)
327 cd05082 PTKc_Csk Catalytic dom 100.0 2.7E-40 5.8E-45 319.8 25.1 241 25-278 5-251 (256)
328 KOG0695 Serine/threonine prote 100.0 1.3E-41 2.8E-46 322.2 15.4 258 24-284 248-521 (593)
329 cd06634 STKc_TAO2 Catalytic do 100.0 2.4E-40 5.2E-45 329.7 25.1 254 24-284 13-272 (308)
330 cd05063 PTKc_EphR_A2 Catalytic 100.0 4.9E-40 1.1E-44 320.0 26.3 251 25-278 4-262 (268)
331 cd05034 PTKc_Src_like Catalyti 100.0 4.4E-40 9.6E-45 318.8 25.9 248 24-278 4-256 (261)
332 KOG2345 Serine/threonine prote 100.0 9.1E-42 2E-46 312.1 13.1 252 25-279 20-296 (302)
333 KOG0194 Protein tyrosine kinas 100.0 4.9E-41 1.1E-45 342.8 19.7 251 25-278 156-415 (474)
334 cd07829 STKc_CDK_like Catalyti 100.0 1.5E-40 3.2E-45 325.4 22.4 251 28-282 1-282 (282)
335 KOG1035 eIF-2alpha kinase GCN2 100.0 1.6E-41 3.5E-46 365.3 16.9 256 23-283 476-875 (1351)
336 cd05040 PTKc_Ack_like Catalyti 100.0 4.2E-40 9.1E-45 318.3 24.9 243 32-278 1-253 (257)
337 cd05041 PTKc_Fes_like Catalyti 100.0 4.6E-40 9.9E-45 316.9 25.0 243 32-278 1-247 (251)
338 cd07838 STKc_CDK4_6_like Catal 100.0 4.6E-40 1E-44 322.7 25.4 249 28-282 1-287 (287)
339 cd05112 PTKc_Itk Catalytic dom 100.0 6.5E-40 1.4E-44 316.7 26.1 248 25-279 3-254 (256)
340 cd05047 PTKc_Tie Catalytic dom 100.0 4.7E-40 1E-44 321.0 25.2 241 32-278 1-263 (270)
341 cd05085 PTKc_Fer Catalytic dom 100.0 7.3E-40 1.6E-44 315.2 26.2 242 32-278 1-246 (250)
342 smart00219 TyrKc Tyrosine kina 100.0 6.2E-40 1.3E-44 316.3 25.7 247 28-278 1-256 (258)
343 KOG0584 Serine/threonine prote 100.0 1.8E-41 3.9E-46 345.2 15.0 254 25-285 38-302 (632)
344 cd05056 PTKc_FAK Catalytic dom 100.0 8.7E-40 1.9E-44 318.8 26.2 250 25-279 5-261 (270)
345 cd05073 PTKc_Hck Catalytic dom 100.0 1.1E-39 2.5E-44 316.3 26.8 248 23-278 3-255 (260)
346 cd08216 PK_STRAD Pseudokinase 100.0 3.1E-40 6.8E-45 329.1 23.3 253 29-285 5-301 (314)
347 cd05110 PTKc_HER4 Catalytic do 100.0 6.2E-40 1.3E-44 325.9 25.0 251 25-279 6-264 (303)
348 cd05046 PTK_CCK4 Pseudokinase 100.0 6.4E-40 1.4E-44 320.4 24.7 250 26-279 5-272 (275)
349 cd05078 PTK_Jak2_Jak3_rpt1 Pse 100.0 1.9E-40 4.1E-45 321.6 20.8 238 32-279 1-256 (258)
350 cd07830 STKc_MAK_like Catalyti 100.0 5E-40 1.1E-44 322.2 23.9 249 28-282 1-283 (283)
351 cd05042 PTKc_Aatyk Catalytic d 100.0 6.9E-40 1.5E-44 319.3 24.3 244 32-278 1-265 (269)
352 cd05076 PTK_Tyk2_rpt1 Pseudoki 100.0 7.7E-40 1.7E-44 320.7 23.4 237 33-279 2-272 (274)
353 KOG1026 Nerve growth factor re 100.0 9.9E-41 2.1E-45 351.0 18.2 251 25-278 485-757 (774)
354 cd05079 PTKc_Jak1_rpt2 Catalyt 100.0 1E-39 2.2E-44 321.0 24.2 249 28-279 6-279 (284)
355 cd05058 PTKc_Met_Ron Catalytic 100.0 1.6E-39 3.4E-44 315.2 25.1 245 32-279 1-255 (262)
356 cd05077 PTK_Jak1_rpt1 Pseudoki 100.0 1.3E-39 2.7E-44 316.9 24.4 238 32-279 1-260 (262)
357 cd05044 PTKc_c-ros Catalytic d 100.0 6.9E-40 1.5E-44 318.9 22.5 244 32-278 1-265 (269)
358 cd06618 PKc_MKK7 Catalytic dom 100.0 2.2E-39 4.7E-44 320.7 25.8 255 25-285 14-279 (296)
359 cd05087 PTKc_Aatyk1_Aatyk3 Cat 100.0 1.7E-39 3.7E-44 316.7 24.7 244 32-278 1-265 (269)
360 cd05576 STKc_RPK118_like Catal 100.0 5.5E-40 1.2E-44 314.7 20.3 228 37-282 4-237 (237)
361 cd05083 PTKc_Chk Catalytic dom 100.0 2.1E-39 4.5E-44 313.2 24.5 240 25-278 5-249 (254)
362 cd05074 PTKc_Tyro3 Catalytic d 100.0 1.8E-39 3.8E-44 316.7 23.7 250 28-279 1-268 (273)
363 cd05081 PTKc_Jak2_Jak3_rpt2 Ca 100.0 4.1E-39 8.9E-44 316.3 25.5 249 26-278 4-278 (284)
364 cd05037 PTK_Jak_rpt1 Pseudokin 100.0 3.7E-39 8E-44 311.6 22.9 235 32-278 1-256 (259)
365 cd08528 STKc_Nek10 Catalytic d 100.0 7.5E-39 1.6E-43 311.8 24.8 249 27-279 1-266 (269)
366 KOG1095 Protein tyrosine kinas 100.0 1.7E-39 3.6E-44 353.0 22.2 250 26-278 692-956 (1025)
367 cd05086 PTKc_Aatyk2 Catalytic 100.0 1.2E-38 2.7E-43 310.7 25.3 244 32-278 1-264 (268)
368 cd05038 PTKc_Jak_rpt2 Catalyti 100.0 9.2E-39 2E-43 313.0 24.3 250 26-278 4-278 (284)
369 PHA02882 putative serine/threo 100.0 1.5E-38 3.3E-43 314.8 26.0 253 23-278 9-291 (294)
370 KOG0587 Traf2- and Nck-interac 100.0 5.5E-39 1.2E-43 336.5 20.9 254 25-285 18-288 (953)
371 KOG0669 Cyclin T-dependent kin 100.0 5.2E-41 1.1E-45 307.4 4.1 264 20-285 11-321 (376)
372 KOG4250 TANK binding protein k 100.0 2.4E-39 5.2E-44 333.4 16.4 241 26-271 13-296 (732)
373 KOG1187 Serine/threonine prote 100.0 3.8E-38 8.2E-43 318.6 24.0 247 25-278 74-347 (361)
374 KOG0671 LAMMER dual specificit 100.0 9.1E-40 2E-44 315.4 11.4 252 22-284 85-411 (415)
375 PLN03225 Serine/threonine-prot 100.0 9E-38 1.9E-42 334.0 23.7 253 24-285 130-456 (566)
376 KOG1151 Tousled-like protein k 100.0 6.3E-39 1.4E-43 313.2 10.5 263 23-285 460-747 (775)
377 KOG1006 Mitogen-activated prot 100.0 4.7E-39 1E-43 296.7 8.4 250 28-284 66-332 (361)
378 smart00220 S_TKc Serine/Threon 100.0 1.4E-36 3.1E-41 288.6 23.8 239 38-282 1-244 (244)
379 KOG0199 ACK and related non-re 100.0 1.2E-37 2.6E-42 318.4 15.4 255 25-283 109-372 (1039)
380 KOG4257 Focal adhesion tyrosin 100.0 4.3E-37 9.4E-42 310.8 18.2 242 30-278 393-644 (974)
381 KOG0668 Casein kinase II, alph 100.0 1.2E-37 2.6E-42 281.8 10.8 249 25-284 37-327 (338)
382 KOG0665 Jun-N-terminal kinase 100.0 2.1E-37 4.7E-42 292.7 12.5 255 24-286 15-317 (369)
383 PLN03224 probable serine/threo 100.0 8.2E-36 1.8E-40 312.1 25.4 260 25-285 144-506 (507)
384 KOG4278 Protein tyrosine kinas 100.0 1.6E-36 3.4E-41 306.2 17.5 241 29-278 270-518 (1157)
385 KOG0670 U4/U6-associated splic 100.0 1.9E-37 4.2E-42 308.0 9.9 254 21-284 427-751 (752)
386 KOG0196 Tyrosine kinase, EPH ( 100.0 9.1E-37 2E-41 315.7 13.5 250 26-279 629-887 (996)
387 KOG0576 Mitogen-activated prot 100.0 2.1E-37 4.6E-42 315.8 6.6 255 25-285 14-277 (829)
388 KOG1094 Discoidin domain recep 100.0 6.5E-36 1.4E-40 300.8 15.7 250 25-278 537-799 (807)
389 KOG1152 Signal transduction se 100.0 4.9E-36 1.1E-40 301.4 11.5 202 25-230 560-771 (772)
390 KOG0664 Nemo-like MAPK-related 100.0 3.8E-37 8.3E-42 284.9 3.2 257 26-285 53-349 (449)
391 KOG1027 Serine/threonine prote 100.0 3.7E-36 8.1E-41 313.9 9.8 252 31-294 514-782 (903)
392 PLN00113 leucine-rich repeat r 100.0 7.2E-35 1.6E-39 332.8 19.8 237 26-279 690-947 (968)
393 KOG1290 Serine/threonine prote 100.0 4.1E-34 8.8E-39 283.1 19.7 131 23-158 74-221 (590)
394 KOG2052 Activin A type IB rece 100.0 6.1E-34 1.3E-38 279.4 17.1 250 21-278 206-498 (513)
395 KOG0200 Fibroblast/platelet-de 100.0 3.9E-33 8.5E-38 301.0 22.7 248 27-278 297-574 (609)
396 KOG0984 Mitogen-activated prot 100.0 8.1E-34 1.8E-38 253.5 13.4 212 25-244 45-269 (282)
397 KOG3653 Transforming growth fa 100.0 1.5E-33 3.2E-38 278.6 15.5 246 25-278 209-498 (534)
398 KOG1025 Epidermal growth facto 100.0 1.1E-33 2.4E-38 293.7 15.3 248 27-278 697-952 (1177)
399 cd00180 PKc Catalytic domain o 100.0 1.8E-31 3.8E-36 247.0 22.9 212 34-280 1-215 (215)
400 KOG1167 Serine/threonine prote 100.0 1.5E-33 3.2E-38 275.8 9.3 255 23-284 33-386 (418)
401 smart00221 STYKc Protein kinas 100.0 5.1E-31 1.1E-35 248.3 23.2 218 28-249 1-223 (225)
402 KOG1345 Serine/threonine kinas 100.0 9.5E-33 2.1E-37 255.7 10.0 256 21-285 19-293 (378)
403 KOG0590 Checkpoint kinase and 100.0 1.7E-32 3.6E-37 293.0 4.9 261 24-285 315-591 (601)
404 KOG1024 Receptor-like protein 100.0 4.1E-30 9E-35 248.5 17.4 251 25-278 283-550 (563)
405 PLN00181 protein SPA1-RELATED; 100.0 7.9E-31 1.7E-35 292.9 11.3 198 83-284 29-270 (793)
406 COG0515 SPS1 Serine/threonine 100.0 4.7E-27 1E-31 230.6 25.9 254 28-284 2-280 (384)
407 PRK09188 serine/threonine prot 100.0 3.4E-28 7.5E-33 244.8 17.9 171 21-201 13-194 (365)
408 smart00750 KIND kinase non-cat 100.0 2.2E-28 4.7E-33 223.1 12.6 158 111-284 1-170 (176)
409 KOG0603 Ribosomal protein S6 k 99.9 1.2E-28 2.6E-33 252.6 5.2 239 33-285 1-249 (612)
410 KOG1164 Casein kinase (serine/ 99.9 1.9E-25 4.2E-30 224.0 22.4 248 27-279 19-293 (322)
411 KOG1165 Casein kinase (serine/ 99.9 2.8E-25 6.1E-30 211.5 19.5 247 21-274 23-290 (449)
412 KOG1163 Casein kinase (serine/ 99.9 4.5E-25 9.8E-30 201.7 17.0 249 19-274 8-275 (341)
413 KOG0606 Microtubule-associated 99.9 7.2E-26 1.6E-30 242.5 12.6 225 19-284 76-320 (1205)
414 KOG0590 Checkpoint kinase and 99.9 6.6E-26 1.4E-30 242.4 5.8 259 25-284 19-291 (601)
415 PRK10359 lipopolysaccharide co 99.9 1.1E-24 2.3E-29 205.1 12.2 175 23-222 28-216 (232)
416 cd05147 RIO1_euk RIO kinase fa 99.9 3.2E-24 6.9E-29 198.6 13.9 141 31-175 2-167 (190)
417 PF14531 Kinase-like: Kinase-l 99.9 1.1E-23 2.4E-28 204.0 13.7 234 27-270 13-288 (288)
418 cd05145 RIO1_like RIO kinase f 99.9 3E-23 6.4E-28 192.3 15.7 142 30-175 1-167 (190)
419 PRK12274 serine/threonine prot 99.9 2.3E-22 5E-27 185.6 14.3 191 29-231 5-210 (218)
420 KOG1240 Protein kinase contain 99.9 2E-23 4.3E-28 224.0 7.2 241 25-279 22-291 (1431)
421 KOG4158 BRPK/PTEN-induced prot 99.9 1.1E-22 2.5E-27 197.7 10.7 250 23-273 154-504 (598)
422 PRK10345 hypothetical protein; 99.9 9.2E-22 2E-26 184.3 15.8 134 31-172 7-156 (210)
423 KOG0195 Integrin-linked kinase 99.9 1.7E-22 3.6E-27 187.7 8.1 241 25-277 189-440 (448)
424 KOG1166 Mitotic checkpoint ser 99.9 7.2E-21 1.6E-25 208.0 16.0 235 25-278 697-948 (974)
425 smart00090 RIO RIO-like kinase 99.8 7.2E-21 1.6E-25 182.2 12.8 143 27-174 29-197 (237)
426 PRK14879 serine/threonine prot 99.8 2E-19 4.4E-24 169.0 18.1 137 32-174 2-143 (211)
427 TIGR03724 arch_bud32 Kae1-asso 99.8 5.8E-19 1.3E-23 164.4 13.7 133 33-174 1-138 (199)
428 cd05144 RIO2_C RIO kinase fami 99.8 4E-19 8.7E-24 165.7 12.1 139 28-176 17-176 (198)
429 KOG1023 Natriuretic peptide re 99.8 7E-19 1.5E-23 180.9 12.0 199 80-278 1-219 (484)
430 PRK09605 bifunctional UGMP fam 99.8 1.8E-18 3.8E-23 185.2 15.6 140 25-174 332-476 (535)
431 KOG1033 eIF-2alpha kinase PEK/ 99.8 7.5E-20 1.6E-24 184.9 4.2 248 25-282 243-515 (516)
432 cd05119 RIO RIO kinase family, 99.8 4.1E-18 9E-23 157.0 12.1 139 30-175 1-164 (187)
433 PRK01723 3-deoxy-D-manno-octul 99.7 1.9E-17 4E-22 158.9 14.9 138 31-174 36-191 (239)
434 cd05120 APH_ChoK_like Aminogly 99.7 2.9E-16 6.3E-21 138.0 11.9 132 30-174 2-138 (155)
435 KOG0606 Microtubule-associated 99.7 1.5E-17 3.2E-22 179.2 4.2 260 25-285 803-1098(1205)
436 PF03822 NAF: NAF domain; Int 99.6 1.8E-16 3.8E-21 116.4 4.4 57 340-396 2-63 (63)
437 KOG0601 Cyclin-dependent kinas 99.6 6.1E-16 1.3E-20 159.4 6.0 256 24-284 112-384 (524)
438 TIGR01982 UbiB 2-polyprenylphe 99.6 7.5E-15 1.6E-19 152.7 13.1 142 32-177 123-309 (437)
439 PRK04750 ubiB putative ubiquin 99.6 1.3E-15 2.8E-20 160.5 6.5 146 24-177 118-316 (537)
440 cd05146 RIO3_euk RIO kinase fa 99.5 4.4E-13 9.5E-18 123.7 13.8 139 31-174 2-173 (197)
441 KOG1243 Protein kinase [Genera 99.5 4.9E-13 1.1E-17 139.4 15.8 171 44-226 30-201 (690)
442 cd05151 ChoK Choline Kinase (C 99.5 3.3E-13 7.3E-18 122.0 10.3 127 31-173 3-135 (170)
443 KOG0601 Cyclin-dependent kinas 99.4 1.3E-13 2.8E-18 142.3 5.9 252 22-283 261-518 (524)
444 KOG1266 Protein kinase [Signal 99.3 1.1E-12 2.4E-17 125.9 6.6 202 78-283 119-335 (458)
445 COG3642 Mn2+-dependent serine/ 99.3 2.7E-11 5.8E-16 108.6 13.0 134 32-174 2-140 (204)
446 KOG3087 Serine/threonine prote 99.2 1.7E-10 3.6E-15 103.1 13.7 144 30-175 11-166 (229)
447 cd05154 ACAD10_11_like Acyl-Co 99.2 5.3E-11 1.1E-15 112.1 11.3 140 32-174 4-206 (223)
448 KOG3741 Poly(A) ribonuclease s 99.2 1.3E-09 2.8E-14 110.9 17.1 211 38-279 288-521 (655)
449 PF01163 RIO1: RIO1 family; I 99.1 8.1E-10 1.8E-14 101.6 12.6 127 41-174 1-155 (188)
450 PRK15123 lipopolysaccharide co 99.1 5.1E-09 1.1E-13 101.9 16.0 129 41-173 37-193 (268)
451 KOG2137 Protein kinase [Signal 99.0 2.5E-10 5.4E-15 119.9 5.1 152 133-285 107-271 (700)
452 COG0478 RIO-like serine/threon 99.0 3.2E-09 6.8E-14 100.8 10.3 136 28-172 93-249 (304)
453 COG4248 Uncharacterized protei 98.9 1.5E-08 3.2E-13 101.0 14.4 231 29-274 14-291 (637)
454 PF06293 Kdo: Lipopolysacchari 98.7 8.8E-08 1.9E-12 89.8 11.8 104 71-174 56-170 (206)
455 PRK09902 hypothetical protein; 98.7 2.7E-07 5.8E-12 85.7 13.4 137 35-173 27-178 (216)
456 PF06176 WaaY: Lipopolysacchar 98.7 2.1E-07 4.5E-12 86.8 12.7 140 24-173 29-182 (229)
457 COG1718 RIO1 Serine/threonine 98.7 4.4E-07 9.6E-12 85.5 13.3 138 31-174 53-215 (268)
458 COG0661 AarF Predicted unusual 98.6 2.2E-07 4.7E-12 97.9 11.6 138 32-177 131-317 (517)
459 KOG0576 Mitogen-activated prot 98.6 2.5E-09 5.4E-14 111.3 -2.9 239 25-283 241-488 (829)
460 TIGR02172 Fb_sc_TIGR02172 Fibr 98.5 1.2E-06 2.6E-11 83.4 13.3 133 32-174 7-182 (226)
461 PF01636 APH: Phosphotransfera 98.5 1.5E-06 3.3E-11 82.1 13.6 136 31-173 2-196 (239)
462 KOG1035 eIF-2alpha kinase GCN2 98.4 2.1E-06 4.6E-11 95.4 13.7 202 72-285 228-440 (1351)
463 PF13095 FTA2: Kinetochore Sim 98.4 1.4E-05 3.1E-10 73.7 15.4 129 25-172 36-206 (207)
464 cd05150 APH Aminoglycoside 3'- 98.3 5.4E-06 1.2E-10 79.6 12.2 133 34-174 6-193 (244)
465 COG2112 Predicted Ser/Thr prot 98.3 5.2E-06 1.1E-10 74.4 10.3 133 25-174 19-155 (201)
466 PF10707 YrbL-PhoP_reg: PhoP r 98.3 2.3E-05 5.1E-10 72.7 14.3 130 32-168 7-165 (199)
467 KOG1235 Predicted unusual prot 98.2 8.2E-06 1.8E-10 86.0 11.7 140 32-176 167-356 (538)
468 PLN02876 acyl-CoA dehydrogenas 98.2 1.7E-05 3.8E-10 89.4 14.3 146 30-177 42-260 (822)
469 KOG1826 Ras GTPase activating 98.2 1.6E-07 3.5E-12 105.8 -2.9 208 74-284 1277-1497(2724)
470 cd05155 APH_ChoK_like_1 Unchar 97.9 6.4E-05 1.4E-09 71.9 10.0 72 32-113 3-81 (235)
471 PF12260 PIP49_C: Protein-kina 97.8 6.9E-05 1.5E-09 69.1 8.6 96 75-174 8-111 (188)
472 PRK09550 mtnK methylthioribose 97.8 0.00046 1E-08 70.9 14.9 80 31-112 31-117 (401)
473 cd05157 ETNK_euk Ethanolamine 97.8 0.00034 7.4E-09 66.6 12.8 75 31-113 3-79 (235)
474 KOG2270 Serine/threonine prote 97.8 0.00031 6.7E-09 69.9 11.9 141 29-173 147-312 (520)
475 TIGR02721 ycfN_thiK thiamine k 97.7 0.00015 3.4E-09 70.1 9.0 132 33-174 3-175 (256)
476 cd05153 HomoserineK_II Homoser 97.7 0.00023 5E-09 70.3 10.4 135 31-173 19-204 (296)
477 PRK10593 hypothetical protein; 97.7 0.0008 1.7E-08 66.8 14.0 78 29-113 17-100 (297)
478 PF02149 KA1: Kinase associate 97.6 0.0001 2.2E-09 51.4 4.9 42 412-454 3-45 (47)
479 KOG2268 Serine/threonine prote 97.6 5.5E-05 1.2E-09 74.0 4.1 134 27-170 93-247 (465)
480 TIGR00938 thrB_alt homoserine 97.5 0.00098 2.1E-08 66.4 12.1 136 31-173 27-216 (307)
481 COG3173 Predicted aminoglycosi 97.4 0.0012 2.6E-08 65.6 11.1 146 28-177 27-231 (321)
482 PRK05231 homoserine kinase; Pr 97.4 0.0021 4.5E-08 64.3 13.1 135 31-173 27-216 (319)
483 cd05156 ChoK_euk Choline Kinas 97.4 0.0013 2.9E-08 65.2 11.2 75 31-113 3-84 (302)
484 PLN02756 S-methyl-5-thioribose 97.2 0.0055 1.2E-07 62.9 12.7 85 30-118 36-129 (418)
485 KOG1093 Predicted protein kina 97.0 0.0026 5.7E-08 66.0 8.4 163 71-287 27-202 (725)
486 TIGR01767 MTRK 5-methylthiorib 96.9 0.0079 1.7E-07 60.7 11.1 86 33-120 2-95 (370)
487 cd05152 MPH2' Macrolide 2'-Pho 96.8 0.0083 1.8E-07 58.8 10.2 31 145-175 186-217 (276)
488 TIGR02906 spore_CotS spore coa 96.6 0.022 4.7E-07 56.6 11.7 29 144-173 187-215 (313)
489 PLN02236 choline kinase 96.6 0.021 4.5E-07 57.9 11.4 136 31-174 41-231 (344)
490 PLN02421 phosphotransferase, a 96.4 0.032 7E-07 56.2 11.3 135 32-174 20-213 (330)
491 PRK12396 5-methylribose kinase 96.2 0.03 6.6E-07 57.3 10.0 88 31-120 34-128 (409)
492 PF01633 Choline_kinase: Choli 96.1 0.022 4.7E-07 53.4 8.1 30 145-174 144-174 (211)
493 KOG1236 Predicted unusual prot 96.0 0.02 4.4E-07 58.1 7.5 61 101-161 320-381 (565)
494 TIGR02904 spore_ysxE spore coa 95.9 0.15 3.2E-06 50.8 13.6 29 145-173 197-225 (309)
495 COG5072 ALK1 Serine/threonine 95.6 0.034 7.4E-07 55.8 7.1 87 83-174 282-370 (488)
496 PTZ00384 choline kinase; Provi 95.6 0.11 2.3E-06 53.5 11.0 76 30-113 54-136 (383)
497 PF03881 Fructosamin_kin: Fruc 95.5 0.25 5.5E-06 48.7 12.8 75 29-111 20-97 (288)
498 PF07387 Seadorna_VP7: Seadorn 95.2 0.072 1.6E-06 49.9 7.4 83 72-170 104-188 (308)
499 PRK11768 serine/threonine prot 95.1 0.57 1.2E-05 47.0 14.3 71 37-112 36-113 (325)
500 PRK06148 hypothetical protein; 94.5 0.53 1.2E-05 54.6 14.0 31 144-174 203-236 (1013)
No 1
>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-61 Score=489.10 Aligned_cols=261 Identities=59% Similarity=1.031 Sum_probs=245.5
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS--GLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~--~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
....++|++++.||+|+||+|++|.+..+++.||+|+++++..... ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 4578999999999999999999999999999999998887633311 35677889999999999 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~ 176 (481)
..+|+|||||.||+|++++.. +++.|.+++.+|+||++||+|||++||+||||||||||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999987 899999999999999999999999999999999999999999 999999999998764
Q ss_pred ccccCCcccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCC-CHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF-SPD 254 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~-s~~ 254 (481)
.....+++.|||+.|+|||++.+.+ |.+.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.++ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 4567789999999999999999988 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+++|+.+||.+||.+|+|+.+|+.||||+.
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999999999999999987
No 2
>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.9e-62 Score=475.70 Aligned_cols=261 Identities=41% Similarity=0.740 Sum_probs=232.4
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch----hHHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS----GLVAHIKREISILRRVRHPNIVQLFEVMAT 97 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 97 (481)
..+.+.|.+.+.||+|+||.|.+|..+.||+.||||++++...... .-...+.+|++||++|+|||||++++++..
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 3477889999999999999999999999999999999988765431 123447799999999999999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEecCCcc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVSDFGLSA 173 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~DFGla~ 173 (481)
.+..||||||++||+|++++.. +.+.|+..+.+++||+.|+.|||++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 9999999999999999999865 789999999999999999999999999999999999999877 579999999999
Q ss_pred cccccccCCcccccCCCCccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCCCC--C
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY--DAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFRS--P 248 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~~--~ 248 (481)
..+ ......+.||||.|+|||++.+.++ ++.++||||+||+||.+|+|++||.+.... .+..+|.+|.+.+ +
T Consensus 328 ~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 328 VSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred ccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 754 4556789999999999999987664 345789999999999999999999887654 4899999998655 2
Q ss_pred C--CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 249 R--WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 249 ~--~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .+|.++++||.+||..||++|||++|+|+||||+..
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 3 389999999999999999999999999999999743
No 3
>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2.5e-61 Score=490.75 Aligned_cols=260 Identities=42% Similarity=0.795 Sum_probs=246.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.-.|-|+++++||.|+-|.|.+|++..||+.+|||++.+...........+.+||.||+.+.||||+++|+++++...+|
T Consensus 9 ~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 9 NTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred ccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEE
Confidence 34788999999999999999999999999999999998875445555677999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~-~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|.||++||+||+++. +|+++|.++.++|+||+.|+.|||..+|+||||||||+|||..+++||+|||+|.+. ..+
T Consensus 89 lvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~g 165 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPG 165 (786)
T ss_pred EEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cCC
Confidence 9999999999999986 589999999999999999999999999999999999999999999999999999864 346
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
.++.+.||+|+|.|||++.+.+|++.++||||||||||.||+|.+||++.|...++.++..|.+..|..+|+++++||++
T Consensus 166 klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ 245 (786)
T KOG0588|consen 166 KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRR 245 (786)
T ss_pred ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHH
Confidence 78899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||..||.+|+|.+||++|||+...
T Consensus 246 ml~VDp~~RiT~~eI~kHP~l~g~ 269 (786)
T KOG0588|consen 246 MLDVDPSTRITTEEILKHPFLSGY 269 (786)
T ss_pred HhccCccccccHHHHhhCchhhcC
Confidence 999999999999999999999753
No 4
>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=2e-60 Score=482.62 Aligned_cols=260 Identities=37% Similarity=0.711 Sum_probs=246.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|+.++.||+|||+.||.+++..+|+.||+|++.+..+.+....+.+.+||+|++.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999988888888899999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|+|+.++|..+++. +.++|.+++.|++||+.||.|||+++|+|||||..|+|++++.+|||+|||||+.... .....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 99999999999986 5899999999999999999999999999999999999999999999999999997653 22344
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
.+.||||.|+||||+...++ +..+||||+||+||.||.|++||...+..+.|.+|...++..|..+|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 68899999999999998888 67899999999999999999999999999999999999999999999999999999999
Q ss_pred cCcCCCCCHhHHHhCcccccCccc
Q 011628 265 TNPDKRITIPEIMENRWFRKGFKH 288 (481)
Q Consensus 265 ~dP~~Rps~~eil~h~~f~~~~~~ 288 (481)
+||.+|||+++||.|+||..++..
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p 278 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTP 278 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcC
Confidence 999999999999999999777644
No 5
>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-57 Score=438.99 Aligned_cols=259 Identities=41% Similarity=0.773 Sum_probs=240.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.-.++|+++++||+|+||+||.++.+.|++.+|+|++++..+......+..+.|..||..++||.||+++..|++..++|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 44789999999999999999999999999999999999998887777889999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|+||+.||+|+..+++ +.++|+.++.|+.+|+.||.|||++||+||||||||||+|.+|+++|+|||+++..-. ..
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--DG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc--CC
Confidence 99999999999999985 8999999999999999999999999999999999999999999999999999985322 23
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLT 260 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 260 (481)
....+.|||+.|||||++.+.+|+ ..+|.|||||++|+|++|.+||.+.+...++.+|..+. ...|..++.+++++++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 345678999999999999999995 57999999999999999999999999999999999999 4556669999999999
Q ss_pred HhcccCcCCCC----CHhHHHhCccccc
Q 011628 261 KLLDTNPDKRI----TIPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rp----s~~eil~h~~f~~ 284 (481)
++|..||++|. ++++|.+||||..
T Consensus 259 ~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 259 KLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred HHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999995 6999999999964
No 6
>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-57 Score=423.68 Aligned_cols=255 Identities=42% Similarity=0.779 Sum_probs=241.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
-.++|++.++||.|+||.|.+++.+.+|..+|+|++++..+.+...++...+|..+|+.+.||+++++++.+.+.+.+|+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 46889999999999999999999999999999999999988877788889999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||++||+|+.++++ +++++..++.|+.||+.||+|||+++|++|||||||||+|.+|.+||+|||+|+... +
T Consensus 122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~-----~ 196 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS-----G 196 (355)
T ss_pred EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----C
Confidence 9999999999999987 799999999999999999999999999999999999999999999999999998543 3
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
...+.||||.|+|||++..++|. ..+|.|||||++|||++|.+||.+.+++.+|.+|..++...|+.+++++++||.++
T Consensus 197 rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~L 275 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKL 275 (355)
T ss_pred cEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHHH
Confidence 35788999999999999999995 57999999999999999999999999999999999999999999999999999999
Q ss_pred cccCcCCCC-----CHhHHHhCccccc
Q 011628 263 LDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 263 L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
|+.|-.+|. ..++|.+||||+.
T Consensus 276 L~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 276 LQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred HhhhhHhhhcCcCCCccccccCccccc
Confidence 999999995 5789999999974
No 7
>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]
Probab=100.00 E-value=5.4e-57 Score=434.78 Aligned_cols=255 Identities=32% Similarity=0.578 Sum_probs=233.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK-IY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~ 102 (481)
..++.+.++.||+|+.|+||+++++.|++.+|+|++... .+....+++.+|+++++.++|||||.+|++|..... ++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 345788899999999999999999999999999999544 355678999999999999999999999999999994 99
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+||+|.+.+.. ++++|....+++.++++||.|||. ++|+||||||+|||++..|.+||||||.|+....
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn--- 231 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN--- 231 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh---
Confidence 99999999999999986 899999999999999999999995 9999999999999999999999999999986543
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHhhCC-CCCCCC-CCH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-----NIMVMYKKIYKGE-FRSPRW-FSP 253 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~ 253 (481)
....+.+||..|||||.+.+..| +.++||||||+.++|+.+|+.||... +..+++..|..+. +..|.. +|+
T Consensus 232 -S~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 232 -SIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred -hhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 25678999999999999999888 67899999999999999999999875 6678888998875 456776 999
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++++||..||++||.+|||+.|+++|||+++.
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 99999999999999999999999999999764
No 8
>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]
Probab=100.00 E-value=3.2e-56 Score=445.16 Aligned_cols=260 Identities=35% Similarity=0.662 Sum_probs=241.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (481)
-..+|..++.||+|+|++|++|+++.+++.||||++.++.+.++..++-+.+|-.+|.+| .||.|+++|..|.++..+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 467999999999999999999999999999999999999888777778889999999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|+||+++|+|.++|.+ |.|++..++.|+.||+.||+|||++|||||||||||||+|.+|++||+|||.|+........
T Consensus 151 FvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 99999999999999987 89999999999999999999999999999999999999999999999999999875432211
Q ss_pred ---------Cc--ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCC
Q 011628 182 ---------GL--FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRW 250 (481)
Q Consensus 182 ---------~~--~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 250 (481)
.. ..+.+||..|++||++..... +..+|||+||||||.|++|.+||.+.+.-.++++|..-.+.+|+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~ 309 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG 309 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC
Confidence 11 145899999999999987655 678999999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+++.+++||+++|..||.+|+|++||.+||||..
T Consensus 310 fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 310 FPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999999999999999964
No 9
>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=2.7e-55 Score=426.33 Aligned_cols=260 Identities=40% Similarity=0.711 Sum_probs=237.0
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.....++|++.+.||+|+||+||+|++++++..||||.+.+... .....+.+..|+.||+.++|||||++++++..++.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 34568899999999999999999999999999999999988764 34567788999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC------CCEEEEecCCcc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN------GDLKVSDFGLSA 173 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~------g~lkl~DFGla~ 173 (481)
+|+|||||.||+|.++++. +.++|..++.++.||+.|+++||+++|+||||||+||||+.. -.+||+|||+|+
T Consensus 84 i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999999986 699999999999999999999999999999999999999875 358999999999
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCC
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRW 250 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~ 250 (481)
... ......+.||+|.|||||++....|+ +|+|+||+|+|||+|++|+.||+..+..+++..+.++.. ..+.+
T Consensus 164 ~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 164 FLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhh
Confidence 765 35567889999999999999888885 689999999999999999999999999999998887753 34667
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++...+|+...|..+|..|.+..+-+.|+++...
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~ 274 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAAN 274 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccC
Confidence 88889999999999999999999999999998654
No 10
>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.7e-55 Score=424.96 Aligned_cols=262 Identities=42% Similarity=0.782 Sum_probs=247.0
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+-.||++.++||.|+||+|.+|.....|+.||||.|+++.+.+......++|||+||..|+||||+.+|++|++.+.+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 45678999999999999999999999999999999999999998888888999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
.|||||+.||+|++++.. +.++|.+++++|+||++|+.|||.++++|||||.+|||+|.|+++||+|||++..+. .
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---D 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---c
Confidence 999999999999999976 789999999999999999999999999999999999999999999999999998754 4
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
...+.++||+|.|.+||++++.+|.++.+|-|||||+||.|+.|..||++.+...+.++|..|.+..|.. +.++.-||+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIR 284 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIR 284 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHH
Confidence 5678999999999999999999999999999999999999999999999999999999999999887764 667899999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
.||..||++|.|+++|-.|=|+.=++.
T Consensus 285 wmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred HHHhcCcccchhHHHHhhhheeecccc
Confidence 999999999999999999988765543
No 11
>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]
Probab=100.00 E-value=1.9e-53 Score=425.59 Aligned_cols=261 Identities=37% Similarity=0.651 Sum_probs=234.6
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..-.++|++++.||+||||.||+|+.+.||+.+|+|++++......+.++.++.|-.+|....+|+||++|..|.+..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 34578999999999999999999999999999999999998888888889999999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc--
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI-- 178 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~-- 178 (481)
||||||++||++..+|.+ +.++|++++.|+.+++.|++-+|+.|++||||||+|+|||..|++||+||||++.....
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 999999999999999875 88999999999999999999999999999999999999999999999999998532110
Q ss_pred -----------------c-cCC-------------------------cccccCCCCccccccccccCCCCCCcchHHHHH
Q 011628 179 -----------------R-QDG-------------------------LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCG 215 (481)
Q Consensus 179 -----------------~-~~~-------------------------~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlG 215 (481)
. .+. ...+.+|||-|+||||+.+++| +..+|+||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG 375 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLG 375 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHH
Confidence 0 000 0124689999999999999998 5679999999
Q ss_pred HHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC--CCCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 216 VILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP--RWFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 216 vil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
||+||||.|.+||.+.++.+.+.+|..-. +..| ..+++++++||.+||. ||++|.. ++||.+||||+.
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 99999999999999999999999998764 4444 3478999999999999 9999984 999999999975
No 12
>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1e-54 Score=403.14 Aligned_cols=249 Identities=34% Similarity=0.608 Sum_probs=223.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-EEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE-VMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-~~~~~~ 99 (481)
+..-...|+|++.||+|+||.||++++..+|..||.|.+.-... +......+..|+.+|++|+|||||++++ .+....
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 34456789999999999999999999999999999999986553 3445677889999999999999999998 444444
Q ss_pred -EEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH--cC--ceecCCCCCcEEEccCCCEEEEec
Q 011628 100 -KIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHA--RG--VYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~--~g--i~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.++||||||.+|+|.++|+. ..++|..+|+++.||+.||.+||+ .. |+||||||.||+++.+|.+||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 49999999999999999863 469999999999999999999999 44 999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CC
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SP 248 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~ 248 (481)
|+++.+.. .....++.+|||+||+||++...+| ..|+||||+||++|||++-+.||.+.+..++..+|.+|+++ +|
T Consensus 173 GL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p 249 (375)
T KOG0591|consen 173 GLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP 249 (375)
T ss_pred hhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc
Confidence 99998754 3345678999999999999999999 57999999999999999999999999999999999999876 66
Q ss_pred -CCCCHHHHHHHHHhcccCcCCCCCH
Q 011628 249 -RWFSPDLIRLLTKLLDTNPDKRITI 273 (481)
Q Consensus 249 -~~~s~~~~~li~~~L~~dP~~Rps~ 273 (481)
..+|.++..||..|+..||+.||+.
T Consensus 250 ~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 250 DEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHhhhHHHHHHHHHccCCcccCCCc
Confidence 6799999999999999999999986
No 13
>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-53 Score=417.62 Aligned_cols=265 Identities=36% Similarity=0.653 Sum_probs=233.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch-----------hHHHHHHHHHHHHHhCCCCCcceE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----------GLVAHIKREISILRRVRHPNIVQL 91 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l 91 (481)
...+.|++++.||+|.||+|.+|++..+++.||||++.+...... .-.+++++||.||++|+|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 347899999999999999999999999999999999987543221 123578999999999999999999
Q ss_pred EEEEEeC--CEEEEEEeccCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 92 FEVMATK--SKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 92 ~~~~~~~--~~~~lv~Ey~~gg~L~~~i~~~~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
+++..+. +.+|||+|||..|.+...=.... +++.++++|+++++.||+|||.+||+||||||.|+||+++|++||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 9999764 68999999999998876655555 99999999999999999999999999999999999999999999999
Q ss_pred cCCccccccc---ccCCcccccCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh
Q 011628 169 FGLSAVSDQI---RQDGLFHTFCGTPAYVAPEVLSR---KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK 242 (481)
Q Consensus 169 FGla~~~~~~---~~~~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~ 242 (481)
||.+..+... ..+..+....|||.|+|||.+.+ ..+.+.+.||||+||+||+|+.|++||-+....+++.+|.+
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn 333 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN 333 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc
Confidence 9998765322 22233456899999999999876 55778899999999999999999999999999999999999
Q ss_pred CCCCCCCC--CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 243 GEFRSPRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 243 ~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
..+.+|.. +.+.+++||.+||++||++|+++.+|..|||......
T Consensus 334 ~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 334 DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 98777765 7899999999999999999999999999999987644
No 14
>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-52 Score=428.47 Aligned_cols=258 Identities=37% Similarity=0.666 Sum_probs=243.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 103 (481)
.++|+++++||+|+||+|++|..+.+++.+|||+++++.+...+.++..+.|-+|+...+ ||.+++++.+|.+.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 679999999999999999999999999999999999999988888999999999999886 9999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||+.||++...++.+.+++..++.|+..++.||.|||++||+|||||.+|||||.+|++||+|||+++.. ...+..
T Consensus 447 vmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~~g~~ 524 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MGQGDR 524 (694)
T ss_pred EEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CCCCCc
Confidence 999999999777777789999999999999999999999999999999999999999999999999999742 234556
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 263 (481)
..|.||||.|||||++.+..| +..+|.|||||+|||||.|+.||.+.+..+++..|...+..+|.|+|.++.++++++|
T Consensus 525 TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll 603 (694)
T KOG0694|consen 525 TSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLL 603 (694)
T ss_pred cccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHh
Confidence 789999999999999999988 6789999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCC-----HhHHHhCcccccC
Q 011628 264 DTNPDKRIT-----IPEIMENRWFRKG 285 (481)
Q Consensus 264 ~~dP~~Rps-----~~eil~h~~f~~~ 285 (481)
.+||++|.. +++|.+||||+..
T Consensus 604 ~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 604 RKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred ccCcccccCCCCCCchhhhhCCccccC
Confidence 999999985 5899999999753
No 15
>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]
Probab=100.00 E-value=2.8e-53 Score=397.14 Aligned_cols=256 Identities=30% Similarity=0.512 Sum_probs=220.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|+.+.++|+|+||+||++++++||+.||||.+-... .+....+-..|||++|++|+|||+|.++++|.....+++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 578999999999999999999999999999999986543 3334455678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|||+-.-|.++-.. .+++++.+++|++|++.|+.|||+++++||||||||||++.+|.+||||||+|+.... ....
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 999987544444433 5799999999999999999999999999999999999999999999999999997653 4556
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--------------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-------------------- 243 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------------- 243 (481)
++.++.|.+|+|||.+.+...++.++|||++||++.||++|.+-|++.+..+....|.+.
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 788999999999999998655578899999999999999999999998876655544321
Q ss_pred -CCCCC----------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 244 -EFRSP----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 244 -~~~~~----------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.++.| +.++.-+.+|+++||..||++|++.+|++.|+||.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 01111 12456789999999999999999999999999993
No 16
>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=2.3e-54 Score=393.60 Aligned_cols=258 Identities=37% Similarity=0.725 Sum_probs=233.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.+.+.|++-+.||+|.|+.||++.+..+|+.+|+|+++....... ..+.+.+|+.|-+.|+||||+++++.+.+....|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 356789999999999999999999999999999999987765544 4577999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEecCCccccccc
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~DFGla~~~~~~ 178 (481)
+|+|++.|++|+.-|.. .-.+|..+-.+++||+.||.|||.+||+|||+||+|+|+... .-+||+|||+|...+
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999999999877654 468999999999999999999999999999999999999654 359999999997654
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC----CCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~ 254 (481)
.........|||.|||||++...+| +.++|||+||||||-||.|++||.+++...+|.+|..+.+..|+ .++++
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 3445677899999999999999998 56799999999999999999999999999999999999765543 48999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+++||++||..||.+|+|+.|.|+|||+.+.
T Consensus 243 Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 9999999999999999999999999999764
No 17
>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=2.2e-52 Score=408.54 Aligned_cols=258 Identities=33% Similarity=0.606 Sum_probs=221.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--KIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 102 (481)
..+|..++.||+|+||.||++.+.++|...|||.+...... ..+.+.+|+.+|++++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 56799999999999999999999999999999999876322 2677899999999999999999999854444 699
Q ss_pred EEEeccCCCchHHHHHc-C-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCccccccc-
Q 011628 103 FVMEYVRGGELFNKVAK-G-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQI- 178 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~- 178 (481)
++|||++||+|.+++.+ + +++|+.++.|.+|++.||+|||++||+||||||+|||++. ++.+||+|||++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999986 4 6999999999999999999999999999999999999999 799999999999865531
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCC--CCCCCCCCHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGE--FRSPRWFSPDL 255 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~--~~~~~~~s~~~ 255 (481)
..........||+.|||||++........++|||||||++.||+||..||.+ .........+.... +..|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1122234578999999999998632333489999999999999999999998 44444444444333 56789999999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++||.+|+..||++|||++++|+|||.+..
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999998764
No 18
>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]
Probab=100.00 E-value=9.6e-53 Score=420.45 Aligned_cols=257 Identities=33% Similarity=0.653 Sum_probs=239.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|.+.+.||+|+||.||+|+.+.+.+.||+|.+++....+ ...+.+.+|++|++.++|||||.++++|++...+|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~-k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNE-KELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCch-HHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 468999999999999999999999999999999998876433 4567899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|||.| +|+.+++. +.++|+.++.++.|+++||.|||+++|+|||+||.|||++.+|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 99999986 7899999999999999999999999999999999999999999999999999987554 3446
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L 263 (481)
+....|||.|||||++.+.+|+ ..+|+||||||+|||++|++||-......+.+.|.+...+.|...|..+.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6778999999999999998885 569999999999999999999999999999999999999999999999999999999
Q ss_pred ccCcCCCCCHhHHHhCcccccCc
Q 011628 264 DTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 264 ~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.+||.+|.|..+++.|||.+...
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999987654
No 19
>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.5e-52 Score=381.22 Aligned_cols=255 Identities=39% Similarity=0.716 Sum_probs=241.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|.||.||+|+.++++-.||+|++.++.+...+...++.||++|...|+||||+++|++|-+...+|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 68899999999999999999999999999999999998888777888999999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||+.+|+|+..+.. .++++..+..|++|++.|+.|||.++|+||||||+|+|++..|.+||+|||.+-... .
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p----~ 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----C
Confidence 999999999999984 469999999999999999999999999999999999999999999999999986532 3
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
+...+.|||.-|.+||...+.+++ ..+|+|++|++.||++.|.+||...+..+.|++|.+.++..|+.++.++.+||.+
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ 255 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLISR 255 (281)
T ss_pred CCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHHH
Confidence 445788999999999999999996 4699999999999999999999999999999999999999999999999999999
Q ss_pred hcccCcCCCCCHhHHHhCccccc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||.++|.+|.+..|++.|||+..
T Consensus 256 ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 256 LLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HhccCccccccHHHHhhhHHHHh
Confidence 99999999999999999999865
No 20
>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=1.7e-51 Score=408.37 Aligned_cols=256 Identities=35% Similarity=0.590 Sum_probs=227.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (481)
.+.|+.+++||+|+||.||+|++..||+.||+|.+..+.. +.++.....|||.||++|+||||+++.++..+. ..+|
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 5689999999999999999999999999999999988763 456777788999999999999999999999877 6899
Q ss_pred EEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|+|||+. +|.-++... .|++.++..|++||+.||+|||++||+|||||.+|||||.+|.+||+|||||+++....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~- 272 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG- 272 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCC-
Confidence 99999976 888888764 79999999999999999999999999999999999999999999999999999876533
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CC--------CCC--
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EF--------RSP-- 248 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~--------~~~-- 248 (481)
...++..+-|.+|+|||.+.+...++..+|+||+||||.||++|++.|.+.+..+...+|++- .+ ..|
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence 334677788999999999998877788999999999999999999999999988888888652 10 111
Q ss_pred -----------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 249 -----------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 249 -----------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
..+++.+.+|+..||..||.+|.|+.++|+++||.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~ 404 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFT 404 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccc
Confidence 12677899999999999999999999999999994
No 21
>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-52 Score=411.45 Aligned_cols=260 Identities=33% Similarity=0.549 Sum_probs=227.5
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 99 (481)
...++.||.+.++||.|+||.||+|+.+.+|+.||||.+++....-++. . -.||+..|++|+ |||||++++++.+.+
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~-nLREvksL~kln~hpniikL~Evi~d~~ 82 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-M-NLREVKSLRKLNPHPNIIKLKEVIRDND 82 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-H-HHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence 3457899999999999999999999999999999999997765432222 2 358999999999 999999999998888
Q ss_pred -EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 100 -KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
.+|+||||++. .|+++++. ..+++..++.|+.||++||+|+|.+|+.|||+||||||+..+..+||+|||+|+...
T Consensus 83 ~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 83 RILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred ceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc
Confidence 99999999975 99999976 469999999999999999999999999999999999999999999999999998543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------- 243 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 243 (481)
....++.++.|.+|+|||++...++++.+.|||++|||++|+.+-++-|++.+..+...+|..-
T Consensus 162 ---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 162 ---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 3345678899999999999999999999999999999999999999999999887777777531
Q ss_pred ------CCCCC-----------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 244 ------EFRSP-----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 244 ------~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.+..| +..++++.+||.+||.+||++|||+.|+++||||+...
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 11111 12678899999999999999999999999999998754
No 22
>PTZ00263 protein kinase A catalytic subunit; Provisional
Probab=100.00 E-value=1.2e-50 Score=408.00 Aligned_cols=255 Identities=40% Similarity=0.752 Sum_probs=232.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 36889999999999999999999999999999999987654444455778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~----- 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD----- 170 (329)
T ss_pred EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC-----
Confidence 9999999999999876 6799999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+....|.++++.+++||.+|
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~ 249 (329)
T PTZ00263 171 RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249 (329)
T ss_pred CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHH
Confidence 1234689999999999988777 578999999999999999999999998888899999998889999999999999999
Q ss_pred cccCcCCCCC-----HhHHHhCccccc
Q 011628 263 LDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 263 L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
|+.||.+||+ +++++.||||..
T Consensus 250 L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 250 LQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred hhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999997 799999999975
No 23
>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-50 Score=393.72 Aligned_cols=260 Identities=31% Similarity=0.545 Sum_probs=229.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.-.+.|++...||.|.-++||+|++..+++.||||+++.++.... .+.+.+|+..|+.++||||++++..|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 347899999999999999999999999999999999999886543 788999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 103 FVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+||.|+.+|++.+++.. .+++|..+..++++++.||.|||++|.+|||||+.||||+.+|.|||+|||.+......+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999999975 469999999999999999999999999999999999999999999999999876433222
Q ss_pred cCC--cccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC------
Q 011628 180 QDG--LFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR------ 249 (481)
Q Consensus 180 ~~~--~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~------ 249 (481)
... .+++..|||+|||||++.. .+| ..|+||||||++..||.+|..||....++.+...-.++.++.+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GY-dfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGY-DFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCc-cchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 111 1267799999999999533 456 57999999999999999999999999998877776776655322
Q ss_pred ----CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 250 ----WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 250 ----~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.++..++.+|..||++||.+|||++++++|+||++.
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~ 299 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA 299 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence 256779999999999999999999999999999875
No 24
>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-51 Score=407.53 Aligned_cols=262 Identities=42% Similarity=0.719 Sum_probs=243.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
...+.|=|.+.++||+|-|++|.+|++.-||+.||||++++.+... -...++.+|+..|+.++|||||++|++..++.+
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 3456788999999999999999999999999999999999887543 344678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCcccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~ 177 (481)
+|+|+|+-+||+|+++|.+ .++.|+.+++||.||+.|+.|||+..++||||||||+.+.+ -|-+||+|||++..+.
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 9999999999999999976 47999999999999999999999999999999999998765 5889999999997654
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIR 257 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~ 257 (481)
+...+.+.||+..|-|||++.+..|+.+++||||||||||.|++|++||...+..+..-.|....+..|..+|.++++
T Consensus 171 --PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrd 248 (864)
T KOG4717|consen 171 --PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRD 248 (864)
T ss_pred --CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHH
Confidence 345678999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
||..||..||.+|.|.++|..++|++..-
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCCC
Confidence 99999999999999999999999998653
No 25
>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt
Probab=100.00 E-value=2.8e-50 Score=398.08 Aligned_cols=253 Identities=34% Similarity=0.654 Sum_probs=229.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654333344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999999875 6799999999999999999999999999999999999999999999999999875422 12
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+....|..+++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 34579999999999988776 57899999999999999999999999988889999998888898999999999999999
Q ss_pred cCcCCCCC-----HhHHHhCccccc
Q 011628 265 TNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps-----~~eil~h~~f~~ 284 (481)
.||.+||+ ++++++||||..
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999964
No 26
>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]
Probab=100.00 E-value=8.4e-50 Score=404.45 Aligned_cols=260 Identities=39% Similarity=0.724 Sum_probs=236.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSK 100 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 100 (481)
..+...|++++.||+|.||.||.++++.||+.+|+|++.+...........+.+|+.||+++. |||||.+++++++...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 445678999999999999999999999999999999999887665545678999999999998 9999999999999999
Q ss_pred EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC----CCEEEEecCCccccc
Q 011628 101 IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN----GDLKVSDFGLSAVSD 176 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~----g~lkl~DFGla~~~~ 176 (481)
+|+|||+|.||+|++.+....++|..+..+++|++.++.|||+.||+||||||+|+|+... +.+|++|||+|....
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999999976569999999999999999999999999999999999999654 479999999998754
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC--CCC--CC
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS--PRW--FS 252 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~--~~~--~s 252 (481)
. .......||||.|+|||++...+| +..+||||+||++|.|++|..||.+.+....+.++..+++.+ +.| +|
T Consensus 191 ~---~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is 266 (382)
T KOG0032|consen 191 P---GERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDIS 266 (382)
T ss_pred C---CceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccC
Confidence 3 456788999999999999988888 568999999999999999999999999988888999987644 333 78
Q ss_pred HHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 253 PDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 253 ~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..++++|++||..||.+|+|+.++|+|||++..
T Consensus 267 ~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 267 ESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred HHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 999999999999999999999999999998653
No 27
>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional
Probab=100.00 E-value=1.8e-49 Score=401.25 Aligned_cols=258 Identities=33% Similarity=0.611 Sum_probs=232.0
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSG-ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
...-.++|++.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3345788999999999999999999976654 689999997765444445667889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||+.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 99999999999999999976 5799999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRL 258 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 258 (481)
...+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..+....|..+++.+.++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 1235689999999999987766 57899999999999999999999999988889999998888899999999999
Q ss_pred HHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
|++||+.||.+|+ |++++++||||..
T Consensus 259 i~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999996 8999999999975
No 28
>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be
Probab=100.00 E-value=1.1e-49 Score=399.88 Aligned_cols=251 Identities=41% Similarity=0.709 Sum_probs=225.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567789999999999999999999999999999999999999
Q ss_pred chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 112 ELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 112 ~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99999875 6799999999999999999999999999999999999999999999999999874221 12223456899
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+....|..+++++.+||.+||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 99999999988777 57899999999999999999999998888888888888888889999999999999999999999
Q ss_pred C-----CHhHHHhCcccccC
Q 011628 271 I-----TIPEIMENRWFRKG 285 (481)
Q Consensus 271 p-----s~~eil~h~~f~~~ 285 (481)
| ++.++++||||...
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999753
No 29
>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]
Probab=100.00 E-value=3.6e-50 Score=370.53 Aligned_cols=255 Identities=33% Similarity=0.548 Sum_probs=223.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|...+.||+|+||.||+|++.+||+.||||.+..... +.+......|||+.|+.++||||+.++++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 589999999999999999999999999999999987753 3445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++. +|...++.. .++...+..|+.|++.||+|||++.|+||||||+|+|++.+|.+||+|||+|+.+..... .
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~--~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR--I 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--c
Confidence 99975 999999863 689999999999999999999999999999999999999999999999999998765333 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCC---------C----
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRS---------P---- 248 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~---------~---- 248 (481)
....+-|.+|+|||.+.+...++..+||||.|||+.||+-|.+-|.+.+..+....|+..- +.. |
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 2333789999999999887766888999999999999999999999998888777776521 100 1
Q ss_pred -------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 -------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 -------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+..++++.+|+.+||..||.+|+|+.|+++|+||..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~ 286 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS 286 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence 114667899999999999999999999999999974
No 30
>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.4e-50 Score=407.91 Aligned_cols=254 Identities=33% Similarity=0.603 Sum_probs=230.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|...+.||+|+-|.||.|+...+++.||||.++....... +-+.+|+.+|+..+|+|||++++.|...+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~k---eLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKK---ELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCch---hhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 4689999999999999999999999999999999998765544 4478999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++||+|.+.+....++|.++..+.++++.||+|||.+||+|||||.+|||++.+|.+||+|||++........ .-
T Consensus 349 MEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR 426 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KR 426 (550)
T ss_pred EeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--cc
Confidence 9999999999999998899999999999999999999999999999999999999999999999999987654332 34
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh-C--CCCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-G--EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~--~~~~~~~~s~~~~~li~~ 261 (481)
.+.+|||+|||||++..+.| +.|.||||||++++||+-|++||-.+++......|.. | +++.|..+|+.+++|+.+
T Consensus 427 ~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~ 505 (550)
T KOG0578|consen 427 STMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR 505 (550)
T ss_pred ccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence 67899999999999999888 6799999999999999999999998887665555544 4 355688899999999999
Q ss_pred hcccCcCCCCCHhHHHhCccccc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||+.||++|+++.|||+||||..
T Consensus 506 cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 506 CLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999954
No 31
>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]
Probab=100.00 E-value=6.9e-51 Score=375.95 Aligned_cols=258 Identities=36% Similarity=0.712 Sum_probs=231.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC-CCCcceEEEEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-----KSGLVAHIKREISILRRVR-HPNIVQLFEVMA 96 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~ 96 (481)
.+-.+|+--+.||+|..++|..+.++.+|+.+|+|++...... ..++.+.-.+|+.||+++. ||||+.+.++++
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 4567899999999999999999999999999999999753221 2245566778999999995 999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
++..+++|+|.|+.|+|+|++.. -.++|.+.+++++||+.|++|||.++|+||||||+|||++++.++||+|||+|+..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999987 47999999999999999999999999999999999999999999999999999864
Q ss_pred cccccCCcccccCCCCcccccccccc------CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--C
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSR------KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--S 247 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~------~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~ 247 (481)
. .+..+...||||+|+|||.+.. .+| +..+|+|+||||+|.|+.|.+||-....+-+.+.|..|++. .
T Consensus 174 ~---~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 174 E---PGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred C---CchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 3 3445678899999999999854 345 56799999999999999999999999999999999999754 4
Q ss_pred CCC--CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 248 PRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 248 ~~~--~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
|.| +|...++||.+||+.||.+|+|++|+|.||||.+
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 666 7889999999999999999999999999999965
No 32
>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.1e-49 Score=387.27 Aligned_cols=259 Identities=32% Similarity=0.512 Sum_probs=232.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++++.||.|.-|+||+++...++..+|+|+++++......-..++.-|-.||+.++||.++.+|..+++....|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 57899999999999999999999999999999999998877666778888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc---
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI--- 178 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~--- 178 (481)
||||+||+|..+.++ +.+++..++.|+.+++.||+|||-.||++||||||||||-++|++.|+||.|+......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999999999876 36999999999999999999999999999999999999999999999999987432100
Q ss_pred -----------------------------c-c---------------------CCcccccCCCCccccccccccCCCCCC
Q 011628 179 -----------------------------R-Q---------------------DGLFHTFCGTPAYVAPEVLSRKGYDAA 207 (481)
Q Consensus 179 -----------------------------~-~---------------------~~~~~~~~gt~~y~APEvl~~~~~~~~ 207 (481)
. . +....+.+||-.|+|||++.+.++ +.
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH-gs 314 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH-GS 314 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC-Cc
Confidence 0 0 001134689999999999999999 46
Q ss_pred cchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC--CCCHHHHHHHHHhcccCcCCCCC----HhHHHhCcc
Q 011628 208 KVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR--WFSPDLIRLLTKLLDTNPDKRIT----IPEIMENRW 281 (481)
Q Consensus 208 ~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps----~~eil~h~~ 281 (481)
++|.|+|||.+|||+.|..||.+.+..+.+.+|......+|. .++..+++||+++|.+||.+|.. +.||.+|||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 799999999999999999999999999999999988776654 46789999999999999999998 999999999
Q ss_pred ccc
Q 011628 282 FRK 284 (481)
Q Consensus 282 f~~ 284 (481)
|+.
T Consensus 395 F~g 397 (459)
T KOG0610|consen 395 FEG 397 (459)
T ss_pred ccC
Confidence 964
No 33
>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=7e-50 Score=406.12 Aligned_cols=263 Identities=46% Similarity=0.812 Sum_probs=246.4
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
....+.|.+.++||+|.|++|.+|++..++..||||++++....... ...+.+|+++|+.++|||||+++.+..++..+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 34578899999999999999999999999999999999987755443 34488999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+.||++++++.+ +++.+..++.+|.|+++|++|||+++|+|||||++||||+.+.++||+|||++..+. .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 999999999999999986 789999999999999999999999999999999999999999999999999998765 3
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
...+.+.||++.|.|||++.+..|+++.+|+||+|++||.|+.|.+||++.+...+..+...+.+..|-.++.++.++|+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 55678999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKGFKH 288 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~~~~ 288 (481)
++|.++|.+|+++++|+.|+|...++..
T Consensus 288 k~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999998766544
No 34
>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N. Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved
Probab=100.00 E-value=1.5e-48 Score=391.58 Aligned_cols=254 Identities=34% Similarity=0.612 Sum_probs=226.2
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL---RRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.++ +.++||||+++++++.....+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999866443334456677777665 456799999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++||+|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999864322 12223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....|..+++.+.++|.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 45789999999999987776 57899999999999999999999999888888888888888888999999999999999
Q ss_pred cCcCCCC-----CHhHHHhCccccc
Q 011628 265 TNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.||.+|| ++.++++||||..
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999 6999999999975
No 35
>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl
Probab=100.00 E-value=5.5e-49 Score=392.77 Aligned_cols=249 Identities=38% Similarity=0.664 Sum_probs=223.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999865444444556788999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCc
Q 011628 114 FNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192 (481)
Q Consensus 114 ~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 192 (481)
.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 999865 6799999999999999999999999999999999999999999999999999875322 1223345689999
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCC-
Q 011628 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRI- 271 (481)
Q Consensus 193 y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp- 271 (481)
|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+..+....|..+++++.+||.+||+.||.+||
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999988777 568999999999999999999999988888889998888888999999999999999999999997
Q ss_pred --CHhHHHhCcccccC
Q 011628 272 --TIPEIMENRWFRKG 285 (481)
Q Consensus 272 --s~~eil~h~~f~~~ 285 (481)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 57999999999764
No 36
>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus
Probab=100.00 E-value=1.6e-48 Score=397.73 Aligned_cols=257 Identities=31% Similarity=0.547 Sum_probs=221.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765444455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ---- 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 180 (481)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999875 6899999999999999999999999999999999999999999999999999875321100
Q ss_pred -----------------------------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc
Q 011628 181 -----------------------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ 231 (481)
Q Consensus 181 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 231 (481)
.......+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 001234689999999999988777 56899999999999999999999998
Q ss_pred hHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhcccCcC---CCCCHhHHHhCccccc
Q 011628 232 NIMVMYKKIYKG--EFRSPR--WFSPDLIRLLTKLLDTNPD---KRITIPEIMENRWFRK 284 (481)
Q Consensus 232 ~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~---~Rps~~eil~h~~f~~ 284 (481)
+....+.++... ....|. .+++++++||.+|+. +|. .||+++||++||||+.
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 888888888763 333443 378999999999775 444 4689999999999975
No 37
>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate
Probab=100.00 E-value=1.4e-48 Score=392.69 Aligned_cols=250 Identities=40% Similarity=0.693 Sum_probs=224.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444445667889999999999999999999999999999999999999
Q ss_pred chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 112 ELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 112 ~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99998875 5799999999999999999999999999999999999999999999999999874221 12223456899
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+....|..+++++.+||.+||++||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987776 57899999999999999999999988888888888888888889999999999999999999999
Q ss_pred C-----CHhHHHhCccccc
Q 011628 271 I-----TIPEIMENRWFRK 284 (481)
Q Consensus 271 p-----s~~eil~h~~f~~ 284 (481)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999964
No 38
>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.
Probab=100.00 E-value=2.1e-48 Score=392.03 Aligned_cols=253 Identities=32% Similarity=0.581 Sum_probs=224.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999975 6799999999999999999999999999999999999999999999999999875432 23
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCC------CCCHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR------WFSPDLI 256 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~------~~s~~~~ 256 (481)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.... ...|. .+++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 45689999999999988766 578999999999999999999999988777766665432 22222 3589999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+||.+||..+|.+||+++++++||||..
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999999999975
No 39
>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in
Probab=100.00 E-value=1.9e-48 Score=390.87 Aligned_cols=250 Identities=40% Similarity=0.709 Sum_probs=224.1
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444445567788999999999999999999999999999999999999
Q ss_pred chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 112 ELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 112 ~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 99998875 5799999999999999999999999999999999999999999999999999864211 12223456899
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 99999999987777 57899999999999999999999998888888888888888888999999999999999999999
Q ss_pred C-----CHhHHHhCccccc
Q 011628 271 I-----TIPEIMENRWFRK 284 (481)
Q Consensus 271 p-----s~~eil~h~~f~~ 284 (481)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 8 8999999999975
No 40
>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.9e-49 Score=379.80 Aligned_cols=260 Identities=30% Similarity=0.490 Sum_probs=222.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----C
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-----K 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-----~ 98 (481)
+..+|...+.||+|+||.|..|.++.+|+.||||.+.... ...-..++..||+.+++.++|+||+.+++++.. -
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 4567777899999999999999999999999999997433 334456888899999999999999999999865 3
Q ss_pred CEEEEEEeccCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+|+|+|++ +.+|.+.++.++ ++++.++.+++||+.||+|+|+.+|+||||||.|+|++.+..+||+|||+|+....
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDK 177 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccc
Confidence 5799999999 569999999876 99999999999999999999999999999999999999999999999999997654
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------- 242 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------- 242 (481)
....+..+.++.|.+|+|||++.....++...||||+|||+.||++|++-|.+.+.......|..
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s 257 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS 257 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 44455667889999999999986655557889999999999999999999988765544444332
Q ss_pred --------CCCCC--------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 --------GEFRS--------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 --------~~~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..... -+..++.+.+|+.+||..||.+|+|++|+|+|||+..-
T Consensus 258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY 316 (359)
T ss_pred HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence 11111 12468899999999999999999999999999999653
No 41
>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica
Probab=100.00 E-value=4.3e-48 Score=394.36 Aligned_cols=257 Identities=33% Similarity=0.619 Sum_probs=223.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998764444455667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC---
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD--- 181 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 181 (481)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999875 67999999999999999999999999999999999999999999999999998643211000
Q ss_pred ---------------------------------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCC
Q 011628 182 ---------------------------------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF 228 (481)
Q Consensus 182 ---------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf 228 (481)
....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence 01123579999999999988777 57899999999999999999999
Q ss_pred CCchHHHHHHHHhhCC--CCCCC--CCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 229 QDQNIMVMYKKIYKGE--FRSPR--WFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 229 ~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
.+.+....+..+.... +..|. .+++++++||.+||. +|.+|++ ++++++||||..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9988877777776543 23333 468999999999997 9999998 999999999975
No 42
>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C. Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory
Probab=100.00 E-value=4e-48 Score=388.59 Aligned_cols=255 Identities=33% Similarity=0.608 Sum_probs=227.2
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP-NIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~ 105 (481)
+|++.+.||+|+||.||+|++..+++.||||++.+...........+..|..+++.+.|+ +|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444556778899999999765 5888999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999864221 12233
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+..+.......|..+++++.+++.+||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 45689999999999988777 56899999999999999999999999888888899888888888999999999999999
Q ss_pred cCcCCCCCH-----hHHHhCccccc
Q 011628 265 TNPDKRITI-----PEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps~-----~eil~h~~f~~ 284 (481)
+||.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999975
No 43
>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal
Probab=100.00 E-value=2.5e-48 Score=389.60 Aligned_cols=250 Identities=36% Similarity=0.662 Sum_probs=223.1
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|+++.+++.||+|++.+...........+.+|..+++.+ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876443334456677888888877 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999998875 6799999999999999999999999999999999999999999999999999864321 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+..+....|.++++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999987776 5689999999999999999999999998888999998888889999999999999999999999
Q ss_pred CCCH------hHHHhCccccc
Q 011628 270 RITI------PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~------~eil~h~~f~~ 284 (481)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCC
Confidence 9998 99999999965
No 44
>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po
Probab=100.00 E-value=3.7e-48 Score=397.60 Aligned_cols=258 Identities=34% Similarity=0.568 Sum_probs=220.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
..|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998765555556678899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ---- 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 180 (481)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999876 6799999999999999999999999999999999999999999999999999753211000
Q ss_pred -----------------------------------------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHH
Q 011628 181 -----------------------------------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF 219 (481)
Q Consensus 181 -----------------------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ 219 (481)
.....+.+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHH
Confidence 001134689999999999988777 57899999999999
Q ss_pred HHhcCCCCCCCchHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhc--ccCcCCCCCHhHHHhCccccc
Q 011628 220 VLMAGYLPFQDQNIMVMYKKIYKG--EFRSPR--WFSPDLIRLLTKLL--DTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 220 elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L--~~dP~~Rps~~eil~h~~f~~ 284 (481)
+|++|..||...+......++... ....|. .+++++.+||.+|| ..+|..|++++++++||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 999999999988776666666532 333343 47999999999965 455666999999999999975
No 45
>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.8e-50 Score=395.55 Aligned_cols=256 Identities=31% Similarity=0.548 Sum_probs=230.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
...|+..+.||+|+||.||+|.+..+++.||+|+++.+... ..+..+.+|+.++.+++++||.++|+.+..+..+|++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 45688889999999999999999999999999999987643 4578899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAKGRL-KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l-~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||.||++.++++.+.+ +|..+.-++++++.|+.|||.++.+|||||+.|||+..+|.+||+|||++........ .
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--r 167 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--R 167 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh--c
Confidence 999999999999998765 9999999999999999999999999999999999999999999999999976544322 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 262 (481)
..+.+|||.||||||+.+.+|+ .|+||||||++.+||++|.+||.+..++.....|-+..++ ....+|+.+++||..|
T Consensus 168 r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~C 246 (467)
T KOG0201|consen 168 RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEAC 246 (467)
T ss_pred cccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHH
Confidence 2788999999999999988885 6899999999999999999999999987766666555433 3446899999999999
Q ss_pred cccCcCCCCCHhHHHhCcccccC
Q 011628 263 LDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|++||+.|||+.++|+|+|+++.
T Consensus 247 L~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 247 LDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred hhcCcccCcCHHHHhhhHHHHhc
Confidence 99999999999999999999874
No 46
>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in
Probab=100.00 E-value=4.1e-48 Score=395.74 Aligned_cols=259 Identities=31% Similarity=0.524 Sum_probs=226.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 57899999999999999999999999999999999765433333445678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus 122 ~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~~~ 200 (370)
T cd05596 122 MEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRC 200 (370)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-cccC
Confidence 999999999999988889999999999999999999999999999999999999999999999999987543211 1122
Q ss_pred cccCCCCccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCC--CCCHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKG---YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR--WFSPDLIR 257 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~~ 257 (481)
...+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+....+.++.... ...|. .+|.++.+
T Consensus 201 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (370)
T cd05596 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280 (370)
T ss_pred CCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHH
Confidence 3568999999999986542 34678999999999999999999999998888888887643 34444 47999999
Q ss_pred HHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 258 LLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
||.+||+.+|.+ |+|++++++||||+.
T Consensus 281 li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 281 LICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 999999999998 999999999999975
No 47
>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I
Probab=100.00 E-value=6.6e-48 Score=385.80 Aligned_cols=250 Identities=32% Similarity=0.628 Sum_probs=220.0
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||.||+|++..+|+.||+|++.+...........+..|..++... +||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999875433223345567788888765 899999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... ........+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999998875 5799999999999999999999999999999999999999999999999999864211 1223345789
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+..+....|.+++.++++||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999988777 5789999999999999999999999888888888887778888999999999999999999999
Q ss_pred CCCH-hHHHhCccccc
Q 011628 270 RITI-PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~-~eil~h~~f~~ 284 (481)
||++ +++++||||..
T Consensus 238 R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 238 RLGVVGNIRGHPFFKT 253 (316)
T ss_pred cCCChHHHHcCCCcCC
Confidence 9998 58999999975
No 48
>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i
Probab=100.00 E-value=5.7e-48 Score=380.31 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=218.7
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 88999999999999999999999999999999866544333345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 108 VRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 108 ~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
++||+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ....
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~ 158 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETV 158 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCee
Confidence 999999888753 3689999999999999999999999999999999999999999999999999875322 1223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
....||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+. ......+.......+..+++++.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 237 (285)
T cd05631 159 RGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICR 237 (285)
T ss_pred cCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHH
Confidence 45679999999999988777 5689999999999999999999987543 233334444455667779999999999
Q ss_pred HhcccCcCCCCC-----HhHHHhCccccc
Q 011628 261 KLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
+||+.||.+||+ ++++++||||..
T Consensus 238 ~~l~~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 238 MLLTKNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred HHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 999999999997 899999999965
No 49
>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to
Probab=100.00 E-value=3.9e-48 Score=388.20 Aligned_cols=250 Identities=36% Similarity=0.637 Sum_probs=223.8
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||.||+|++..+++.||+|++.+...........+..|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876544444556677899998876 799999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999998865 6799999999999999999999999999999999999999999999999999874322 2223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+..+....|.++++++.++|.+||++||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 999999999987777 5689999999999999999999999999899999999888889999999999999999999999
Q ss_pred CC-------CHhHHHhCccccc
Q 011628 270 RI-------TIPEIMENRWFRK 284 (481)
Q Consensus 270 Rp-------s~~eil~h~~f~~ 284 (481)
|| +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 8999999999964
No 50
>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an
Probab=100.00 E-value=4.9e-48 Score=396.78 Aligned_cols=257 Identities=37% Similarity=0.632 Sum_probs=221.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765444455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR----- 179 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~----- 179 (481)
||++||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999875 679999999999999999999999999999999999999999999999999975321000
Q ss_pred ----------------------------------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHH
Q 011628 180 ----------------------------------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF 219 (481)
Q Consensus 180 ----------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ 219 (481)
......+.+||+.|+|||++.+.++ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHH
Confidence 0001124579999999999988887 46899999999999
Q ss_pred HHhcCCCCCCCchHHHHHHHHhhCC--CCCC--CCCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 220 VLMAGYLPFQDQNIMVMYKKIYKGE--FRSP--RWFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 220 elltg~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
+|++|..||.+.+......++.... ...| ..+++++.++|.+|+ .+|.+|++ ++++++||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 9999999999888777666665432 2333 457999999999986 59999997 999999999965
No 51
>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=1.7e-47 Score=385.04 Aligned_cols=257 Identities=35% Similarity=0.615 Sum_probs=220.3
Q ss_pred CeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
+|++++.||+|+||.||+|++. .+++.||+|++.+.... .....+.+.+|+.+++.+ +||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5999999999999999999864 47899999999765432 223456678999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~- 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE- 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC-
Confidence 999999999999999865 579999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc----hHHHHHHHHhhCCCCCCCCCCHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ----NIMVMYKKIYKGEFRSPRWFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~----~~~~~~~~i~~~~~~~~~~~s~~~~ 256 (481)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... ........+.......|..+++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 122335689999999999977654467899999999999999999999643 3345555666666777888999999
Q ss_pred HHHHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
++|.+||+.||++|| +++++++||||+.
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999999999 7889999999975
No 52
>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of
Probab=100.00 E-value=4.8e-48 Score=396.11 Aligned_cols=257 Identities=31% Similarity=0.582 Sum_probs=220.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997655444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC---
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD--- 181 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~--- 181 (481)
||++||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999875 67999999999999999999999999999999999999999999999999998632110000
Q ss_pred ------------------------------------------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHH
Q 011628 182 ------------------------------------------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILF 219 (481)
Q Consensus 182 ------------------------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ 219 (481)
......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 00013579999999999988777 57899999999999
Q ss_pred HHhcCCCCCCCchHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhcccCcCCC---CCHhHHHhCccccc
Q 011628 220 VLMAGYLPFQDQNIMVMYKKIYKG--EFRSPR--WFSPDLIRLLTKLLDTNPDKR---ITIPEIMENRWFRK 284 (481)
Q Consensus 220 elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~s~~~~~li~~~L~~dP~~R---ps~~eil~h~~f~~ 284 (481)
+|++|..||.+.+....+..+... ....|. .+++++.+||.+||. +|.+| +|+.+++.||||..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999988877777777653 233343 478999999999997 77765 59999999999964
No 53
>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament
Probab=100.00 E-value=9.3e-48 Score=379.36 Aligned_cols=253 Identities=29% Similarity=0.492 Sum_probs=212.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++.+.||.|+||.||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 57899999999999999999999999999999999754322 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.| +|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CCc
Confidence 999986 89888864 3589999999999999999999999999999999999999999999999999875332 122
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------------ 244 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------------ 244 (481)
......|++.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 23445789999999998764444678999999999999999999998876654444332210
Q ss_pred -CCC-----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 -FRS-----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 -~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
... ...+++++++||.+||++||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 001 12367889999999999999999999999999998
No 54
>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha. Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien
Probab=100.00 E-value=3.6e-48 Score=389.07 Aligned_cols=250 Identities=40% Similarity=0.704 Sum_probs=223.6
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444566788999999999999999999999999999999999999
Q ss_pred chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 112 ELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 112 ~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
+|...+.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99998875 579999999999999999999997 7999999999999999999999999999864221 1222345679
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+.......|..+++++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 999999999987777 5789999999999999999999999888888888888888888899999999999999999999
Q ss_pred CC-----CHhHHHhCccccc
Q 011628 270 RI-----TIPEIMENRWFRK 284 (481)
Q Consensus 270 Rp-----s~~eil~h~~f~~ 284 (481)
|+ ++.++++||||..
T Consensus 238 R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCC
Confidence 97 8999999999975
No 55
>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes
Probab=100.00 E-value=9.6e-48 Score=378.23 Aligned_cols=254 Identities=30% Similarity=0.478 Sum_probs=212.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2234567789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++++.+..+... +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 99999877666543 579999999999999999999999999999999999999999999999999997643211 1223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------------C
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------F 245 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------~ 245 (481)
....|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 34679999999999987776 568999999999999999999998765433322221100 0
Q ss_pred CC-------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 RS-------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 ~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.. ...+|+++.+||.+||++||++|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 00 11267889999999999999999999999999998
No 56
>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the
Probab=100.00 E-value=3.8e-48 Score=392.27 Aligned_cols=257 Identities=35% Similarity=0.671 Sum_probs=226.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR----- 179 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~----- 179 (481)
||++|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999876 589999999999999999999999999999999999999999999999999987543322
Q ss_pred ----------------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHH
Q 011628 180 ----------------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY 237 (481)
Q Consensus 180 ----------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~ 237 (481)
.........||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0112345679999999999988776 57899999999999999999999998887777
Q ss_pred HHHhh--CCCCCCCC--CCHHHHHHHHHhcccCcCCCCC-HhHHHhCccccc
Q 011628 238 KKIYK--GEFRSPRW--FSPDLIRLLTKLLDTNPDKRIT-IPEIMENRWFRK 284 (481)
Q Consensus 238 ~~i~~--~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps-~~eil~h~~f~~ 284 (481)
.++.. .....|.. +++++.+||.+||. ||.+||+ ++++++||||..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 77776 34444433 59999999999997 9999999 999999999975
No 57
>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]
Probab=100.00 E-value=1.4e-48 Score=370.04 Aligned_cols=257 Identities=34% Similarity=0.476 Sum_probs=223.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA--TKSKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~ 102 (481)
.+.|+.+..|++|+||.||+|+++.|++.||+|.++.+. .+.++--.-.|||.++.+++|||||.+.++.. +-+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 568999999999999999999999999999999998776 34455556679999999999999999998875 446799
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||||+. +|..++.. .++...+++.++.|+++|++|||.+.|+||||||+|+|+++.|.+||+|||+|+.++..
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-- 230 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-- 230 (419)
T ss_pred eeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC--
Confidence 99999976 88888876 47999999999999999999999999999999999999999999999999999976643
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-----------CCCCC
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-----------FRSPR 249 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------~~~~~ 249 (481)
...++..+-|.+|+|||.+.+...++.++|+||+|||+.||+++.+-|.+........+|+.-- ...|.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA 310 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence 2335566789999999999988777888999999999999999999999998887777776410 00110
Q ss_pred -------------------C--CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 250 -------------------W--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 250 -------------------~--~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+ ++....+|+..+|..||.+|.|++|.|+|.||...
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 0 45778999999999999999999999999999763
No 58
>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and
Probab=100.00 E-value=1.2e-47 Score=384.93 Aligned_cols=255 Identities=32% Similarity=0.609 Sum_probs=227.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|..++..+ +||+|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876543344455667788888877 5899999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+.+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999999865 6799999999999999999999999999999999999999999999999999874321 12233
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 45689999999999988777 57899999999999999999999999888889999888888888999999999999999
Q ss_pred cCcCCCCCH-----hHHHhCccccc
Q 011628 265 TNPDKRITI-----PEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps~-----~eil~h~~f~~ 284 (481)
.||.+|++. .++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999974
No 59
>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor. Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.
Probab=100.00 E-value=5.7e-48 Score=395.37 Aligned_cols=257 Identities=33% Similarity=0.587 Sum_probs=220.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654433344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR----- 179 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~----- 179 (481)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999876 578999999999999999999999999999999999999999999999999975321000
Q ss_pred ------------------------------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc
Q 011628 180 ------------------------------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA 223 (481)
Q Consensus 180 ------------------------------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt 223 (481)
........+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence 0001123579999999999988777 578999999999999999
Q ss_pred CCCCCCCchHHHHHHHHhhCC--CCC--CCCCCHHHHHHHHHhcccCcCCCC---CHhHHHhCccccc
Q 011628 224 GYLPFQDQNIMVMYKKIYKGE--FRS--PRWFSPDLIRLLTKLLDTNPDKRI---TIPEIMENRWFRK 284 (481)
Q Consensus 224 g~~Pf~~~~~~~~~~~i~~~~--~~~--~~~~s~~~~~li~~~L~~dP~~Rp---s~~eil~h~~f~~ 284 (481)
|..||.+.+.......+.... ... ...+++++.++|.+|+ .+|.+|+ |++++++||||..
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 999999888776666665432 222 3357899999999976 5999999 9999999999975
No 60
>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found
Probab=100.00 E-value=9.6e-48 Score=392.93 Aligned_cols=260 Identities=32% Similarity=0.547 Sum_probs=224.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999999976543333344567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||++||+|.+++....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 121 v~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~ 199 (370)
T cd05621 121 VMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVR 199 (370)
T ss_pred EEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-cee
Confidence 9999999999999988889999999999999999999999999999999999999999999999999997643211 112
Q ss_pred ccccCCCCccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCC--CCCHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKG---YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR--WFSPDLI 256 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~--~~s~~~~ 256 (481)
..+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+.++.... +..|. .+++.++
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 24668999999999987543 34678999999999999999999999988887888887643 34444 4689999
Q ss_pred HHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
++|.+||..+|.+ |+|++|+++||||+.
T Consensus 280 ~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 280 NLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 9999999866654 899999999999975
No 61
>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr
Probab=100.00 E-value=1.7e-47 Score=383.95 Aligned_cols=250 Identities=38% Similarity=0.649 Sum_probs=219.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS-ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998654433333444555554 56889999999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 999998875 5799999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+..+....+..+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 999999999988777 5689999999999999999999999988888888988887788888999999999999999999
Q ss_pred CCCH----hHHHhCccccc
Q 011628 270 RITI----PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~----~eil~h~~f~~ 284 (481)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCCCCHHHHHcCCCcCC
Confidence 9997 69999999965
No 62
>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp
Probab=100.00 E-value=1.4e-47 Score=383.51 Aligned_cols=250 Identities=36% Similarity=0.686 Sum_probs=219.6
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+..|..++..+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876543333445556677777654 799999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 999999865 6899999999999999999999999999999999999999999999999999874322 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......|.+++.++.+||.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 999999999987776 5789999999999999999999999888888888888777888899999999999999999999
Q ss_pred CCCHh-HHHhCccccc
Q 011628 270 RITIP-EIMENRWFRK 284 (481)
Q Consensus 270 Rps~~-eil~h~~f~~ 284 (481)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 238 RLGVDGDIRQHPFFRG 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99864 8889999975
No 63
>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl
Probab=100.00 E-value=1.7e-47 Score=385.02 Aligned_cols=250 Identities=34% Similarity=0.630 Sum_probs=218.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445566788999999998 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++... .........+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence 999998865 689999999999999999999999999999999999999999999999999986421 11223345789
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---------hHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---------NIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
|+.|+|||++.+..+ +.++|+|||||++|+|++|..||... .....+..+.......|..+++.+.++|.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999999988777 56899999999999999999999631 12335566677777889999999999999
Q ss_pred HhcccCcCCCCC------HhHHHhCccccc
Q 011628 261 KLLDTNPDKRIT------IPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps------~~eil~h~~f~~ 284 (481)
+||+.||.+|+| ++++++||||..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 789999999964
No 64
>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,
Probab=100.00 E-value=2.2e-47 Score=383.36 Aligned_cols=250 Identities=36% Similarity=0.632 Sum_probs=218.5
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS-ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+|+.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997654333333445556654 56789999999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999988875 6799999999999999999999999999999999999999999999999999864221 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...++..+.......++..+..+.++|.+||+.+|.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 999999999988777 5689999999999999999999999888888888888877777778999999999999999999
Q ss_pred CCCH----hHHHhCccccc
Q 011628 270 RITI----PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~----~eil~h~~f~~ 284 (481)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9986 58999999974
No 65
>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in
Probab=100.00 E-value=2e-47 Score=383.42 Aligned_cols=252 Identities=40% Similarity=0.704 Sum_probs=222.3
Q ss_pred EeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 31 GKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
++.||+|+||.||+|++. .+++.||+|++.+.... .......+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 47899999999765432 12234567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 107 YVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 107 y~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
|++|++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 9999999999875 6789999999999999999999999999999999999999999999999999864321 122334
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhccc
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 265 (481)
..+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+....|..+++++.+||.+||++
T Consensus 159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 5689999999999987766 578999999999999999999999988888888888888888999999999999999999
Q ss_pred CcCCCC-----CHhHHHhCcccccC
Q 011628 266 NPDKRI-----TIPEIMENRWFRKG 285 (481)
Q Consensus 266 dP~~Rp-----s~~eil~h~~f~~~ 285 (481)
||++|| +++++++||||...
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999753
No 66
>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an
Probab=100.00 E-value=2.5e-47 Score=378.86 Aligned_cols=255 Identities=30% Similarity=0.510 Sum_probs=209.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||+||+|++..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999999754322 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+. ++|.+.+.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99996 577777754 5699999999999999999999999999999999999999999999999999864322 112
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhh--CCC--------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYK--GEF-------------- 245 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~--~~~-------------- 245 (481)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+.. +..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 234567899999999987655446789999999999999999999987532 222222211 000
Q ss_pred -----C--CC---------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 246 -----R--SP---------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 246 -----~--~~---------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
. .+ ..+++++.+||.+||+.||.+|||+.|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~ 293 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSD 293 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccccc
Confidence 0 00 013567899999999999999999999999999975
No 67
>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase. Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor
Probab=100.00 E-value=2.5e-47 Score=383.63 Aligned_cols=257 Identities=32% Similarity=0.542 Sum_probs=222.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765434445667889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 99999999999975 5799999999999999999999999999999999999999999999999999975432111 12
Q ss_pred ccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--C--CCCCCCCHH
Q 011628 184 FHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--F--RSPRWFSPD 254 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~--~~~~~~s~~ 254 (481)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... . +....++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2233578999999999999999999999888777777776542 2 223357999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+.+||.+||. +|.+|||++++++||||.+
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999998 9999999999999999975
No 68
>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C. Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re
Probab=100.00 E-value=2.8e-47 Score=381.58 Aligned_cols=250 Identities=38% Similarity=0.697 Sum_probs=223.5
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||||++.+...........+.+|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444456677899999888 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999998876 5899999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......|..+++.+.+||.+||..||++
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 999999999988777 5689999999999999999999999888888888888888888889999999999999999999
Q ss_pred CCCH-----hHHHhCccccc
Q 011628 270 RITI-----PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~-----~eil~h~~f~~ 284 (481)
|||+ .++++||||..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCC
Confidence 9999 99999999976
No 69
>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.9e-49 Score=370.27 Aligned_cols=260 Identities=39% Similarity=0.705 Sum_probs=241.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.+-+++|..+++||+|+||+|.+++.+.+++.+|+|+++++-+...+.+..-.-|-++|+.++||.+..+...|...+.+
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34589999999999999999999999999999999999998877766777777899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+.||+|+-.+.+ ..++|+.++.|-..|++||.|||+++|++||||.+|+|+|.+|++||+|||+++. ....
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~ 321 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKY 321 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cccc
Confidence 999999999999988876 5799999999999999999999999999999999999999999999999999874 2234
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
.....+.||||.|+|||++....| +..+|.|.+||++|||++|++||...+...++..|..++.++|..++++++.|+.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred cceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 455678999999999999999888 5679999999999999999999999999999999999999999999999999999
Q ss_pred HhcccCcCCCC-----CHhHHHhCccccc
Q 011628 261 KLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.+|.+||.+|. .+.||.+|+||..
T Consensus 401 GLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 401 GLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred HHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999998 4899999999964
No 70
>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha. Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a
Probab=100.00 E-value=4.9e-47 Score=380.64 Aligned_cols=255 Identities=32% Similarity=0.605 Sum_probs=226.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+|++.+.||+|+||+||+|++..+|+.||+|++.+...........+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765433444566778999998886 577888999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 99999999999876 6899999999999999999999999999999999999999999999999999874321 11223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+.......|..+++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 45679999999999987776 56899999999999999999999999888888889888888888999999999999999
Q ss_pred cCcCCCCC-----HhHHHhCccccc
Q 011628 265 TNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps-----~~eil~h~~f~~ 284 (481)
+||.+|++ .+++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 478999999975
No 71
>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2. Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul
Probab=100.00 E-value=1.9e-47 Score=389.34 Aligned_cols=257 Identities=32% Similarity=0.586 Sum_probs=222.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.++..++||||+++++.+.....+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655444455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ---- 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 180 (481)
||++||+|.+++.+ +.+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999875 6799999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc
Q 011628 181 -----------------------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ 231 (481)
Q Consensus 181 -----------------------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~ 231 (481)
.....+.+||+.|+|||++.+.++ +.++|||||||++|+|++|..||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence 011224589999999999988887 56899999999999999999999998
Q ss_pred hHHHHHHHHhhCC--CCCCC--CCCHHHHHHHHHhcccCcCCCC---CHhHHHhCccccc
Q 011628 232 NIMVMYKKIYKGE--FRSPR--WFSPDLIRLLTKLLDTNPDKRI---TIPEIMENRWFRK 284 (481)
Q Consensus 232 ~~~~~~~~i~~~~--~~~~~--~~s~~~~~li~~~L~~dP~~Rp---s~~eil~h~~f~~ 284 (481)
+....+.++.... ...|. .+++++++||.+|+ .||.+|+ +++++++||||..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 8888887776532 33333 37899999999987 4999998 4899999999975
No 72
>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta. Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in
Probab=100.00 E-value=4e-47 Score=380.17 Aligned_cols=250 Identities=33% Similarity=0.643 Sum_probs=219.6
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||||++................|..+++.. +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876433233345566788888764 899999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999976 5799999999999999999999999999999999999999999999999999864221 1222345679
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++||||+||++|+|++|..||...+....+..+.......|.+++.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 999999999987777 5789999999999999999999999888888888877777788899999999999999999999
Q ss_pred CCCHh-HHHhCccccc
Q 011628 270 RITIP-EIMENRWFRK 284 (481)
Q Consensus 270 Rps~~-eil~h~~f~~ 284 (481)
||++. ++++||||..
T Consensus 238 R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 238 RLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCCChHHHHcCcccCC
Confidence 99996 8999999976
No 73
>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1. Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an
Probab=100.00 E-value=4.5e-47 Score=388.19 Aligned_cols=259 Identities=32% Similarity=0.542 Sum_probs=223.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 58999999999999999999999999999999999765433333445678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++||+|.+++....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++....... ....
T Consensus 122 ~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~~~ 200 (371)
T cd05622 122 MEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRC 200 (371)
T ss_pred EcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999987543211 1122
Q ss_pred cccCCCCccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC--CCCCHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKG---YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP--RWFSPDLIR 257 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~--~~~s~~~~~ 257 (481)
.+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|..||...+....+.++.... ...| ..+++.+++
T Consensus 201 ~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 280 (371)
T cd05622 201 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280 (371)
T ss_pred cCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHH
Confidence 4568999999999986543 24678999999999999999999999998888888887643 3333 458999999
Q ss_pred HHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 258 LLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
||.+||..++.+ |+++++|++||||..
T Consensus 281 li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 281 LICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 999999854443 789999999999975
No 74
>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]
Probab=100.00 E-value=2.8e-47 Score=383.03 Aligned_cols=248 Identities=31% Similarity=0.556 Sum_probs=215.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcE-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES-VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-KIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~ 102 (481)
.....+.+.||+|+||+||+|.+ .|+. ||||++......... .+.+.+|+.+|++++|||||+++|++.+.. ..+
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 45567778899999999999998 4556 999999876544433 778999999999999999999999999988 799
Q ss_pred EEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCcEEEccCC-CEEEEecCCcccccc
Q 011628 103 FVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARG-VYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQ 177 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~g-i~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~ 177 (481)
|||||+++|+|.+++.. +.++...+..++.||+.|++|||+++ |+||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999965 68999999999999999999999999 99999999999999998 999999999986543
Q ss_pred cccCCcccccCCCCccccccccc--cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh-C-CCCCCCCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLS--RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-G-EFRSPRWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~--~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~-~~~~~~~~s~ 253 (481)
.. .......||+.|||||++. ...| +.|+||||+|+++|||+||..||.+.........+.. + ....|..+++
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 21 2223368999999999998 4566 6799999999999999999999999887666655543 3 3455777999
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..|+.+||..||.+||++.+|+.
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 9999999999999999999999976
No 75
>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o
Probab=100.00 E-value=4.9e-47 Score=381.69 Aligned_cols=250 Identities=33% Similarity=0.641 Sum_probs=217.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++.++ +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876544445566788899988877 799999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 999988865 6799999999999999999999999999999999999999999999999999864221 1222345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC---------chHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD---------QNIMVMYKKIYKGEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~s~~~~~li~ 260 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.. .........+.......|..++..+.+||.
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 999999999988777 5689999999999999999999952 122345566667777888899999999999
Q ss_pred HhcccCcCCCCC------HhHHHhCccccc
Q 011628 261 KLLDTNPDKRIT------IPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps------~~eil~h~~f~~ 284 (481)
+||+.||.+||| ++++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999998 589999999965
No 76
>PLN00034 mitogen-activated protein kinase kinase; Provisional
Probab=100.00 E-value=1.4e-46 Score=381.89 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=214.2
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++++.||+|+||.||+|++..+++.||||++.... .......+.+|+.+++.++|+||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34678999999999999999999999999999999986543 2345567889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
+||||+.+|+|.+. ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D 223 (353)
T ss_pred EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence 99999999998653 345778889999999999999999999999999999999999999999999987643211 1
Q ss_pred cccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---HHHHHHHhh-CCCCCCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYK-GEFRSPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~-~~~~~~~~~s~~ 254 (481)
......||..|+|||++.. ..+.+.++|||||||++|+|++|..||..... ......+.. .....+..++++
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2245679999999999743 23445689999999999999999999974322 222222222 234456678999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+||.+||+.||++|||+.|+++||||.+.
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 9999999999999999999999999999764
No 77
>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt
Probab=100.00 E-value=1.5e-46 Score=377.39 Aligned_cols=250 Identities=37% Similarity=0.647 Sum_probs=217.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHH-HHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREI-SILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei-~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|. .+++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4799999999999999999999999999865433322333444444 456889999999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 999999876 5799999999999999999999999999999999999999999999999999874321 2223445689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+.......++.+++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 999999999988776 5689999999999999999999999888888888888777777789999999999999999999
Q ss_pred CCCHh----HHHhCccccc
Q 011628 270 RITIP----EIMENRWFRK 284 (481)
Q Consensus 270 Rps~~----eil~h~~f~~ 284 (481)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99876 8999999954
No 78
>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=6.7e-48 Score=386.28 Aligned_cols=257 Identities=30% Similarity=0.518 Sum_probs=237.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK-IYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~l 103 (481)
+++|+.++++|+|+||.+++++++..++.+++|.+........ ......+|+.+++++.|||||.+++.|..++. .+|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 6789999999999999999999999999999999988775544 34478899999999999999999999998888 999
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||+||+||+|.+.|.+ ..++|+.+..||.|++.|+.|||+++|+|||||+.||+++.++.+||+|||+|+..+..
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 9999999999999975 25999999999999999999999999999999999999999999999999999976542
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
.....+..|||.||+||++.+.+| +.|+|||||||++|||++-+.+|...+...+..+|..+. .+.|..++.+++.+|
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 246678999999999999999999 579999999999999999999999999999999999987 677999999999999
Q ss_pred HHhcccCcCCCCCHhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.||.++|..||++.++|.+|.....
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999999887643
No 79
>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos
Probab=100.00 E-value=1.6e-46 Score=378.24 Aligned_cols=255 Identities=31% Similarity=0.523 Sum_probs=207.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK-----SKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 101 (481)
+|++.+.||+|+||.||+|++..+++.||||.+...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999998753222 22345678999999999999999999988543 358
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+. ++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 689888865 5799999999999999999999999999999999999999999999999999975332111
Q ss_pred -CCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------- 242 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------- 242 (481)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 122345689999999999865 344 6789999999999999999999987654322211110
Q ss_pred -----------CCCCC-----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 243 -----------GEFRS-----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 243 -----------~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
...+. .+.+++.+.++|.+||+.||++|||++|+++||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~ 295 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG 295 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence 00000 1236788999999999999999999999999999964
No 80
>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g
Probab=100.00 E-value=1.5e-46 Score=369.34 Aligned_cols=248 Identities=30% Similarity=0.475 Sum_probs=213.2
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||+||++.+..+++.||+|.+.+...........+..|+.+++.++||||+++++++.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999765544333446678899999999999999999999999999999999999999
Q ss_pred HHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccC
Q 011628 114 FNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188 (481)
Q Consensus 114 ~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 188 (481)
...+.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 887732 46899999999999999999999999999999999999999999999999998754321 12234467
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... ......+.......|..+++.+.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 9999999999988777 5689999999999999999999976432 3344445555556677899999999999999
Q ss_pred cCcCCCC-----CHhHHHhCccccc
Q 011628 265 TNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.||++|| +++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999964
No 81
>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]
Probab=100.00 E-value=4.4e-47 Score=365.71 Aligned_cols=257 Identities=35% Similarity=0.560 Sum_probs=220.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN-IVQLFEVMATKS---- 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~---- 99 (481)
+..|+.++.||+|+||+||+|+.+.+|+.||+|.+..+... ++.-....||+.+++.|+|+| |+++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 66788889999999999999999999999999999876532 334456789999999999999 999999998877
Q ss_pred --EEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 --KIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 --~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
.+++|+||++. +|.+++.. ..++...++.+++||+.||+|||++||+||||||+|||++.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 89888865 24788899999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---------
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--------- 243 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------- 243 (481)
+.... ....+...++|.+|+|||++.+...++...||||+|||++||++++.-|.+.+.......|..-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 86542 2233567789999999999999866678899999999999999999999999887777777541
Q ss_pred ---------CCCCCCC------------CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 ---------EFRSPRW------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ---------~~~~~~~------------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
....+.| .+++..+++.+||+.+|.+|.|+..++.||||...
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 1111222 23478999999999999999999999999999764
No 82
>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2. Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.
Probab=100.00 E-value=1.3e-46 Score=377.13 Aligned_cols=250 Identities=36% Similarity=0.644 Sum_probs=218.7
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREIS-ILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998665433333445555554 67889999999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 999988865 5799999999999999999999999999999999999999999999999999874221 1223345689
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+..+.......|...+..+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 999999999987777 5689999999999999999999999988888888888888888889999999999999999999
Q ss_pred CCCH----hHHHhCccccc
Q 011628 270 RITI----PEIMENRWFRK 284 (481)
Q Consensus 270 Rps~----~eil~h~~f~~ 284 (481)
||++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 49999999964
No 83
>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of
Probab=100.00 E-value=4.6e-47 Score=381.74 Aligned_cols=249 Identities=38% Similarity=0.645 Sum_probs=216.2
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
||+|+||+||+|++..+++.||+|++.+.............+|..++..+ .||||+++++++.....+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999765443333344455677777665 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|.+.+.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999998865 6799999999999999999999999999999999999999999999999999864321 2223346789
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC-CCCHHHHHHHHHhcccCcC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR-WFSPDLIRLLTKLLDTNPD 268 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~-~~s~~~~~li~~~L~~dP~ 268 (481)
|+.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+..+....|. .+++++.+||.+||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 999999999876544467899999999999999999999999888888888888776664 4799999999999999999
Q ss_pred CCC----CHhHHHhCccccc
Q 011628 269 KRI----TIPEIMENRWFRK 284 (481)
Q Consensus 269 ~Rp----s~~eil~h~~f~~ 284 (481)
+|| +++++++||||..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HCCCCCCCHHHHhcCccccC
Confidence 998 7999999999975
No 84
>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2. Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=4.9e-46 Score=374.64 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=216.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..++..||+|++.... .......+.+|+.+++.++||||+++++++...+.+++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999997653 234557789999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||++||+|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----c
Confidence 999999999999976 5799999999999999999999986 699999999999999999999999999875422 2
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHH----------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKI---------------------- 240 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i---------------------- 240 (481)
......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+..++...+
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2345679999999999987766 57899999999999999999999765543332211
Q ss_pred ------------------------hhCCC-C-CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 241 ------------------------YKGEF-R-SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 241 ------------------------~~~~~-~-~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..... . ....+++++++||.+||+.||++|||+.+|++||||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 11110 0 112368899999999999999999999999999999754
No 85
>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase. Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate
Probab=100.00 E-value=5.6e-47 Score=379.20 Aligned_cols=249 Identities=37% Similarity=0.687 Sum_probs=220.8
Q ss_pred eEecccCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||++++. .+|+.||+|++.+..... .....+.+|+.++++++||||+++++++.....+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999863 578999999998654322 23345678999999999999999999999999999999999
Q ss_pred CCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccccc
Q 011628 109 RGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187 (481)
Q Consensus 109 ~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 187 (481)
.||+|.+.+.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecc
Confidence 99999999875 5799999999999999999999999999999999999999999999999999875432 11223456
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP 267 (481)
+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+.......|..+++.+.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 89999999999987776 57899999999999999999999998888888888888888888999999999999999999
Q ss_pred CCCCC-----HhHHHhCccccc
Q 011628 268 DKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 268 ~~Rps-----~~eil~h~~f~~ 284 (481)
.+||| +++++.||||..
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCC
Confidence 99999 778999999975
No 86
>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta. Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways
Probab=100.00 E-value=2.2e-46 Score=376.57 Aligned_cols=250 Identities=33% Similarity=0.633 Sum_probs=218.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++.++ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554445567788999999888 699999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|+|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999998865 6899999999999999999999999999999999999999999999999999864221 1223345789
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-------hHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-------NIMVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
|+.|+|||++.+..+ +.++|||||||++|+|++|..||... .....+..+.......|..++..+.++|.+|
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 999999999987777 57899999999999999999999531 2234556666666778888999999999999
Q ss_pred cccCcCCCCC------HhHHHhCccccc
Q 011628 263 LDTNPDKRIT------IPEIMENRWFRK 284 (481)
Q Consensus 263 L~~dP~~Rps------~~eil~h~~f~~ 284 (481)
|+.||.+|++ ++++++||||..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 9999999998 579999999975
No 87
>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,
Probab=100.00 E-value=3.3e-46 Score=367.76 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=218.5
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.|++.+.||+|+||+||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++..++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999988999999999976544333334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+.||+|.+.+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 9999999988753 3689999999999999999999999999999999999999999999999999875322 122
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH----HHHHHhhCCCCCCCCCCHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPDLIRLL 259 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~~~~li 259 (481)
....+|++.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+... ....+.......+..+++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 234579999999999987666 568999999999999999999998765432 233334444556667899999999
Q ss_pred HHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 260 TKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 260 ~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.+||..||.+|| +++++++||||.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999975
No 88
>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,
Probab=100.00 E-value=4.6e-46 Score=374.87 Aligned_cols=258 Identities=30% Similarity=0.540 Sum_probs=218.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998654444445566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999999975 4799999999999999999999999999999999999999999999999999865332111 11
Q ss_pred ccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC---CCCCHH
Q 011628 184 FHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP---RWFSPD 254 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 254 (481)
....+||+.|+|||++.. ....+.++||||+||++|+|++|..||.+.+....+..+.... +..| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 223579999999999863 2334678999999999999999999999888777777776532 2222 347999
Q ss_pred HHHHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
++++|++||..++++ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999998764444 889999999999964
No 89
>PTZ00283 serine/threonine protein kinase; Provisional
Probab=100.00 E-value=8.5e-46 Score=391.72 Aligned_cols=261 Identities=32% Similarity=0.522 Sum_probs=227.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
...++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 3468999999999999999999999999999999999876533 334566889999999999999999988775432
Q ss_pred -----EEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 100 -----KIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 100 -----~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.+++||||+++|+|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 37899999999999998853 35899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCC
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSP 248 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~ 248 (481)
|+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+......++..+.. +.|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 99976543333333456789999999999988777 5789999999999999999999999888888777777654 457
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+++++.+++.+||+.||.+||++.++++|||++..
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 7899999999999999999999999999999998653
No 90
>PTZ00267 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=1.7e-45 Score=388.44 Aligned_cols=258 Identities=29% Similarity=0.479 Sum_probs=225.2
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKS-GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
+....|.+.+.||+|+||.||.|.+..+ ++.||+|.+.... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 4456799999999999999999998877 7889999875432 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
|+||||++||+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999999887742 368999999999999999999999999999999999999999999999999998654
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDL 255 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~ 255 (481)
.........+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.......+..+.. +.|..+++++
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 3222233456789999999999987776 6789999999999999999999999888777777777654 3566789999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.++|.+||.+||++|||+++++.|+|++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999864
No 91
>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla
Probab=100.00 E-value=1.1e-45 Score=364.15 Aligned_cols=251 Identities=31% Similarity=0.472 Sum_probs=207.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMA----- 96 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~----- 96 (481)
.+|++.+.||+|+||+||+|++.. +++.||+|++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 57889999987654222 2334456788777766 6999999999985
Q ss_pred eCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
....+++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456899999997 588888864 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-C------
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-R------ 246 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~------ 246 (481)
..... .......||+.|+|||++.+..+ +.++||||+||++|+|++|.+||.+.+......++..... +
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 54321 23345679999999999987766 5689999999999999999999998876666555543210 0
Q ss_pred --------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 --------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 --------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..+.+++.+.+||.+||+.||++|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012467788999999999999999999999999997
No 92
>PTZ00036 glycogen synthase kinase; Provisional
Probab=100.00 E-value=1.2e-45 Score=385.75 Aligned_cols=249 Identities=28% Similarity=0.453 Sum_probs=204.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK------ 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------ 98 (481)
..+|++++.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 468999999999999999999999999999999886432 1234799999999999999999886432
Q ss_pred --CEEEEEEeccCCCchHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecC
Q 011628 99 --SKIYFVMEYVRGGELFNKVA-----KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFG 170 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~-----~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFG 170 (481)
..+++||||+++ +|.+.+. ...+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 247799999986 6666553 24699999999999999999999999999999999999999765 69999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------- 243 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------- 243 (481)
+|+.... .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++...
T Consensus 217 la~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9975432 122335678999999999876544467899999999999999999999987655444443321
Q ss_pred ----------CC------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 244 ----------EF------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 244 ----------~~------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.. ..|...++++.+||.+||+.||.+|||+.|+++||||..
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~ 356 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDD 356 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHh
Confidence 00 123446789999999999999999999999999999965
No 93
>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw
Probab=100.00 E-value=1.2e-45 Score=371.90 Aligned_cols=258 Identities=29% Similarity=0.518 Sum_probs=219.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654333444556788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+.||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC-cce
Confidence 99999999999975 579999999999999999999999999999999999999999999999999986432211 112
Q ss_pred ccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC---CCCCHH
Q 011628 184 FHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP---RWFSPD 254 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~---~~~s~~ 254 (481)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ...| ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234679999999999862 2333678999999999999999999999988888888886653 2223 357899
Q ss_pred HHHHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
+++||++||..+|.+ |++++++++||||..
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999964
No 94
>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]
Probab=100.00 E-value=9.5e-47 Score=363.05 Aligned_cols=251 Identities=32% Similarity=0.535 Sum_probs=213.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS---- 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 99 (481)
..=.|+-.+++|.|+||.||.|...++++.||||.+-.++... .+|+++|+.++|||||++..+|....
T Consensus 22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 4457999999999999999999999999999999986665332 27999999999999999998885432
Q ss_pred -EEEEEEeccCCCchHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCc
Q 011628 100 -KIYFVMEYVRGGELFNKVA-----KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLS 172 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~-----~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla 172 (481)
...+||||++. +|.+.++ +.+++.-.++-|++||++||.|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 34589999976 8988887 3579999999999999999999999999999999999999987 89999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---------
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--------- 243 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------- 243 (481)
+..... ....++..|..|+|||.+.+...++.+.||||+||++.||+.|++-|.+.+.......|.+-
T Consensus 174 K~L~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 174 KVLVKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eeeccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 875432 22357788999999999988877788999999999999999999999998876666555431
Q ss_pred --------CCC------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 --------EFR------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 --------~~~------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.. .....++++.+|+.++|..+|.+|.++.|++.||||..-
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL 312 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence 111 122368899999999999999999999999999999754
No 95
>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=2.2e-45 Score=373.99 Aligned_cols=257 Identities=28% Similarity=0.480 Sum_probs=210.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
.+.++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 468999999999999999999999999999999999976532 2334566789999999999999999999986543
Q ss_pred ---EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 100 ---KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 100 ---~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
.+|+||||+.+ +|.+.+. ..+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 5666554 358999999999999999999999999999999999999999999999999987432
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------------- 242 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------------- 242 (481)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+..
T Consensus 175 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 T---NFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred c---CccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 2 222345678999999999988777 5689999999999999999999987654332222111
Q ss_pred --------CCCC--------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 243 --------GEFR--------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 243 --------~~~~--------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.... .+...++.+++||.+||..||++|||+.|+++||||...+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 1000 0112357789999999999999999999999999997654
No 96
>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play
Probab=100.00 E-value=1.9e-45 Score=366.39 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=212.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 57899999999999999999999999999999999765422 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP--TK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC--cc
Confidence 999986 78777754 35899999999999999999999999999999999999999999999999998753321 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------- 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------- 243 (481)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2234568999999999876554467899999999999999999999876654433333210
Q ss_pred CCC-----------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 EFR-----------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ~~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
... ....+++++++||.+||+.||.+|||++|+++||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 000 112368899999999999999999999999999999754
No 97
>PHA03212 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.8e-45 Score=378.62 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=205.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||.||+|++..+++.||+|.... ..+.+|+.+++.++||||+++++++......++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 34689999999999999999999999999999997532 235689999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|+|++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 161 v~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~ 238 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN 238 (391)
T ss_pred EEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence 999995 688888765 679999999999999999999999999999999999999999999999999997533211 12
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch-------HHHHHHHH---------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-------IMVMYKKI--------------- 240 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i--------------- 240 (481)
.....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .......+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred ccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2345689999999999988777 678999999999999999998764321 00111111
Q ss_pred -----------hhCCCC----CCC-----CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 241 -----------YKGEFR----SPR-----WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 241 -----------~~~~~~----~~~-----~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...... .|. .++.++.+||.+||+.||.+|||++|+++||||+..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 111110 111 245679999999999999999999999999999753
No 98
>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi
Probab=100.00 E-value=3.6e-45 Score=360.98 Aligned_cols=253 Identities=42% Similarity=0.773 Sum_probs=228.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997665444455677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||+++++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999876 67999999999999999999999999999999999999999999999999998754321 2
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...+|++.|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+..+....|..+++.++++|.+||.
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 34578999999999877655 56899999999999999999999988877788888888888888899999999999999
Q ss_pred cCcCCCC-----CHhHHHhCccccc
Q 011628 265 TNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
.||.+|+ +++++++||||..
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred CCHHHccCcccCCHHHHHcCccccc
Confidence 9999999 8999999999964
No 99
>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta. Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.
Probab=100.00 E-value=1.7e-45 Score=370.75 Aligned_cols=258 Identities=29% Similarity=0.508 Sum_probs=219.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999997654333344566788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+.||+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999975 579999999999999999999999999999999999999999999999999987543211 111
Q ss_pred ccccCCCCccccccccccC----CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCC---CCCHH
Q 011628 184 FHTFCGTPAYVAPEVLSRK----GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPR---WFSPD 254 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~---~~s~~ 254 (481)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|..||...+....+.++.... ++.|. .++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2345799999999998652 223578999999999999999999999888877777776543 33333 36899
Q ss_pred HHHHHHHhcccCcCC--CCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDK--RITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~--Rps~~eil~h~~f~~ 284 (481)
++++|.+||..++.+ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 568999999999974
No 100
>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is
Probab=100.00 E-value=1.1e-45 Score=373.75 Aligned_cols=255 Identities=28% Similarity=0.473 Sum_probs=213.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++++.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 467899999999999999999999999999999999876432 222345677899999999999999999987543
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|+++|++ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3578999988 7799998888889999999999999999999999999999999999999999999999999987543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------ 244 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------ 244 (481)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 23456799999999998775445778999999999999999999998766544433332110
Q ss_pred ----------C-CC--------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 ----------F-RS--------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 ----------~-~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
. .. ....++.+.+||.+||..||.+|||+.|+++||||.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~ 303 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQ 303 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhc
Confidence 0 00 1235677899999999999999999999999999975
No 101
>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity. Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....
Probab=100.00 E-value=1.5e-45 Score=356.26 Aligned_cols=252 Identities=42% Similarity=0.737 Sum_probs=213.7
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++++.||+|+||+||+|++..+++.||+|++........ ......+|+.+++.++||||+++++++......+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence 8999999999999999999999999999999987754332 233445699999999999999999999999999999999
Q ss_pred cCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccc
Q 011628 108 VRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT 186 (481)
Q Consensus 108 ~~gg~L~~~i~-~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 186 (481)
+.+++|.+++. .+.+++..+..++.||+.||.+||++|++|+||||+||+++.++.++|+|||++.... ........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccc
Confidence 99999999998 5789999999999999999999999999999999999999999999999999987431 12233456
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhCCCCC----CCCCCHHHHHHH
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGEFRS----PRWFSPDLIRLL 259 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~~----~~~~s~~~~~li 259 (481)
..+++.|+|||++......+.++|+||||+++|+|++|..||... +......+........ ....++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 788999999999873334477999999999999999999999987 3334443333322111 111248899999
Q ss_pred HHhcccCcCCCCCHhHHHhCccc
Q 011628 260 TKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999997
No 102
>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase. Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription
Probab=100.00 E-value=1.5e-45 Score=377.05 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=213.2
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-----KI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 101 (481)
+|++++.||+|+||.||+|.+..+|+.||||.+.... ......+.+.+|+.+++.++||||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4889999999999999999998999999999986532 22234567889999999999999999999998776 79
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~ 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence 99999997 578777765 67999999999999999999999999999999999999999999999999999754321 1
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh------------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK------------------ 242 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~------------------ 242 (481)
........+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12233457899999999998765456789999999999999999999988765544443321
Q ss_pred -----CCC---------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 -----GEF---------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 -----~~~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
... ......++++.+||.+||+.||.+|||+.|+++||||...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111 1223357889999999999999999999999999999764
No 103
>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t
Probab=100.00 E-value=7.6e-45 Score=352.37 Aligned_cols=256 Identities=30% Similarity=0.540 Sum_probs=220.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK--SGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+.|++.+.||+|+||.||.|.+..+++.||+|.+....... ......+.+|+.++++++||||+++++++.....+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 1234678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD- 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~- 181 (481)
++||++|++|.+.+.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999999875 57899999999999999999999999999999999999999999999999998754322111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li 259 (481)
.......|++.|+|||++.+..+ +.++||||||+++|+|++|..||...+......++... ....|..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 11134568899999999987765 67899999999999999999999887665555554433 3445677899999999
Q ss_pred HHhcccCcCCCCCHhHHHhCccc
Q 011628 260 TKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999997
No 104
>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1. Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst
Probab=100.00 E-value=7e-45 Score=366.64 Aligned_cols=255 Identities=27% Similarity=0.459 Sum_probs=215.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|.+..++..+|+|++.... .......+.+|+++++.++||||+++++++.+.+.+|+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3578999999999999999999999999999999987643 23345678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||+.||+|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 156 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 156 (333)
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence 9999999999999876 5789999999999999999999985 799999999999999999999999999875422
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHH-----------------------
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK----------------------- 238 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~----------------------- 238 (481)
.......|++.|+|||++.+..+ +.++|+|||||++|+|++|..||..........
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (333)
T cd06650 157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG 235 (333)
T ss_pred hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence 12234579999999999987666 578999999999999999999997654332211
Q ss_pred ---------------------HHhhCC-CCC-CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 239 ---------------------KIYKGE-FRS-PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 239 ---------------------~i~~~~-~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+.... ... ...++.++++||.+||+.||++|||+.|++.||||+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 111111 011 12367889999999999999999999999999999764
No 105
>PTZ00284 protein kinase; Provisional
Probab=100.00 E-value=4.8e-45 Score=384.34 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=201.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH------PNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~~~~~ 98 (481)
.++|++.+.||+|+||+||+|.+..+++.||||+++... ........|+.+++.+.| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996432 223445678888877755 4588888888764
Q ss_pred -CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCC-------------
Q 011628 99 -SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENG------------- 162 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g------------- 162 (481)
..+|+|||++ |++|.+++.+ +.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999988 6788888765 689999999999999999999998 5999999999999998766
Q ss_pred ---CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHH
Q 011628 163 ---DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKK 239 (481)
Q Consensus 163 ---~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 239 (481)
.+||+|||++.... ......+||+.|+|||++.+..| +.++|||||||++|+|++|++||.+.+.......
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875422 12245689999999999988877 5689999999999999999999987665433322
Q ss_pred HhhCCCCC----------------------------CC--------------CCCHHHHHHHHHhcccCcCCCCCHhHHH
Q 011628 240 IYKGEFRS----------------------------PR--------------WFSPDLIRLLTKLLDTNPDKRITIPEIM 277 (481)
Q Consensus 240 i~~~~~~~----------------------------~~--------------~~s~~~~~li~~~L~~dP~~Rps~~eil 277 (481)
+....... +. ..++.+.+||.+||++||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 21110000 00 0134578999999999999999999999
Q ss_pred hCcccccCc
Q 011628 278 ENRWFRKGF 286 (481)
Q Consensus 278 ~h~~f~~~~ 286 (481)
+||||.+.+
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998643
No 106
>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V
Probab=100.00 E-value=3.3e-45 Score=369.24 Aligned_cols=251 Identities=27% Similarity=0.447 Sum_probs=204.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 468999999999999999999852 345789999987542 223446788999999999 899999999988764
Q ss_pred -CEEEEEEeccCCCchHHHHHcC---------------------------------------------------------
Q 011628 99 -SKIYFVMEYVRGGELFNKVAKG--------------------------------------------------------- 120 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~~--------------------------------------------------------- 120 (481)
..+|++|||++||+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 4689999999999999988641
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccc
Q 011628 121 ------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYV 194 (481)
Q Consensus 121 ------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 194 (481)
.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...............+++.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 36778889999999999999999999999999999999999999999999997542211111122345678899
Q ss_pred cccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHH-HHHHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCC
Q 011628 195 APEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIM-VMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRI 271 (481)
Q Consensus 195 APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~-~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rp 271 (481)
|||++.+..+ +.++|||||||++|+|++ |..||.+.... .....+..+. ...|..+++++.+++.+||+.||.+||
T Consensus 244 aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 9999987776 578999999999999997 99999876543 3333344333 445677899999999999999999999
Q ss_pred CHhHHHh
Q 011628 272 TIPEIME 278 (481)
Q Consensus 272 s~~eil~ 278 (481)
|+.++++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999986
No 107
>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn
Probab=100.00 E-value=5.7e-45 Score=371.60 Aligned_cols=256 Identities=27% Similarity=0.446 Sum_probs=211.5
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 467899999999999999999999999999999999976432 223446678999999999999999999987543
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHHh-cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999976 66666643 48899999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-----------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF----------- 245 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------- 245 (481)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+.++.....
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 222345679999999999988777 5689999999999999999999988766555444432100
Q ss_pred -----------C--------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 -----------R--------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 -----------~--------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .....+..+++||.+||+.||.+|||++|+++||||...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0 001134578999999999999999999999999999754
No 108
>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as
Probab=100.00 E-value=9.9e-45 Score=357.35 Aligned_cols=254 Identities=28% Similarity=0.450 Sum_probs=215.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+++++.+...+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999976654444445567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+.|++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 9999999988853 3589999999999999999999999999999999999999999999999999865321 112
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---HHHHHHh-hCCCCCCCCCCHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---VMYKKIY-KGEFRSPRWFSPDLIRLL 259 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~-~~~~~~~~~~s~~~~~li 259 (481)
.....|++.|+|||++.+..+ +.++||||+||++|+|++|..||...... .....+. ......+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 234579999999999987776 57899999999999999999999864321 1122221 122334566899999999
Q ss_pred HHhcccCcCCCCC-----HhHHHhCccccc
Q 011628 260 TKLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 260 ~~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
.+||+.||.+||| ++|+++||||..
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 899999999965
No 109
>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok
Probab=100.00 E-value=6.2e-45 Score=369.95 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=210.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 467899999999999999999999999999999999876432 233456678999999999999999999988643
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 56666543 58999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------- 243 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 243 (481)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+....+..+...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 222345679999999999988777 56899999999999999999999876654333322110
Q ss_pred ---------CC--------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 244 ---------EF--------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 244 ---------~~--------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.. ..+...+.++++||.+||+.||.+|||+.|+++||||...+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 00 00112356789999999999999999999999999997543
No 110
>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-46 Score=351.77 Aligned_cols=253 Identities=36% Similarity=0.662 Sum_probs=220.0
Q ss_pred CCCCccCCeeE-EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 011628 20 NQSPLLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMAT 97 (481)
Q Consensus 20 ~~~~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 97 (481)
+...+.++|.+ -++||-|-.|+|-.+.++.||+.+|+|++... ...+||+++.-+.+ |||||.++++|++
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 44567899988 57899999999999999999999999998532 34678999888775 9999999999865
Q ss_pred ----CCEEEEEEeccCCCchHHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEE
Q 011628 98 ----KSKIYFVMEYVRGGELFNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVS 167 (481)
Q Consensus 98 ----~~~~~lv~Ey~~gg~L~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~ 167 (481)
...+.+|||.++||+|+..++. | .++|.++..+++||..|+.|||+.+|.||||||||+|.... ..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 4578899999999999999986 3 49999999999999999999999999999999999999764 469999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch----HHHHHHHHhhC
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKG 243 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~ 243 (481)
|||+|+... ....+.+.|-||+|+|||++....|+ ...|+||+||++|.|++|++||.... ...+..+|..|
T Consensus 207 DfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 207 DFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred ccccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 999998643 24567889999999999999888886 46999999999999999999997543 24567888888
Q ss_pred CCCC--CCC--CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 244 EFRS--PRW--FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 244 ~~~~--~~~--~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+.+ |.| +|.+++++|+++|..+|.+|.|++++++|||+..
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 7554 455 7999999999999999999999999999999865
No 111
>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou
Probab=100.00 E-value=8e-45 Score=357.42 Aligned_cols=250 Identities=33% Similarity=0.505 Sum_probs=205.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMAT-----K 98 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~-----~ 98 (481)
+|++.+.||+|+||+||+|++..+++.||+|.+...... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 699999999999999999999999999999998764322 22233455777777666 69999999998864 3
Q ss_pred CEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
..++++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 468999999985 88888765 35899999999999999999999999999999999999999999999999998764
Q ss_pred cccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-----------
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE----------- 244 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 244 (481)
... .......||+.|+|||++.+..+ +.++||||+||++|+|++|..||..........++....
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 321 22234578999999999987766 578999999999999999999998776655444443210
Q ss_pred -------C---------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 -------F---------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 -------~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+ ...+.++..+.+||.+||++||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112367788999999999999999999999999998
No 112
>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1e-46 Score=380.37 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=228.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
-+.|+|+..||.|+||+||+|.+++++-..|.|+|... ..+...++.-||.||..|.||+||++++.|...+++||+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 35689999999999999999999999999999999643 345677888999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
.|||.||-....+.. ..+.+++++.+.+|++.||.|||+++|+|||||..|||++-+|.++|+|||.+...... ..
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~q 185 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--RQ 185 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH--Hh
Confidence 999999999888764 57999999999999999999999999999999999999999999999999998753221 22
Q ss_pred cccccCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC---CCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR---SPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---~~~~~s~~ 254 (481)
...++.|||+|||||++. ..+|+ .++||||||++|.+|..+.+|....+++.+..+|.+.+++ .|..++..
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~ 264 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRS 264 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhH
Confidence 235789999999999974 45664 6899999999999999999999999999999999887654 37888999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+|+.+||.+||..||++.+|++||||+..
T Consensus 265 F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 265 FSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred HHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9999999999999999999999999999854
No 113
>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase. Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl
Probab=100.00 E-value=1.8e-44 Score=357.92 Aligned_cols=256 Identities=30% Similarity=0.510 Sum_probs=213.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 67899999999999999999999999999999998755322 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+. ++|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~--~~ 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC--CC
Confidence 99997 488888764 46899999999999999999999999999999999999999999999999998753321 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------- 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------- 243 (481)
......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+.......+...
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 239 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence 2234467899999999876554567899999999999999999999887654443332210
Q ss_pred CCCCC-----------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 EFRSP-----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
....| ..+++.+.+||.+||+.||.+|||++|+++||||+.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~ 292 (301)
T cd07873 240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292 (301)
T ss_pred ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 00111 2468889999999999999999999999999999653
No 114
>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr
Probab=100.00 E-value=1.4e-44 Score=354.65 Aligned_cols=247 Identities=26% Similarity=0.456 Sum_probs=208.1
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||.||++++..+|+.||+|.+.............+..|+.+++.++||||+++++++.....+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443333344566799999999999999999999999999999999999999
Q ss_pred HHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 114 FNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 114 ~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
.+.+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++..... ........|+
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 988754 2588999999999999999999999999999999999999999999999999875432 1122345789
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch----HHHHHHHHhhCCCCC-CCCCCHHHHHHHHHhccc
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKGEFRS-PRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~-~~~~s~~~~~li~~~L~~ 265 (481)
+.|+|||++.+..+ +.++||||+||++|+|++|..||.... ............... ...+++++++||.+||++
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 99999999987775 678999999999999999999997642 234444444444333 245899999999999999
Q ss_pred CcCCCCCH----hHHHhCccccc
Q 011628 266 NPDKRITI----PEIMENRWFRK 284 (481)
Q Consensus 266 dP~~Rps~----~eil~h~~f~~ 284 (481)
||.+||++ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 67889999964
No 115
>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with
Probab=100.00 E-value=2.6e-44 Score=354.23 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=219.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.|+..+.||+|+||+||+|.+..+++.||+|.+.............+.+|+.+++.++|+||+++++.+..++..|++||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48889999999999999999999999999999977654444445567889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 9999999888753 3699999999999999999999999999999999999999999999999999865322 122
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH----HHHHHhhCCCCCCCCCCHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPDLIRLL 259 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~~~~li 259 (481)
.....|++.|+|||++.+..+ +.++|+||+||++|+|++|..||....... ....+.......+..+++++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 234579999999999987766 568999999999999999999998765432 333334444555667899999999
Q ss_pred HHhcccCcCCCCC-----HhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRIT-----IPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps-----~~eil~h~~f~~~ 285 (481)
.+||+.||.+||+ +.++++|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8899999999753
No 116
>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]
Probab=100.00 E-value=2.9e-45 Score=375.98 Aligned_cols=252 Identities=33% Similarity=0.522 Sum_probs=215.8
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-----CCcceEEEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-H-----PNIVQLFEVM 95 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-H-----pnIv~l~~~~ 95 (481)
..+..||++.+.||+|+||+|.+|.+.+|++.||||+++... .+..+...|+.+|..|+ | -|+|+++++|
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 455679999999999999999999999999999999997654 56777888999999997 4 3799999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC--CEEEEecC
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG--DLKVSDFG 170 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g--~lkl~DFG 170 (481)
...++.|||.|.++ -+|+++++. .+++...++.+++||+.||.+||+.||||+|||||||||.+-+ .+||+|||
T Consensus 258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999999995 599999986 4699999999999999999999999999999999999997654 69999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------- 243 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------- 243 (481)
.|+.... .. .+++-+..|+|||++.+.+|+ .+.||||||||+.||++|.+-|.+.+..+.+..|..-
T Consensus 337 SSc~~~q----~v-ytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 337 SSCFESQ----RV-YTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cccccCC----cc-eeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 9986443 22 388999999999999999996 5799999999999999999999988776665555320
Q ss_pred ---------------------------------------------CCCCCCC-----------CCHHHHHHHHHhcccCc
Q 011628 244 ---------------------------------------------EFRSPRW-----------FSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 244 ---------------------------------------------~~~~~~~-----------~s~~~~~li~~~L~~dP 267 (481)
....|.. -...+.+||++||+.||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 0001100 01237899999999999
Q ss_pred CCCCCHhHHHhCccccc
Q 011628 268 DKRITIPEIMENRWFRK 284 (481)
Q Consensus 268 ~~Rps~~eil~h~~f~~ 284 (481)
.+|+|..|+++||||..
T Consensus 491 ~~R~tp~qal~Hpfl~~ 507 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTG 507 (586)
T ss_pred hhcCCHHHHhcCccccc
Confidence 99999999999999974
No 117
>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.
Probab=100.00 E-value=7.2e-44 Score=344.36 Aligned_cols=252 Identities=27% Similarity=0.542 Sum_probs=218.6
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-KSKIYFVM 105 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv~ 105 (481)
+|++.+.||.|+||.||.|.+..+++.||+|.+...... ....+.+.+|+.++++++|||++++++.+.. ...+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999989999999999765432 2345668899999999999999999998764 44689999
Q ss_pred eccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 106 EYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 106 Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||+++++|.+.+.. ..+++.+++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999999864 3589999999999999999999999999999999999999999999999999875432 122
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLTK 261 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 261 (481)
......|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. ..+..+++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3345678999999999987766 5689999999999999999999988777666666666654 4566789999999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||++||++|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
No 118
>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate
Probab=100.00 E-value=5.6e-44 Score=347.30 Aligned_cols=255 Identities=30% Similarity=0.579 Sum_probs=218.8
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc------hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK------SGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
+|.++..||+|+||.||+|.+..+++.||+|.+....... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 6899999999999999999998899999999987543221 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
.+++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 678999999999999999999999999999999999999999999999999987654211
Q ss_pred c----CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-CCCCCCCCCHH
Q 011628 180 Q----DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPD 254 (481)
Q Consensus 180 ~----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 254 (481)
. ........|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+......++... ....|..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 111123468899999999987666 56899999999999999999999887665555554443 23456678999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+.++|.+||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
No 119
>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2
Probab=100.00 E-value=5.1e-44 Score=350.92 Aligned_cols=252 Identities=33% Similarity=0.540 Sum_probs=208.7
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999998999999999875432 22334667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 107 YVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 107 y~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|+. ++|.+++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.+|.++|+|||++...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 997 588887753 46899999999999999999999999999999999999999999999999998754321 12
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------- 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------- 243 (481)
......+++.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2234467899999999876554467899999999999999999999876543222221110
Q ss_pred -C---------CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 244 -E---------FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 244 -~---------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ......+++++.++|.+||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0 00123478899999999999999999999999999997
No 120
>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin
Probab=100.00 E-value=7.4e-44 Score=355.78 Aligned_cols=258 Identities=35% Similarity=0.589 Sum_probs=224.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999899999999998765544445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-
Q 011628 106 EYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD- 181 (481)
Q Consensus 106 Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~- 181 (481)
||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999875 36899999999999999999999999999999999999999999999999998643221100
Q ss_pred --------------------------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH
Q 011628 182 --------------------------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV 235 (481)
Q Consensus 182 --------------------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~ 235 (481)
.......|+..|+|||++.+..+ +.++||||||+++|+|++|..||.+.+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 01123468899999999987766 678999999999999999999999888777
Q ss_pred HHHHHhhCCCCCCCC--CCHHHHHHHHHhcccCcCCCCC----HhHHHhCccccc
Q 011628 236 MYKKIYKGEFRSPRW--FSPDLIRLLTKLLDTNPDKRIT----IPEIMENRWFRK 284 (481)
Q Consensus 236 ~~~~i~~~~~~~~~~--~s~~~~~li~~~L~~dP~~Rps----~~eil~h~~f~~ 284 (481)
.+..+.......+.. +++.+.++|.+||..||++||| ++++++||||+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 777776655544443 6899999999999999999999 999999999965
No 121
>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase. Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down
Probab=100.00 E-value=8.8e-44 Score=354.50 Aligned_cols=253 Identities=27% Similarity=0.466 Sum_probs=213.8
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..++..+|+|.+..+. ......++.+|+++++.++||||+++++++..++.+|++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 46999999999999999999999999999999987542 2345567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++|++|.+++.. +.+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||++..... ..
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence 99999999999975 679999999999999999999997 5999999999999999999999999999864322 22
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------------- 242 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------------- 242 (481)
....+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 345678999999999877665 5789999999999999999999976553332222211
Q ss_pred ---------------CC-CCCC-CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 ---------------GE-FRSP-RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 ---------------~~-~~~~-~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.. ...| ..+++++.+||.+||..||++|||+.++++||||.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00 0111 1267889999999999999999999999999999764
No 122
>PHA03207 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=7.4e-44 Score=367.13 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=206.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNV--KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.+..+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+.+++.++||||+++++++.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 44678999999999999999999764 356789999886432 24579999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+|++||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999996 588888864 679999999999999999999999999999999999999999999999999997544322
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---HHHHHHHhhC-------------
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYKG------------- 243 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~------------- 243 (481)
.........||+.|+|||++.+..| +.++|||||||++|+|++|..||.+... ...+..+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred ccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 2222335679999999999987777 5689999999999999999999965421 1111111110
Q ss_pred ----------------CCCCC-----CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 ----------------EFRSP-----RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ----------------~~~~~-----~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+..| ..++.++.++|.+||..||++|||+.|++.||||.+.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 01111 1246678999999999999999999999999999763
No 123
>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=9.5e-44 Score=352.26 Aligned_cols=255 Identities=29% Similarity=0.522 Sum_probs=219.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
...+|++.+.||+|+||.||+|++..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+..+...|+
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence 357999999999999999999999899999999999765432 23567899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 95 v~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~ 172 (296)
T cd06654 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSK 172 (296)
T ss_pred eecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc--ccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999998753321 112
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLT 260 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~ 260 (481)
.....|++.|+|||.+.+..+ +.++||||+||++|+|++|..||...+.......+.... ...+..+++.+.++|.
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 251 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (296)
T ss_pred cCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence 234578999999999877665 578999999999999999999998876643333332221 2335568899999999
Q ss_pred HhcccCcCCCCCHhHHHhCccccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+||..+|++|||+.++++||||..
T Consensus 252 ~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHCcCCcccCcCHHHHhhChhhhc
Confidence 999999999999999999999965
No 124
>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-45 Score=347.54 Aligned_cols=262 Identities=29% Similarity=0.590 Sum_probs=224.0
Q ss_pred CCCccCCeeE-EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 21 QSPLLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 21 ~~~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
.+.+.+-|++ .+.||+|+||.|-.+.+..+|..+|||++++.. .....++.||++++.+++ |+||+.++++|+++
T Consensus 72 ~g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 72 SGKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred cchHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3445667777 578999999999999999999999999998763 355688999999999995 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEecCCccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFGLSAV 174 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~---lkl~DFGla~~ 174 (481)
+.+|+|||-+.||.|...|.+ ..++|.++.++.++|+.||.|||.+||.||||||+|||...... +|||||.+..-
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg 228 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSG 228 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccc
Confidence 999999999999999999876 57999999999999999999999999999999999999976654 79999998754
Q ss_pred cccc-----ccCCcccccCCCCccccccccc----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCc--------------
Q 011628 175 SDQI-----RQDGLFHTFCGTPAYVAPEVLS----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-------------- 231 (481)
Q Consensus 175 ~~~~-----~~~~~~~~~~gt~~y~APEvl~----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-------------- 231 (481)
.... .....+.+.||+..|||||+.. ...++..+.|.||||+|||-||+|++||.+.
T Consensus 229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr 308 (463)
T KOG0607|consen 229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR 308 (463)
T ss_pred cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence 2211 1122345789999999999862 2233456899999999999999999999652
Q ss_pred -hHHHHHHHHhhCCCCCCCC----CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 232 -NIMVMYKKIYKGEFRSPRW----FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 232 -~~~~~~~~i~~~~~~~~~~----~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
-...++..|..|.+.+|.. +|.++++||+.+|..|+.+|.++.++++|||++.-
T Consensus 309 ~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 309 VCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC 367 (463)
T ss_pred HHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence 1356788899998877653 89999999999999999999999999999999753
No 125
>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc
Probab=100.00 E-value=2.2e-43 Score=340.57 Aligned_cols=252 Identities=27% Similarity=0.492 Sum_probs=221.7
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+++.|++|.+...... ......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 489999999999999999999999999999999765433 3345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|++|++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 9999999999865 36899999999999999999999999999999999999999999999999998754332 122
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 262 (481)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+..+ .+..+++++.++|.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 244578999999999987766 56899999999999999999999988877777777766543 3446889999999999
Q ss_pred cccCcCCCCCHhHHHhCccc
Q 011628 263 LDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f 282 (481)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
No 126
>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.3e-45 Score=354.44 Aligned_cols=261 Identities=33% Similarity=0.604 Sum_probs=235.3
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
......+|..+.+||.|+||+|-+|..+.+.+.+|||+++++-+.+.+.++--..|-++|... +-|.++.++.++.+.+
T Consensus 344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 344577899999999999999999999999999999999988766554444445677777766 4788999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||+.||+|.-.|+. |++.|..+..|+..|+.||-+||++||++||||..|||++.+|++||+|||+++. ..
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--cc
Confidence 99999999999999988887 8999999999999999999999999999999999999999999999999999873 22
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRL 258 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~l 258 (481)
.......+.||||.|+|||++...+| +..+|.||+||+||||++|++||++++..++++.|......+|..+|.++.++
T Consensus 502 ~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 502 FDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred cCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence 33445678999999999999999998 56799999999999999999999999999999999999999999999999999
Q ss_pred HHHhcccCcCCCCC-----HhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps-----~~eil~h~~f~~ 284 (481)
.+.+|.+.|.+|.. -.+|..||||+.
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 99999999999974 468999999975
No 127
>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p
Probab=100.00 E-value=6.1e-44 Score=356.54 Aligned_cols=246 Identities=28% Similarity=0.481 Sum_probs=193.5
Q ss_pred EeEecccCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 011628 31 GKLLGHGTFAKVYHARNV--KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKIYFVME 106 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~E 106 (481)
+++||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999975 3678999999865432 2346789999999999999999999854 457899999
Q ss_pred ccCCCchHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEecCCc
Q 011628 107 YVRGGELFNKVAK----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLS 172 (481)
Q Consensus 107 y~~gg~L~~~i~~----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl----~~~g~lkl~DFGla 172 (481)
|+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 78777642 148999999999999999999999999999999999999 45678999999999
Q ss_pred ccccccc-cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---------HHHHHHHhh
Q 011628 173 AVSDQIR-QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---------MVMYKKIYK 242 (481)
Q Consensus 173 ~~~~~~~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---------~~~~~~i~~ 242 (481)
+...... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||..... ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7653321 112234568899999999997765557789999999999999999999964321 011111111
Q ss_pred C----------------------------CCCC----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 243 G----------------------------EFRS----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 243 ~----------------------------~~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. .... ....++.+.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0000 01135678999999999999999999999999998
No 128
>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a
Probab=100.00 E-value=1.9e-43 Score=351.35 Aligned_cols=258 Identities=33% Similarity=0.620 Sum_probs=221.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+..+..+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999987664333344567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ---- 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~---- 180 (481)
||++|++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||+++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999975 6789999999999999999999999999999999999999999999999999864211000
Q ss_pred ---------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCC---
Q 011628 181 ---------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSP--- 248 (481)
Q Consensus 181 ---------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~--- 248 (481)
........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+.+.......+..+....|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 001123467889999999877666 6789999999999999999999998887777777776654332
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
..+++++.++|.+||++||++||+ +.++++||||..
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 257899999999999999999998 799999999964
No 129
>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1.7e-43 Score=350.59 Aligned_cols=254 Identities=30% Similarity=0.542 Sum_probs=220.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 4679999999999999999999999999999999875432 2345678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
+||+.|++|..++....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~ 172 (296)
T cd06655 95 MEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (296)
T ss_pred EEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc--ccC
Confidence 999999999999988889999999999999999999999999999999999999999999999999987543211 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~ 261 (481)
....|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||...+.......+.... ...+..+++.+.++|.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 251 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR 251 (296)
T ss_pred CCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence 34578999999999977666 568999999999999999999998877654444443332 33456688999999999
Q ss_pred hcccCcCCCCCHhHHHhCccccc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||..||.+|||+.+++.||||+.
T Consensus 252 ~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 252 CLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HhhcChhhCCCHHHHhhChHhhh
Confidence 99999999999999999999974
No 130
>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase. Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1
Probab=100.00 E-value=1.5e-43 Score=343.48 Aligned_cols=255 Identities=30% Similarity=0.552 Sum_probs=219.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||.|+||+||+|.+..++..+|+|++....... ....+.+|+.+++.++||||+++++.+......|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997654322 4577899999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 106 EYVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 106 Ey~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||++|++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999865 35899999999999999999999999999999999999999999999999998765432221
Q ss_pred --CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CC-----CCCCH
Q 011628 182 --GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SP-----RWFSP 253 (481)
Q Consensus 182 --~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~-----~~~s~ 253 (481)
.......|+..|+|||++......+.++|+|||||++|+|++|..||...+....+.++...... .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 12244578999999999876644477899999999999999999999888776666666554322 11 24678
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+.+++.+||..||++|||+++|+.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
No 131
>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase. Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea
Probab=100.00 E-value=1.7e-43 Score=347.24 Aligned_cols=254 Identities=31% Similarity=0.543 Sum_probs=215.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++..+..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999989999999999765432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 107 YVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 107 y~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|+ |++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999999864 5699999999999999999999999999999999999999999999999999876543211 223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--------------------
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------- 244 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------- 244 (481)
....|+..|+|||++.+....+.++||||+||++|+|++|.+||.+.+....+..+....
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 456789999999998765555778999999999999999999998776554444433210
Q ss_pred -CC---------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 245 -FR---------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 245 -~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
+. .....+..+.++|.+||..+|++|||++++++||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 0123568899999999999999999999999999983
No 132
>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)
Probab=100.00 E-value=1.2e-43 Score=346.83 Aligned_cols=256 Identities=31% Similarity=0.556 Sum_probs=223.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||.|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.....+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999976532 233466789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
||+++++|.+++..+++++..+..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||+++...... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999997654321 1223
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCC-CCHHHHHHHHHhc
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRW-FSPDLIRLLTKLL 263 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~-~s~~~~~li~~~L 263 (481)
...|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...+.......+..+.. ..+.. +++++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 4578899999999987765 6789999999999999999999988776666555555433 33344 7899999999999
Q ss_pred ccCcCCCCCHhHHHhCcccccCc
Q 011628 264 DTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 264 ~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
..+|++|||++++++||||++..
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCCC
Confidence 99999999999999999997653
No 133
>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1. Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.
Probab=100.00 E-value=5.2e-44 Score=346.01 Aligned_cols=252 Identities=29% Similarity=0.592 Sum_probs=222.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+......|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999988999999999987655444566789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 107 YVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 107 y~~gg~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
|+.|++|.+.+... .+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~---~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCC---cccc
Confidence 99999999999764 8999999999999999999999999999999999999999999999999998754321 1234
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---HHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYKGEFRSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~~~~~~s~~~~~li~~~ 262 (481)
...|+..|+|||++.+..+ +.++|+||||+++|+|++|..||...+. ..............|..+++.+.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678899999999977665 6789999999999999999999987663 33333333355666778899999999999
Q ss_pred cccCcCCCCCH--hHHHhCccc
Q 011628 263 LDTNPDKRITI--PEIMENRWF 282 (481)
Q Consensus 263 L~~dP~~Rps~--~eil~h~~f 282 (481)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999997
No 134
>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also
Probab=100.00 E-value=3.8e-44 Score=351.89 Aligned_cols=252 Identities=30% Similarity=0.543 Sum_probs=208.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999976432 22234567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 107 YVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 107 y~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence 9975 77777653 57999999999999999999999999999999999999999999999999998754321 1223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCC-CCchHHHHHHHHhhCC-------------------
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPF-QDQNIMVMYKKIYKGE------------------- 244 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf-~~~~~~~~~~~i~~~~------------------- 244 (481)
....+++.|+|||++.+....+.++|||||||++|+|++|..|| .+.+....+..+....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877554467899999999999999988885 4444433333332110
Q ss_pred C----------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 F----------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ...+.+++++.+||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112367889999999999999999999999999997
No 135
>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-44 Score=363.43 Aligned_cols=245 Identities=25% Similarity=0.459 Sum_probs=212.8
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.+++++.||+|-||.||.|.+. ....||+|.+....... ..+.+|+++|++|+|+|||++++++..+..+|||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 4456889999999999999983 33589999997754332 446699999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|++.|+|.++++. +.+.......++.||++|++||+++++|||||...||||+++..+||+|||||+.... .....
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d-~~Y~~ 360 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD-DEYTA 360 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC-Cceee
Confidence 9999999999986 4699999999999999999999999999999999999999999999999999994321 11111
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 261 (481)
.....-...|.|||.+....+ +.|||||||||+||||+| |+.||.+.+..+....+.+| +++.|..+|+++.+++..
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~ 439 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKS 439 (468)
T ss_pred cCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHH
Confidence 122223567999999988777 679999999999999999 99999999999999999888 478899999999999999
Q ss_pred hcccCcCCCCCHhHHHh
Q 011628 262 LLDTNPDKRITIPEIME 278 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~ 278 (481)
||..+|++|||++.+..
T Consensus 440 CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 440 CWHEDPEDRPTFETLRE 456 (468)
T ss_pred HhhCCcccCCCHHHHHH
Confidence 99999999999986643
No 136
>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti
Probab=100.00 E-value=7.6e-44 Score=349.23 Aligned_cols=256 Identities=34% Similarity=0.516 Sum_probs=220.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||.|+||.||+|.+..++..||+|++... .......+.+|+.+++.++||||+++++++..+...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 35799999999999999999999889999999998654 223456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 999999999999875 469999999999999999999999999999999999999999999999999886543211 1
Q ss_pred cccccCCCCccccccccccC----CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRK----GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPDL 255 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~ 255 (481)
......|++.|+|||++... ...+.++|+|||||++|+|++|..||...+......++..+.. ..|..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 22345789999999997532 1224679999999999999999999998877766667766542 3356688999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.++|.+||+.+|.+|||++++++||||.+.
T Consensus 239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999754
No 137
>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]
Probab=100.00 E-value=6.7e-47 Score=353.52 Aligned_cols=253 Identities=27% Similarity=0.465 Sum_probs=224.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..-|.++.+||+|+||.||+|.++++|+.+|||.+..+. ....+.+|+.||++|..|++|++|+.+.....+|||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 456889999999999999999999999999999987654 346688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||||..|+..+.++. ..++|+++..+++.-+.||+|||...-+|||||..|||++.+|..||+|||.|....... .
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A 184 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence 999999999999864 579999999999999999999999999999999999999999999999999987543322 2
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLL 259 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li 259 (481)
..++..|||.|||||++..-+|++ ++||||||++..||..|++||.+-.++....-|-... ++-|...|.++.+||
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~-~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDT-KADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred hhCccccCcccccHHHHHHhccch-hhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 236789999999999999999964 7999999999999999999999988876554443332 334666789999999
Q ss_pred HHhcccCcCCCCCHhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++||-++|++|.|+-++++|||++..
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 99999999999999999999999765
No 138
>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5. Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p
Probab=100.00 E-value=3e-43 Score=345.38 Aligned_cols=250 Identities=24% Similarity=0.466 Sum_probs=211.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.++++++||||+++++.+......++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36899999999999999999999999999999987653 2234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
||+++++|... ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..... ....
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----cccc
Confidence 99999998654 4578999999999999999999999999999999999999999999999999875432 2234
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch-------HHHHHHHHhhCCCC--CCCCCCHHHH
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-------IMVMYKKIYKGEFR--SPRWFSPDLI 256 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-------~~~~~~~i~~~~~~--~~~~~s~~~~ 256 (481)
..+|++.|+|||++.+..+ +.++|+|||||++|+|++|..||.... .......+...... ....+++++.
T Consensus 152 ~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 5689999999999987766 578999999999999999999996532 12222333322221 1334788999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++|.+||+.||++||+++++++||||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999753
No 139
>PTZ00266 NIMA-related protein kinase; Provisional
Probab=100.00 E-value=1.4e-43 Score=388.40 Aligned_cols=265 Identities=27% Similarity=0.492 Sum_probs=218.5
Q ss_pred CCCCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 011628 17 KDQNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 17 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
....+..+.++|++++.||+|+||+||+|++..++..||+|++...... ......+.+|+.+++.++||||+++++++.
T Consensus 4 ~~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~ 82 (1021)
T PTZ00266 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFL 82 (1021)
T ss_pred cccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEE
Confidence 3445667789999999999999999999999999999999999765433 334567889999999999999999999885
Q ss_pred e--CCEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc-------CceecCCCCCcEEEcc--
Q 011628 97 T--KSKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHAR-------GVYHRDLKPENLLLDE-- 160 (481)
Q Consensus 97 ~--~~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~-------gi~HrDLKp~NILl~~-- 160 (481)
. ...+||||||+.+|+|.+++.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 83 de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~ 162 (1021)
T PTZ00266 83 NKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGI 162 (1021)
T ss_pred ecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCc
Confidence 4 4579999999999999998864 5699999999999999999999985 4999999999999964
Q ss_pred ---------------CCCEEEEecCCcccccccccCCcccccCCCCccccccccccC-CCCCCcchHHHHHHHHHHHhcC
Q 011628 161 ---------------NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSCGVILFVLMAG 224 (481)
Q Consensus 161 ---------------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~elltg 224 (481)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|
T Consensus 163 ~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 163 RHIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 23489999999975432 2223456799999999998643 2236789999999999999999
Q ss_pred CCCCCCchHH-HHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 225 YLPFQDQNIM-VMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 225 ~~Pf~~~~~~-~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..||...+.. .+...+..+........++++.+||.+||..+|.+||++.|+|.|||+...
T Consensus 240 k~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 240 KTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred CCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 9999866543 333333333322234578999999999999999999999999999999754
No 140
>PHA03211 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=1.7e-43 Score=369.41 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=203.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.++++++||||+++++++......++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 5689999999999999999999999999999996422 2345899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99995 688888764 469999999999999999999999999999999999999999999999999997653322222
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC--------chHHHHHHHHhhCCC---------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD--------QNIMVMYKKIYKGEF--------- 245 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~--------~~~~~~~~~i~~~~~--------- 245 (481)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|..|+-. .....+.+.+.....
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2234679999999999988777 5789999999999999998765421 111222222222111
Q ss_pred --------------------CCCC-----CCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 246 --------------------RSPR-----WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 246 --------------------~~~~-----~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..+. .+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0111 24568999999999999999999999999999964
No 141
>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding
Probab=100.00 E-value=1e-43 Score=352.12 Aligned_cols=256 Identities=29% Similarity=0.521 Sum_probs=219.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
...+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++++......|+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l 93 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 93 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEE
Confidence 458999999999999999999999999999999999754322 23567889999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||++|++|.+++.+..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....... ..
T Consensus 94 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~ 171 (297)
T cd06656 94 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SK 171 (297)
T ss_pred eecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc--cC
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987543211 12
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-C--CCCCCCCCHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-E--FRSPRWFSPDLIRLLT 260 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~--~~~~~~~s~~~~~li~ 260 (481)
.....|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+... . ...|..+++.+.+|+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN 250 (297)
T ss_pred cCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence 234578999999999987666 57899999999999999999999876654332222222 1 2245667889999999
Q ss_pred HhcccCcCCCCCHhHHHhCcccccC
Q 011628 261 KLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+||..||++||+++++++||||+..
T Consensus 251 ~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 251 RCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred HHccCChhhCcCHHHHhcCchhccc
Confidence 9999999999999999999999753
No 142
>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4. Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.
Probab=100.00 E-value=2.1e-43 Score=343.08 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=215.6
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL---KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+|++++.||+|+||.||+|.+ .+++.+|+|.+...... .......+.+|+.+++.++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999986 58899999998754321 12334678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc---
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR--- 179 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~--- 179 (481)
++||++|++|.+++.+ +.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999976 678999999999999999999999999999999999999999999999999987542211
Q ss_pred -cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHH
Q 011628 180 -QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDL 255 (481)
Q Consensus 180 -~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~ 255 (481)
.........|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1122334578999999999987766 56899999999999999999999876654443333332 124566689999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.++|++||.++|.+||++.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
No 143
>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio
Probab=100.00 E-value=2.4e-43 Score=346.06 Aligned_cols=254 Identities=29% Similarity=0.486 Sum_probs=211.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.....+++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999998999999999865432 2223355778999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++++.|..++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 99999988888765 579999999999999999999999999999999999999999999999999987643321 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------------C-
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-------------------E- 244 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-------------------~- 244 (481)
....++..|+|||++.+....+.++|+||+||++|+|++|..||.+.+..+....+... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567899999999876554467899999999999999999999876543332222110 0
Q ss_pred -CCC----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 -FRS----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 -~~~----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+. ...++..+.+||.+||+++|++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000 12357889999999999999999999999999997
No 144
>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha. Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype
Probab=100.00 E-value=1.2e-43 Score=356.62 Aligned_cols=254 Identities=24% Similarity=0.422 Sum_probs=206.5
Q ss_pred eEEeEeccc--CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 29 EIGKLLGHG--TFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 29 ~i~~~LG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+++++||+| +|++||++++..+|+.||+|.++.+.. .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 357889999 789999999999999999999976543 23455678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc---
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--- 180 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~--- 180 (481)
|+++|+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.++++|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999999864 3589999999999999999999999999999999999999999999999986532211110
Q ss_pred --CCcccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC----------
Q 011628 181 --DGLFHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR---------- 246 (481)
Q Consensus 181 --~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~---------- 246 (481)
........++..|+|||++.+. ++ +.++||||+||++|+|++|..||..............+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0111223577889999998753 34 57899999999999999999999875543333222222110
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 247 ------------------------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 247 ------------------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
....+++.+.+||.+||+.||++|||++|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 01124678999999999999999999999999999965
No 145
>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.4e-45 Score=390.83 Aligned_cols=258 Identities=32% Similarity=0.532 Sum_probs=228.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|+|+++||+|+||.|.+++++.|++.||+|++++....+......|..|-.+|...+.+.|+.++..|.+..++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 47899999999999999999999999999999999886555444456688899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||++||+|..++.+ +++||++++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-..+..+ ...
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V~ 232 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVR 232 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC-cEE
Confidence 999999999999987 579999999999999999999999999999999999999999999999999876544321 223
Q ss_pred ccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCC--CCCCHHH
Q 011628 184 FHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSP--RWFSPDL 255 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~--~~~s~~~ 255 (481)
....+|||-|++||++.. .+.++..+|.||+||++|||+.|..||...+....|.+|.+- .+.+| ..+|.++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 456799999999999853 245577899999999999999999999999999999999875 46666 5689999
Q ss_pred HHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 256 IRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
++||.+++ .+|+.|.. ++++..||||..
T Consensus 313 kdLI~~ll-~~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 313 KDLIEALL-CDREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHHHHh-cChhhhcccccHHHHHhCccccC
Confidence 99999987 47788887 999999999964
No 146
>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase. Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ
Probab=100.00 E-value=1.7e-43 Score=344.83 Aligned_cols=252 Identities=31% Similarity=0.525 Sum_probs=211.8
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK---- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~---- 98 (481)
..++|++.+.||+|+||.||+|++..+++.||+|++..... ....+.+|+.+++++ +||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 46789999999999999999999999999999999875431 235678899999998 699999999998653
Q ss_pred --CEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
..+|++|||+.+++|.+++.. ..+++..+..++.|++.|+.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 468999999999999999875 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC--C
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--R 246 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~ 246 (481)
..... ........|++.|+|||++.+ ..+ +.++|+||+||++|+|++|..||...........+..... .
T Consensus 160 ~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 160 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred ecccc--cccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 54321 122345679999999999853 234 5689999999999999999999987665544444433321 2
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+..++.++.+|+.+||..||.+|||+.++++||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 234578899999999999999999999999999997
No 147
>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.2e-43 Score=345.27 Aligned_cols=251 Identities=31% Similarity=0.516 Sum_probs=211.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.....+|++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999876532 2235577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||+++++|.+++.. +.+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccc
Confidence 999999999999865 68999999999999999999999999999999999999999999999999998654321 112
Q ss_pred ccccCCCCccccccccc---cCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-----CCCCCHHH
Q 011628 184 FHTFCGTPAYVAPEVLS---RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-----PRWFSPDL 255 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~---~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~s~~~ 255 (481)
.....|++.|+|||++. ...+ +.++|+|||||++|+|++|..||................... ...++..+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred cccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 23457899999999974 2334 568999999999999999999997665443333333333222 12367889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
.++|.+||..+|++|||+++|++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
No 148
>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase. Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.
Probab=100.00 E-value=3.8e-43 Score=346.75 Aligned_cols=254 Identities=32% Similarity=0.497 Sum_probs=217.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||.||+|++..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 477999999999999999999999999999999986542 33456788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||++|++|...+.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++...... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 999999999888753 56899999999999999999999999999999999999999999999999988643221 11
Q ss_pred cccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~ 254 (481)
......+++.|+|||++.+ ..+ +.++|+|||||++|+|++|..||...+......++..... ..+..++.+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME 244 (292)
T ss_pred ccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence 2234568899999999853 223 4679999999999999999999988776666666654432 235567889
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+.++|.+||..||++||+++++++||||..
T Consensus 245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 245 FRDFLKTALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 999999999999999999999999999864
No 149
>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated
Probab=100.00 E-value=1.8e-43 Score=343.90 Aligned_cols=252 Identities=31% Similarity=0.493 Sum_probs=211.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++++.....+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 5689999999999999999999999999999999975432 2235678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||+++++|.+++.. +.+++..+..++.|++.|+.|||++||+||||||+||+++.++.++|+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cc
Confidence 999999999998864 679999999999999999999999999999999999999999999999999987543211 11
Q ss_pred ccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-----CCCCCHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-----PRWFSPDLI 256 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~s~~~~ 256 (481)
.....|++.|+|||++... ...+.++|+||+||++|+|++|..||...........+....+.. +..++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 2345789999999998432 222568999999999999999999997665444333333332222 234678999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
+||++||..+|++|||+++|++|+|
T Consensus 243 ~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCHHHHhcCCC
Confidence 9999999999999999999999987
No 150
>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti
Probab=100.00 E-value=4.5e-43 Score=338.83 Aligned_cols=252 Identities=31% Similarity=0.588 Sum_probs=221.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||.+++..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999999765432 2344678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+.+++|.+.+.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--L 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--h
Confidence 9999999998864 2589999999999999999999999999999999999999999999999999875433211 1
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~ 262 (481)
.....|++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+.. ..+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 223468899999999877665 5789999999999999999999998887777777766654 35667899999999999
Q ss_pred cccCcCCCCCHhHHHhCccc
Q 011628 263 LDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f 282 (481)
|+.+|++||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999997
No 151
>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa
Probab=100.00 E-value=7e-43 Score=337.46 Aligned_cols=252 Identities=29% Similarity=0.542 Sum_probs=222.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||.|+||.||.+++..+++.+++|.+....... .....+.+|+.++++++|+||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|++|++|.+.+.. ..+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 9999999999865 358999999999999999999999999999999999999999999999999987543322 12
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~ 262 (481)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.+. .+..++.++.++|.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 345678999999999877665 56899999999999999999999998887777777776543 3456789999999999
Q ss_pred cccCcCCCCCHhHHHhCccc
Q 011628 263 LDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f 282 (481)
|.++|.+|||+.++++|+|+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999985
No 152
>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=1.8e-43 Score=347.71 Aligned_cols=254 Identities=28% Similarity=0.511 Sum_probs=216.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++++.||+|+||.||+|++..+++.||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999899999999986542 2233467889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 106 EYVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++.....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--- 155 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA--- 155 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC---
Confidence 999999999988764 79999999999999999999997 5999999999999999999999999999865322
Q ss_pred CCcccccCCCCccccccccccCCC-----CCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHH---HHhhCC-CCCCCCC
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGY-----DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK---KIYKGE-FRSPRWF 251 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~---~i~~~~-~~~~~~~ 251 (481)
.......|++.|+|||++.+... .+.++|+|||||++|+|++|..||........+. .+..+. ...|..+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 156 -SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred -CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 22345578899999999854332 2568999999999999999999997655443333 333333 3456668
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++++.++|.+||..+|++||+++++++||||.+.
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~ 268 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence 9999999999999999999999999999999754
No 153
>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase. Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.
Probab=100.00 E-value=3.8e-43 Score=344.84 Aligned_cols=254 Identities=32% Similarity=0.504 Sum_probs=216.5
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
-|++.+.||+|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3789999999999999999999999999999986542 2345667889999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 107 YVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 107 y~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|+++++|...+.. +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...... ....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--cccc
Confidence 9999999988754 57999999999999999999999999999999999999999999999999998653221 1122
Q ss_pred cccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIR 257 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~ 257 (481)
....|++.|+|||++.. ....+.++|+||+||++|+|++|..||...+.......+.... ...|..++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD 240 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence 34578999999999842 1222468999999999999999999998877666655555443 2345668899999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+|.+||+.||.+|||++++++||||...
T Consensus 241 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 241 FLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 9999999999999999999999999764
No 154
>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte
Probab=100.00 E-value=4.3e-43 Score=342.27 Aligned_cols=256 Identities=33% Similarity=0.583 Sum_probs=214.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-------KSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
+|.+.+.||+|+||.||+|.+..+|+.||+|.+...... .....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 699999999999999999999889999999998643211 1123456889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+++||||+.|++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999876 68999999999999999999999999999999999999999999999999998754332
Q ss_pred ccCCcccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCC----CCC
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSP----RWF 251 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~----~~~ 251 (481)
..........|+..|+|||++.... ..+.++|+||||+++|+|++|..||...........+.... ...+ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222233457899999999987654 23678999999999999999999998765544444333221 2222 235
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+.++.++|.+||.++|.+|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 8899999999999999999999999999996
No 155
>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer
Probab=100.00 E-value=2.1e-43 Score=346.50 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=215.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSG-----ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 457999999999999999999976554 689999986543 2344567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 100 KIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
..|++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999999864 3478889999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.++|+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999875322211122334567889999999877666 578999999999999998 999999888877777776
Q ss_pred hCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+. ...|..+++++.+|+.+||+.||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 665 34567789999999999999999999999999874
No 156
>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti
Probab=100.00 E-value=1.1e-43 Score=363.41 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=207.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||.||+|++..+ +..||+|++..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 46799999999999999999986543 35799999976532 23456788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-----------------------------------------------------------
Q 011628 99 SKIYFVMEYVRGGELFNKVAK----------------------------------------------------------- 119 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~----------------------------------------------------------- 119 (481)
..+|+||||+++|+|.+++..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999998753
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccccc
Q 011628 120 ------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187 (481)
Q Consensus 120 ------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 187 (481)
.++++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..............
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 13678889999999999999999999999999999999999999999999998754321111111223
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHHHHHHhcc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~~L~ 264 (481)
.+++.|+|||++.+..+ +.++|||||||++|+|++ |..||........+...... ....|..+++++.++|.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 45678999999977666 678999999999999997 99999876554444344333 344567789999999999999
Q ss_pred cCcCCCCCHhHHHh
Q 011628 265 TNPDKRITIPEIME 278 (481)
Q Consensus 265 ~dP~~Rps~~eil~ 278 (481)
.||.+|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999976
No 157
>PHA02988 hypothetical protein; Provisional
Probab=100.00 E-value=3.3e-43 Score=346.38 Aligned_cols=239 Identities=20% Similarity=0.270 Sum_probs=208.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEec
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----KSKIYFVMEY 107 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey 107 (481)
..||+|++|.||+|.. +|+.||||++...........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999987 789999999987654444556788899999999999999999999876 4578999999
Q ss_pred cCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 108 VRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 108 ~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
++||+|.+++.. +.+++.....++.|++.|+.|||+. +++||||||+|||++.++.+||+|||+++..... ..
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cc
Confidence 999999999976 5789999999999999999999984 9999999999999999999999999998754321 12
Q ss_pred ccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHHHHHH
Q 011628 186 TFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 261 (481)
...|++.|+|||++.+ ..+ +.++|||||||++|+|++|..||.+.+....+..+..+ .++.|..+++.+.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4568999999999975 345 67899999999999999999999998887777777544 345565789999999999
Q ss_pred hcccCcCCCCCHhHHHh
Q 011628 262 LLDTNPDKRITIPEIME 278 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~ 278 (481)
||+.||++|||+.++++
T Consensus 258 cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 258 CTSHDSIKRPNIKEILY 274 (283)
T ss_pred HhcCCcccCcCHHHHHH
Confidence 99999999999999986
No 158
>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k
Probab=100.00 E-value=3.9e-43 Score=348.84 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=204.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK----------------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (481)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 5789999999999999999998532 34479999987643 23345678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCcee
Q 011628 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKG--------------------RLKEDLARKYFQQLISAVGFCHARGVYH 148 (481)
Q Consensus 89 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--------------------~l~e~~~~~~~~ql~~al~yLH~~gi~H 148 (481)
+++++++...+..++||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999999999999999999999999988542 2567788999999999999999999999
Q ss_pred cCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCC
Q 011628 149 RDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYL 226 (481)
Q Consensus 149 rDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~ 226 (481)
|||||+|||++.++.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999999875432211112233456788999999877666 578999999999999986 678
Q ss_pred CCCCchHHHHHHHHhh---C-----CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 227 PFQDQNIMVMYKKIYK---G-----EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 227 Pf~~~~~~~~~~~i~~---~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
||...+.......+.. . ....|+.+++.+.+|+.+||+.||.+|||+.+|.+
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8887655444333211 1 12235567899999999999999999999999953
No 159
>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase. Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi
Probab=100.00 E-value=4e-43 Score=340.54 Aligned_cols=247 Identities=39% Similarity=0.712 Sum_probs=218.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+..+..+|+++||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999889999999999876554445567899999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCc
Q 011628 114 FNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192 (481)
Q Consensus 114 ~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 192 (481)
.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ......|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999976 468999999999999999999999999999999999999999999999999987543321 2234578999
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch--HHHHHHHHhh--CCCCCCCCCCHHHHHHHHHhcccCcC
Q 011628 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN--IMVMYKKIYK--GEFRSPRWFSPDLIRLLTKLLDTNPD 268 (481)
Q Consensus 193 y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~--~~~~~~~~~s~~~~~li~~~L~~dP~ 268 (481)
|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... ....+.++.. .....|...++++.++|.+||..||+
T Consensus 158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 999999877666 568999999999999999999998776 6667777763 34566777789999999999999999
Q ss_pred CCCC-----HhHHHhCccccc
Q 011628 269 KRIT-----IPEIMENRWFRK 284 (481)
Q Consensus 269 ~Rps-----~~eil~h~~f~~ 284 (481)
+||+ ++|+++||||..
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999964
No 160
>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development
Probab=100.00 E-value=6.5e-43 Score=340.25 Aligned_cols=256 Identities=28% Similarity=0.510 Sum_probs=213.8
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKI 101 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 101 (481)
-.|++++.||+|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++.. ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3699999999999999999999999999999998754321 22345678899999999999999999998865 4678
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR- 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~- 179 (481)
++++||+++++|.+.+.. +.+++...+.++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 999999999999999876 578999999999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~ 257 (481)
.........|+..|+|||.+.+..+ +.++|+||+||++|+|++|..||...........+... ....|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 1112234568899999999987665 56899999999999999999999877655444443322 23446678889999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
++ +||..+|++||+++||++||||+
T Consensus 241 li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 241 FL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99 67778999999999999999986
No 161
>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re
Probab=100.00 E-value=1e-42 Score=338.48 Aligned_cols=256 Identities=28% Similarity=0.509 Sum_probs=214.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKI 101 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 101 (481)
.+|++++.||+|+||.||.|++..+++.||||.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999999999999999998654321 22345678899999999999999999998866 3578
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|++|||++|++|.+++.. +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 899999999999999876 5789999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHHHH
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDLIR 257 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~ 257 (481)
........|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...........+.... ...|..++..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 112234568999999999977665 578999999999999999999998776554444443322 3345667888999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
+|.+||. +|++||+++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999974
No 162
>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10. Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing
Probab=100.00 E-value=4.6e-43 Score=349.12 Aligned_cols=257 Identities=33% Similarity=0.483 Sum_probs=213.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (481)
.++|++.+.||+|+||.||+|.+..+|+.||+|++....... .....+.+|+.++++++|+||+++++++... +.+|
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 678999999999999999999999999999999987554222 2233456899999999999999999998754 5789
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+||||+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~- 162 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA- 162 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc-
Confidence 99999975 78888764 569999999999999999999999999999999999999999999999999987644321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-----------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG----------------- 243 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~----------------- 243 (481)
.......+++.|+|||++.+....+.++|||||||++|+|++|..||...+....+..+...
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07845 163 -KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241 (309)
T ss_pred -CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence 12233356788999999876554467899999999999999999999988776665555431
Q ss_pred --CCCC-----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 --EFRS-----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 --~~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+.. ..++++++.+||.+||+.||++|||+++++.||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~ 296 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK 296 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence 0111 12358889999999999999999999999999999754
No 163
>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their
Probab=100.00 E-value=3e-43 Score=342.17 Aligned_cols=256 Identities=28% Similarity=0.542 Sum_probs=214.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL---KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+|+.++.||+|+||.||.|.+..+++.||+|++...... .......+.+|+.++++++||||+++++++...+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 588999999999999999999999999999999754321 12345778999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCccccccccc-
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQ- 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~~~- 180 (481)
|+||+.|++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999999875 6799999999999999999999999999999999999998876 599999999875433211
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---HHHHHHh--hCCCCCCCCCCHH
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---VMYKKIY--KGEFRSPRWFSPD 254 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~--~~~~~~~~~~s~~ 254 (481)
........|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...... .....+. ......|..++++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 111223468899999999977666 57899999999999999999999754432 2222221 1223456678899
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
+.+++.+||..+|.+|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999984
No 164
>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI
Probab=100.00 E-value=2.7e-43 Score=345.94 Aligned_cols=254 Identities=29% Similarity=0.494 Sum_probs=213.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999998899999999986544322 34566889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++++.|..+... +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999999888765 46999999999999999999999999999999999999999999999999998754321 1223
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------------C
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------F 245 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------~ 245 (481)
....++..|+|||++.+....+.++|||||||++|+|++|..||...........+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 445688999999998765555678999999999999999999998765443333322100 0
Q ss_pred ------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 ------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 ------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..++.++..+.+|+.+||+.+|++||++.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0123467889999999999999999999999999998
No 165
>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1. Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto
Probab=100.00 E-value=2.8e-43 Score=344.03 Aligned_cols=256 Identities=35% Similarity=0.692 Sum_probs=226.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv 104 (481)
.+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++++. ||||+++++++...+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765444444577889999999998 99999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC--
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD-- 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~-- 181 (481)
|||+.+++|.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.+++++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999976 48999999999999999999999999999999999999999999999999998764432211
Q ss_pred ----------------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC
Q 011628 182 ----------------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF 245 (481)
Q Consensus 182 ----------------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~ 245 (481)
.......|+..|+|||++....+ +.++|+||||++++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 12234567899999999876654 6789999999999999999999998887777777777777
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCH----hHHHhCccc
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITI----PEIMENRWF 282 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~----~eil~h~~f 282 (481)
..|..+++.+.++|.+||+.+|.+|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888899999999999999999999999 999999997
No 166
>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor
Probab=100.00 E-value=7.3e-43 Score=340.21 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=211.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.++++++||||+++++++......
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 357999999999999999999865 356789999987653 223446688999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999999865 478999999999999999999999999999999999999999999999999876432111
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
. .......++..|+|||++.+..+ +.++||||+||++|++++ |..||.+.+.......+..+. .+.|..++..+.+
T Consensus 162 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 I-YTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred h-hcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 0 11112345678999999987766 578999999999999775 999999887777777666553 4557778999999
Q ss_pred HHHHhcccCcCCCCCHhHHHh
Q 011628 258 LLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~ 278 (481)
++.+||+.+|.+|||+++|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999976
No 167
>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with
Probab=100.00 E-value=1.5e-42 Score=334.72 Aligned_cols=251 Identities=32% Similarity=0.537 Sum_probs=219.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++.+......++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999865433 2345778899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCcccccccccCC
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~~~~~ 182 (481)
|++|++|.+++.. ..+++..+..++.|++.|++|||++|++|+||||+||+++.++ .+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 9999999999975 2489999999999999999999999999999999999998655 5799999998754322 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 261 (481)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+. ...+..+++++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 2234568999999999987665 568999999999999999999999888777776666554 34566789999999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||..||++|||+.|+++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999996
No 168
>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi
Probab=100.00 E-value=6.9e-43 Score=343.14 Aligned_cols=248 Identities=31% Similarity=0.502 Sum_probs=203.0
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILR---RVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
.||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++ ..+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997654432222233344544443 4479999999999999999999999999
Q ss_pred CCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccC
Q 011628 110 GGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188 (481)
Q Consensus 110 gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 188 (481)
||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999998865 67999999999999999999999999999999999999999999999999998654321 123457
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch---HHHHHHHHhhCCCCCCCCCCHHHHHHHHHhccc
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN---IMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 265 (481)
|++.|+|||.+.+....+.++||||+||++|+|++|..||.... ...............|..+++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643333578999999999999999999997532 222222223334456777899999999999999
Q ss_pred CcCCCC-----CHhHHHhCccccc
Q 011628 266 NPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 266 dP~~Rp-----s~~eil~h~~f~~ 284 (481)
||.+|| |+.++++||||+.
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccC
Confidence 999999 6999999999975
No 169
>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is
Probab=100.00 E-value=5.4e-43 Score=346.30 Aligned_cols=257 Identities=33% Similarity=0.485 Sum_probs=215.2
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+|++.+.||+|+||.||+|.+..+++.||||.+...... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 699999999999999999999889999999999765433 123445677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+ +++|.+++... .+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 89999999764 59999999999999999999999999999999999999999999999999987644321 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-----------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF----------------- 245 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------------- 245 (481)
......+++.|+|||.+.+....+.++|+||+||++|+|++|.+||.+.+....+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345688999999986655557789999999999999999988987766554444432100
Q ss_pred ------C-----CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 246 ------R-----SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 246 ------~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
. .....+..+.++|.+||.+||++|||+.|++.|+||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~ 289 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDP 289 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCC
Confidence 0 0123467899999999999999999999999999998753
No 170
>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit. Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce
Probab=100.00 E-value=2.8e-43 Score=360.64 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=206.5
Q ss_pred cCCeeEEeEecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARN-----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||+||+|.+ ..++..||||++..... ......+.+|+.+++.+ +||||+++++++...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 34677899999865432 23346788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcC----------------------------------------------------------
Q 011628 99 SKIYFVMEYVRGGELFNKVAKG---------------------------------------------------------- 120 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~---------------------------------------------------------- 120 (481)
+..|+|||||+||+|.+++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 9999999999999999888531
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 121 ------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 121 ------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 36778899999999999999999999999999999999999999999999987543222111
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHH-HHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVM-YKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~-~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
......++..|+|||++.+..+ +.++|||||||++|+|++ |..||........ ...+..+. ...|...+.++.+||
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 1122345678999999987776 578999999999999998 9999987654433 33333332 334566788999999
Q ss_pred HHhcccCcCCCCCHhHHHhC
Q 011628 260 TKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h 279 (481)
.+||+.||++|||+.+|++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
No 171
>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1. Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops
Probab=100.00 E-value=1.2e-42 Score=335.56 Aligned_cols=253 Identities=30% Similarity=0.544 Sum_probs=217.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI--LKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+|+..+.||+|+||+||+|.+..+++.|++|.+..... ......+.+.+|+.+++.++||||+++++++.....+|++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 68899999999999999999988999999999875432 1223457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+||++|++|.+++.+ +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999976 458999999999999999999999999999999999999999999999999987543322 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh-C-CCCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-G-EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~-~~~~~~~~s~~~~~li~~ 261 (481)
.....|++.|+|||.+......+.++|+|||||++|+|++|..||...........+.. . ....+..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987655236789999999999999999999987665444444433 2 234566789999999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||+.+|++||++.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
No 172
>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase
Probab=100.00 E-value=5.7e-43 Score=352.90 Aligned_cols=259 Identities=30% Similarity=0.519 Sum_probs=211.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
+.++|++.+.||+|+||.||+|++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 4579999999999999999999999999999999986432 223456678899999999999999999887654
Q ss_pred CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
..+|+++||+.+ +|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 358999999975 8888888888999999999999999999999999999999999999999999999999998754322
Q ss_pred cc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------
Q 011628 179 RQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------- 242 (481)
Q Consensus 179 ~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------- 242 (481)
.. .......+|++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223467899999999876544446789999999999999999999977654322221110
Q ss_pred CC-------C----C-----CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 GE-------F----R-----SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 ~~-------~----~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.. . . ..+.+++++.++|.+||+.+|++|||+.++++||||...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00 0 0 012357889999999999999999999999999999764
No 173
>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati
Probab=100.00 E-value=1.3e-42 Score=335.51 Aligned_cols=248 Identities=32% Similarity=0.579 Sum_probs=217.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||++.+..+++.+|+|.++.... ....+.+.+|+.+++.++||||+++++.+...+.+|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 59999999999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+++++|.+++.. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++....... ..
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--AY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc--cc
Confidence 9999999998864 358999999999999999999999999999999999999999999999999987543221 12
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHh
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLTKL 262 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~~ 262 (481)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.. +.|..++..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 234578999999999977665 5689999999999999999999998887777777766654 35667889999999999
Q ss_pred cccCcCCCCCHhHHHhC
Q 011628 263 LDTNPDKRITIPEIMEN 279 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h 279 (481)
|+.||++|||+.+|+..
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999863
No 174
>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=9.2e-45 Score=364.28 Aligned_cols=252 Identities=29% Similarity=0.466 Sum_probs=222.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
..|.=++.||.|+||.||.|++..+.+.||||.+........+-..+|.+|+..|++++|||+|.+.++|......|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 45777899999999999999999999999999998876666666788999999999999999999999999999999999
Q ss_pred eccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||-| +-.|++. +.++.|.++..+..+.+.||.|||+++.||||||..|||+++.|.|||+|||.|.+...
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------ 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ 178 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------
Confidence 99965 6667664 46799999999999999999999999999999999999999999999999999986543
Q ss_pred ccccCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-C-CCCCCHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSR---KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-S-PRWFSPDLIRL 258 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~-~~~~s~~~~~l 258 (481)
.++++|||+||||||+.. ..|++ ++|||||||+..||...++|+-..|.+.....|...+.+ . ...+|..+++|
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdg-kvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~F 257 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNF 257 (948)
T ss_pred hhcccCCccccchhHheeccccccCC-ccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHH
Confidence 357899999999999743 34654 799999999999999999999999988777777665433 2 23368899999
Q ss_pred HHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|..||++-|.+|||.+++++|+|+...
T Consensus 258 vd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 258 VDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred HHHHHhhCcccCCcHHHHhhcchhccC
Confidence 999999999999999999999998764
No 175
>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent
Probab=100.00 E-value=6.5e-43 Score=341.88 Aligned_cols=255 Identities=29% Similarity=0.594 Sum_probs=217.9
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR---HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 103 (481)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987543 2234567889999999997 9999999999999999999
Q ss_pred EEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 104 VMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|||++|++|.+++..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCC-CCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPR-WFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~-~~s~~~~~li~~ 261 (481)
.....|+..|+|||.+.+....+.++|+|||||++|+|++|..||...........+..... ..+. .++.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 23457899999999986544446789999999999999999999988766554444333322 2222 278899999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||+.||++||++.+++.|+||++.
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~ 261 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAH 261 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhcc
Confidence 999999999999999999999764
No 176
>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ
Probab=100.00 E-value=1.5e-42 Score=335.90 Aligned_cols=251 Identities=35% Similarity=0.566 Sum_probs=215.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... ...+.+.+|+.+++.++||||+++++++.....+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 3689999999999999999999988999999999976532 2457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.+||+|||++....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence 999999999998865 579999999999999999999999999999999999999999999999999987543321 1
Q ss_pred cccccCCCCccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-----CCCCCCHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRK---GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-----SPRWFSPD 254 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~~ 254 (481)
......++..|+|||.+.+. .+ +.++|+||||+++|+|++|..||.+.+.......+....+. .+..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 22345788999999998765 55 56899999999999999999999887655544444444222 23345788
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
+.+++.+||..+|..|||+.+++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
No 177
>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter
Probab=100.00 E-value=6.5e-43 Score=342.47 Aligned_cols=256 Identities=27% Similarity=0.499 Sum_probs=221.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
...|+..+.||.|+||.||.|.+..+++.||+|++..... ......+.+|+.+++.+.||||+++++++.+....|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 3568899999999999999999988999999999875432 23457788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||++|++|.+++..+++++..+..++.|++.|++|||+++++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999987543211 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhc
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLL 263 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L 263 (481)
....++..|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..+. ...+..++..+.++|.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 33568889999999877665 678999999999999999999998877665555443332 2334457888999999999
Q ss_pred ccCcCCCCCHhHHHhCcccccC
Q 011628 264 DTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 264 ~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+|++||++++++.|+||.+.
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhc
Confidence 9999999999999999999764
No 178
>PHA03209 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=5.6e-43 Score=356.15 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=198.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++++.||+|+||.||+|++..+++.||+|+..... ...|+.++++++||||+++++++......++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 357999999999999999999999999999999854332 24699999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99996 578887754 5799999999999999999999999999999999999999999999999999874322 12
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC-CCCchH---------HHHHHHHhhC-C---CCCC
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLP-FQDQNI---------MVMYKKIYKG-E---FRSP 248 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~P-f~~~~~---------~~~~~~i~~~-~---~~~~ 248 (481)
......||+.|+|||++.+..+ +.++|||||||++|+|+++..| |..... ......+... . ...+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 2234679999999999988777 5789999999999999985444 433110 0011111110 0 0000
Q ss_pred ------------------------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 ------------------------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 ------------------------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..++.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 124667788999999999999999999999999974
No 179
>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase. Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK
Probab=100.00 E-value=8.7e-43 Score=354.04 Aligned_cols=258 Identities=27% Similarity=0.483 Sum_probs=212.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 357899999999999999999999999999999999865432 223445677899999999999999999988644
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 888877654 8999999999999999999999999999999999999999999999999997543
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------- 243 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 243 (481)
. ........|++.|+|||++.+..+ +.++|||||||++|+|++|..||...+....+.++...
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 122344578999999999988777 57899999999999999999999876654443333210
Q ss_pred ---------CCC--------------C-------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 244 ---------EFR--------------S-------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 244 ---------~~~--------------~-------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
... . +...++.++++|.+||+.||.+|||+.|++.||||+.++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 000 0 1123556899999999999999999999999999987654
No 180
>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning
Probab=100.00 E-value=1e-42 Score=341.98 Aligned_cols=255 Identities=33% Similarity=0.562 Sum_probs=214.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++...+..|++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 579999999999999999999999999999999875432 2344577889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
||++++.+..+..+ ..+++..+..++.|++.|+.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99999877776655 5699999999999999999999999999999999999999999999999999876543221 133
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--------------------C-
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------------G- 243 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------------~- 243 (481)
....++..|+|||++.+....+.++|+||+|+++|+|++|..||.+.+.......+.. +
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 4567889999999998773446789999999999999999999987654433322211 0
Q ss_pred CC-----------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 244 EF-----------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 244 ~~-----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+ ..+..+++++.+||++||..+|++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1233458889999999999999999999999999997
No 181
>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I
Probab=100.00 E-value=1.1e-42 Score=338.73 Aligned_cols=252 Identities=34% Similarity=0.557 Sum_probs=212.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC----
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS---- 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~---- 99 (481)
.++|++.+.||+|+||.||+|.+..+++.+++|++..... ....+.+|+.+++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 5899999999999999999999988999999999876532 235688999999999 6999999999996644
Q ss_pred --EEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 --KIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 --~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
.+|+||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 58999999999999988753 46899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCC----CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG----YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--- 245 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--- 245 (481)
...... ........|++.|+|||++.... ..+.++|||||||++|+|++|..||..........++..+..
T Consensus 161 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 238 (275)
T cd06608 161 AQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL 238 (275)
T ss_pred eecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC
Confidence 754321 12223457899999999975422 225689999999999999999999987766555555555432
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..+..++..+.+||.+||..||++|||+.++++|||+
T Consensus 239 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 239 KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233467899999999999999999999999999996
No 182
>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea
Probab=100.00 E-value=9.1e-43 Score=341.93 Aligned_cols=252 Identities=31% Similarity=0.521 Sum_probs=210.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT----- 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----- 97 (481)
..++|++.+.||.|+||.||+|++..+++.+|+|++.... .....+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 3589999999999999999999999999999999986543 2335678899999998 69999999999853
Q ss_pred -CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 98 -KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 98 -~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
...+|++|||+.+|+|.+++.. ..+++..+..++.||+.|+.|||++||+|+||||+||+++.++.++|+|||++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 4678999999999999999864 358899999999999999999999999999999999999999999999999987
Q ss_pred cccccccCCcccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-- 246 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-- 246 (481)
..... ........|++.|+|||++.. ..+ +.++|+|||||++|+|++|..||...........+......
T Consensus 170 ~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 246 (282)
T cd06636 170 QLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL 246 (282)
T ss_pred hhhcc--ccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence 54321 122345678999999999853 234 56899999999999999999999876654444333333211
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+..++.++.+||.+||..||.+|||+.||++||||
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 233578999999999999999999999999999997
No 183
>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin. Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre
Probab=100.00 E-value=3e-42 Score=340.03 Aligned_cols=254 Identities=27% Similarity=0.466 Sum_probs=212.7
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK---- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~---- 98 (481)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++++ +||||+++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 4688999999999999999999999999999999986532 2235577899999999 799999999998653
Q ss_pred -CEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 99 -SKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..+|+||||++|++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 368999999999999988752 46899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCC----CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG----YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--- 245 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~----~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--- 245 (481)
........ ......|+..|+|||++.... ..+.++|||||||++|+|++|..||...+.......+..+..
T Consensus 176 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 253 (291)
T cd06639 176 AQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL 253 (291)
T ss_pred hhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC
Confidence 75432111 123456899999999985432 125789999999999999999999988766555555544422
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
..+..++..+.+||.+||+.+|++||++.+|++||||+
T Consensus 254 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 254 LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23455778899999999999999999999999999984
No 184
>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]
Probab=100.00 E-value=5.6e-44 Score=312.07 Aligned_cols=255 Identities=31% Similarity=0.563 Sum_probs=219.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|.-.++||+|+||+||+|++.++++.||+|.++.+. .+++......|||.+++.++|.|||+++++..+..++-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46777889999999999999999999999999998765 33445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|||.. +|..+... |.++.+.++.++.|++.||.|||++++.||||||.|+|++.+|.+|++|||+++.++... ..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Ee
Confidence 99965 78777764 789999999999999999999999999999999999999999999999999998765422 23
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC--C-----CC----CCC--
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG--E-----FR----SPR-- 249 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--~-----~~----~~~-- 249 (481)
+...+-|.+|.+|.++.+...++...|+||.|||+.|+.. |.+.|++.+.....++|+.. . ++ .|.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 4445679999999999888777788999999999999986 88889999888888777642 1 11 111
Q ss_pred ----------------CCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 250 ----------------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 250 ----------------~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.++..-++|+.++|..+|.+|+++++.++||||..
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 12344689999999999999999999999999964
No 185
>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex
Probab=100.00 E-value=8.5e-43 Score=342.32 Aligned_cols=252 Identities=33% Similarity=0.558 Sum_probs=209.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.|++.+.||.|+||.||+|++..+++.||||.+..... .......+.+|+.++++++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999875532 22234568899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+. ++|..++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 588888754 46899999999999999999999999999999999999999999999999998754321 112
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------------- 244 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------------- 244 (481)
.....+++.|+|||++.+....+.++|||||||++|+|++|..||...+......++....
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 2344678899999998776655678999999999999999999998765443332222100
Q ss_pred -C---------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 -F---------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 -~---------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+ .....++++++++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 0122367889999999999999999999999999998
No 186
>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the
Probab=100.00 E-value=1.3e-42 Score=342.38 Aligned_cols=253 Identities=32% Similarity=0.544 Sum_probs=206.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 57899999999999999999999889999999998764322 1223466899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS--K 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC--c
Confidence 999985 89988865 468999999999999999999999999999999999999999999999999986432211 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhC------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG------------------ 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~------------------ 243 (481)
......+++.|+|||++.+....+.++||||+||++|+|++|..||.+.. .......+...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12233578899999998764434678999999999999999999997654 22222222110
Q ss_pred ---CCC---------CCCCCC--HHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 244 ---EFR---------SPRWFS--PDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 244 ---~~~---------~~~~~s--~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
... ....++ .++.+++.+||+++|.+|||+.+++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 001234 778999999999999999999999999998
No 187
>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl
Probab=100.00 E-value=1.4e-42 Score=344.72 Aligned_cols=258 Identities=27% Similarity=0.448 Sum_probs=207.5
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
...++|++.+.||+|+||.||+|.+..+++.||||.+...... ......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 4577899999999999999999999999999999998754322 223345678999999999999999999986543
Q ss_pred -----EEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 -----KIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 -----~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..|+||||+.+ +|.+.+... .+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 46999999975 788777653 6899999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC--CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--CCC---
Q 011628 173 AVSDQIRQD--GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEF--- 245 (481)
Q Consensus 173 ~~~~~~~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~--- 245 (481)
......... .......++..|+|||.+.+....+.++||||+|+++|+|++|..||...+.......+.. +..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 754332211 1223456788999999987654446789999999999999999999987665433222211 100
Q ss_pred --------------CC-------------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 --------------RS-------------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 --------------~~-------------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.. +...++.+.+||.+||..||.+|||++++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00 11135678899999999999999999999999998
No 188
>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi
Probab=100.00 E-value=2.6e-42 Score=333.88 Aligned_cols=252 Identities=34% Similarity=0.634 Sum_probs=219.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv 104 (481)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.. ....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 599999999999999999999999999999998765432 3345678899999999999999999998754 4578999
Q ss_pred EeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-----HcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 105 MEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCH-----ARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH-----~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
|||+++++|.+++.. +.+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999998863 46899999999999999999999 89999999999999999999999999999876
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCH
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSP 253 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~ 253 (481)
..... .......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. ..+..++.
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 54322 11334578999999999977665 5789999999999999999999998877777777776654 34667889
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+.+++.+||+.+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
No 189
>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-44 Score=366.16 Aligned_cols=250 Identities=30% Similarity=0.520 Sum_probs=217.8
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
-+||+|+||+||.|++..|....|||.+.... ....+-+..||.+.++|+|.|||+++|.+..++.+-|+||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 37999999999999999999999999996543 345567889999999999999999999999999999999999999
Q ss_pred chHHHHHc--CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCcccccccccCCcccc
Q 011628 112 ELFNKVAK--GRL--KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQDGLFHT 186 (481)
Q Consensus 112 ~L~~~i~~--~~l--~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~ 186 (481)
+|.++++. |++ +|..+..|.+||++||.|||++.|+|||||-+|+|++. .|.+||+|||.++.... -+....+
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence 99999985 777 88899999999999999999999999999999999975 68999999999986543 3445678
Q ss_pred cCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCch-H-HHHH-HHHhhCCCCCCCCCCHHHHHHHHH
Q 011628 187 FCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQN-I-MVMY-KKIYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~-~~~~-~~i~~~~~~~~~~~s~~~~~li~~ 261 (481)
.-||..|||||++... +| +.++|||||||++.||.||++||.... + ..++ ..+++-.++.|..+|.++++||.+
T Consensus 736 FTGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filr 814 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILR 814 (1226)
T ss_pred cccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHH
Confidence 8899999999999543 45 678999999999999999999997643 2 2222 233555677888999999999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccCcc
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
|+.++|.+||++.++|.+||++.+.+
T Consensus 815 cFepd~~~R~sA~~LL~DpFlq~~~k 840 (1226)
T KOG4279|consen 815 CFEPDPCDRPSAKDLLQDPFLQHNNK 840 (1226)
T ss_pred HcCCCcccCccHHHhccCcccccCCC
Confidence 99999999999999999999987643
No 190
>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=8.1e-45 Score=359.57 Aligned_cols=258 Identities=34% Similarity=0.601 Sum_probs=238.4
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..-..+.+++-+||-|+||.|-+++.......+|+|++++..+.+....+.+..|-.||..++.|.||++|..|.+...+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34467788999999999999999987665556999999998888777788899999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|++||-|-||+|+..+.. |.+.+..++.|...+++|++|||++||++|||||||++++.+|-+||.|||+|+... .
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~ 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---S 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---c
Confidence 999999999999999986 789999999999999999999999999999999999999999999999999998654 3
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~l 258 (481)
.....+.||||.|+|||++.+++++ ..+|.||||+++|||++|.+||.+.+++..|+.|.+|- +..|..++..+.+|
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 4556789999999999999999996 46999999999999999999999999999999999984 67799999999999
Q ss_pred HHHhcccCcCCCCC-----HhHHHhCcccc
Q 011628 259 LTKLLDTNPDKRIT-----IPEIMENRWFR 283 (481)
Q Consensus 259 i~~~L~~dP~~Rps-----~~eil~h~~f~ 283 (481)
|+++...+|.+|.. +.+|.+|.||.
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 99999999999985 89999999994
No 191
>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co
Probab=100.00 E-value=1.6e-42 Score=340.29 Aligned_cols=249 Identities=31% Similarity=0.504 Sum_probs=206.7
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKRE---ISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E---i~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
.||+|+||.||+|++..+++.||+|.+.+..............| +.+++...||||+++++++...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987543322211222233 345555689999999999999999999999999
Q ss_pred CCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccC
Q 011628 110 GGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188 (481)
Q Consensus 110 gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 188 (481)
||+|.+++.. +.+++..++.++.|++.|+.|||+++|+||||||+||+++.++.++|+|||++...... .....+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999998865 57999999999999999999999999999999999999999999999999998754321 223457
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhccc
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~ 265 (481)
|+..|+|||++.+....+.++||||+||++|+|++|..||.+. ........+.......|..+|+++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875433357899999999999999999999876 3344444444445666777899999999999999
Q ss_pred CcCCCC-----CHhHHHhCcccccC
Q 011628 266 NPDKRI-----TIPEIMENRWFRKG 285 (481)
Q Consensus 266 dP~~Rp-----s~~eil~h~~f~~~ 285 (481)
+|.+|| ++.++++||||...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCC
Confidence 999999 99999999999753
No 192
>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase. Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of
Probab=100.00 E-value=9.5e-43 Score=341.28 Aligned_cols=247 Identities=32% Similarity=0.508 Sum_probs=210.7
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++...+.+|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765433333445567899999999999999999999999999999999999999
Q ss_pred HHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCC
Q 011628 114 FNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 114 ~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 999865 3 699999999999999999999999999999999999999999999999999875432 2222345678
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTN 266 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~d 266 (481)
..|+|||++.+..+ +.++|+||+||++|+|++|..||..... ..+...+.......+..+++.+.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 89999999877665 5789999999999999999999976543 233333344445566678999999999999999
Q ss_pred cCCCC-----CHhHHHhCccccc
Q 011628 267 PDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 267 P~~Rp-----s~~eil~h~~f~~ 284 (481)
|.+|| ++.+++.||||.+
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhc
Confidence 99999 8888999999964
No 193
>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a
Probab=100.00 E-value=1.1e-42 Score=335.54 Aligned_cols=249 Identities=30% Similarity=0.524 Sum_probs=215.5
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.+|+|.+..... ...+.+|+.+++.++||||+++++++.....+|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 679999999999999999999988899999999865431 567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+.+++|.+++.. ..+++..++.++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--K 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--c
Confidence 99999999999864 4689999999999999999999999999999999999999999999999999876433221 2
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~ 260 (481)
.....|+..|+|||++.+..+ +.++||||+|+++|+|++|..||...........+... ....+..++..+.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 233458899999999987766 57899999999999999999999877655443333322 22334557889999999
Q ss_pred HhcccCcCCCCCHhHHHhCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f 282 (481)
+||+.||++|||+.|++.||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
No 194
>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4
Probab=100.00 E-value=4.2e-42 Score=333.09 Aligned_cols=255 Identities=32% Similarity=0.594 Sum_probs=215.6
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
||++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|+||++++++....+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 699999999999999999999889999999999766533 3456789999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC-c-
Q 011628 107 YVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG-L- 183 (481)
Q Consensus 107 y~~gg~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~- 183 (481)
|+++++|.+++..+ .+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999774 68999999999999999999999999999999999999999999999999987643322111 1
Q ss_pred ccccCCCCccccccccccCC--CCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhC-CCCCCCCC--CHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKG--YDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG-EFRSPRWF--SPDLIR 257 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~-~~~~~~~~--s~~~~~ 257 (481)
.....+++.|+|||++.+.. ..+.++||||||+++|++++|..||.... .......+..+ ....|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 22457889999999987654 13578999999999999999999997653 22222223222 23445544 899999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+|.+||+.+|.+|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
No 195
>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re
Probab=100.00 E-value=9.6e-43 Score=336.93 Aligned_cols=250 Identities=36% Similarity=0.688 Sum_probs=219.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||.|+||.||+|++..+|+.+|+|++.............+.+|+.++++++||||+++++.+......|+++||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999889999999999766544445567789999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc------CCcccc
Q 011628 114 FNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ------DGLFHT 186 (481)
Q Consensus 114 ~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~------~~~~~~ 186 (481)
.+++.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999976 6799999999999999999999999999999999999999999999999999875332211 112234
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCC--CHHHHHHHHHhcc
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWF--SPDLIRLLTKLLD 264 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~--s~~~~~li~~~L~ 264 (481)
..++..|+|||.+....+ +.++|+||||+++|+|++|..||........+..+..+....|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 568889999999877664 6789999999999999999999998888888888877666666555 8999999999999
Q ss_pred cCcCCCCCH---hHHHhCccccc
Q 011628 265 TNPDKRITI---PEIMENRWFRK 284 (481)
Q Consensus 265 ~dP~~Rps~---~eil~h~~f~~ 284 (481)
.+|.+|||+ .++++||||.+
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999964
No 196
>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express
Probab=100.00 E-value=6.8e-43 Score=345.58 Aligned_cols=257 Identities=27% Similarity=0.487 Sum_probs=219.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...+.|.....||+|+||.||++.+..++..||||.+.... ....+.+.+|+.+++.++||||+++++.+...+..|
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 34566777889999999999999998899999999986543 233466889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
+||||++|++|.+++..+.+++..+..++.||+.|+.|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus 96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~ 173 (292)
T cd06658 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VP 173 (292)
T ss_pred EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc--cc
Confidence 9999999999999998888999999999999999999999999999999999999999999999999998653321 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li 259 (481)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+... .......++..+.+++
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 2234578999999999977666 56899999999999999999999887765555544432 2223335788999999
Q ss_pred HHhcccCcCCCCCHhHHHhCcccccC
Q 011628 260 TKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+||..||.+|||++++++||||...
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~ 278 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLA 278 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhcc
Confidence 99999999999999999999999754
No 197
>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3. Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int
Probab=100.00 E-value=2.7e-42 Score=338.04 Aligned_cols=254 Identities=27% Similarity=0.505 Sum_probs=220.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
-|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 37788999999999999999988999999999865432 2345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccc
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHT 186 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~ 186 (481)
|+++++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNT 160 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhcc
Confidence 9999999999988889999999999999999999999999999999999999999999999999986543211 11234
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhccc
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 265 (481)
..|+..|+|||.+.+... +.++|+||+||++|+|++|..||...+.......+..+. ...+..++.++.++|.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 568899999999876655 568999999999999999999998877665555554443 234566889999999999999
Q ss_pred CcCCCCCHhHHHhCcccccC
Q 011628 266 NPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 266 dP~~Rps~~eil~h~~f~~~ 285 (481)
+|.+||++.++++||||.+.
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhh
Confidence 99999999999999999764
No 198
>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-44 Score=355.70 Aligned_cols=253 Identities=34% Similarity=0.662 Sum_probs=220.0
Q ss_pred CCeeE--EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 26 GRYEI--GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 26 ~~y~i--~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
.-|+| .++||+|-||+||-|+++++|+.||||+|++.+....+ ..+++.|+.||+.++||.||.+-..+++.+.+++
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFV 640 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFV 640 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEE
Confidence 44666 58999999999999999999999999999988765543 3778999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEecCCccccccc
Q 011628 104 VMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---DLKVSDFGLSAVSDQI 178 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---~lkl~DFGla~~~~~~ 178 (481)
|||-+.|.-|.-.+. +|++++.....++.||+.||.|||-++|+|+||||||||+.... .+||||||+|++.+.
T Consensus 641 VMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE- 719 (888)
T KOG4236|consen 641 VMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE- 719 (888)
T ss_pred EehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch-
Confidence 999997744444443 48999999999999999999999999999999999999997654 589999999998654
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCC----CCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPR----WFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~s~~ 254 (481)
.....+.+|||.|+|||++..++|. ..-|+||.|||+|.-|+|..||.... ++..+|.+..+.+|+ .++++
T Consensus 720 --ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~ 794 (888)
T KOG4236|consen 720 --KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPE 794 (888)
T ss_pred --hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHH
Confidence 3344678999999999999999996 45999999999999999999998764 345566666655543 38999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+.+||..+|+..-.+|+|+++.+.|||++.-
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 9999999999999999999999999999753
No 199
>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1. Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25
Probab=100.00 E-value=3.6e-43 Score=344.11 Aligned_cols=255 Identities=28% Similarity=0.508 Sum_probs=218.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
..|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 467888999999999999999988999999999875432 234567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
||+++++|.+++..+.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~ 159 (277)
T cd06642 82 EYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRN 159 (277)
T ss_pred EccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhhh
Confidence 99999999999988889999999999999999999999999999999999999999999999999987543211 1122
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcc
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 264 (481)
...|+..|+|||++.+..+ +.++|+|||||++|+|++|..||...........+..+. ...+..++.++.++|.+||+
T Consensus 160 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 238 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLN 238 (277)
T ss_pred cccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHcc
Confidence 3468899999999987766 568999999999999999999998766555444443332 22344578889999999999
Q ss_pred cCcCCCCCHhHHHhCcccccC
Q 011628 265 TNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 265 ~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+|++|||+.++++||||.+.
T Consensus 239 ~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 239 KDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred CCcccCcCHHHHHHhHHHHHH
Confidence 999999999999999999753
No 200
>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase. Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm
Probab=100.00 E-value=2.8e-42 Score=340.53 Aligned_cols=254 Identities=33% Similarity=0.478 Sum_probs=208.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE----
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSK---- 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~---- 100 (481)
++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999876532 2233456788999999995 6999999999877665
Q ss_pred -EEEEEeccCCCchHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCc
Q 011628 101 -IYFVMEYVRGGELFNKVAK------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLS 172 (481)
Q Consensus 101 -~~lv~Ey~~gg~L~~~i~~------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla 172 (481)
.|++|||+++ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78887753 24799999999999999999999999999999999999998 889999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-------
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF------- 245 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------- 245 (481)
...... ........+++.|+|||++.+....+.++|+||||+++|+|++|..||.+.+......++.....
T Consensus 159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 754321 11223346788999999986644446789999999999999999999988766554444432100
Q ss_pred ----------CC-----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 246 ----------RS-----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 246 ----------~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.. .+.+++++.+||.+||..||.+|||+.|++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 123688899999999999999999999999999984
No 201
>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12
Probab=100.00 E-value=3.6e-42 Score=348.28 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=214.9
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~--- 99 (481)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 46789999999999999999999999999999999986543 22334466889999999999999999999987653
Q ss_pred ---EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 100 ---KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 100 ---~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
.+++||||+ |++|.+++..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 468999999 7799999888889999999999999999999999999999999999999999999999999987533
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-----------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF----------- 245 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~----------- 245 (481)
. ......+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+....+.++.....
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 2 123456789999999987644446789999999999999999999987765444443322110
Q ss_pred --------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 --------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 --------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.....+++.+.++|.+||+.||.+|||+.+++.||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0123567889999999999999999999999999999764
No 202
>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as
Probab=100.00 E-value=1.3e-42 Score=346.58 Aligned_cols=246 Identities=27% Similarity=0.485 Sum_probs=192.1
Q ss_pred EeEecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 011628 31 GKLLGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKIYFVME 106 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~E 106 (481)
+..||+|+||+||+|++.. ++..||+|.+..... ...+.+|+.+++.++||||+++++++.. ...+|++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 5789999999999999754 668899999865432 2346789999999999999999998854 567899999
Q ss_pred ccCCCchHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE----ccCCCEEEEecCCc
Q 011628 107 YVRGGELFNKVAK----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL----DENGDLKVSDFGLS 172 (481)
Q Consensus 107 y~~gg~L~~~i~~----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl----~~~g~lkl~DFGla 172 (481)
|+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9875 77776641 248899999999999999999999999999999999999 45678999999999
Q ss_pred cccccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---------HHHHHHhh
Q 011628 173 AVSDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---------VMYKKIYK 242 (481)
Q Consensus 173 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---------~~~~~i~~ 242 (481)
+....... ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...... ....++..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 76533211 112345678999999999977555577899999999999999999999643210 00000000
Q ss_pred ----------------------------CCC----------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 243 ----------------------------GEF----------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 243 ----------------------------~~~----------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
... ......+..+.+||.+||+.||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 000 0011235568899999999999999999999999997
No 203
>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]
Probab=100.00 E-value=7.4e-44 Score=349.14 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=226.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.+.|+.-++||+|+||.||-++-+.||+-+|.|.+.+..+....--.....|-.|+.+++.+.||.+-..|++.+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 56788999999999999999999999999999999887766554445577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|..|.||+|.-.|-+ | .++|..++.|+.+|+.||++||+++|++|||||+|||+|+.|+++|+|+|+|..... .
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~---g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE---G 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC---C
Confidence 999999999777754 4 799999999999999999999999999999999999999999999999999985432 3
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCCCCCCCCHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFRSPRWFSPDLIR 257 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~~~~~~s~~~~~ 257 (481)
......+||.+|||||++.+..| +...|.|||||+||+|+.|+.||..... .++-+.+......+|..+|+++++
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eaks 419 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKS 419 (591)
T ss_pred CccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHHHH
Confidence 33455699999999999998887 5679999999999999999999976532 355566677777888999999999
Q ss_pred HHHHhcccCcCCCC-----CHhHHHhCccccc
Q 011628 258 LLTKLLDTNPDKRI-----TIPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~Rp-----s~~eil~h~~f~~ 284 (481)
|.+.+|.+||.+|. +++++.+||||+.
T Consensus 420 lc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 420 LCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence 99999999999998 4789999999975
No 204
>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1. Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the
Probab=100.00 E-value=1.4e-42 Score=342.79 Aligned_cols=254 Identities=34% Similarity=0.497 Sum_probs=212.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (481)
.++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.++++++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999989999999999765432 23445677899999999999999999998877 8999
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+||||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99999975 89888865 358999999999999999999999999999999999999999999999999987654321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC----------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---------------- 244 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------------- 244 (481)
.......+++.|+|||++.+....+.++|+||+|+++|+|++|..||..........++....
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 222345678999999998765545678999999999999999999998876655444432210
Q ss_pred ---------------CCCCCC-CCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 ---------------FRSPRW-FSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ---------------~~~~~~-~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
...+.. +++.+.++|.+||+.||++|||+.|++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 011222 58889999999999999999999999999998
No 205
>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase. Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.
Probab=100.00 E-value=3.3e-42 Score=337.31 Aligned_cols=248 Identities=32% Similarity=0.534 Sum_probs=205.0
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK--SKIYFV 104 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lv 104 (481)
|++.+.||+|+||.||+|.+..+++.||+|.+....... . .....+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 789999999999999999999999999999987543221 1 223457899999885 99999999999887 889999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.| +|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++. +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999975 77777764 46899999999999999999999999999999999999999 99999999998754321 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC------------------C
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------------E 244 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------------~ 244 (481)
......+++.|+|||++...++.+.++||||+||++|+|++|..||.+.+.......+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2234568899999998766555577899999999999999999999887655444433221 0
Q ss_pred CCC-----------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 FRS-----------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~~~-----------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+.. ...++..+.++|.+||+++|++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 111 12467899999999999999999999999999997
No 206
>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi
Probab=100.00 E-value=1.8e-42 Score=350.35 Aligned_cols=257 Identities=30% Similarity=0.472 Sum_probs=211.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
+.++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 56899999999999999999999999999999999876542 3346688999999999999999999776543
Q ss_pred ---------CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEe
Q 011628 99 ---------SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSD 168 (481)
Q Consensus 99 ---------~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~D 168 (481)
...|++|||+. ++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 58999888888999999999999999999999999999999999999985 55789999
Q ss_pred cCCccccccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---
Q 011628 169 FGLSAVSDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--- 244 (481)
Q Consensus 169 FGla~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--- 244 (481)
||+++....... .+......|+..|+|||++.+....+.++|||||||++|+|++|..||...+.......+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432211 1122334678999999987654444678999999999999999999998766544444332210
Q ss_pred ----------------------CC-----CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 ----------------------FR-----SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 ----------------------~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.. ....++.++.+||.+||+.||.+|||+++++.||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 11246788999999999999999999999999999974
No 207
>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity
Probab=100.00 E-value=1.2e-42 Score=337.43 Aligned_cols=252 Identities=30% Similarity=0.520 Sum_probs=216.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+.....+|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999976542 244567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||+.|++|.+++.. ..+++..+..++.|++.|++|||+ .|++|+||||+||+++.++.++|+|||.+.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 99999999999975 578999999999999999999999 999999999999999999999999999986543211
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHhhCC-CCCCCC-CCHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-----NIMVMYKKIYKGE-FRSPRW-FSPDL 255 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-----~~~~~~~~i~~~~-~~~~~~-~s~~~ 255 (481)
.....|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||... ........+.... ...+.. +++++
T Consensus 156 -~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 156 -AKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred -hhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 122678999999999987766 57899999999999999999999764 2334444444433 233443 78999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.++|.+||..||++|||+.+++.||||++
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999965
No 208
>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin. Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear
Probab=100.00 E-value=3e-42 Score=338.81 Aligned_cols=252 Identities=28% Similarity=0.508 Sum_probs=209.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE-----e
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMA-----T 97 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~-----~ 97 (481)
..++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 4689999999999999999999999999999999886432 1235577899999999 6999999999874 3
Q ss_pred CCEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
+..+|+||||++|++|.+++.. ..+++..++.++.|++.||.|||+++++||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 4679999999999999988742 46899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCcccccccccc-----CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSR-----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--- 244 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~-----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--- 244 (481)
...... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...........+....
T Consensus 172 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (286)
T cd06638 172 AQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPT 248 (286)
T ss_pred eecccC--CCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc
Confidence 754321 112234578999999999853 223 568999999999999999999998876554444433322
Q ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
...|..++..+.++|.+||+.||++|||+.|+++|+||
T Consensus 249 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 22355578899999999999999999999999999997
No 209
>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase
Probab=100.00 E-value=4.6e-42 Score=333.88 Aligned_cols=252 Identities=29% Similarity=0.536 Sum_probs=212.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++...+..|++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998764444445556788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 105 MEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999988752 348999999999999999999999999999999999999999999999999987643211
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch--HHHHHHHHhhCCCC-C-CCCCCHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN--IMVMYKKIYKGEFR-S-PRWFSPDL 255 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~~-~-~~~~s~~~ 255 (481)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||.... .......+.....+ . +..++..+
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred --HHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 12234578999999999987766 568999999999999999999996543 23444444443322 2 23577889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.++|.+||..+|++|||+.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999873
No 210
>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor
Probab=100.00 E-value=2.4e-42 Score=345.30 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=209.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES----VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..+|++.+.||+|+||.||+|++..+++. ||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 45799999999999999999998766654 8999986432 234456788999999999999999999998764 5
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.++++||+.+|+|.+.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 7899999999999999875 36899999999999999999999999999999999999999999999999999865432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 256 (481)
..........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ..+.+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 22111222345678999999987776 578999999999999997 99999887765554444333 2455677899999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h 279 (481)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999986
No 211
>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85. Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.
Probab=100.00 E-value=3e-42 Score=338.19 Aligned_cols=251 Identities=35% Similarity=0.569 Sum_probs=210.2
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||.|++|.||+|++..+|+.||||++...... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 599999999999999999999999999999999765322 223556789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 107 YVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 107 y~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|+.+ +|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--N 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--c
Confidence 9986 88887764 358999999999999999999999999999999999999999999999999987543211 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------------ 244 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------------ 244 (481)
......+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+......++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998765555678999999999999999999998876555444433210
Q ss_pred --CC---------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 --FR---------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 --~~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+ ..+.+++.+.++|.+||+.||.+||++.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 012357789999999999999999999999999998
No 212
>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=2.2e-42 Score=339.99 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=216.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... .....+.+.+|+++++.++||||+++++.+.....+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 367999999999999999999999999999999987543 234567788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+++++|.+++.. +.+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++..... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----S 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----h
Confidence 999999999999876 679999999999999999999997 6999999999999999999999999999864322 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-----------HHHHHHHhhCC-CCCCCC
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-----------MVMYKKIYKGE-FRSPRW 250 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-----------~~~~~~i~~~~-~~~~~~ 250 (481)
.....+|+..|+|||++.+..+ +.++|+||+||++|+|++|..||..... ......+.... ...+..
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 1234578999999999876655 5689999999999999999999986443 12333333332 222222
Q ss_pred -CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 251 -FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 251 -~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
++.++.+|+.+||++||++|||++|+++|+||.+..
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 778899999999999999999999999999997653
No 213
>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=3.7e-42 Score=337.95 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=211.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEc----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..+|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 367999999999999999999853 356789999987533 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 101 IYFVMEYVRGGELFNKVAK------------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~------------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
.|++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 9999999999999999852 2378888999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.+||+|||+++...............++..|+|||++.+..+ +.++|+|||||++|+|++ |..||.+.+.......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999975432221122234456778999999977666 578999999999999998 999998877666655555
Q ss_pred hCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
... ...+..+++.+.+++.+||+.||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 45577789999999999999999999999999874
No 214
>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase. Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess
Probab=100.00 E-value=6.1e-42 Score=337.82 Aligned_cols=253 Identities=30% Similarity=0.484 Sum_probs=204.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+++.++|+||+++++++..+...|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998755322 2234567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+. ++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||+++...... .
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS--Q 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--C
Confidence 99996 566666543 468899999999999999999999999999999999999999999999999987533211 1
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhC------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKG------------------ 243 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~------------------ 243 (481)
......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.. +...++...
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2234467899999999876443356899999999999999999999765432 222221110
Q ss_pred --C-CC--CC---------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 244 --E-FR--SP---------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 244 --~-~~--~~---------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. .. .+ ...++++.+++.+||..||.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00 00 0125678999999999999999999999999997
No 215
>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt
Probab=100.00 E-value=2.3e-42 Score=338.30 Aligned_cols=251 Identities=23% Similarity=0.373 Sum_probs=213.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998743 46789999987543 2234577899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCE
Q 011628 100 KIYFVMEYVRGGELFNKVAK---------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~---------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~l 164 (481)
..|++|||++|++|.+++.. ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999999864 237888999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC
Q 011628 165 KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG 243 (481)
Q Consensus 165 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~ 243 (481)
||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999999874322111111223456788999999987776 568999999999999998 99999888777777777766
Q ss_pred CCC-CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 244 EFR-SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 244 ~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
... .+..++..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 543 35678899999999999999999999999986
No 216
>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do
Probab=100.00 E-value=3.6e-42 Score=333.46 Aligned_cols=246 Identities=34% Similarity=0.648 Sum_probs=208.5
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISIL-RRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
+.||+|+||.||+|.+..+++.||+|++.+...........+..|..++ ...+||||+++++++...+.+|+++||+.|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998765432222333444555544 455899999999999999999999999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999976 6799999999999999999999999999999999999999999999999999875322 234568
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC----CCCCCHHHHHHHHHhccc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS----PRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~----~~~~s~~~~~li~~~L~~ 265 (481)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+..+.... +..+++.+.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987664 678999999999999999999999888777777766554322 335789999999999999
Q ss_pred CcCCCC---CHhHHHhCccccc
Q 011628 266 NPDKRI---TIPEIMENRWFRK 284 (481)
Q Consensus 266 dP~~Rp---s~~eil~h~~f~~ 284 (481)
||++|| +++|++.||||.+
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhc
Confidence 999999 4579999999965
No 217
>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment
Probab=100.00 E-value=6.5e-42 Score=333.02 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=213.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++.+.||+|+||+||+|++..+ ...||+|.+.... .......+.+|+.+++.++||||+++++.+......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 35799999999999999999998644 4579999986543 233456688899999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|++|||+++++|.+++.. +.+++..+..++.|++.|+.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 999999999999999865 578999999999999999999999999999999999999999999999999998654211
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~ 257 (481)
.........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+ ..+.+..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1111112344678999999987666 578999999999999998 99999887776666666655 34556678999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhC
Q 011628 258 LLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h 279 (481)
++.+||+.+|++||++.+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999999999874
No 218
>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=7.7e-45 Score=392.47 Aligned_cols=259 Identities=32% Similarity=0.578 Sum_probs=223.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
.+.-||.-+..||.|.||.||.|.+..||+..|+|.+...... ....+.+.+|..++..++|||+|++|++-...+..|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3466899999999999999999999999999999998765543 345577899999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc--
Q 011628 103 FVMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR-- 179 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~-- 179 (481)
|.||||+||+|.++++.|+ .+|...+.|..|++.|+.|||++||+||||||+||+++.+|.+|++|||.|.......
T Consensus 1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 9999999999999999875 6777788899999999999999999999999999999999999999999987543321
Q ss_pred cCCcccccCCCCccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhC-CCCCCCCCCHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRK---GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKG-EFRSPRWFSPD 254 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~ 254 (481)
-.+.+....|||.|||||++.+. +. +-++|||||||++.||+||+.||...+.. .+..++-.| .++.|..+|++
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~-~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGH-GGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccCCC-CcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 23456678999999999999654 34 34699999999999999999999875432 333333344 57789999999
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.++||.+||..||++|.++.||++|.|-.
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 99999999999999999999999999853
No 219
>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta
Probab=100.00 E-value=5.9e-42 Score=337.72 Aligned_cols=256 Identities=20% Similarity=0.296 Sum_probs=212.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 5789999999999999999997642 355899999865432 223345778999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 100 KIYFVMEYVRGGELFNKVAKG-----------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~-----------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
..|+||||+++|+|.+++... .++...+..++.|++.||.|||++||+||||||+|||++.++.++|+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999999998641 245678899999999999999999999999999999999999999999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CC
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FR 246 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~ 246 (481)
||+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.........+..+. ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 999875322111111122345778999999877666 578999999999999998 899998887777776666554 34
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh------Ccccc
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME------NRWFR 283 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~------h~~f~ 283 (481)
.+..+++.+.+++.+||+.||++|||+.++++ ||||+
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 56677899999999999999999999999987 78875
No 220
>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly
Probab=100.00 E-value=5.4e-42 Score=337.98 Aligned_cols=249 Identities=23% Similarity=0.379 Sum_probs=211.7
Q ss_pred CCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.+|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 57999999999999999999852 345679999886532 2345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHcC--------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 011628 101 IYFVMEYVRGGELFNKVAKG--------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~--------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
+|++|||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEe
Confidence 99999999999999998642 3899999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCCC
Q 011628 167 SDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEF 245 (481)
Q Consensus 167 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~ 245 (481)
+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+..
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99999875422111111223446788999999987666 568999999999999998 9999998887777777777653
Q ss_pred -CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 246 -RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 246 -~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+..+++++.+|+.+||+.||.+|||+.+++.
T Consensus 241 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 241 LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 446678999999999999999999999999965
No 221
>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.
Probab=100.00 E-value=5e-42 Score=331.21 Aligned_cols=252 Identities=34% Similarity=0.607 Sum_probs=216.8
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||+|.+..+|..+|+|.+....... ...+.+.+|+.+++.++||||+++++.+.....+|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 6999999999999999999999999999999997654322 234567899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-EEEEecCCcccccccccCC
Q 011628 107 YVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD-LKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 107 y~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~-lkl~DFGla~~~~~~~~~~ 182 (481)
|+++++|.+++... .+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||.+...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 99999999998652 4799999999999999999999999999999999999998864 699999998764321 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLTK 261 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~~ 261 (481)
......|++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+.. ..+..++.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 2234568999999999876665 5789999999999999999999998777666666655543 3355678899999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||..+|++|||+.++++||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
No 222
>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor. Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh
Probab=100.00 E-value=4.7e-42 Score=336.21 Aligned_cols=253 Identities=20% Similarity=0.301 Sum_probs=210.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
..++|++.+.||+|+||.||.|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 35789999999999999999998642 45689999986432 122345678999999999999999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEE
Q 011628 99 SKIYFVMEYVRGGELFNKVAKG-----------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVS 167 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~-----------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~ 167 (481)
...++||||+++++|.+++... .++...+..++.|++.||.|||++|++||||||+||+++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999998642 24677889999999999999999999999999999999999999999
Q ss_pred ecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-C
Q 011628 168 DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-F 245 (481)
Q Consensus 168 DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~ 245 (481)
|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9999864322111111122356788999999977666 678999999999999999 799999888777666666554 3
Q ss_pred CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 246 RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 246 ~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+..+++.+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4566788999999999999999999999999864
No 223
>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes. Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular
Probab=100.00 E-value=5e-42 Score=330.95 Aligned_cols=244 Identities=27% Similarity=0.454 Sum_probs=204.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|++..+++.||+|.+.... ..+....+.+|+.+++.++||||+++++++.....+|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999899999999886432 3345567889999999999999999999999999999999999999
Q ss_pred chHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 112 ELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 112 ~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999865 3589999999999999999999999999999999999999999999999999875332111111111123
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcccCc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP 267 (481)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...........+... ....+..++..+.+++.+||+.+|
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999977666 568999999999999997 99999877665555555443 345566788999999999999999
Q ss_pred CCCCCHhHHHh
Q 011628 268 DKRITIPEIME 278 (481)
Q Consensus 268 ~~Rps~~eil~ 278 (481)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
No 224
>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi
Probab=100.00 E-value=2.4e-42 Score=341.70 Aligned_cols=255 Identities=30% Similarity=0.527 Sum_probs=218.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc---hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 5899999999999999999999988999999999865432 2245678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
+||+++++|.+++.+..+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~ 172 (293)
T cd06647 95 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKR 172 (293)
T ss_pred EecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc--ccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999886543221 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-C--CCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG-E--FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~-~--~~~~~~~s~~~~~li~~ 261 (481)
....|++.|+|||.+....+ +.++|+|||||++|++++|..||...+.......+..+ . +..+..++..+.++|.+
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 251 (293)
T ss_pred ccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence 34568999999999877666 56899999999999999999999877654433333222 1 22344567889999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||..+|.+||++++++.|+||+..
T Consensus 252 ~l~~~p~~Rp~~~~il~h~~~~~~ 275 (293)
T cd06647 252 CLEMDVEKRGSAKELLQHPFLKIA 275 (293)
T ss_pred HccCChhhCcCHHHHhcCHHHhcC
Confidence 999999999999999999999764
No 225
>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They
Probab=100.00 E-value=1.2e-41 Score=327.61 Aligned_cols=252 Identities=36% Similarity=0.657 Sum_probs=222.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||.|+||.||+|.+..+++.||+|++...... ......+.+|+++++.++|||++++++.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 699999999999999999999889999999999765432 2445678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 107 YVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 107 y~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|++|++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999998864 569999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLT 260 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 260 (481)
.......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+............. ..|..++..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 23345678999999999877765 5689999999999999999999998877777776666543 446678899999999
Q ss_pred HhcccCcCCCCCHhHHHhCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f 282 (481)
+||..+|.+|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
No 226
>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the
Probab=100.00 E-value=3.4e-42 Score=343.05 Aligned_cols=255 Identities=29% Similarity=0.500 Sum_probs=205.6
Q ss_pred CeeEEeEecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIY 102 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 102 (481)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999875422334456678899999999999999999999888 8899
Q ss_pred EEEeccCCCchHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc----CCCEEEEecCCc
Q 011628 103 FVMEYVRGGELFNKVAK------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE----NGDLKVSDFGLS 172 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~----~g~lkl~DFGla 172 (481)
+||||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 66665532 26899999999999999999999999999999999999999 899999999998
Q ss_pred cccccccc-CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH---------HHHHHhh
Q 011628 173 AVSDQIRQ-DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV---------MYKKIYK 242 (481)
Q Consensus 173 ~~~~~~~~-~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------~~~~i~~ 242 (481)
........ .......++++.|+|||++.+....+.++|||||||++|+|++|..||.+..... ....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76433222 1122345789999999998765444678999999999999999999997543211 0000000
Q ss_pred ------------------------C--CCCCC-----------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 243 ------------------------G--EFRSP-----------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 243 ------------------------~--~~~~~-----------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ....+ ...+..+.+++.+||+.||++|||+.|++.||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0 00111 1456789999999999999999999999999998
No 227
>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins. Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily
Probab=100.00 E-value=1e-41 Score=339.19 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=216.2
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.....+|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++......
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34457799999999999999999999889999999998755444444556788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+||||+.| +|.+.+. .+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 999999975 6666654 35799999999999999999999999999999999999999999999999999865332
Q ss_pred cCCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CC-CCCCCHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RS-PRWFSPDL 255 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~-~~~~s~~~ 255 (481)
.....|++.|+|||++.+ ....+.++||||+|+++|+|++|..||...+.......+..... .. +..++..+
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 124568899999999742 22335689999999999999999999988776655444443322 22 33467889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.++|.+||..||++||++.+|+.||||.+.
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 999999999999999999999999999764
No 228
>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu
Probab=100.00 E-value=5.9e-42 Score=333.68 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=209.0
Q ss_pred eeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK---- 100 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 100 (481)
|++++.||+|+||.||.|....+ +..||+|.+..+... ......+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 67899999999999999987653 478999998765332 2345678899999999999999999998866554
Q ss_pred --EEEEEeccCCCchHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 101 --IYFVMEYVRGGELFNKVAK-------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 101 --~~lv~Ey~~gg~L~~~i~~-------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
.+++|||+++|+|...+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 7999999999999988743 2589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCC
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPR 249 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~ 249 (481)
++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+....+..+..+. ...|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875432221111222345678999999876666 678999999999999999 999998887777777766653 45677
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+++.+.+++.+||+.||++|||+.+++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 889999999999999999999999999874
No 229
>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i
Probab=100.00 E-value=2.7e-42 Score=342.11 Aligned_cols=255 Identities=29% Similarity=0.527 Sum_probs=218.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..-|+....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++..+...|++
T Consensus 20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 3446667789999999999999988999999999865432 2345678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 105 MEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|||+++++|..++....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 97 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~ 174 (297)
T cd06659 97 MEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKR 174 (297)
T ss_pred EecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccc
Confidence 999999999998887889999999999999999999999999999999999999999999999999986433211 122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC---CCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---~~~~~~~s~~~~~li~~ 261 (481)
...+|++.|+|||++.+..+ +.++|+||+||++|+|++|..||...........+.... ...+..+++.+.++|.+
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~ 253 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER 253 (297)
T ss_pred cceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence 34678999999999987666 678999999999999999999998777665555554332 22344578899999999
Q ss_pred hcccCcCCCCCHhHHHhCcccccC
Q 011628 262 LLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
||+.+|.+||+++++++||||.+.
T Consensus 254 ~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 254 MLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred HhcCCcccCcCHHHHhhChhhccC
Confidence 999999999999999999999754
No 230
>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=5.2e-43 Score=369.76 Aligned_cols=247 Identities=32% Similarity=0.520 Sum_probs=207.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEE-EEe-----
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEV-MAT----- 97 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~-~~~----- 97 (481)
..+++|.+.|.+|||+.||+|++...|..||+|++-.. ++...+.+++||++|++|+ |+|||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34678899999999999999999888899999998654 4566788999999999997 9999999993 321
Q ss_pred -CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEecCC
Q 011628 98 -KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 98 -~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
.-.++|.||||.||.|-|+++. .+|+|.++.+||.|+++||.+||... |||||||-|||||+.+|+.||||||.
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 1257899999999999999974 46999999999999999999999997 99999999999999999999999999
Q ss_pred ccccccccc--CCc--c---cccCCCCcccccccc---ccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh
Q 011628 172 SAVSDQIRQ--DGL--F---HTFCGTPAYVAPEVL---SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 172 a~~~~~~~~--~~~--~---~~~~gt~~y~APEvl---~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~ 241 (481)
++-.-.... .+. + -...-|+.|+|||++ .+.+. +.|+|||+|||+||-||...+||++... ..|.
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWALGclLYkLCy~t~PFe~sg~----laIl 267 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWALGCLLYKLCYFTTPFEESGK----LAIL 267 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEE
Confidence 874222110 000 0 023569999999997 34454 6799999999999999999999998743 3567
Q ss_pred hCCCCCCC--CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGEFRSPR--WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~~~~~~--~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++.+.+|+ .++..+.+||+.||+.||++||++.|++.+
T Consensus 268 ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 268 NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 78877765 689999999999999999999999998874
No 231
>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK
Probab=100.00 E-value=3.1e-42 Score=348.70 Aligned_cols=257 Identities=30% Similarity=0.460 Sum_probs=216.4
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK- 100 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~- 100 (481)
..+.++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3568899999999999999999999999999999999865432 22344667789999999999999999988766554
Q ss_pred -----EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 101 -----IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 101 -----~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
.|+|+||+ |++|.+++..+++++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 669999998888999999999999999999999999999999999999999999999999998754
Q ss_pred cccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC---------
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--------- 246 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--------- 246 (481)
.. ......+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 32 1234578899999999866444467899999999999999999999877665555444331100
Q ss_pred ----------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 247 ----------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 247 ----------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
....+++.+.++|.+||+.||.+|||+.+|+.||||.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~ 304 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcccc
Confidence 012358899999999999999999999999999999864
No 232
>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase. Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays
Probab=100.00 E-value=9.9e-42 Score=331.36 Aligned_cols=248 Identities=25% Similarity=0.441 Sum_probs=213.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
...|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++||||+++++++.....++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 356999999999999999999999999999999986542 2245678999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999999999864 35899999999999999999999999999999999999999999999999998754331111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 259 (481)
......+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+....+..+..+ ....|..+++++.++|
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM 238 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence 1112234667999999877766 568999999999999998 99999988877777776654 3455677899999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.||++|||+.++++
T Consensus 239 ~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 239 RACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred HHHccCCcccCCCHHHHHH
Confidence 9999999999999999976
No 233
>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun
Probab=100.00 E-value=1e-41 Score=335.74 Aligned_cols=254 Identities=30% Similarity=0.524 Sum_probs=218.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|.-.+.||+|++|.||+|.+..+++.+|+|+++... ....+.+.+|+.+++.++||||+++++++...+..|+++
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 34566789999999999999998899999999986433 223456789999999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
||+.|++|.+.+..+++++..+..++.|++.|++|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 96 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~ 173 (285)
T cd06648 96 EFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK 173 (285)
T ss_pred eccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999876433211 1223
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC---CCCCCHHHHHHHHHh
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS---PRWFSPDLIRLLTKL 262 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~s~~~~~li~~~ 262 (481)
...|++.|+|||.+.+..+ +.++|+||+||++|+|++|..||...+.......+..+..+. +..+++.+.++|.+|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 4568999999999977666 568999999999999999999998887776666666553222 333788999999999
Q ss_pred cccCcCCCCCHhHHHhCcccccC
Q 011628 263 LDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 263 L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|+.+|++|||+.++++||||.+.
T Consensus 253 l~~~p~~Rpt~~~il~~~~~~~~ 275 (285)
T cd06648 253 LVRDPAQRATAAELLNHPFLAKA 275 (285)
T ss_pred cccChhhCcCHHHHccCcccccC
Confidence 99999999999999999999764
No 234
>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2. Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly
Probab=100.00 E-value=2.8e-42 Score=338.66 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=214.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
..+|++.+.||+|+||.||+|.+..+ ++.||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45689999999999999999987543 5789999997543 2334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 100 KIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999999852 2478888999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 999999999875432222222234456789999999876666 568999999999999998 999999888877777777
Q ss_pred hCCC-CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+.. ..+..++..+.+|+.+||+.+|.+||++.+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7653 4577789999999999999999999999999873
No 235
>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc
Probab=100.00 E-value=6.5e-42 Score=335.85 Aligned_cols=251 Identities=33% Similarity=0.544 Sum_probs=209.1
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++.+.||.|++|.||+|.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++......|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 78899999999999999999999999999999765422 23345677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 108 VRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 108 ~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
+. ++|.+++... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 6899988653 5899999999999999999999999999999999999999999999999998754321 1122
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--------------------
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------- 244 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------- 244 (481)
....+++.|+|||++.+....+.++|+||||+++|+|++|..||...+......++....
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578899999998765444678999999999999999999998776544333332210
Q ss_pred ---------CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 ---------FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ---------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
......+++.+.++|.+||++||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 01123467889999999999999999999999999997
No 236
>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins. Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of
Probab=100.00 E-value=1.3e-41 Score=329.49 Aligned_cols=254 Identities=30% Similarity=0.565 Sum_probs=220.0
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|++|.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++......|++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765422 34577889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+++++|.+++.. +.+++..+..++.|++.|+.|||+ +|++||||+|+||+++.++.++|+|||++........ .
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--Q 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC--c
Confidence 99999999999976 789999999999999999999999 9999999999999999999999999999876533221 1
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhCC-CCCCCC-CCHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGE-FRSPRW-FSPDLIRL 258 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~-~~~~~~-~s~~~~~l 258 (481)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ........+.... ...+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 234568899999999877655 67899999999999999999999776 4445555555443 334455 78999999
Q ss_pred HHHhcccCcCCCCCHhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
|.+||.++|++|||+.++++||||+.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999964
No 237
>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h
Probab=100.00 E-value=1.1e-41 Score=329.65 Aligned_cols=246 Identities=25% Similarity=0.435 Sum_probs=209.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||.||+|++. .+..+|+|.+...... ...+.+|+.+++.++||||+++++++......|++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 56999999999999999999874 4568999988654322 346788999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++||+|.+.+.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 99999999999864 4689999999999999999999999999999999999999999999999999875322111 01
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 261 (481)
.....++..|+|||++.+..+ +.++|+||||+++|+|++ |..||...+.......+..+. ...|...+..+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 112235668999999987766 568999999999999999 999999888777777777664 33466678899999999
Q ss_pred hcccCcCCCCCHhHHHh
Q 011628 262 LLDTNPDKRITIPEIME 278 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~ 278 (481)
||+.+|.+|||++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999985
No 238
>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase. Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK
Probab=100.00 E-value=2e-41 Score=325.85 Aligned_cols=254 Identities=31% Similarity=0.545 Sum_probs=218.9
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv 104 (481)
+|.+.+.||+|++|.||+|.+..+++.|++|++...... ......+.+|+.++++++||||+++++.+... ..++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999889999999999765432 34467788999999999999999999999988 899999
Q ss_pred EeccCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+||+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 9999999999999764 899999999999999999999999999999999999999999999999999876544322112
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhh--CCCCCCCCCCHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYK--GEFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~--~~~~~~~~~s~~~~~li~ 260 (481)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||.... .......+.. .....|..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 344678999999999876654 678999999999999999999998765 3333333332 234556778999999999
Q ss_pred HhcccCcCCCCCHhHHHhCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f 282 (481)
+||+.||++||++.++++||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
No 239
>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6. Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs
Probab=100.00 E-value=1.2e-41 Score=333.76 Aligned_cols=253 Identities=27% Similarity=0.472 Sum_probs=205.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISI-LRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
++|++.+.||+|+||.||+|++..+|+.||+|.+....... ....+..|+.+ ++.++||||+++++++.....+|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999987653222 22345556664 6777899999999999999999999
Q ss_pred EeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 105 MEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
|||++ |+|.+++.. ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 577666643 3689999999999999999999998 9999999999999999999999999998754321
Q ss_pred ccCCcccccCCCCcccccccccc----CCCCCCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhC-CCCCC-CCC
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSR----KGYDAAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKG-EFRSP-RWF 251 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~----~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~-~~~~~-~~~ 251 (481)
.......|+..|+|||++.+ .++ +.++|+|||||++|+|++|..||.... .......+..+ ....| ..+
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred ---cccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 11223568899999998854 233 568999999999999999999997532 22333333333 22333 357
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|.++.++|.+||..+|.+|||+.++++||||++.
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 8999999999999999999999999999999864
No 240
>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological
Probab=100.00 E-value=1.1e-41 Score=332.98 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=212.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+++.++||||+++++++....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ 82 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence 56899999999999999999998643 4789999986543 2233456789999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 100 KIYFVMEYVRGGELFNKVAK-----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
..|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence 99999999999999999853 1367889999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CC
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FR 246 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~ 246 (481)
||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+. ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence 999875433221122234457889999999876665 678999999999999998 999998887777666666543 45
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.|..++..+.++|.+||+.+|++|||+.+++.
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 57778999999999999999999999999986
No 241
>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl. Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor
Probab=100.00 E-value=8.9e-42 Score=332.75 Aligned_cols=250 Identities=22% Similarity=0.366 Sum_probs=207.1
Q ss_pred eeEEeEecccCceEEEEEEEcCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC------C
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGE--SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK------S 99 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~------~ 99 (481)
|.+++.||+|+||.||+|++..++. .||+|.+..... .......+.+|+.+++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999877765 699999876432 334457788999999999999999999987432 2
Q ss_pred EEEEEEeccCCCchHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..+++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 24789999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRW 250 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~ 250 (481)
+...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||........+..+..+. ...+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 76432211111123356778999999987666 678999999999999999 899998877777777777654 345667
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++..+.++|.+||+.||++|||+++|+++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999864
No 242
>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase. Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well
Probab=100.00 E-value=1e-41 Score=333.96 Aligned_cols=252 Identities=21% Similarity=0.350 Sum_probs=210.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4679999999999999999999977 77889999886443 2233456888999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC---CEEEEe
Q 011628 100 KIYFVMEYVRGGELFNKVAKG--------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---DLKVSD 168 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~--------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---~lkl~D 168 (481)
..|++|||+.|++|.+++... .+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 999999999999999998642 488999999999999999999999999999999999998765 599999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCC
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFR 246 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~ 246 (481)
||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 999875422111111112234568999999977666 678999999999999997 99999987766666555443 345
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.|..++..+.+++.+||+.+|++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 567789999999999999999999999999986
No 243
>PLN00009 cyclin-dependent kinase A; Provisional
Probab=100.00 E-value=1.2e-41 Score=336.07 Aligned_cols=256 Identities=32% Similarity=0.528 Sum_probs=210.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 36899999999999999999999889999999998665322 23345678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCccccccccc
Q 011628 105 MEYVRGGELFNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~~~ 180 (481)
|||+++ +|.+.+.. . .+++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999964 78777754 2 3688899999999999999999999999999999999985 457999999998754321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC----------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE---------------- 244 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------------- 244 (481)
........|++.|+|||++.+....+.++||||+||++|+|++|..||...+......++....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1122345678999999998765444678999999999999999999998776554444432210
Q ss_pred -------CC------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 -------FR------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 -------~~------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+. ....+++.+.++|.+||+.+|++||++.+++.||||..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 00 11346788999999999999999999999999999975
No 244
>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=9.7e-43 Score=348.56 Aligned_cols=256 Identities=29% Similarity=0.453 Sum_probs=208.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 103 (481)
...|+++++||+||.++||++..- +.+.+|+|.+.... .+...+..+.+|+..|.+|+ |.+||++|++-..++.+|+
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 678999999999999999999974 44556666554332 34567788999999999995 9999999999999999999
Q ss_pred EEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||-+ .+|..+++++ .++.-.++.|.+||+.|+.++|++||+|.||||.|+|+ -.|.+||+|||+|.........
T Consensus 438 vmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccccc
Confidence 999753 5999999874 34445899999999999999999999999999999998 4579999999999865543333
Q ss_pred CcccccCCCCccccccccccCCCC----------CCcchHHHHHHHHHHHhcCCCCCCCch-HHHHHHHHhhCC--CCCC
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYD----------AAKVDIWSCGVILFVLMAGYLPFQDQN-IMVMYKKIYKGE--FRSP 248 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~----------~~~~DiwSlGvil~elltg~~Pf~~~~-~~~~~~~i~~~~--~~~~ 248 (481)
-...+-+||+.||+||.+....+. +.++||||||||||+|+.|++||.... ...-+..|.... ..+|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 344577999999999998654432 568999999999999999999998754 444455555542 3444
Q ss_pred CCCCHH-HHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 249 RWFSPD-LIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 249 ~~~s~~-~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..-+.. +.++++.||..||++|||+.++|+|||++-
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 433333 999999999999999999999999999863
No 245
>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho
Probab=100.00 E-value=2.9e-41 Score=328.25 Aligned_cols=255 Identities=28% Similarity=0.505 Sum_probs=215.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI--LKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKI 101 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 101 (481)
.+|++++.||+|+||.||+|++..+++.||+|.+..... ........+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999864321 1233456788999999999999999999998664 568
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
++++||++|++|.+.+.. +.+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999999875 5789999999999999999999999999999999999999999999999999975432111
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHHHH
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDLIR 257 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~ 257 (481)
........|+..|+|||.+.+..+ +.++|+|||||++|+|++|..||.+........++.... ...|..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 112234568999999999987665 578999999999999999999998876655555554332 3457778999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+|.+||. +|.+||++.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
No 246
>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5. Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the
Probab=100.00 E-value=4e-42 Score=346.42 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=211.8
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE----eCC
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA----TKS 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~----~~~ 99 (481)
+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 35789999999999999999999999999999999876432 2234567788999999999999999998875 345
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+||||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7899999996 589888865 56999999999999999999999999999999999999999999999999998754322
Q ss_pred cc--CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--------------
Q 011628 179 RQ--DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------------- 242 (481)
Q Consensus 179 ~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------------- 242 (481)
.. ........|+..|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 11 11223457899999999986644446789999999999999999999987654332221111
Q ss_pred ---------C---CCCC-----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 ---------G---EFRS-----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 ---------~---~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .... .+..++++.++|.+||+.+|.+|||+++++.||||.+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~ 300 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY 300 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence 0 0000 13368889999999999999999999999999999754
No 247
>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-
Probab=100.00 E-value=7.6e-42 Score=352.34 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=206.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
.++|++++.||+|+||.||+|.+... +..||||++.... .......+.+|+.+++.+. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 56788999999999999999987533 3479999996543 2234567889999999996 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-----------------------------------------------------------
Q 011628 99 SKIYFVMEYVRGGELFNKVAK----------------------------------------------------------- 119 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~----------------------------------------------------------- 119 (481)
..+|+|||||++|+|.+++..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999988753
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC
Q 011628 120 --------------------------------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 120 --------------------------------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~ 161 (481)
..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHH-HHHHH
Q 011628 162 GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIM-VMYKK 239 (481)
Q Consensus 162 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~-~~~~~ 239 (481)
+.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...... ..+..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 9999999999875433222112233457788999999987666 578999999999999997 99999876443 33344
Q ss_pred HhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 240 IYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 240 i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+..+ ....+..+++++.+++.+||+.||++|||+.++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4433 24456678899999999999999999999998876
No 248
>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases. Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast
Probab=100.00 E-value=3e-41 Score=324.64 Aligned_cols=252 Identities=33% Similarity=0.624 Sum_probs=220.1
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|+.++++++|||++++++++.+...+|++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 699999999999999999999889999999999776532 2455778999999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 107 YVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 107 y~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
|+++++|.+++.. +.+++..++.++.|++.|+.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 9999999999876 6899999999999999999999999999999999999999999999999999976543221 123
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh-hCCCCCCCCCCHHHHHHHHHhcc
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY-KGEFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~s~~~~~li~~~L~ 264 (481)
...|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+......++. ......+..+++.+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4578999999999877664 678999999999999999999998766544444443 33345567789999999999999
Q ss_pred cCcCCCCCHhHHHhCccc
Q 011628 265 TNPDKRITIPEIMENRWF 282 (481)
Q Consensus 265 ~dP~~Rps~~eil~h~~f 282 (481)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999997
No 249
>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2. Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A
Probab=100.00 E-value=8.6e-42 Score=339.38 Aligned_cols=249 Identities=24% Similarity=0.414 Sum_probs=207.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES--VAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~--vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++.+.||+|+||.||+|.+..++.. +|+|.+... ........+.+|+.++.++ +||||+++++++...+.+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 56899999999999999999999877765 466665432 2334456788999999999 899999999999999999
Q ss_pred EEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCE
Q 011628 102 YFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~l 164 (481)
|+||||+++++|.+++... .+++..++.++.|++.|++|||++|++||||||+|||++.++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 9999999999999998642 47899999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC
Q 011628 165 KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG 243 (481)
Q Consensus 165 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~ 243 (481)
||+|||++........ .....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+
T Consensus 164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 239 (303)
T cd05088 164 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239 (303)
T ss_pred EeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence 9999999863221111 111234667999999877665 578999999999999998 99999887777666666544
Q ss_pred C-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 244 E-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 244 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
. ...+..+++++.+||.+||+.+|++||++++++.+
T Consensus 240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 33455678999999999999999999999999985
No 250
>PRK13184 pknD serine/threonine-protein kinase; Reviewed
Probab=100.00 E-value=1.1e-41 Score=372.29 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=207.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+++|++++.||+|+||.||+|++..+|+.||+|++...........+++.+|+.+++.++||||+++++++...+..|++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47999999999999999999999999999999999765444444567788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 105 MEYVRGGELFNKVAK------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
|||++||+|.+++.. ..++...+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999998853 12455678899999999999999999999999999999999999999999999
Q ss_pred cccccccc----------------CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH
Q 011628 173 AVSDQIRQ----------------DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM 236 (481)
Q Consensus 173 ~~~~~~~~----------------~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~ 236 (481)
........ .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76421100 001123579999999999988776 6789999999999999999999987654332
Q ss_pred HHHH-hhCC--CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 237 YKKI-YKGE--FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 237 ~~~i-~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.... .... ......+++.+.+++.+||+.||++||+..+.+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2221 1111 1112357889999999999999999987655544
No 251
>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto
Probab=100.00 E-value=4.8e-42 Score=346.55 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=204.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT- 97 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~- 97 (481)
.++|++++.||+|+||.||+|++.. +++.||+|++.... .....+.+.+|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3589999999999999999997543 45789999986543 223346678899999999 79999999998865
Q ss_pred CCEEEEEEeccCCCchHHHHHc----------------------------------------------------------
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK---------------------------------------------------------- 119 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~---------------------------------------------------------- 119 (481)
...++++|||+++++|.+++..
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 4578999999999999988753
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCcccc
Q 011628 120 ----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195 (481)
Q Consensus 120 ----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 195 (481)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++................++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 2578899999999999999999999999999999999999999999999999975432111111223456778999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHH-HHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCC
Q 011628 196 PEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMY-KKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRIT 272 (481)
Q Consensus 196 PEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~-~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps 272 (481)
||++.+..+ +.++|||||||++|+|++ |..||.+....+.. ..+..+. ...|...++++.+++.+||+.+|++||+
T Consensus 244 PE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 322 (337)
T cd05054 244 PESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT 322 (337)
T ss_pred cHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 999988777 568999999999999998 99999875443333 3333332 3446667899999999999999999999
Q ss_pred HhHHHhC
Q 011628 273 IPEIMEN 279 (481)
Q Consensus 273 ~~eil~h 279 (481)
++|+++|
T Consensus 323 ~~ell~~ 329 (337)
T cd05054 323 FSELVEI 329 (337)
T ss_pred HHHHHHH
Confidence 9999875
No 252
>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.
Probab=100.00 E-value=7.8e-42 Score=332.24 Aligned_cols=250 Identities=30% Similarity=0.564 Sum_probs=212.2
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|++..+++.+|||.+.............+.+|+.+++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 67999999999999999999998999999999887654444445567889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 106 EYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999998862 45899999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH--HHHHHHHhhCCCC--CCCCCCHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI--MVMYKKIYKGEFR--SPRWFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~~~~~~--~~~~~s~~~~ 256 (481)
........|++.|+|||.+.+..+ +.++|+||||+++|+|++|..||.+... ......+.....+ .+..+++.+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 122345678999999999977766 5689999999999999999999976533 3444444433322 2345788999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||..||++|||+.+|++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999998865
No 253
>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,
Probab=100.00 E-value=1.1e-41 Score=336.00 Aligned_cols=252 Identities=25% Similarity=0.450 Sum_probs=212.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
.++|++.+.||+|+||.||+|.+... ...+|+|.+..... ......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 47899999999999999999997643 37899999875432 23346688999999999 799999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~ 161 (481)
..+|++|||+.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 999999999999999999853 358899999999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHH
Q 011628 162 GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKI 240 (481)
Q Consensus 162 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i 240 (481)
+.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||........+..+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999976433221111122335678999999877666 578999999999999997 99999988877777776
Q ss_pred hhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 241 YKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 241 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+. ...+..++..+.+|+.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6654 34566788999999999999999999999999874
No 254
>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14
Probab=100.00 E-value=1.3e-41 Score=344.43 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=211.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 356899999999999999999999989999999999875432 222345677899999999999999999988643
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
...|++++++ |++|.+++..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 7899998888889999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------ 244 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------ 244 (481)
. ......|++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+....
T Consensus 172 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred c-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 2 22345789999999998664444678999999999999999999998765444333322110
Q ss_pred -----------CCC--------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 245 -----------FRS--------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 245 -----------~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
... ....++++.++|.+||+.||.+|||+.+++.||||++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~ 306 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence 000 11257789999999999999999999999999999864
No 255
>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan
Probab=100.00 E-value=1.6e-41 Score=327.59 Aligned_cols=245 Identities=26% Similarity=0.446 Sum_probs=213.4
Q ss_pred eEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.+++.++|+||+++++++.....++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999766 8999999997654322 4577889999999999999999999999999999999999
Q ss_pred CCCchHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 109 RGGELFNKVAK----------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 109 ~gg~L~~~i~~----------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
++++|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999975 56899999999999999999999999999999999999999999999999999765432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........+++.|+|||.+....+ +.++|||||||++|+|++ |..||...........+..+. ...|..+++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 21122334567889999999877655 678999999999999999 699999988877777777553 456778899999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h 279 (481)
+++.+||+.||.+|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999874
No 256
>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants. Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati
Probab=100.00 E-value=8.4e-42 Score=344.62 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=210.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
+..+|++.+.||+|+||+||.|++..+++.||||.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 567899999999999999999999999999999998754322 22345677899999999999999999987654
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+|+++||+. ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 688888865 6799999999999999999999999999999999999999999999999999875432
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh---------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--------------- 242 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--------------- 242 (481)
. ........++..|+|||++......+.++|||||||++|+|++|..||.+.+.......+..
T Consensus 161 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 K--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred C--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 1 12234557899999999986544446789999999999999999999987654322221110
Q ss_pred --------CC-----C---CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 243 --------GE-----F---RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 243 --------~~-----~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.. . ...+.+++++.++|.+||+.+|++|||++++++||||..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~ 296 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS 296 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence 00 0 012347889999999999999999999999999999964
No 257
>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a
Probab=100.00 E-value=4.3e-41 Score=326.54 Aligned_cols=250 Identities=30% Similarity=0.571 Sum_probs=212.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.++++++|+||+++++++......+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999998899999999987654444445677889999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 106 EYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999998853 35899999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch--HHHHHHHHhhCCC-CCCC-CCCHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN--IMVMYKKIYKGEF-RSPR-WFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~-~~~~-~~s~~~~ 256 (481)
........|++.|+|||.+.+..+ +.++|+|||||++|+|++|..||.... .......+..+.. +.|. .++..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 122234578999999999987776 568999999999999999999996543 3344445444433 2333 6788999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
++|.+||..+|++|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
No 258
>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase. Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina
Probab=100.00 E-value=3.1e-41 Score=328.58 Aligned_cols=247 Identities=30% Similarity=0.503 Sum_probs=205.8
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
-..||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++..++.+++++||++|
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 458999999999999998899999999986543 22346788999999999999999999999999999999999999
Q ss_pred CchHHHHHc--CCC--CHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCcccccccccCCccc
Q 011628 111 GELFNKVAK--GRL--KEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 111 g~L~~~i~~--~~l--~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
++|.+.+.. +.+ ++..+..++.|++.|+.|||++||+||||||+||+++. ++.++|+|||++...... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 167 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTE 167 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccc
Confidence 999999875 345 88899999999999999999999999999999999986 679999999998754321 12223
Q ss_pred ccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchH--HHHHHH-HhhCCCCCCCCCCHHHHHHHHH
Q 011628 186 TFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNI--MVMYKK-IYKGEFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~-i~~~~~~~~~~~s~~~~~li~~ 261 (481)
...|++.|+|||++.+.. ..+.++|+||+|+++|+|++|..||..... ...+.. ........|..+++++.+++.+
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 446899999999986533 235789999999999999999999976432 222221 1222344577789999999999
Q ss_pred hcccCcCCCCCHhHHHhCccc
Q 011628 262 LLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~f 282 (481)
||+.+|.+|||+.+++.||||
T Consensus 248 ~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997
No 259
>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional
Probab=100.00 E-value=1.4e-41 Score=331.83 Aligned_cols=245 Identities=25% Similarity=0.438 Sum_probs=203.9
Q ss_pred ccCCeeEEeEe--cccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 011628 24 LLGRYEIGKLL--GHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSK 100 (481)
Q Consensus 24 ~~~~y~i~~~L--G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 100 (481)
+.++|++.+.+ |+|+||.||++.+..++..+|+|++....... .|+.....+ +||||+++++.+...+.
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 35678887776 99999999999999999999999987653221 122222222 69999999999999999
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~ 178 (481)
.|+||||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 9999999999999999976 4899999999999999999999999999999999999999998 999999999875432
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH----HHHHHhhCCCCCCCCCCHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV----MYKKIYKGEFRSPRWFSPD 254 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~----~~~~i~~~~~~~~~~~s~~ 254 (481)
.....|++.|+|||++.+..+ +.++|+||+|+++|+|++|..||....... ............+..+++.
T Consensus 163 -----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (267)
T PHA03390 163 -----PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKN 236 (267)
T ss_pred -----CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHH
Confidence 123468999999999988776 568999999999999999999997553221 1222223344556678999
Q ss_pred HHHHHHHhcccCcCCCCC-HhHHHhCcccc
Q 011628 255 LIRLLTKLLDTNPDKRIT-IPEIMENRWFR 283 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps-~~eil~h~~f~ 283 (481)
+.+||.+||+++|.+||+ ++++++||||.
T Consensus 237 ~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 237 ANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred HHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999996 69999999995
No 260
>PHA03210 serine/threonine kinase US3; Provisional
Probab=100.00 E-value=8.6e-42 Score=361.95 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=196.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcC-CCcEEEEEEe--------------ecccccchhHHHHHHHHHHHHHhCCCCC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVI--------------DKEKILKSGLVAHIKREISILRRVRHPN 87 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i--------------~~~~~~~~~~~~~~~~Ei~il~~l~Hpn 87 (481)
.+.++|++++.||+|+||+||++..+. ++...+.|.+ .+...........+.+|+.+++.++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 456899999999999999999987654 2233333311 1111112234456789999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC
Q 011628 88 IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 88 Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~ 161 (481)
|+++++++...+..|+++|++. ++|.+++..+ ......++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 9999999999999999999995 4777766432 23467788999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCC-CCCCc--hHHHHHH
Q 011628 162 GDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYL-PFQDQ--NIMVMYK 238 (481)
Q Consensus 162 g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~-Pf~~~--~~~~~~~ 238 (481)
+.+||+|||++....... .......+||+.|+|||++.+..+ +.++|||||||++|+|++|.. ||... +......
T Consensus 304 ~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 999999999997653321 112234689999999999988777 568999999999999999875 44322 1212222
Q ss_pred HHhhC------CCC---------------------C-----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 239 KIYKG------EFR---------------------S-----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 239 ~i~~~------~~~---------------------~-----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++... .++ . ...++.++.++|.+||+.||.+|||+.|++.||||...
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 11110 000 0 01245678889999999999999999999999999764
No 261
>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]
Probab=100.00 E-value=2.6e-43 Score=352.62 Aligned_cols=233 Identities=27% Similarity=0.498 Sum_probs=207.4
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
++-||.|+.|.||+|+. .++.||||.++.-+ .-+|+-|++|+||||+.|.++|.....++||||||..
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 56799999999999987 67899999875322 2478889999999999999999999999999999999
Q ss_pred CchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 111 GELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 111 g~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
|.|...++.+ .+.......|..+|+.|+.|||.+.|||||||.-||||..+..+||+|||.++..... ...-.++|
T Consensus 197 GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaG 273 (904)
T KOG4721|consen 197 GQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAG 273 (904)
T ss_pred ccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhh
Confidence 9999999875 6899999999999999999999999999999999999999999999999999865433 23346899
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHHHHHHHHhcccCc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~~~li~~~L~~dP 267 (481)
|..|||||++.+.+. +.|+|||||||+|||||||..||.+-+...+...+-... ++.|..++..++=||++||+-.|
T Consensus 274 TVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp 352 (904)
T KOG4721|consen 274 TVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP 352 (904)
T ss_pred hHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence 999999999998877 679999999999999999999999888776665554443 56788899999999999999999
Q ss_pred CCCCCHhHHHhC
Q 011628 268 DKRITIPEIMEN 279 (481)
Q Consensus 268 ~~Rps~~eil~h 279 (481)
..||++.+|+.|
T Consensus 353 RNRPSFrqil~H 364 (904)
T KOG4721|consen 353 RNRPSFRQILLH 364 (904)
T ss_pred CCCccHHHHHHH
Confidence 999999999998
No 262
>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul
Probab=100.00 E-value=9.1e-42 Score=344.17 Aligned_cols=261 Identities=32% Similarity=0.483 Sum_probs=213.8
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC--
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK-- 98 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~-- 98 (481)
..+.++|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 34678999999999999999999999889999999998654222 22335567899999999 999999999988653
Q ss_pred CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
...|+||||+.+ +|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 468999999974 9999998778899999999999999999999999999999999999999999999999998754332
Q ss_pred ccC---CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-----------
Q 011628 179 RQD---GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE----------- 244 (481)
Q Consensus 179 ~~~---~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~----------- 244 (481)
... .......|++.|+|||++.+....+.++|+||||+++|+|++|+.||.+........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 211 233446789999999998665555678999999999999999999998765443333221110
Q ss_pred ----------------C----CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 ----------------F----RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 ----------------~----~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
. .....++.++.++|.+||+.||.+|||+.++++||||++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~ 300 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence 0 011226888999999999999999999999999999976
No 263
>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases. Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include
Probab=100.00 E-value=4.7e-41 Score=331.13 Aligned_cols=253 Identities=28% Similarity=0.476 Sum_probs=210.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KSKIYF 103 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 103 (481)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ......+.+|++++++++||||+++++++.. ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999999876432 2345678899999999999999999998865 347899
Q ss_pred EEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 104 VMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
||||++|++|.+++.. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999887642 45899999999999999999999999999999999999999999999999998653321
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHhhCCC-CCC----
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-----NIMVMYKKIYKGEF-RSP---- 248 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-----~~~~~~~~i~~~~~-~~~---- 248 (481)
......++..|+|||.+.+..+ +.++|+|||||++|+|++|..||... ...+....+..... ..+
T Consensus 159 ----~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 ----LAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ----ccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 1123467889999999877666 56899999999999999999999865 22333333333211 111
Q ss_pred --CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 249 --RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 249 --~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+++.+.++|.+||..||.+|||+.|++.||||.+.
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 1246789999999999999999999999999999654
No 264
>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the
Probab=100.00 E-value=1.8e-41 Score=325.91 Aligned_cols=246 Identities=43% Similarity=0.758 Sum_probs=220.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|+||.||.+.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++.+..+..+|++|||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999999877655445567789999999999999999999999999999999999999999
Q ss_pred HHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCc
Q 011628 114 FNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPA 192 (481)
Q Consensus 114 ~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~ 192 (481)
.+++.. +.+++..+..++.|++.|+.|||+++++|+||+|+||+++.++.++|+|||++....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999976 478999999999999999999999999999999999999999999999999987643321 12345678899
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCC
Q 011628 193 YVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRIT 272 (481)
Q Consensus 193 y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps 272 (481)
|+|||...+... +.++|+||||+++|+|++|..||...+.......+....+..|..++..+.++|.+||..||++||+
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999877655 5689999999999999999999988877777778877778888888999999999999999999999
Q ss_pred H---hHHHhCccc
Q 011628 273 I---PEIMENRWF 282 (481)
Q Consensus 273 ~---~eil~h~~f 282 (481)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
No 265
>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=2.8e-41 Score=336.14 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=212.1
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVK-------SGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFE 93 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~ 93 (481)
....++|.+++.||+|+||.||+|++.. ++..+|+|.+.... .......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3346899999999999999999998643 23579999997643 223346688899999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 94 VMATKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 94 ~~~~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
++......|+||||+.+|+|.+++... .++...+..++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999999999999642 378889999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMV 235 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~ 235 (481)
+++.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+...
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999875432111111122234578999999977666 578999999999999998 999998887777
Q ss_pred HHHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 236 MYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 236 ~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
....+..+. ...|..++.++.+||.+||..+|.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 666665554 34566789999999999999999999999999874
No 266
>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2. Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve
Probab=100.00 E-value=3.2e-41 Score=330.60 Aligned_cols=250 Identities=23% Similarity=0.364 Sum_probs=208.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..+|++.+.||+|+||+||+|++..+++ .||+|++.... .......+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence 4689999999999999999999877776 48999986543 23345678899999999999999999999875 45
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.++++||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 7899999999999999865 46899999999999999999999999999999999999999999999999998765422
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+. .+.+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 11111122345678999999977766 568999999999999998 999998876666555555543 345667899999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||+.||++||++.++++
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999985
No 267
>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph
Probab=100.00 E-value=3.7e-41 Score=332.06 Aligned_cols=258 Identities=33% Similarity=0.583 Sum_probs=216.4
Q ss_pred CeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
.|++.+.||.|+||.||.|++. .+|+.||+|++...... .....+.+.+|+.+++.+ +||||+++++++.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999975 47899999999764322 223346678899999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 999999999999999875 578999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCccccccccccC-CCCCCcchHHHHHHHHHHHhcCCCCCCCch----HHHHHHHHhhCCCCCCCCCCHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKGEFRSPRWFSPDL 255 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 255 (481)
........|+..|+|||.+... ...+.++||||||+++|+|++|..||...+ .......+.....+.|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1222346789999999998643 233568999999999999999999997432 33444555555566677789999
Q ss_pred HHHHHHhcccCcCCCC-----CHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRI-----TIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rp-----s~~eil~h~~f~~~ 285 (481)
.+++.+||+.||++|| ++++++.||||.+.
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 9999999999999997 89999999999764
No 268
>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely
Probab=100.00 E-value=1.7e-41 Score=336.02 Aligned_cols=258 Identities=29% Similarity=0.538 Sum_probs=211.1
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-- 99 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-- 99 (481)
....++|++.+.||+|+||.||+|.+..+|+.||+|+++..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 45678999999999999999999999999999999999765322 223356778999999999999999999987654
Q ss_pred --------EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 100 --------KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 100 --------~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.+|+++||+++ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 79999999987 67676664 46899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CC-
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EF- 245 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~- 245 (481)
|++........ .......+++.|+|||++.+....+.++|||||||++|+|++|+.||...+.......+... ..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 99876433221 11222356788999998865544467899999999999999999999877655444333321 10
Q ss_pred --------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 --------------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 --------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.....+++.+.++|.+||..||.+|||+++++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0012367899999999999999999999999999997
No 269
>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3. Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r
Probab=100.00 E-value=3.2e-41 Score=331.06 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=207.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGES----VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.++|++++.||+|+||+||+|.+..+++. +++|.+.... .......+..|+.+++.++||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 46899999999999999999999877764 6777764322 2233466788999999999999999999875 456
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.++++||+++|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999964 46899999999999999999999999999999999999999999999999999754322
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...+..++.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 22222334567788999999977666 578999999999999998 999998877666555555554 344556788899
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||..||++|||+.|+++
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999976
No 270
>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn. Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa
Probab=100.00 E-value=2.8e-41 Score=327.42 Aligned_cols=247 Identities=21% Similarity=0.396 Sum_probs=209.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|.+ .++..||+|.+..... ..+.+.+|+.+++.++||||+++++++......|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 56899999999999999999986 4567899999865432 246688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 999999999999864 4688999999999999999999999999999999999999999999999999976432111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
.......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...........+..+. .+.+..++.++.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 11122345678999999877665 568999999999999998 999998877766666665542 334456789999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||..+|++|||++++++
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999875
No 271
>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po
Probab=100.00 E-value=3e-41 Score=330.92 Aligned_cols=252 Identities=35% Similarity=0.568 Sum_probs=211.3
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKIYFVM 105 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lv~ 105 (481)
|++.+.||+|+||.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|||++++++++... ...|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999899999999998764 2334456678999999999999999999999888 8999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||+++ +|.+.+.. ..+++..++.++.|++.||+|||++|++|+||||+||++++++.++|+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 88888865 3799999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--C----------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--F---------------- 245 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~---------------- 245 (481)
.....++..|+|||.+.+....+.++||||||+++|+|++|..||...+.......+.... .
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 2344678899999987665444678999999999999999999998877655544443210 0
Q ss_pred -----C--------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 -----R--------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 -----~--------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ....+++.+.++|.+||..+|.+||++.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 001137889999999999999999999999999997
No 272
>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1. Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.
Probab=100.00 E-value=3.4e-41 Score=333.87 Aligned_cols=248 Identities=24% Similarity=0.416 Sum_probs=208.4
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGE--SVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (481)
++|++.+.||+|+||.||+|+...++. .+++|.+.... .....+.+.+|+.+++++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999877765 46888876322 223456788999999999 7999999999999999999
Q ss_pred EEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 011628 103 FVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lk 165 (481)
++|||+++++|.+++... .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999998642 378899999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC
Q 011628 166 VSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 166 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~ 244 (481)
|+|||++........ ......+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+........++..+.
T Consensus 160 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCccccceec---cCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999864221111 111223557999999877666 578999999999999997 999999888777777776653
Q ss_pred -CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 245 -FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 245 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
...|..+++++.+|+.+||+.+|.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566789999999999999999999999999764
No 273
>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke
Probab=100.00 E-value=2.6e-41 Score=333.80 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=209.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCC----------------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSG----------------ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~----------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (481)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... ......+.+|+.++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876543 5689999876532 2456778899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKG------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 89 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
+++++++......+++|||+.+++|.+++... .+++..++.++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 99999999999999999999999999998652 489999999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCCCchHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYLPFQDQNIM 234 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~~~ 234 (481)
+++.++.++|+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999875432221222234566788999999877655 678999999999999998 78899876655
Q ss_pred HHHHHHhhC--------CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 235 VMYKKIYKG--------EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 235 ~~~~~i~~~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+..+... ....+..++.++.+++.+||+.||.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 555444322 12335567889999999999999999999999965
No 274
>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=4.8e-41 Score=333.84 Aligned_cols=254 Identities=22% Similarity=0.415 Sum_probs=213.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEc-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNV-------KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEV 94 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~ 94 (481)
...++|++++.||+|+||.||+|++. .++..||+|.+.... .......+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 44789999999999999999999753 234579999986542 223456788999999999 79999999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEE
Q 011628 95 MATKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLL 157 (481)
Q Consensus 95 ~~~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NIL 157 (481)
+......|++|||+.+|+|.+++... .++...+..++.|++.||.|||++|++||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999999999998642 3677889999999999999999999999999999999
Q ss_pred EccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHH
Q 011628 158 LDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVM 236 (481)
Q Consensus 158 l~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~ 236 (481)
++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+....
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999876543222222233456778999999977666 568999999999999998 8999998887777
Q ss_pred HHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 237 YKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 237 ~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
...+..+. ...+..++..+.+|+.+||..+|.+|||+.++++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 249 FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 77776553 34466788999999999999999999999999874
No 275
>PTZ00024 cyclin-dependent protein kinase; Provisional
Probab=100.00 E-value=2.5e-41 Score=340.61 Aligned_cols=261 Identities=30% Similarity=0.415 Sum_probs=213.4
Q ss_pred ccCCeeE-EeEecccCceEEEEEEEcCCCcEEEEEEeecccccch-----------hHHHHHHHHHHHHHhCCCCCcceE
Q 011628 24 LLGRYEI-GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----------GLVAHIKREISILRRVRHPNIVQL 91 (481)
Q Consensus 24 ~~~~y~i-~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~HpnIv~l 91 (481)
+.+||.. .+.||+|+||+||+|++..+++.||||++........ .....+.+|+.+++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 4678864 6789999999999999999999999999865432210 011246789999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecC
Q 011628 92 FEVMATKSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 92 ~~~~~~~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFG 170 (481)
++++......|++|||+. |+|.+.+.. ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999997 589888865 579999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc------------cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHH
Q 011628 171 LSAVSDQIR------------QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYK 238 (481)
Q Consensus 171 la~~~~~~~------------~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~ 238 (481)
++....... .........+++.|+|||.+.+....+.++|+|||||++|+|++|..||.+.+......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 987544110 01122334578899999998765555778999999999999999999998877655544
Q ss_pred HHhhCC--CC--------------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 239 KIYKGE--FR--------------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 239 ~i~~~~--~~--------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+.... .. .....+.++.++|.+||+.+|.+|||+++++.||||+..
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 443210 00 012357789999999999999999999999999999754
No 276
>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n
Probab=100.00 E-value=3.8e-41 Score=332.43 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=211.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|.+.+.||+|+||.||+|.+. .++..+++|.+.... ....+.+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 467999999999999999999854 245679999886443 223456889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC
Q 011628 100 KIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG 162 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g 162 (481)
..++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999864 2378999999999999999999999999999999999999999
Q ss_pred CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHh
Q 011628 163 DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIY 241 (481)
Q Consensus 163 ~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~ 241 (481)
.++|+|||++................|++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 999999999875432211112233457889999999987666 568999999999999998 999998887777777676
Q ss_pred hCCC-CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 242 KGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 242 ~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+.. ..+..++..+.+++.+||+.+|++|||+.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 6654 345567899999999999999999999999976
No 277
>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein. Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi
Probab=100.00 E-value=3.4e-41 Score=332.52 Aligned_cols=249 Identities=24% Similarity=0.403 Sum_probs=208.4
Q ss_pred CeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... ......+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235789998865432 23346788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 102 YFVMEYVRGGELFNKVAK-------------------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-------------------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
|+++||+.+++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999998753 2377889999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMV 235 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~ 235 (481)
|+++++.+||+|||+++...............++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999875432211111223456778999999876665 578999999999999998 999999888777
Q ss_pred HHHHHhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 236 MYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 236 ~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
....+..+ ....|..++.++.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 66665544 24456778999999999999999999999999976
No 278
>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a
Probab=100.00 E-value=6e-41 Score=325.32 Aligned_cols=247 Identities=25% Similarity=0.400 Sum_probs=209.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++......|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 467999999999999999999974 567899999875432 235578899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+.|++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999999752 5899999999999999999999999999999999999999999999999999765421111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
......++..|+|||++.+..+ +.++|+||||+++|+|++ |+.||.+.+.......+.... ...+..++..+.+++
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 1111223457999999877665 578999999999999999 999999887777776665542 345666889999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.+|.+||++.+++.
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999875
No 279
>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=5.4e-41 Score=335.20 Aligned_cols=251 Identities=24% Similarity=0.425 Sum_probs=210.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-------SGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMA 96 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~ 96 (481)
.++|.+++.||+|+||.||+|++.. ....+|+|.+.... .......+.+|+.+++.+ .||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 5799999999999999999998642 34579999987543 223456788999999999 6999999999999
Q ss_pred eCCEEEEEEeccCCCchHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAK-----------------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD 159 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~-----------------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~ 159 (481)
....+|++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 99999999999999999999864 2378889999999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHH
Q 011628 160 ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYK 238 (481)
Q Consensus 160 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 238 (481)
.++.+||+|||+++...............+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+....+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999975432211111222334568999999977666 578999999999999999 899999888777777
Q ss_pred HHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 239 KIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 239 ~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..+. ...+..++.++.+++.+||..||++|||+.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 766654 3456678889999999999999999999999986
No 280
>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins. Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic
Probab=100.00 E-value=2.7e-41 Score=335.61 Aligned_cols=257 Identities=32% Similarity=0.526 Sum_probs=207.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK----- 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~----- 98 (481)
..++|++.+.||+|+||.||+|.+..+++.+|+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 368999999999999999999999999999999998765422 22234567899999999999999999887443
Q ss_pred ---CEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 99 ---SKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 99 ---~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
..+|+||||+.+ +|...+.. ..+++..+..++.|+++||.|||++||+||||||+||+++.++.++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 357999999975 67666653 479999999999999999999999999999999999999999999999999987
Q ss_pred cccccccC---------CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC
Q 011628 174 VSDQIRQD---------GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 174 ~~~~~~~~---------~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 244 (481)
........ .......|++.|+|||++.+....+.++||||+||++|+|++|..||.+.+.......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~ 243 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 54322111 112234678899999998665444678999999999999999999998877665555443210
Q ss_pred C-----------------------CCC-------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 F-----------------------RSP-------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~-----------------------~~~-------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
. ..+ ..+++.+.++|.+||+.||.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 244 GTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 0 000 1244678899999999999999999999999998
No 281
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=100.00 E-value=2.5e-42 Score=352.83 Aligned_cols=245 Identities=34% Similarity=0.545 Sum_probs=216.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
++.+.|++...+|.|+|+.|..+.+..+++..++|++.+.... ..+|+.++... +||||+++++++.++...
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCcee
Confidence 5678999999999999999999999999999999999876322 23577666666 699999999999999999
Q ss_pred EEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE-ccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL-DENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl-~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+|||++.|+.|.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 999999999999999987665558888999999999999999999999999999999 58899999999998754332
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCCCCCCCCHHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFRSPRWFSPDLIRLL 259 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~~~~~s~~~~~li 259 (481)
..+.|-|..|+|||++...+| +..+||||||++||+||+|+.||..... .++..++..+.+. .++|..+++||
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred ---hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 456678899999999998888 5679999999999999999999976544 4777777766655 78999999999
Q ss_pred HHhcccCcCCCCCHhHHHhCccc
Q 011628 260 TKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.+||+.||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
No 282
>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome. Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds
Probab=100.00 E-value=3.8e-41 Score=326.25 Aligned_cols=248 Identities=24% Similarity=0.381 Sum_probs=208.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++.+.||+|+||+||.|.+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++......|++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 357999999999999999999874 3456999998754321 34578899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+|+|.+++.. ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||+++....... .
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~ 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-T 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-e
Confidence 999999999999875 3689999999999999999999999999999999999999999999999999875322111 0
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLT 260 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 260 (481)
......++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+.. ..+...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1112235577999999977666 568999999999999998 9999988877767777766543 345567899999999
Q ss_pred HhcccCcCCCCCHhHHHhC
Q 011628 261 KLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h 279 (481)
+||+.||.+|||+.+|+.+
T Consensus 236 ~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 236 SCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHcCCCcccCCCHHHHHHh
Confidence 9999999999999999864
No 283
>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2. Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp
Probab=100.00 E-value=2e-41 Score=342.77 Aligned_cols=252 Identities=25% Similarity=0.430 Sum_probs=204.0
Q ss_pred cCCeeEEeEecccCceEEEEEEE-----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARN-----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT- 97 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~- 97 (481)
.++|++++.||+|+||+||+|++ ..+++.||||++..... ......+.+|+.++..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 46899999999999999999985 34678999999975432 23356688999999999 68999999998765
Q ss_pred CCEEEEEEeccCCCchHHHHHcC---------------------------------------------------------
Q 011628 98 KSKIYFVMEYVRGGELFNKVAKG--------------------------------------------------------- 120 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~~--------------------------------------------------------- 120 (481)
...++++|||+++|+|.+++...
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 45689999999999999988531
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 121 -----------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 121 -----------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
.++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 256778889999999999999999999999999999999999999999999875422111111123345
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHH-HHHHHHhhC-CCCCCCCCCHHHHHHHHHhcccC
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIM-VMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTN 266 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~-~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~d 266 (481)
++.|+|||++.+..+ +.++||||||+++|+|++ |..||...... .....+..+ ....|.+.++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 678999999877666 578999999999999997 99999875433 223333333 34557778999999999999999
Q ss_pred cCCCCCHhHHHhC
Q 011628 267 PDKRITIPEIMEN 279 (481)
Q Consensus 267 P~~Rps~~eil~h 279 (481)
|.+|||+.+|++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999986
No 284
>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk. Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom
Probab=100.00 E-value=2.3e-41 Score=327.86 Aligned_cols=247 Identities=23% Similarity=0.427 Sum_probs=212.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++++.||.|+||.||+|.+.. +..+|+|++..... .....+.+|+.+++.++||||+++++++......|++
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999976 89999999876532 2345688999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++++|.+++.. ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 999999999999975 3589999999999999999999999999999999999999999999999999875432111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 259 (481)
......++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+....+..+..+ ..+.+..+++.+.++|
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred -cccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 1123345678999999877666 568999999999999998 89999888777777766654 3455677899999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.||.+|||+.+|++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999976
No 285
>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase. Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio
Probab=100.00 E-value=4.7e-41 Score=325.50 Aligned_cols=243 Identities=23% Similarity=0.358 Sum_probs=204.0
Q ss_pred EecccCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 33 LLGHGTFAKVYHARN--VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
.||+|+||.||+|.+ ..++..+|+|++.... ......+.+.+|+.+++.+.||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999964 4578899999987543 23345677889999999999999999999875 4567899999999
Q ss_pred CchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-CcccccC
Q 011628 111 GELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD-GLFHTFC 188 (481)
Q Consensus 111 g~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~~~~~ 188 (481)
|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999865 57999999999999999999999999999999999999999999999999998754322110 0112234
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcccC
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTN 266 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~d 266 (481)
+++.|+|||.+....+ +.++|+|||||++|+|++ |..||...+.......+.++. ...|..+++++.++|.+||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 4678999999876555 568999999999999998 999999887777777776654 4567779999999999999999
Q ss_pred cCCCCCHhHHHh
Q 011628 267 PDKRITIPEIME 278 (481)
Q Consensus 267 P~~Rps~~eil~ 278 (481)
|++||++++|..
T Consensus 239 p~~Rp~~~~i~~ 250 (257)
T cd05116 239 VDERPGFAVVEL 250 (257)
T ss_pred chhCcCHHHHHH
Confidence 999999999875
No 286
>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4. Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo
Probab=100.00 E-value=3.4e-41 Score=333.46 Aligned_cols=253 Identities=29% Similarity=0.506 Sum_probs=215.0
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|+-...||+|+||.||+|.+..+++.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|++|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 333478999999999999999999999999985432 23356688999999999999999999999999999999999
Q ss_pred cCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccccc
Q 011628 108 VRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187 (481)
Q Consensus 108 ~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 187 (481)
+++++|.+++..+++++..++.++.|++.|++|||++|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 999999999888889999999999999999999999999999999999999999999999999876432211 112345
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC---CCCCCCCCCHHHHHHHHHhcc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG---EFRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~s~~~~~li~~~L~ 264 (481)
.|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+... .......+++.+.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 78999999999876665 57899999999999999999999887665544444332 222344578999999999999
Q ss_pred cCcCCCCCHhHHHhCcccccCc
Q 011628 265 TNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 265 ~dP~~Rps~~eil~h~~f~~~~ 286 (481)
.+|.+||++.+++.||||.+..
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CCcccCcCHHHHhcChHHhccC
Confidence 9999999999999999998764
No 287
>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-42 Score=351.40 Aligned_cols=249 Identities=22% Similarity=0.436 Sum_probs=216.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..+...++..||+|.||+||+|++.. .||||+++.+.... +..+.+++|+.++++-+|.||+-+.|++..+.. .|
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 35667789999999999999999854 49999998877554 477899999999999999999999999998887 99
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|+.+|+|.+|+.++.- -+|.....+.|++|++.|+.|||.++|+|||||..||++.+++.|||+|||++.........
T Consensus 465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~ 544 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE 544 (678)
T ss_pred eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence 9999999999999864 57999999999999999999999999999999999999999999999999999876655555
Q ss_pred CcccccCCCCcccccccccc---CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-----CCCCCCH
Q 011628 182 GLFHTFCGTPAYVAPEVLSR---KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-----SPRWFSP 253 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~---~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~~~~~s~ 253 (481)
..+....|...|||||+++. .+| +..+||||+||++|||++|.+||...+...+...+-.|... .-..++.
T Consensus 545 ~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk 623 (678)
T KOG0193|consen 545 QQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK 623 (678)
T ss_pred cccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence 55667788999999999863 344 67899999999999999999999987777776666666322 2334667
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++++|+..||.+++++||.+.+||.
T Consensus 624 ~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 624 AMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHhcCcccCccHHHHHH
Confidence 8999999999999999999999986
No 288
>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3. Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co
Probab=100.00 E-value=1.4e-40 Score=332.29 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=214.8
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..+.|...+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++|||++++++++.+....|+
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 98 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 34568888999999999999999989999999999976654444455678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||+.| +|.+.+.. +.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 99 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----- 172 (313)
T cd06633 99 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----- 172 (313)
T ss_pred EEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence 9999964 77777653 568999999999999999999999999999999999999999999999999886422
Q ss_pred CcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--CCCCCCHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIR 257 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~ 257 (481)
......|+..|+|||++.. .+..+.++|||||||++|+|++|..||...+.......+.....+ ....++..+.+
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRG 251 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHH
Confidence 1234578999999999842 233356899999999999999999999887765555555444322 12346788999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|+.+||+.+|.+||++.+++.||||+..
T Consensus 252 li~~~l~~~P~~Rp~~~~~l~~~~~~~~ 279 (313)
T cd06633 252 FVDYCLQKIPQERPASAELLRHDFVRRD 279 (313)
T ss_pred HHHHHccCChhhCcCHHHHhcCcccCCC
Confidence 9999999999999999999999999753
No 289
>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src. Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo
Probab=100.00 E-value=5.6e-41 Score=326.19 Aligned_cols=247 Identities=24% Similarity=0.375 Sum_probs=207.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|++..+ ..||+|++...... ...+.+|+.+++.++||||+++++.+. ....|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence 357899999999999999999988655 46999998764421 246788999999999999999999874 456899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~- 156 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 156 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence 9999999999999975 358999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. .+.+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 111223446778999999877666 578999999999999999 899998877766666665542 44456688999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||++||++|||+.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999876
No 290
>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows
Probab=100.00 E-value=3.6e-41 Score=326.12 Aligned_cols=247 Identities=24% Similarity=0.428 Sum_probs=208.1
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.+|++.+.||+|+||.||+|++. ++..+|+|++...... ...+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 46899999999999999999875 5678999998654322 245678999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||++|++|.+++.. +.+++..++.++.|++.|+.|||++|++||||||+||+++.++.+||+|||+++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 99999999999864 4689999999999999999999999999999999999999999999999999875432111 01
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~ 261 (481)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.......+..+ ....|..+++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 111223457999999987766 568999999999999999 89999887777666666655 345566789999999999
Q ss_pred hcccCcCCCCCHhHHHhC
Q 011628 262 LLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h 279 (481)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999863
No 291
>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept
Probab=100.00 E-value=5.6e-41 Score=333.47 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=209.9
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVM 95 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 95 (481)
....++|++.+.||+|+||.||+|.+. .++..||+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 344678999999999999999999853 345689999987543 223456788999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
...+..|++|||+.+|+|.+++... .+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 9999999999999999999998652 3899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC--CCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE--FRSPR 249 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~--~~~~~ 249 (481)
................+++.|+|||++.+..+ +.++||||+||++|+|++ |..||........+.+..... ...+.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 267 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE 267 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence 75432211111123346788999999877666 568999999999999998 999998776554444443332 23456
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..++.+.+++.+||.++|++|||+.++++
T Consensus 268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 68899999999999999999999999986
No 292
>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase. Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481
Probab=100.00 E-value=6.9e-41 Score=365.92 Aligned_cols=150 Identities=33% Similarity=0.644 Sum_probs=139.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
.+++|++++.||+|+||+||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.....+|+
T Consensus 2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence 36899999999999999999999999999999999987655555566788999999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 104 VMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999975 678999999999999999999999999999999999999999999999999985
No 293
>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and
Probab=100.00 E-value=2.1e-41 Score=340.16 Aligned_cols=257 Identities=32% Similarity=0.479 Sum_probs=216.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-----KI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 101 (481)
||++.+.||+|+||.||+|++..+++.||||.+.... ......+.+.+|+.+++.++||||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999998899999999987643 22344567889999999999999999999987765 78
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|++|||+.+ +|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999984 88888876 4799999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC--C-----------
Q 011628 181 -DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--R----------- 246 (481)
Q Consensus 181 -~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--~----------- 246 (481)
........+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+.+....+..+..... .
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 12234456899999999998773446789999999999999999999998876665555443110 0
Q ss_pred ------------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 247 ------------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 247 ------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+.+++.+.++|.+||+++|.+|||+++++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 012367889999999999999999999999999999753
No 294
>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1. Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron
Probab=100.00 E-value=1.5e-40 Score=332.62 Aligned_cols=256 Identities=27% Similarity=0.448 Sum_probs=217.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
..-..|+..+.||+|+||.||+|++..++..||+|++.............+.+|+.+++.++|||++++++++......|
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAW 101 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEE
Confidence 34455899999999999999999998899999999997654444455677889999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+||||+.| +|.+.+. ...+++..+..++.|++.|+.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 102 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--- 177 (317)
T cd06635 102 LVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--- 177 (317)
T ss_pred EEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence 99999975 7777664 35789999999999999999999999999999999999999999999999998864322
Q ss_pred CCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--CCCCCCHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~ 256 (481)
.....|++.|+|||++.. .+..+.++|+||+||++|+|++|..||...+.......+..+... .+..+++.+.
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 254 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR 254 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHH
Confidence 234578999999999742 223366899999999999999999999887766666666554432 2345788899
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++|.+||+.+|.+||++.++++|+|+...
T Consensus 255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 255 NFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred HHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 99999999999999999999999998654
No 295
>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases. Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core
Probab=100.00 E-value=1.3e-40 Score=318.76 Aligned_cols=248 Identities=35% Similarity=0.603 Sum_probs=213.4
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58999999999999999999988999999999976542 345678899999999999999999999999999999999
Q ss_pred ccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 107 YVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 107 y~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
|++|++|.+++... .+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999998764 799999999999999999999999999999999999999999999999999876543221 3
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-C--CCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-F--RSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-~--~~~~~~s~~~~~li~~ 261 (481)
....|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+.... . ..+..++..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45578999999999876654 678999999999999999999998875443333333222 2 2233348899999999
Q ss_pred hcccCcCCCCCHhHHHhCcc
Q 011628 262 LLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h~~ 281 (481)
||+.||.+|||+.+++.|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
No 296
>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity. Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....
Probab=100.00 E-value=2e-41 Score=329.18 Aligned_cols=247 Identities=31% Similarity=0.537 Sum_probs=204.5
Q ss_pred eEEeEecccCceEEEEEEEc----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 29 EIGKLLGHGTFAKVYHARNV----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
++.+.||.|+||.||+|... ..+..|+||++... ......+.+.+|+.++++++||||+++++++......++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999987 35678999999543 2333467889999999999999999999999988889999
Q ss_pred EeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||+++|+|.+++... .+++.....++.|++.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999764 7999999999999999999999999999999999999999999999999998765221111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
.......+...|+|||.+.+..+ +.++||||||+++||+++ |..||.+.+......++..+. ...+..++..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 12233456788999999977765 679999999999999999 789999988877777776654 445677899999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
No 297
>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains. Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an
Probab=100.00 E-value=6.6e-41 Score=322.93 Aligned_cols=250 Identities=30% Similarity=0.504 Sum_probs=219.5
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+|++.+.||+|+||.||++.+..+++.+|+|.+....... .....+.+|+.+++.++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5999999999999999999999999999999997654322 334567789999999999999999999999999999999
Q ss_pred ccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 107 YVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 107 y~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998865 46899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRLLT 260 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~li~ 260 (481)
......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...+.......+..+.+ ..+..++.++.+++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 2334568999999999987666 5689999999999999999999998887776666666554 345568899999999
Q ss_pred HhcccCcCCCCCHhHHHhCccc
Q 011628 261 KLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h~~f 282 (481)
+||..+|++|||+.++++||++
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
No 298
>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U
Probab=100.00 E-value=9.1e-41 Score=335.96 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=211.0
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-KSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~ 102 (481)
..++|++.+.||.|+||.||+|.+..+++.||+|.+.+... .....+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 46789999999999999999999999999999999865432 22344667899999999999999999999865 56789
Q ss_pred EEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 103 FVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
+++||+ +++|.+++..+.+++..+..++.|++.||.|||++||+||||+|.||+++.++.++|+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----- 160 (328)
T ss_pred EEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-----
Confidence 999998 56899988888899999999999999999999999999999999999999999999999999874322
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--------------------
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK-------------------- 242 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-------------------- 242 (481)
......+++.|+|||++.+....+.++|+||+||++|+|++|..||........+..+.+
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd07856 161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240 (328)
T ss_pred CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence 223456788999999986644446789999999999999999999987654322211110
Q ss_pred ------CCCCC-----CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 243 ------GEFRS-----PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 243 ------~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..... .+.+++.+.++|.+||+.+|++|||+++++.||||...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 00011 12467889999999999999999999999999999754
No 299
>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase. Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13
Probab=100.00 E-value=5.2e-41 Score=339.56 Aligned_cols=254 Identities=31% Similarity=0.503 Sum_probs=209.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK---- 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~---- 98 (481)
.+.++|.+.+.||+|+||.||+|++..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 456899999999999999999999988999999999876432 223445678999999999999999999998654
Q ss_pred --CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 99 --SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 --~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
..+|+|+||+.+ +|.... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 356999999964 666654 3468999999999999999999999999999999999999999999999999987532
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC------------
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------ 244 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------ 244 (481)
. ......|++.|+|||++.+....+.++|+|||||++|+|++|+.||.+.+....+..+....
T Consensus 169 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 169 A-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred C-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 2 12345678999999998764444678999999999999999999999876554444333210
Q ss_pred -----------CCC--------CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 245 -----------FRS--------PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 245 -----------~~~--------~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
... .+..++.+.+||.+||+.||.+||++++++.||||..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 000 1235778999999999999999999999999999965
No 300
>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A. Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory
Probab=100.00 E-value=6.2e-41 Score=329.07 Aligned_cols=250 Identities=23% Similarity=0.363 Sum_probs=209.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
..+|.+.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 357889999999999999999743 356789999876432 234567899999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC
Q 011628 100 KIYFVMEYVRGGELFNKVAKG----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD 163 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~ 163 (481)
..|++|||+++++|.+++... .+++..+..++.|++.|+.|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 999999999999999998642 3788999999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhh
Q 011628 164 LKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYK 242 (481)
Q Consensus 164 lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~ 242 (481)
+||+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |.+||...........+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 99999999864322111111223345788999999987776 568999999999999998 9999988776666666655
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 243 GE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 243 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+. ...+..+++.+.++|.+||+.||.+||++++|++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 53 4556778999999999999999999999999975
No 301
>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase. Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou
Probab=100.00 E-value=7.3e-41 Score=329.27 Aligned_cols=254 Identities=30% Similarity=0.558 Sum_probs=219.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
....|++.+.||+|+||.||.|.+..+++.||+|++..... ....+.+|+.+++.++|+||+++++++......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 56679999999999999999999988899999999976532 34667899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
++||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999999874 79999999999999999999999999999999999999999999999999886543211
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CCCCCCCHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RSPRWFSPDLIRL 258 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~~~~~s~~~~~l 258 (481)
.......+++.|+|||++.+..+ +.++|+|||||++|+|++|..||...+.......+..... ..+..++..+.++
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 249 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHH
Confidence 12234467899999999877666 5789999999999999999999998776555555443322 2233378899999
Q ss_pred HHHhcccCcCCCCCHhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
|.+||+.+|.+|||+.+++.|+||.+
T Consensus 250 i~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 250 LNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHhccChhhCcCHHHHhhChHhhc
Confidence 99999999999999999999999986
No 302
>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase. Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M
Probab=100.00 E-value=5.9e-41 Score=330.27 Aligned_cols=251 Identities=24% Similarity=0.372 Sum_probs=211.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4679999999999999999998743 67899999987543 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 100 KIYFVMEYVRGGELFNKVAKG-----------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~-----------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
..|++|||+++|+|.+++... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999999999998632 367888999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMV 235 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~ 235 (481)
+++.++.++|+|||++................+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999874322111111122345677999999877766 578999999999999997 889998877777
Q ss_pred HHHHHhhCCC-CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 236 MYKKIYKGEF-RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 236 ~~~~i~~~~~-~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
....+..+.. ..|..++.++.+||.+||+.+|.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777766653 446678899999999999999999999999875
No 303
>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul
Probab=100.00 E-value=8.9e-41 Score=325.36 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=210.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++|++++.||+|+||.||+|++..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999865443 79999986543 223456788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|++|||++|++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999875 468999999999999999999999999999999999999999999999999987643321
Q ss_pred cCC-cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 180 QDG-LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 180 ~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
... ......++..|+|||.+.+..+ +.++|+|||||++|++++ |..||.+.........+..+. .+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 111 1111223568999999987666 678999999999999886 999998877666666666542 344556789999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||+++|.+||++.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999975
No 304
>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1. Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co
Probab=100.00 E-value=1.6e-40 Score=334.41 Aligned_cols=257 Identities=30% Similarity=0.461 Sum_probs=206.0
Q ss_pred CeeEEeEecccCceEEEEEEEcCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKS--GESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT----KS 99 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~----~~ 99 (481)
+|++.+.||+|+||.||+|++..+ +..||+|.+.... ........+.+|+.+++++ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 599999999999999999999887 8999999986532 2223346678899999999 59999999987543 24
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+++||+. ++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 588888865 57999999999999999999999999999999999999999999999999999754322
Q ss_pred cc--CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC-------------
Q 011628 179 RQ--DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG------------- 243 (481)
Q Consensus 179 ~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~------------- 243 (481)
.. ........|++.|+|||++.+....+.++||||+||++|+|++|..||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112234578999999998765433367899999999999999999999876543333222110
Q ss_pred ------------C---CC---CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 244 ------------E---FR---SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 244 ------------~---~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .. .....+..+.+++.+||+.||.+|||+.+++.||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 00 112257889999999999999999999999999999764
No 305
>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]
Probab=100.00 E-value=3.5e-42 Score=318.41 Aligned_cols=250 Identities=27% Similarity=0.471 Sum_probs=210.7
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.+.+..||.|+.|+|++++.+.+|...|||.+.+.. ..+..+++.+.+.++...+ +|+||+.+|+|..+..++|.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 345678999999999999999999999999997754 3455788999999888876 9999999999999999999999
Q ss_pred ccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
.+.. .+..++. +++++|..+-++...++.||.||.+ +||+|||+||+|||+|+.|++|+||||++...-... .
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---A 247 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---A 247 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc---c
Confidence 9853 4444444 3689999999999999999999985 599999999999999999999999999997643322 2
Q ss_pred ccccCCCCccccccccccC---CCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCCC-C--CCCCHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRK---GYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFRS-P--RWFSPDLI 256 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~---~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~-~--~~~s~~~~ 256 (481)
.....|.+.|||||.+... .| ..++||||||++|+||.||+.||.+.+. -+...++.+.+++. | ..+|+.++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kY-DiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~ 326 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKY-DIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ 326 (391)
T ss_pred cccccCCccccCccccCCCCCCcc-chhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence 2345799999999998533 45 3579999999999999999999998543 46677777765543 2 23899999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 257 RLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+|+..||.+|+.+||...++|+|||+..
T Consensus 327 ~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 327 SFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred HHHHHHhhcCcccCcchHHHhcCcceee
Confidence 9999999999999999999999999864
No 306
>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr
Probab=100.00 E-value=9.8e-41 Score=325.28 Aligned_cols=251 Identities=23% Similarity=0.377 Sum_probs=210.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.+.|++.+.||+|+||.||+|.+..+++ .||||.+.... .......+.+|+.+++.++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999877664 69999986542 234457789999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
++||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999874 468999999999999999999999999999999999999999999999999987543222
Q ss_pred cCCcccccC---CCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHH
Q 011628 180 QDGLFHTFC---GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPD 254 (481)
Q Consensus 180 ~~~~~~~~~---gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~ 254 (481)
......... .+..|+|||.+.+..+ +.++||||+||++|+|++ |..||...+.......+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 2457999999987776 568999999999999886 99999887776666666543 23445667899
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHh
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+.+++.+||..+|.+||++++|+.
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999986
No 307
>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta. Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig
Probab=100.00 E-value=4e-41 Score=338.33 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=202.9
Q ss_pred eEeccc--CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHG--TFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G--~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
..||+| +||+||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..+...|+|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999998765432 2445788999999999999999999999999999999999999
Q ss_pred CCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC----
Q 011628 110 GGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG---- 182 (481)
Q Consensus 110 gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~---- 182 (481)
+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999999875 358999999999999999999999999999999999999999999999998653221111000
Q ss_pred -cccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---------------
Q 011628 183 -LFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF--------------- 245 (481)
Q Consensus 183 -~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~--------------- 245 (481)
......++..|+|||++.+.. ..+.++||||+||++|+|++|..||.+............+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 001123566799999986632 125789999999999999999999987654433333222111
Q ss_pred --------------------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 246 --------------------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 246 --------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
+.+..+++.+.+||++||+.||++|||++|+++||||....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 01122567799999999999999999999999999997643
No 308
>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including
Probab=100.00 E-value=6e-41 Score=331.66 Aligned_cols=250 Identities=19% Similarity=0.292 Sum_probs=203.7
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCC--------------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSG--------------ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQL 91 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~--------------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l 91 (481)
++|++.+.||+|+||.||++++..++ ..||+|.+.... .......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 58999999999999999999875432 358999987543 23345678899999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCchHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE
Q 011628 92 FEVMATKSKIYFVMEYVRGGELFNKVAKG-------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL 158 (481)
Q Consensus 92 ~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~-------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl 158 (481)
++++......|+||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill 162 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence 99999999999999999999999988542 26788899999999999999999999999999999999
Q ss_pred ccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCCCchHHHH
Q 011628 159 DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYLPFQDQNIMVM 236 (481)
Q Consensus 159 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~~~~~ 236 (481)
+.++.+||+|||++................+++.|+|||++.+..+ +.++|+|||||++|+|++ |..||...+....
T Consensus 163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 9999999999999875322111112223445778999999877666 678999999999999988 7789987665444
Q ss_pred HHHHhh-----CC---CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 237 YKKIYK-----GE---FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 237 ~~~i~~-----~~---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
...+.. +. ...+..+++.+.+|+.+||+.||++|||+++|++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 333321 11 2235557899999999999999999999999975
No 309
>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3. Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to
Probab=100.00 E-value=9.6e-41 Score=336.40 Aligned_cols=253 Identities=23% Similarity=0.413 Sum_probs=211.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKS-------GESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVM 95 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~ 95 (481)
...+|++++.||+|+||.||.|++... +..||+|.+.... .......+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 346899999999999999999986432 2368999886542 223456788999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEE
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLL 158 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl 158 (481)
.....+|++|||+++|+|.+++... .++...+..++.|++.||.|||++|++||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 9999999999999999999998641 36778889999999999999999999999999999999
Q ss_pred ccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHH
Q 011628 159 DENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMY 237 (481)
Q Consensus 159 ~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~ 237 (481)
+.++.+||+|||+++...............++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999875433221111222344567999999987766 568999999999999998 89999988877777
Q ss_pred HHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 238 KKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 238 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+..+. ...+..++.++.+++.+||+.+|++|||+.+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7776553 34566788999999999999999999999999986
No 310
>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea
Probab=100.00 E-value=1.6e-40 Score=325.59 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=212.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.++|++++.||+|+||+||+|.+..+|+ .+|+|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 5789999999999999999999877665 589998865532 3345678899999999999999999999887 78
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+++|||+.+|+|.+.+.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999999875 46899999999999999999999999999999999999999999999999999765422
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........++..|+|||.+....+ +.++|+|||||++|++++ |..||.+.........+..+. .+.|...+..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 11111112234568999999876666 568999999999999998 999999988777777776654 455667889999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||..||+.|||+.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999875
No 311
>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign
Probab=100.00 E-value=1.2e-40 Score=327.26 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=202.3
Q ss_pred cCCe-eEEeEecccCceEEEEEE----EcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-
Q 011628 25 LGRY-EIGKLLGHGTFAKVYHAR----NVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK- 98 (481)
Q Consensus 25 ~~~y-~i~~~LG~G~fg~Vy~a~----~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~- 98 (481)
.+|| ++.+.||+|+||+||++. ...++..||+|++..... ......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4677 999999999999998865 335788999999876432 22346678899999999999999999987653
Q ss_pred -CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 -SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 -~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+|++|||+.+++|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 4689999999999999999888899999999999999999999999999999999999999999999999999875432
Q ss_pred cccC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH--H-------------HHHHHh
Q 011628 178 IRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM--V-------------MYKKIY 241 (481)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~-------------~~~~i~ 241 (481)
.... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||...... . ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 1111 11122345677999999877665 57899999999999999999998653211 0 011111
Q ss_pred hC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 242 KG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 242 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+ ..+.+..++..+.+++.+||+.+|++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 12345667899999999999999999999999985
No 312
>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk. Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r
Probab=100.00 E-value=9e-41 Score=323.89 Aligned_cols=247 Identities=23% Similarity=0.392 Sum_probs=207.4
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+...... ...+.+|+.++++++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 4578999999999999999999864 5677999998765432 245789999999999999999999875 456899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999999999864 3589999999999999999999999999999999999999999999999999975432111
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
.......++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+ ..+.+...+..+.+|
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 158 -TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred -ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 11122335667999999876665 568999999999999999 99999888777766666554 345566788999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||.++|++|||++++.+
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999874
No 313
>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2. Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit
Probab=100.00 E-value=9.7e-41 Score=330.35 Aligned_cols=251 Identities=20% Similarity=0.309 Sum_probs=204.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK----------------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (481)
.++|++.+.||+|+||.||++.+.. ++..||+|++.... .......+.+|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986532 34579999987542 23345678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcE
Q 011628 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAKG------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENL 156 (481)
Q Consensus 89 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NI 156 (481)
+++++++......|++|||+.+++|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999998652 256778999999999999999999999999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCCCchHH
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYLPFQDQNIM 234 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~~~ 234 (481)
|++.++.++|+|||+++...............+++.|+|||+..+..+ +.++|+|||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999875422111111223345678999998876666 678999999999999998 78999876654
Q ss_pred HHHHHHhh--------CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 235 VMYKKIYK--------GEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 235 ~~~~~i~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
........ ...+.+..+++.+.+|+.+||+.||++|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 44332211 123445668899999999999999999999999875
No 314
>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta. Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D
Probab=100.00 E-value=8.6e-41 Score=344.46 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=207.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEc-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV-----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
.++|.+++.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.++.++. ||||+++++++...
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 467889999999999999999964 345689999997543 2233456889999999997 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcC----------------------------------------------------------
Q 011628 99 SKIYFVMEYVRGGELFNKVAKG---------------------------------------------------------- 120 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~---------------------------------------------------------- 120 (481)
+.+|+||||+++|+|.+++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999999988532
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc
Q 011628 121 -----------------------------------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD 159 (481)
Q Consensus 121 -----------------------------------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~ 159 (481)
.++...++.++.||+.||.|||++|++||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 245667888999999999999999999999999999999
Q ss_pred cCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHH
Q 011628 160 ENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYK 238 (481)
Q Consensus 160 ~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~ 238 (481)
.++.+||+|||+++...............+++.|+|||.+.+..+ +.++|||||||++|+|++ |..||..........
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 999999999999975432111111223467889999999987666 678999999999999998 899998765444333
Q ss_pred H-HhhC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 239 K-IYKG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 239 ~-i~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
. +..+ ....|..++.++.+|+.+||..+|.+||++.+|++.
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3 3333 244567789999999999999999999999999874
No 315
>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.1e-42 Score=346.74 Aligned_cols=257 Identities=34% Similarity=0.599 Sum_probs=221.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
.-|..++.||-|+||+|.+++..+|...+|+|.+++..+...+.+..++.|-.||..-..+.||++|..|.+.+++|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 45888999999999999999999999999999999988877778888999999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc-----
Q 011628 106 EYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR----- 179 (481)
Q Consensus 106 Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~----- 179 (481)
+|++||++..++-+ |-|+|+.++.|+.+|..|+++.|..|+|||||||+|||||.+|++||+||||++-+...-
T Consensus 709 dYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY 788 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 788 (1034)
T ss_pred eccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence 99999999988754 889999999999999999999999999999999999999999999999999986432100
Q ss_pred -------cCC----------------------------cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC
Q 011628 180 -------QDG----------------------------LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG 224 (481)
Q Consensus 180 -------~~~----------------------------~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg 224 (481)
.+. ..+..+||+.|+|||++...+| +..+|.||.|||||||+.|
T Consensus 789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~~g 867 (1034)
T KOG0608|consen 789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEMLVG 867 (1034)
T ss_pred cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHhhC
Confidence 000 1145689999999999999998 5679999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhC----CCCCCCCCCHHHHHHHHHhcccCcCCCCC---HhHHHhCccccc
Q 011628 225 YLPFQDQNIMVMYKKIYKG----EFRSPRWFSPDLIRLLTKLLDTNPDKRIT---IPEIMENRWFRK 284 (481)
Q Consensus 225 ~~Pf~~~~~~~~~~~i~~~----~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~eil~h~~f~~ 284 (481)
+.||.+.++.+...++.+= .+.....+|+++.++|.++. .+++.|.. .+|+..||||+-
T Consensus 868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 9999888766554444321 34556679999999999854 57778874 778999999964
No 316
>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4. Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates
Probab=100.00 E-value=6.1e-41 Score=329.99 Aligned_cols=253 Identities=24% Similarity=0.390 Sum_probs=205.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv 104 (481)
++|+..+.||+|+||.||++.+..+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4577788999999999999999999999999998765322 34566889999999996 99999999999999999999
Q ss_pred EeccCCCchHH---HHH---cCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 105 MEYVRGGELFN---KVA---KGRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 105 ~Ey~~gg~L~~---~i~---~~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
|||+.+ +|.+ .+. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999875 4433 322 25799999999999999999999975 999999999999999999999999999865322
Q ss_pred cccCCcccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCC-CC----CC
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEF-RS----PR 249 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~-~~----~~ 249 (481)
........|++.|+|||++.+. ...+.++||||+||++|+|++|..||..... .....++..+.. .. +.
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 ---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred ---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1112334689999999998765 2336789999999999999999999976542 222333333322 11 22
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.+++++.+||.+||++||++|||+++|++||||++
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 37889999999999999999999999999999975
No 317
>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes. Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an
Probab=100.00 E-value=1.8e-40 Score=321.87 Aligned_cols=247 Identities=23% Similarity=0.391 Sum_probs=205.9
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ....+.+|+.+++.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 357899999999999999999987544 5699998865432 2355788999999999999999999875 456899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-
Confidence 9999999999999965 247899999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
........++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.........+..+ ....+..++..+.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHEL 235 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHH
Confidence 111122345678999999876665 678999999999999999 99999988776666666554 234466688999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||.+||++||+++++++
T Consensus 236 i~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 236 MKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHHccCCcccCcCHHHHHH
Confidence 99999999999999999875
No 318
>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk. Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr
Probab=100.00 E-value=1.7e-40 Score=322.00 Aligned_cols=247 Identities=22% Similarity=0.402 Sum_probs=207.7
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++++.||+|+||.||+|.. .+++.||+|.+...... ...+.+|+.+++.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 457899999999999999999986 46788999998754422 356788999999999999999999864 457899
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 9999999999999864 3689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
.......++..|+|||++....+ +.++||||||+++|+|++ |.+||.+.+.......+..+. ...+...+.++.++
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred -ccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11123345678999999877665 578999999999999998 999999887766666665542 34566688999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
|.+||+.+|++|||+++++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999875
No 319
>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi
Probab=100.00 E-value=2.3e-40 Score=320.51 Aligned_cols=243 Identities=25% Similarity=0.376 Sum_probs=203.4
Q ss_pred eEecccCceEEEEEEEcCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNVKSG---ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~---~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||+|.+..++ ..+|+|.+...... ...+.+.+|+.+++.++||||+++++++. ...++++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876654 78999999766532 34567889999999999999999999876 45689999999
Q ss_pred CCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC-cccc
Q 011628 109 RGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG-LFHT 186 (481)
Q Consensus 109 ~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~-~~~~ 186 (481)
.+|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999976 459999999999999999999999999999999999999999999999999987543221110 0111
Q ss_pred cCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcc
Q 011628 187 FCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLD 264 (481)
Q Consensus 187 ~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~ 264 (481)
..++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...|..+++.++++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 123467999999977666 568999999999999998 999998887766666665553 35577789999999999999
Q ss_pred cCcCCCCCHhHHHh
Q 011628 265 TNPDKRITIPEIME 278 (481)
Q Consensus 265 ~dP~~Rps~~eil~ 278 (481)
.+|++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
No 320
>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They
Probab=100.00 E-value=7.1e-41 Score=327.84 Aligned_cols=251 Identities=35% Similarity=0.589 Sum_probs=211.0
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++.+.||+|++|.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++..+..+|+++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67889999999999999999889999999998765432 23456788999999999999999999999999999999999
Q ss_pred cCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 108 VRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 108 ~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
+.+ +|.+.+.. +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 88887765 479999999999999999999999999999999999999999999999999987554322 1223
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------------CC
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE-------------------FR 246 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-------------------~~ 246 (481)
...++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+......++.... ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 35678899999998776344778999999999999999999998877655544432210 00
Q ss_pred -----------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 -----------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 -----------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..+.++.++.++|.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 012357889999999999999999999999999997
No 321
>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk
Probab=100.00 E-value=2.4e-40 Score=319.93 Aligned_cols=242 Identities=26% Similarity=0.477 Sum_probs=209.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++......|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 46899999999999999999987 589999999976532 356788999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 9999999999998753 58999999999999999999999999999999999999999999999999987642211
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li 259 (481)
....++..|+|||++....+ +.++|+||||+++|+|++ |..||...+.......+..+ ....+..+++.+.++|
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred ---ccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 12344667999999876655 568999999999999997 99999888777666665544 3345667899999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||..+|++|||+.++++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 233 KDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999986
No 322
>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa. Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho
Probab=100.00 E-value=2.3e-40 Score=321.10 Aligned_cols=242 Identities=23% Similarity=0.361 Sum_probs=201.9
Q ss_pred EecccCceEEEEEEEc--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 011628 33 LLGHGTFAKVYHARNV--KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRG 110 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~--~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~g 110 (481)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 4899999999999875 345679999987543 2344567889999999999999999999875 4578999999999
Q ss_pred CchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-Cccccc
Q 011628 111 GELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD-GLFHTF 187 (481)
Q Consensus 111 g~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~~~~ 187 (481)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......... ......
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999864 57999999999999999999999999999999999999999999999999998754321111 011112
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhccc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDT 265 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~ 265 (481)
.+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ...|...++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 33578999999877666 568999999999999996 999999887777766666654 456777899999999999999
Q ss_pred CcCCCCCHhHHHh
Q 011628 266 NPDKRITIPEIME 278 (481)
Q Consensus 266 dP~~Rps~~eil~ 278 (481)
||++||++.+|.+
T Consensus 238 ~~~~Rp~~~~i~~ 250 (257)
T cd05115 238 KWEDRPNFAKVEE 250 (257)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999976
No 323
>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check
Probab=100.00 E-value=7.5e-41 Score=324.24 Aligned_cols=252 Identities=31% Similarity=0.553 Sum_probs=212.9
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--KSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
||.+.+.||+|+||.||++.+..++..+++|++...... .......+.+|+.+++.++||||+++++.+......+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 799999999999999999999888777877776543221 112334567899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 105 MEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+||+++++|.+.+.. ..+++..++.++.|++.|+.|||++|++|+||+|+||+++. +.++|+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999988753 46899999999999999999999999999999999999975 5799999999875432
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-CCCCCCCHHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-RSPRWFSPDLIRL 258 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-~~~~~~s~~~~~l 258 (481)
.........|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||...........+..+.. ..+..++.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 1222334568899999999877666 4679999999999999999999988777666666666543 3456688999999
Q ss_pred HHHhcccCcCCCCCHhHHHhCccc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f 282 (481)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
No 324
>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]
Probab=100.00 E-value=4.1e-42 Score=323.00 Aligned_cols=260 Identities=29% Similarity=0.500 Sum_probs=211.5
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-C
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-K 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~ 98 (481)
....|++...||+|+||.||+|..+.++. .+|||.+.-++. ..+.....-||+.+++.++||||+.+..++.+ +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 46789999999999999999997655433 689999976643 22445667899999999999999999999977 8
Q ss_pred CEEEEEEeccCCCchHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC----CCEEEEe
Q 011628 99 SKIYFVMEYVRGGELFNKVAK------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN----GDLKVSD 168 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~----g~lkl~D 168 (481)
..+|+++||++. +|.+.|.- ..++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 899999999986 88888853 358999999999999999999999999999999999999988 8999999
Q ss_pred cCCcccccccccC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---------HHHHH
Q 011628 169 FGLSAVSDQIRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---------MVMYK 238 (481)
Q Consensus 169 FGla~~~~~~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---------~~~~~ 238 (481)
||+++++...-.. ......+-|.+|+|||.+.+...++.+.|+|+.|||+.||++-++-|.+... .....
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999987643221 1334567799999999999988889999999999999999998888754321 12233
Q ss_pred HHhh--CCC---------CCCCC--------------------------CCHHHHHHHHHhcccCcCCCCCHhHHHhCcc
Q 011628 239 KIYK--GEF---------RSPRW--------------------------FSPDLIRLLTKLLDTNPDKRITIPEIMENRW 281 (481)
Q Consensus 239 ~i~~--~~~---------~~~~~--------------------------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~ 281 (481)
+|++ |-+ ..|.+ -++...+|+.+||..||.+|+|+++.++|+|
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y 339 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY 339 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence 3322 100 11211 2455899999999999999999999999999
Q ss_pred cccC
Q 011628 282 FRKG 285 (481)
Q Consensus 282 f~~~ 285 (481)
|++.
T Consensus 340 F~~d 343 (438)
T KOG0666|consen 340 FTED 343 (438)
T ss_pred cccC
Confidence 9865
No 325
>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase). Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It
Probab=100.00 E-value=2.4e-40 Score=324.41 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=209.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-KS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~ 99 (481)
.++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.+++.++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4689999999999999999999876 35889999886432 33445778899999999999999999998765 56
Q ss_pred EEEEEEeccCCCchHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecC
Q 011628 100 KIYFVMEYVRGGELFNKVAK---------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~---------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFG 170 (481)
..++++||+.+++|.+++.. ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 78999999999999999864 348899999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCC
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSP 248 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~ 248 (481)
+++...............++..|+|||++.+..+ +.++|||||||++|++++ |..||...+.......+..+. +..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 9975422111111122345678999999977666 578999999999999999 999999887777666665543 3445
Q ss_pred CCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 249 RWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 249 ~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 567899999999999999999999999985
No 326
>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase. Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines
Probab=100.00 E-value=2.4e-40 Score=325.93 Aligned_cols=258 Identities=33% Similarity=0.575 Sum_probs=215.0
Q ss_pred CeeEEeEecccCceEEEEEEEc---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNV---KSGESVAIKVIDKEKIL-KSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~---~~~~~vAvK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 101 (481)
+|++.+.||+|+||.||+|++. .+++.||||++.+.... .......+.+|+.+++++ +||||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999998754322 223446678999999999 599999999999999999
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
|+||||+.||+|.+.+.. +.+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 999999999999999875 578999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccCCCCccccccccccCC-CCCCcchHHHHHHHHHHHhcCCCCCCCch----HHHHHHHHhhCCCCCCCCCCHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKG-YDAAKVDIWSCGVILFVLMAGYLPFQDQN----IMVMYKKIYKGEFRSPRWFSPDL 255 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~-~~~~~~DiwSlGvil~elltg~~Pf~~~~----~~~~~~~i~~~~~~~~~~~s~~~ 255 (481)
.......+|++.|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... .......+.......|..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11123456899999999986543 23568999999999999999999996432 23444555566667777889999
Q ss_pred HHHHHHhcccCcCCCCC---HhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRIT---IPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps---~~eil~h~~f~~~ 285 (481)
.++|.+||+.||++||| +.++++||||+..
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999999999999998 5678999999653
No 327
>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase. Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re
Probab=100.00 E-value=2.7e-40 Score=319.82 Aligned_cols=241 Identities=27% Similarity=0.460 Sum_probs=205.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA-TKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~l 103 (481)
..+|++.+.||+|+||.||+|.. .|..||+|.+.... ..+.+.+|+.++++++|||++++++++. .....|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 45899999999999999999976 58889999986432 2456789999999999999999999764 5567999
Q ss_pred EEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+++++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~-- 155 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 155 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc--
Confidence 99999999999998752 3789999999999999999999999999999999999999999999999998743221
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
.....++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. ...+..+++.+.++
T Consensus 156 ---~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 156 ---QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred ---CCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 123345678999999877666 568999999999999997 999999887777766665553 34466789999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||+.+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
No 328
>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.3e-41 Score=322.16 Aligned_cols=258 Identities=33% Similarity=0.630 Sum_probs=231.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 102 (481)
-..+|.++++||+|+|++|.+++.++|.+.+|+|+++++-..+.+.+..+..|-.+..+- +||.+|-++.+|.++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 367999999999999999999999999999999999998877777777777788777766 6999999999999999999
Q ss_pred EEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 103 FVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+|.||++||+|.-.+++ ++++|+.++.|...|+.||.|||++||++||||..|+|+|..|++||+|+|+++. .....
T Consensus 328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~l~~g 405 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GLGPG 405 (593)
T ss_pred EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--CCCCC
Confidence 99999999999666654 7899999999999999999999999999999999999999999999999999874 23455
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-------ch-HHHHHHHHhhCCCCCCCCCCH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-------QN-IMVMYKKIYKGEFRSPRWFSP 253 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-------~~-~~~~~~~i~~~~~~~~~~~s~ 253 (481)
....+.||||.|+|||++.+..| +..+|.|+|||+++||++|+.||+- .+ ...+++-|.....+.|..+|-
T Consensus 406 d~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsv 484 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSV 484 (593)
T ss_pred cccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeeh
Confidence 56788999999999999999988 6789999999999999999999952 22 345677778888999999999
Q ss_pred HHHHHHHHhcccCcCCCC------CHhHHHhCccccc
Q 011628 254 DLIRLLTKLLDTNPDKRI------TIPEIMENRWFRK 284 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rp------s~~eil~h~~f~~ 284 (481)
.+..+++..|++||.+|. ...++..|+||+.
T Consensus 485 kas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 485 KASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred hhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 999999999999999996 4789999999973
No 329
>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2. Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin
Probab=100.00 E-value=2.4e-40 Score=329.74 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=213.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
...+|...+.||+|+||.||+|++..+++.+|+|.+............++.+|+.+++.++|||++++++++......|+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 34568889999999999999999999999999999876443333445678899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 104 VMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
||||+. |+|.+.+. ...+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~---- 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----
Confidence 999997 57777664 34689999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC--CCCCCCHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR--SPRWFSPDLIR 257 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~--~~~~~s~~~~~ 257 (481)
.....|++.|+|||++.+ ....+.++|||||||++|+|++|..||...+.......+..+..+ .+..++..+.+
T Consensus 168 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 168 --ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred --cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 123568899999999742 222356899999999999999999999877655444444444322 23457888999
Q ss_pred HHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 258 LLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
||.+||..+|++||+++++++|||+.+
T Consensus 246 li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 246 FVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHhhCCcccCCCHHHHhhCccccc
Confidence 999999999999999999999999965
No 330
>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2. Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored
Probab=100.00 E-value=4.9e-40 Score=319.98 Aligned_cols=251 Identities=23% Similarity=0.360 Sum_probs=209.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+|+..+.||+|+||.||+|.+..++. .+|+|.+.... .......+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4578999999999999999999876654 79999986543 223356788999999999999999999999999999
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|+||||+++++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999864 578999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCcc-cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 180 QDGLF-HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 180 ~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..... .....++.|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+. .+.+..++..+.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 11223457999999977666 578999999999999997 999998877766666665542 334455789999
Q ss_pred HHHHHhcccCcCCCCCHhHHHh
Q 011628 257 RLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+||..+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999986
No 331
>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t
Probab=100.00 E-value=4.4e-40 Score=318.83 Aligned_cols=248 Identities=23% Similarity=0.410 Sum_probs=210.8
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
..++|++.+.||+|+||.||+|.+. .++.||||.+..... ....+.+|+.+++.++||||+++++++......++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3578999999999999999999974 567899999875442 23567899999999999999999999999899999
Q ss_pred EEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+++++|.+++.. ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999999965 3689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~l 258 (481)
.......++..|+|||.+.+..+ +.++|+||+|+++|+|++ |+.||.+.+.......+..+ ....+...+.++.++
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11112234578999999987665 678999999999999998 99999888777777777655 344566678999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||+.+|.+||+++++++
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999874
No 332
>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]
Probab=100.00 E-value=9.1e-42 Score=312.08 Aligned_cols=252 Identities=26% Similarity=0.440 Sum_probs=205.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----C
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK-----S 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~ 99 (481)
..||++.+.||+|||+.||++++..+++.+|+|.+.... .+..+.+.+|+...++++|||+++++++...+ .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 579999999999999999999999999999999997664 23467788999999999999999998776433 3
Q ss_pred EEEEEEeccCCCchHHHHHc----C-CCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 100 KIYFVMEYVRGGELFNKVAK----G-RLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~----~-~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..||+++|...|+|.+.++. | -++|.++..|+.++++||++||+.. .+||||||.|||+.+.+.++|.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 59999999999999998864 3 5999999999999999999999998 999999999999999999999999998
Q ss_pred ccccccccCC-------cccccCCCCccccccccccCCC--CCCcchHHHHHHHHHHHhcCCCCCCCchH--HHHHHHHh
Q 011628 173 AVSDQIRQDG-------LFHTFCGTPAYVAPEVLSRKGY--DAAKVDIWSCGVILFVLMAGYLPFQDQNI--MVMYKKIY 241 (481)
Q Consensus 173 ~~~~~~~~~~-------~~~~~~gt~~y~APEvl~~~~~--~~~~~DiwSlGvil~elltg~~Pf~~~~~--~~~~~~i~ 241 (481)
+...-.-... ....-..|..|+|||.+.-+.+ .+.++|||||||+||+|+.|.-||+..-. ..+.-.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 7532211110 0112346889999999854433 25789999999999999999999964321 12222334
Q ss_pred hCCCCCC--CCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGEFRSP--RWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~~~~~--~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++.+..| ..+|..+.++|+.||+.||.+||++.+++.+
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 4444433 3489999999999999999999999999874
No 333
>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.9e-41 Score=342.77 Aligned_cols=251 Identities=25% Similarity=0.445 Sum_probs=214.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc---E-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE---S-VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~-vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.++-.+.+.||+|+||.||+|+.+..+. . ||+|....+..........+.+|.++|++++|||||++||+.....-
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3455667999999999999999765422 3 89999876444455677889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
+|+|||+|.||+|.+++++. .++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||+++.....
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~ 315 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY 315 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence 99999999999999999873 4999999999999999999999999999999999999999999999999998754321
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC--CCCCCCCCHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE--FRSPRWFSPDL 255 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~s~~~ 255 (481)
..... ...-...|+|||.+...-| +.++||||+||++||+++ |..||.+........+|.... .+.|...+.++
T Consensus 316 ~~~~~--~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 316 VMKKF--LKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred eeccc--cccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 11110 1124578999999987755 789999999999999999 889999999999999996554 34566678889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHh
Q 011628 256 IRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..++.+|+..||++|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999875
No 334
>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the
Probab=100.00 E-value=1.5e-40 Score=325.35 Aligned_cols=251 Identities=36% Similarity=0.596 Sum_probs=210.8
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|++.+.||+|+||.||.|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+...+++|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 778899999999999999999999999999998654 2233456677899999999999999999999999999999999
Q ss_pred cCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 108 VRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 108 ~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
+.+ +|.+++... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++....... ....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL--RTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc--cccC
Confidence 984 899999764 79999999999999999999999999999999999999999999999999987543321 1223
Q ss_pred ccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--------------------CC
Q 011628 186 TFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--------------------EF 245 (481)
Q Consensus 186 ~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--------------------~~ 245 (481)
...++..|+|||.+.+....+.++|+|||||++|+|++|..||...+......++... .+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 3456788999999876644477899999999999999999999887655544443221 00
Q ss_pred C---------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 246 R---------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 246 ~---------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
+ ..+.++..+.++|.+||+.||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0 011247789999999999999999999999999997
No 335
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=100.00 E-value=1.6e-41 Score=365.30 Aligned_cols=256 Identities=32% Similarity=0.565 Sum_probs=211.4
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----- 97 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----- 97 (481)
....+|+.++.||+||||.||+++++-+|+.||||.|.... .......+.+|+..+.+|+|||||++|..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 35677888999999999999999999999999999998764 33456779999999999999999999832210
Q ss_pred --------------------------------------------------------------------------------
Q 011628 98 -------------------------------------------------------------------------------- 97 (481)
Q Consensus 98 -------------------------------------------------------------------------------- 97 (481)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C--------CEEEEEEeccCCCchHHHHHcCCCC--HHHHHHHHHHHHHHHHHH
Q 011628 98 --------------------------K--------SKIYFVMEYVRGGELFNKVAKGRLK--EDLARKYFQQLISAVGFC 141 (481)
Q Consensus 98 --------------------------~--------~~~~lv~Ey~~gg~L~~~i~~~~l~--e~~~~~~~~ql~~al~yL 141 (481)
+ ..+||-||||+...|.+++..+.+. .+.+|++|+||++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 1268999999999999999887664 889999999999999999
Q ss_pred HHcCceecCCCCCcEEEccCCCEEEEecCCccccc----c------------cccCCcccccCCCCccccccccccCC--
Q 011628 142 HARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD----Q------------IRQDGLFHTFCGTPAYVAPEVLSRKG-- 203 (481)
Q Consensus 142 H~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~APEvl~~~~-- 203 (481)
|++||+||||||.||++++++.|||+|||+|+... . ....+..+..+||..|+|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999999998611 0 01122345679999999999997765
Q ss_pred CCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCCCCCCCCC----CHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 204 YDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRSPRWF----SPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 204 ~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~~----s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..|+|+|||||||+||+. ||.. .........+.++.++.|..+ -+.-..+|+.||+.||.+|||+.|+|+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 23679999999999999984 5654 344566777777777766322 234678999999999999999999999
Q ss_pred Ccccc
Q 011628 279 NRWFR 283 (481)
Q Consensus 279 h~~f~ 283 (481)
+.||.
T Consensus 871 s~llp 875 (1351)
T KOG1035|consen 871 SELLP 875 (1351)
T ss_pred ccCCC
Confidence 99987
No 336
>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase. Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and
Probab=100.00 E-value=4.2e-40 Score=318.25 Aligned_cols=243 Identities=25% Similarity=0.438 Sum_probs=205.1
Q ss_pred eEecccCceEEEEEEEcC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNVK-SGE--SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||+|.+.. +++ .||||.+...... ...+.+.+|+.++++++||||+++++++.. ...+++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876543 556788999999999999999999999988 8899999999
Q ss_pred CCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC-Ccc
Q 011628 109 RGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD-GLF 184 (481)
Q Consensus 109 ~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~~ 184 (481)
++++|.+.+... .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999998753 5899999999999999999999999999999999999999999999999998765332111 111
Q ss_pred cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC--CCCCCCCCCHHHHHHHHH
Q 011628 185 HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG--EFRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~~~~~li~~ 261 (481)
....++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+..+....+... ....+..++..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 23457788999999877666 568999999999999998 99999887776666665532 233455678999999999
Q ss_pred hcccCcCCCCCHhHHHh
Q 011628 262 LLDTNPDKRITIPEIME 278 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~ 278 (481)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999976
No 337
>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k
Probab=100.00 E-value=4.6e-40 Score=316.85 Aligned_cols=243 Identities=28% Similarity=0.432 Sum_probs=205.3
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++......|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999877 999999998765432 34567889999999999999999999999999999999999999
Q ss_pred chHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 112 ELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 112 ~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999865 4689999999999999999999999999999999999999999999999999875432111111112234
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcccCc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~~~L~~dP 267 (481)
+..|+|||++.+..+ +.++|+|||||++|+|++ |..||...........+..+ ....|..++..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 567999999877665 678999999999999998 89999887766666666544 344566788999999999999999
Q ss_pred CCCCCHhHHHh
Q 011628 268 DKRITIPEIME 278 (481)
Q Consensus 268 ~~Rps~~eil~ 278 (481)
.+|||+.|+++
T Consensus 237 ~~Rp~~~ell~ 247 (251)
T cd05041 237 ENRPSFSEIYN 247 (251)
T ss_pred hhCcCHHHHHH
Confidence 99999999986
No 338
>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both
Probab=100.00 E-value=4.6e-40 Score=322.70 Aligned_cols=249 Identities=32% Similarity=0.504 Sum_probs=206.5
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE----
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV---RHPNIVQLFEVMATKSK---- 100 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l---~HpnIv~l~~~~~~~~~---- 100 (481)
|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++++ +||||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988899999999975543 223334566788877766 59999999999988776
Q ss_pred -EEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 101 -IYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 101 -~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
++++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78888765 258999999999999999999999999999999999999999999999999987653
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-------C---
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF-------R--- 246 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~-------~--- 246 (481)
.. .......++..|+|||++.+..+ +.++|+||+||++|+|++|..||.+.+..+...++..... .
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 32 12234457889999999987665 5789999999999999999999998876666555543100 0
Q ss_pred -----------------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 247 -----------------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 247 -----------------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
....+++.+.++|.+||+.||.+||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 001245778999999999999999999999999997
No 339
>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase. Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ
Probab=100.00 E-value=6.5e-40 Score=316.71 Aligned_cols=248 Identities=24% Similarity=0.410 Sum_probs=209.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||.||+|.+. ++..+|+|.+...... ...+.+|+.+++.++||||+++++++......|++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 357999999999999999999874 4778999998654322 24577899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 105 MEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
|||+.+++|.+++.. +.++++.++.++.|++.|+.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 156 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence 999999999999864 468999999999999999999999999999999999999999999999999987542211 11
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHH
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLT 260 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~ 260 (481)
......++..|+|||++.+..+ +.++|+||||+++|+|++ |..||...........+..+. ...|...+..+.+|+.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 235 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ 235 (256)
T ss_pred ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 1122335678999999977666 568999999999999998 999999887777777766553 3345667899999999
Q ss_pred HhcccCcCCCCCHhHHHhC
Q 011628 261 KLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~h 279 (481)
+||+.+|++|||+.+++++
T Consensus 236 ~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 236 HCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHcccChhhCCCHHHHHHh
Confidence 9999999999999999863
No 340
>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases. Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l
Probab=100.00 E-value=4.7e-40 Score=321.01 Aligned_cols=241 Identities=24% Similarity=0.429 Sum_probs=200.9
Q ss_pred eEecccCceEEEEEEEcCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecc
Q 011628 32 KLLGHGTFAKVYHARNVKSGE--SVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
+.||+|+||.||+|++..++. .+|+|.+.... .......+.+|+.+++++ +||||+++++++.....+|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988776 46888876432 223456788999999999 7999999999999999999999999
Q ss_pred CCCchHHHHHcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 109 RGGELFNKVAKG-----------------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 109 ~gg~L~~~i~~~-----------------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
++|+|.+++... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998642 378899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCC
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPR 249 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~ 249 (481)
+........ ......++.|+|||++....+ +.++|||||||++|+|++ |..||.+.+....+..+..+. ...+.
T Consensus 159 ~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhhh---ccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 863221111 112234567999999877666 578999999999999997 999998877776666665542 34455
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.++.++.+++.+||..||.+|||++++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 67899999999999999999999999986
No 341
>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer. Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c
Probab=100.00 E-value=7.3e-40 Score=315.24 Aligned_cols=242 Identities=29% Similarity=0.481 Sum_probs=203.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
+.||+|+||.||+|.. .++..+|+|++.... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4689999999999985 478899999987543 2233456889999999999999999999999999999999999999
Q ss_pred chHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCC
Q 011628 112 ELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCG 189 (481)
Q Consensus 112 ~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~g 189 (481)
+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ .......+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence 99999864 4689999999999999999999999999999999999999999999999999864322111 11112244
Q ss_pred CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcccCc
Q 011628 190 TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 190 t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP 267 (481)
++.|+|||++.+..+ +.++||||||+++|++++ |..||...+.......+..+. ...+..++..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999876655 678999999999999998 999998877766666665543 34566789999999999999999
Q ss_pred CCCCCHhHHHh
Q 011628 268 DKRITIPEIME 278 (481)
Q Consensus 268 ~~Rps~~eil~ 278 (481)
++|||+.++++
T Consensus 236 ~~Rp~~~~l~~ 246 (250)
T cd05085 236 ENRPKFSELQK 246 (250)
T ss_pred ccCCCHHHHHH
Confidence 99999999976
No 342
>smart00219 TyrKc Tyrosine kinase, catalytic domain. Phosphotransferases. Tyrosine-specific kinase subfamily.
Probab=100.00 E-value=6.2e-40 Score=316.28 Aligned_cols=247 Identities=28% Similarity=0.475 Sum_probs=210.9
Q ss_pred eeEEeEecccCceEEEEEEEcCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSG----ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~----~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
+++.+.||+|+||.||+|.+..++ ..||+|++..... ......+.+|+.+++.++||||+++++++...+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467899999999999999998766 8999999965532 2245778899999999999999999999999999999
Q ss_pred EEeccCCCchHHHHHcC--C-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAKG--R-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~--~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||++|++|.+.+... . +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998753 2 99999999999999999999999999999999999999999999999999876543211
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
... ....+++.|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+.......+..+. ...+..++.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 11236789999999866555 678999999999999998 899999887777777776654 34466789999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||..||.+|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999986
No 343
>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]
Probab=100.00 E-value=1.8e-41 Score=345.19 Aligned_cols=254 Identities=25% Similarity=0.546 Sum_probs=220.9
Q ss_pred cCCe-eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 011628 25 LGRY-EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-LKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK-- 100 (481)
Q Consensus 25 ~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 100 (481)
.+|| +....||+|+|-+||+|.|..+|-.||--.+..... .......++..|+.+|+.|+|||||++|++|.+..+
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 5778 668899999999999999999999998554443333 344567889999999999999999999999988665
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCcEEEccC-CCEEEEecCCccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR--GVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSD 176 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~--gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~ 176 (481)
+.+|+|.+.+|+|+.++++ ++++...++.|.+||+.||.|||++ .|+|||||-+||+|+.+ |.|||+|+|||++..
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8899999999999999987 7899999999999999999999998 49999999999999875 899999999998754
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCCCCC--CCCCCH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRS--PRWFSP 253 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~--~~~~s~ 253 (481)
. ......+|||.|||||+.. ..|+ ..+||||||..+.||+|+..||.. .++..+|+++..|..+. ..--.|
T Consensus 198 ~----s~aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 198 K----SHAKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred c----cccceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 3 2344579999999999986 5675 579999999999999999999987 57889999999986432 222478
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++++||.+||.. ...|+|+.|+|+||||...
T Consensus 272 evr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 999999999999 8999999999999999875
No 344
>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase. Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions
Probab=100.00 E-value=8.7e-40 Score=318.75 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=208.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
..+|.+.+.||+|+||.||+|.+... ...||||...... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 35699999999999999999987544 3468999886543 22345678899999999999999999998875 457
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
|++|||+++|+|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 899999999999999975 358999999999999999999999999999999999999999999999999987543221
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
.. ......+++.|+|||.+....+ +.++|||||||++|+|++ |..||...........+..+. ...|..+++.+.+
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 162 YY-KASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred ce-ecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 11 1112334568999999877666 578999999999999986 999998887766666666553 4557778999999
Q ss_pred HHHHhcccCcCCCCCHhHHHhC
Q 011628 258 LLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~h 279 (481)
+|.+||..+|.+|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999998863
No 345
>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase. Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa
Probab=100.00 E-value=1.1e-39 Score=316.32 Aligned_cols=248 Identities=22% Similarity=0.385 Sum_probs=207.1
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.+|+.+++.++|+||+++++++.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 35789999999999999999999864 56679999886532 234568889999999999999999999887 7789
Q ss_pred EEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 103 FVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
++|||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999975 357888999999999999999999999999999999999999999999999987543211
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIR 257 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~ 257 (481)
........++..|+|||++....+ +.++|+|||||++|++++ |..||.+.+.......+..+. ...+...+.++.+
T Consensus 157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred -cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 111122345677999999976655 668999999999999998 999999877666666655543 3445678899999
Q ss_pred HHHHhcccCcCCCCCHhHHHh
Q 011628 258 LLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 258 li~~~L~~dP~~Rps~~eil~ 278 (481)
++.+||+++|++||++.+++.
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
No 346
>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein. Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc
Probab=100.00 E-value=3.1e-40 Score=329.14 Aligned_cols=253 Identities=23% Similarity=0.382 Sum_probs=199.7
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
.+++.+|.| |.||.+++..+++.||||++..... .......+.+|+.+++.++||||+++++++......|++|||+
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 344444444 5556666666999999999986532 2345678999999999999999999999999999999999999
Q ss_pred CCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc-----
Q 011628 109 RGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ----- 180 (481)
Q Consensus 109 ~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~----- 180 (481)
.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999999875 3689999999999999999999999999999999999999999999999998864321111
Q ss_pred CCcccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC-------------
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF------------- 245 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~------------- 245 (481)
........++..|+|||++.+. ++ +.++|+||+||++|+|++|..||..............+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1112344678889999998653 34 5689999999999999999999987654332222111110
Q ss_pred ---------------------CCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 ---------------------RSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 ---------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
..+..++.++.+|+.+||..||++|||++++++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 0011234678899999999999999999999999999754
No 347
>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4. Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin
Probab=100.00 E-value=6.2e-40 Score=325.93 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=206.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..+|++.+.||+|+||.||+|.+..+|. .||+|.+.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4678999999999999999999887776 47888876543 223344678999999999999999999998754 4
Q ss_pred EEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.++++||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6799999999999999875 36899999999999999999999999999999999999999999999999999764332
Q ss_pred ccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHH
Q 011628 179 RQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLI 256 (481)
Q Consensus 179 ~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~ 256 (481)
..........++..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+. ++.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22112223456778999999877666 578999999999999997 999998876555444444433 444566788999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h 279 (481)
+++.+||..+|++||+++++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999874
No 348
>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4. Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s
Probab=100.00 E-value=6.4e-40 Score=320.37 Aligned_cols=250 Identities=23% Similarity=0.396 Sum_probs=210.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
.+|++.+.||+|+||.||+|+.+. +.+.||+|.+.... .......+.+|+.++++++||||+++++++.....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999754 34679999886543 22356778899999999999999999999999899
Q ss_pred EEEEEeccCCCchHHHHHc-C---------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecC
Q 011628 101 IYFVMEYVRGGELFNKVAK-G---------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~---------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFG 170 (481)
.|+||||+++|+|.+++.. . .+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999999875 3 48999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCCC--CC
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEF--RS 247 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~--~~ 247 (481)
++...... .........+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+..+.. ..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 98643211 1112233456788999999876665 568999999999999998 8999987766666666665543 34
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+..++..+.+++.+||+.+|.+|||+.+++..
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55688999999999999999999999999864
No 349
>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity
Probab=100.00 E-value=1.9e-40 Score=321.61 Aligned_cols=238 Identities=24% Similarity=0.373 Sum_probs=197.6
Q ss_pred eEecccCceEEEEEEEcCCCcE-------EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 32 KLLGHGTFAKVYHARNVKSGES-------VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~-------vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
+.||+|+||.||+|.+..++.. +|+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4689999999999998665443 8888875432 23456678899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--------EEEEecCCccc
Q 011628 105 MEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD--------LKVSDFGLSAV 174 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~--------lkl~DFGla~~ 174 (481)
|||+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999999753 5899999999999999999999999999999999999988765 69999998864
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCchHHHHHHHHhhCCCCCCCCCCH
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIMVMYKKIYKGEFRSPRWFSP 253 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~ 253 (481)
... .....+++.|+|||++.+....+.++|||||||++|+|++| ..||...+..... .........|...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 321 12356889999999997655446789999999999999998 5777665544332 234445566666788
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++.+||.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999863
No 350
>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases. Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili
Probab=100.00 E-value=5e-40 Score=322.24 Aligned_cols=249 Identities=35% Similarity=0.544 Sum_probs=206.3
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 106 (481)
|++.+.||+|+||+||+|.+..+++.||||.+....... ......+|+..+++++ ||||+++++++..+...|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 789999999999999999998899999999986543221 1223457999999999 9999999999999999999999
Q ss_pred ccCCCchHHHHHc-C--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 107 YVRGGELFNKVAK-G--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 107 y~~gg~L~~~i~~-~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+ +|+|.+.+.. . .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 99 7799888865 2 6899999999999999999999999999999999999999999999999998754321 22
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--C-----------------
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--E----------------- 244 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~----------------- 244 (481)
.....|+..|+|||++.+....+.++|+||||+++++|++|..||...+....+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 234568899999999865544467899999999999999999999877654444333210 0
Q ss_pred CC-----------CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 245 FR-----------SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 245 ~~-----------~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
.. .....++.+.++|++||+.+|++|||++|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999997
No 351
>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina
Probab=100.00 E-value=6.9e-40 Score=319.29 Aligned_cols=244 Identities=20% Similarity=0.303 Sum_probs=192.8
Q ss_pred eEecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 468999999999997533 44578888875432 22344567889999999999999999999999999999999999
Q ss_pred CCchHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 110 GGELFNKVAKG------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 110 gg~L~~~i~~~------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|+|.+++... ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998652 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred ccccCCCCccccccccccC------CCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCC-----CCCC
Q 011628 184 FHTFCGTPAYVAPEVLSRK------GYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFR-----SPRW 250 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~------~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~-----~~~~ 250 (481)
.....+++.|+|||++... ...+.++|||||||++|+|++ |..||...........+... ... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1233467789999997532 223568999999999999999 89999887655554444332 222 2335
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+++.+.+++..|+ .||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 7888999999998 59999999999986
No 352
>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt
Probab=100.00 E-value=7.7e-40 Score=320.67 Aligned_cols=237 Identities=24% Similarity=0.350 Sum_probs=193.4
Q ss_pred EecccCceEEEEEEEcCC------------------------CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 011628 33 LLGHGTFAKVYHARNVKS------------------------GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI 88 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~------------------------~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI 88 (481)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2358899886542 2334567889999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----
Q 011628 89 VQLFEVMATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---- 162 (481)
Q Consensus 89 v~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---- 162 (481)
+++++++......|+||||+++|+|..++.. +.+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998864 5789999999999999999999999999999999999998654
Q ss_pred ---CEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHh-cCCCCCCCchHHHHHH
Q 011628 163 ---DLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLM-AGYLPFQDQNIMVMYK 238 (481)
Q Consensus 163 ---~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ell-tg~~Pf~~~~~~~~~~ 238 (481)
.+|++|||++..... .....++..|+|||.+.+....+.++|||||||++|+|+ +|..||..........
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753211 122357888999999876444467899999999999985 7999998766544322
Q ss_pred HHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 239 KIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 239 ~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
........|...++.+.++|.+||+.+|++|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2333344555567889999999999999999999999874
No 353
>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]
Probab=100.00 E-value=9.9e-41 Score=351.02 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=216.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
...-+..+.||+|+||+||+|+... ....||||.++... ......+|+||++++..++|||||+++|+|..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 4566778999999999999998642 34679999997654 3346789999999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc-C----------C----CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCE
Q 011628 100 KIYFVMEYVRGGELFNKVAK-G----------R----LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~----------~----l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~l 164 (481)
-+|+|+||+..|+|.+++.. + . ++..+...++.||+.|++||-++.++||||-..|+||.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 99999999999999999853 1 1 7788999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC
Q 011628 165 KVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG 243 (481)
Q Consensus 165 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~ 243 (481)
||+|||+++..=............-..+|||||.+....| +.+|||||+||+|||+++ |..||.+....+....|..|
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 9999999984211111111112233578999999988888 668999999999999998 99999999999999999988
Q ss_pred C-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 244 E-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 244 ~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
. ++.|..+|.++.+|+..||+.+|.+||++.||-.
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 7 6789999999999999999999999999999854
No 354
>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a
Probab=100.00 E-value=1e-39 Score=320.99 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=201.0
Q ss_pred eeEEeEecccCceEEEEEEE----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 011628 28 YEIGKLLGHGTFAKVYHARN----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK--SKI 101 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 101 (481)
|++.+.||+|+||.||.|+. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 68999999999999999984 3578899999986543 233456789999999999999999999998775 578
Q ss_pred EEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
++||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999999999999865 358999999999999999999999999999999999999999999999999987543221
Q ss_pred cC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch---------------HHHHHHHHhhC
Q 011628 180 QD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN---------------IMVMYKKIYKG 243 (481)
Q Consensus 180 ~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---------------~~~~~~~i~~~ 243 (481)
.. .......|+..|+|||++.+..+ +.++|||||||++|+|+++..|+.... .......+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 11 11234567778999999877665 568999999999999999876653211 11111112222
Q ss_pred -CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 244 -EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 244 -~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..+.+..+++.+.+|+.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 233456688999999999999999999999999874
No 355
>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron. Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca
Probab=100.00 E-value=1.6e-39 Score=315.17 Aligned_cols=245 Identities=23% Similarity=0.389 Sum_probs=199.8
Q ss_pred eEecccCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEec
Q 011628 32 KLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA-TKSKIYFVMEY 107 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lv~Ey 107 (481)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++. .+...+++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 34579999885432 2334567889999999999999999999765 45668999999
Q ss_pred cCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc--CCc
Q 011628 108 VRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGL 183 (481)
Q Consensus 108 ~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~ 183 (481)
+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999875 3567788899999999999999999999999999999999999999999999874322110 011
Q ss_pred ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 011628 184 FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTK 261 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~ 261 (481)
.....+++.|+|||.+.+..+ +.++|||||||++|+|++ |.+||...+.......+..+. ...+..+++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 123346778999999877666 578999999999999999 577888777766666666654 34466678999999999
Q ss_pred hcccCcCCCCCHhHHHhC
Q 011628 262 LLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 262 ~L~~dP~~Rps~~eil~h 279 (481)
||..+|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999863
No 356
>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1. Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom
Probab=100.00 E-value=1.3e-39 Score=316.95 Aligned_cols=238 Identities=24% Similarity=0.354 Sum_probs=194.7
Q ss_pred eEecccCceEEEEEEEcC------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 32 KLLGHGTFAKVYHARNVK------------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~------------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
+.||+|+||+||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 23358999876542 234456788999999999999999999999999
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC-------EEEEecC
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD-------LKVSDFG 170 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~-------lkl~DFG 170 (481)
..+++|||+++|+|..++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888864 46899999999999999999999999999999999999987764 8999999
Q ss_pred CcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHh-cCCCCCCCchHHHHHHHHhhCCCCCCC
Q 011628 171 LSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLM-AGYLPFQDQNIMVMYKKIYKGEFRSPR 249 (481)
Q Consensus 171 la~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ell-tg~~Pf~~~~~~~~~~~i~~~~~~~~~ 249 (481)
++..... .....|+..|+|||.+......+.++|||||||++|+|+ .|..||......+.. ....+......
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 8864321 123467889999999875444467899999999999997 599999876654432 33344444444
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 457889999999999999999999999874
No 357
>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros. Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male
Probab=100.00 E-value=6.9e-40 Score=318.90 Aligned_cols=244 Identities=24% Similarity=0.393 Sum_probs=202.5
Q ss_pred eEecccCceEEEEEEEcCCC------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 32 KLLGHGTFAKVYHARNVKSG------ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+.||+|+||.||+|++.... +.+|+|.+.... .......+.+|+.+++.++||||+++++++......|++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999986543 689999886542 1233456888999999999999999999999999999999
Q ss_pred eccCCCchHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-----CEEEEecCCc
Q 011628 106 EYVRGGELFNKVAK--------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-----DLKVSDFGLS 172 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-----~lkl~DFGla 172 (481)
||++|++|.+++.. ..+++..+..++.|++.|+.|||+++++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999999863 2378899999999999999999999999999999999999887 8999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRW 250 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~ 250 (481)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+.......+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 75322111111123345788999999977666 678999999999999998 99999887766666665543 3455677
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++..+.++|.+||..+|.+||+++++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 8999999999999999999999999875
No 358
>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7. Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it
Probab=100.00 E-value=2.2e-39 Score=320.68 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=207.5
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 103 (481)
.+.|++.+.||+|+||.||+|.+..+++.||||.+...... .....+.+|+.++..+. ||||+++++++.+....|+
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 57899999999999999999999888999999999754321 23345666777676664 9999999999999999999
Q ss_pred EEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
+|||+.+ +|.+++.. +.+++..+..++.|++.|+.|||+ .||+||||+|+||+++.++.+||+|||++.......
T Consensus 92 v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~- 169 (296)
T cd06618 92 CMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK- 169 (296)
T ss_pred EeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-
Confidence 9999854 67776654 578999999999999999999997 599999999999999999999999999987543211
Q ss_pred CCcccccCCCCccccccccccCC---CCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCC-C--CCCCCH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKG---YDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFR-S--PRWFSP 253 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~---~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~-~--~~~~s~ 253 (481)
......+++.|+|||.+.+.. ..+.++||||||+++|+|++|..||..... .+.+..+...... . ...++.
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSP 247 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCH
Confidence 112345788999999986543 235689999999999999999999976433 3444444444322 2 223688
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
++.+|+.+||..||.+||++++++.||||+..
T Consensus 248 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 99999999999999999999999999999754
No 359
>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells
Probab=100.00 E-value=1.7e-39 Score=316.69 Aligned_cols=244 Identities=18% Similarity=0.238 Sum_probs=193.1
Q ss_pred eEecccCceEEEEEEEcC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHGTFAKVYHARNVK--SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
+.||+|+||.||+|.... ++..+|+|.+..... ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 468999999999998643 557899998865532 2233568889999999999999999999999999999999999
Q ss_pred CCchHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 110 GGELFNKVAKG------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 110 gg~L~~~i~~~------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
+|+|.+++... ..++..+..++.|++.|++|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999998641 356778889999999999999999999999999999999999999999999864322111111
Q ss_pred ccccCCCCccccccccccCC------CCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCC-----CCC
Q 011628 184 FHTFCGTPAYVAPEVLSRKG------YDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRS-----PRW 250 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl~~~~------~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~-----~~~ 250 (481)
.....|++.|+|||++.+.. ..+.++||||+|+++|+|++ |..||..............+ .... ...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 22356788899999985432 12568999999999999996 99999876655443333222 2211 223
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.++.+.+++.+|+ .+|++|||+++|+.
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999998 68999999999975
No 360
>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins. Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha
Probab=100.00 E-value=5.5e-40 Score=314.72 Aligned_cols=228 Identities=25% Similarity=0.437 Sum_probs=192.2
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHH
Q 011628 37 GTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNK 116 (481)
Q Consensus 37 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~ 116 (481)
|+||+||+|++..+++.||+|.+..... ..+|...+....||||+++++++......|++|||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976431 22344555556799999999999999999999999999999999
Q ss_pred HHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCcccc
Q 011628 117 VAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVA 195 (481)
Q Consensus 117 i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~A 195 (481)
+.+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 865 57999999999999999999999999999999999999999999999999987643321 223456788999
Q ss_pred ccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCH--
Q 011628 196 PEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITI-- 273 (481)
Q Consensus 196 PEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~-- 273 (481)
||.+.+..+ +.++|+||+|+++|+|++|..||........ .......|.++++.+.++|.+||+.||++||++
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876666 5689999999999999999998765332100 112245678899999999999999999999985
Q ss_pred ---hHHHhCccc
Q 011628 274 ---PEIMENRWF 282 (481)
Q Consensus 274 ---~eil~h~~f 282 (481)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
No 361
>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase. Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki
Probab=100.00 E-value=2.1e-39 Score=313.20 Aligned_cols=240 Identities=27% Similarity=0.491 Sum_probs=204.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
..+|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 36799999999999999999864 78899999986532 235678899999999999999999998654 47999
Q ss_pred EeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999999875 25899999999999999999999999999999999999999999999999998753221
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
......+..|+|||.+.+..+ +.++|+|||||++|+|++ |..||...+.......+..+. ...+..+++.+.+++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred --CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 122334678999999876665 578999999999999997 999999887776666665553 334556889999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.+|++||++++++.
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 231 TSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999976
No 362
>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3. Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac
Probab=100.00 E-value=1.8e-39 Score=316.71 Aligned_cols=250 Identities=22% Similarity=0.388 Sum_probs=206.1
Q ss_pred eeEEeEecccCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 011628 28 YEIGKLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS----- 99 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~----- 99 (481)
|++.+.||+|+||.||+|.... +++.||||++..+.. .....+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6789999999999999998653 578999999976542 3334567889999999999999999999886532
Q ss_pred -EEEEEEeccCCCchHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 100 -KIYFVMEYVRGGELFNKVAK-------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~~-------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 35789999999999887642 1478899999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCC
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPR 249 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~ 249 (481)
++...............+++.|++||.+.+..+ +.++|||||||++|+|++ |..||.+.+....+..+..+. ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 875432111111123345678999999877666 568999999999999999 999998887777777666553 44566
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+++.+.+++.+||+.+|++|||+.+++..
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999999863
No 363
>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3. Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th
Probab=100.00 E-value=4.1e-39 Score=316.32 Aligned_cols=249 Identities=24% Similarity=0.392 Sum_probs=199.3
Q ss_pred CCeeEEeEecccCceEEEEEEE----cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 011628 26 GRYEIGKLLGHGTFAKVYHARN----VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KS 99 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~----~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 99 (481)
.+|++.+.||+|+||.||.|.. ..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4799999999999999999974 4578899999986543 2345678899999999999999999998754 35
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
.+++||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 68999999999999999865 4689999999999999999999999999999999999999999999999999976432
Q ss_pred cccCC-cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH---------------HHHHHh
Q 011628 178 IRQDG-LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV---------------MYKKIY 241 (481)
Q Consensus 178 ~~~~~-~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------------~~~~i~ 241 (481)
..... ......++..|+|||++.+..+ +.++|||||||++|+|++|..|+....... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 11110 1112234456999999977666 578999999999999999877764332110 011112
Q ss_pred hC--CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 242 KG--EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 242 ~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.. .++.+..++.++.+||.+||..+|++|||+.+|++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 21 23445668899999999999999999999999986
No 364
>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki
Probab=100.00 E-value=3.7e-39 Score=311.55 Aligned_cols=235 Identities=22% Similarity=0.300 Sum_probs=192.5
Q ss_pred eEecccCceEEEEEEEcCCC----------cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 32 KLLGHGTFAKVYHARNVKSG----------ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~----------~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998766 3578887754431 14667899999999999999999999888 778
Q ss_pred EEEEeccCCCchHHHHHc-C-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-------CEEEEecCCc
Q 011628 102 YFVMEYVRGGELFNKVAK-G-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-------DLKVSDFGLS 172 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-------~lkl~DFGla 172 (481)
++||||+++|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999975 3 589999999999999999999999999999999999999888 7999999998
Q ss_pred ccccccccCCcccccCCCCccccccccccC-CCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCCCCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRK-GYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGEFRSPRW 250 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~-~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 250 (481)
..... .....++..|+|||++.+. ...+.++|||||||++|+|++ |..||...+......... .....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75332 1234567889999998766 234678999999999999999 688887765333222222 22222322
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
....+.++|.+||..+|.+|||+.++++
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3478999999999999999999999986
No 365
>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10. Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.
Probab=100.00 E-value=7.5e-39 Score=311.81 Aligned_cols=249 Identities=27% Similarity=0.548 Sum_probs=210.0
Q ss_pred CeeEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccc-------cchhHHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKI-------LKSGLVAHIKREISILRR-VRHPNIVQLFEVMAT 97 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~-------~~~~~~~~~~~Ei~il~~-l~HpnIv~l~~~~~~ 97 (481)
.|++.+.||+|+||.||+|++.. +++.+|+|.+..... ........+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 688999999864321 122344567788888865 799999999999999
Q ss_pred CCEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCC
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGL 171 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGl 171 (481)
.+..+++|||++|++|.+++.. ..+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999888732 468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-C-C
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-P-R 249 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-~-~ 249 (481)
+....... ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..+.... + .
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 87643321 3345678999999999987665 678999999999999999999998887776666666654332 2 2
Q ss_pred CCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 250 WFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 250 ~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+++.+.++|.+||+.||++||++.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 578999999999999999999999998764
No 366
>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.7e-39 Score=353.00 Aligned_cols=250 Identities=24% Similarity=0.431 Sum_probs=212.9
Q ss_pred CCeeEEeEecccCceEEEEEEEcCC-Cc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKS-GE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSK 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~-~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~ 100 (481)
..-++++.||+|+||.||.|..... |. .||||.+.+. .+.+....+.+|..+|+.++|||||+++|++.+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 4668899999999999999997653 33 3888887654 355667889999999999999999999999999999
Q ss_pred EEEEEeccCCCchHHHHHcC--------CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 101 IYFVMEYVRGGELFNKVAKG--------RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~--------~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
.+|++|||+||+|..+|++. .++......++.|++.|..||++++++||||...|+||+....+||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999863 3888999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHH-hhCCCCCCCC
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKI-YKGEFRSPRW 250 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i-~~~~~~~~~~ 250 (481)
+..-.......-....-...|||||.+....+ +.|+|||||||+|||+++ |..||.+.+..++.... ..|++..|..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 82111110000011123467999999987655 779999999999999999 99999998887777644 4557888999
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++..+.+++..||+.+|++||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999987
No 367
>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2. Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage
Probab=100.00 E-value=1.2e-38 Score=310.73 Aligned_cols=244 Identities=20% Similarity=0.280 Sum_probs=192.7
Q ss_pred eEecccCceEEEEEEEcCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHGTFAKVYHARNVKS--GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~--~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
+.||+|+||.||+|+.... ...+++|.+..... ......+.+|+.+++.++||||+++++.+......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 23566777654432 2345678899999999999999999999999999999999999
Q ss_pred CCchHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcc
Q 011628 110 GGELFNKVAKG-----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLF 184 (481)
Q Consensus 110 gg~L~~~i~~~-----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~ 184 (481)
+|+|.+++.+. ..++..+..++.|++.||+|||+++++||||||+|||++.++.++|+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999998642 3567788899999999999999999999999999999999999999999997532111111122
Q ss_pred cccCCCCccccccccccCC------CCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-C-----CCCCCC
Q 011628 185 HTFCGTPAYVAPEVLSRKG------YDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-F-----RSPRWF 251 (481)
Q Consensus 185 ~~~~gt~~y~APEvl~~~~------~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~-----~~~~~~ 251 (481)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+....+..+..+. . ..+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3457889999999975321 12468999999999999996 688998777666655554432 1 223347
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
++.+.+++.+|| .+|++||++++|++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 67999999999975
No 368
>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases. Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut
Probab=100.00 E-value=9.2e-39 Score=313.01 Aligned_cols=250 Identities=24% Similarity=0.380 Sum_probs=203.6
Q ss_pred CCeeEEeEecccCceEEEEEEEc----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNV----KSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT--KS 99 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~--~~ 99 (481)
.+|++.+.||+|+||.||+|+.. .++..||+|++...... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 56889999999999999999864 34889999999765432 345778999999999999999999999877 56
Q ss_pred EEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..+++|||+++++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 799999999999999999764 499999999999999999999999999999999999999999999999999976542
Q ss_pred cccC-CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHH---------------HHHHHh
Q 011628 178 IRQD-GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMV---------------MYKKIY 241 (481)
Q Consensus 178 ~~~~-~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---------------~~~~i~ 241 (481)
.... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||....... ....+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 11112345567999999877665 568999999999999999999986542211 112222
Q ss_pred hC-CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 242 KG-EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 242 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+ ..+.+..++.++.+++.+||+.+|.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 22 23445667889999999999999999999999986
No 369
>PHA02882 putative serine/threonine kinase; Provisional
Probab=100.00 E-value=1.5e-38 Score=314.75 Aligned_cols=253 Identities=15% Similarity=0.219 Sum_probs=193.0
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccc--hhH------HHHHHHHHHHHHhCCCCCcceE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILK--SGL------VAHIKREISILRRVRHPNIVQL 91 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~--~~~------~~~~~~Ei~il~~l~HpnIv~l 91 (481)
...++|++.+.||+|+||+||+|++..+ +..+|+|+........ ... ......++..++.+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4467999999999999999999998777 6778888754332110 000 0112234455667789999999
Q ss_pred EEEEEeCC----EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 011628 92 FEVMATKS----KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 92 ~~~~~~~~----~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
++++.... ..++++|++.. ++.+.+.. ...++..+..++.|++.||.|||++||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 99876543 45788888754 56666655 34788999999999999999999999999999999999999999999
Q ss_pred EecCCccccccccc-----CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-H------
Q 011628 167 SDFGLSAVSDQIRQ-----DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-M------ 234 (481)
Q Consensus 167 ~DFGla~~~~~~~~-----~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~------ 234 (481)
+|||+|+....... ........||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+. .
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999976432111 111233579999999999988777 6789999999999999999999986632 1
Q ss_pred --HHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 235 --VMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 235 --~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
....++..+.... ...++.+.+++..|+..+|++||++++|++
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 247 KCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1223334443333 346888999999999999999999999975
No 370
>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]
Probab=100.00 E-value=5.5e-39 Score=336.48 Aligned_cols=254 Identities=30% Similarity=0.543 Sum_probs=222.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----C
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMAT-----K 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~-----~ 98 (481)
.+.|+|..+||.|.+|+||+++++.+++.+|+|+.+.... ..+.++.|..|++.+ .|||++.+|+++.- +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 5789999999999999999999999999999999877642 335577899999988 59999999999854 5
Q ss_pred CEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~ 175 (481)
+.+|||||||.||+.-|++++ +++.|+.+..+++.++.|+.+||.+.++|||||-.|||++.+|.|||+|||++...
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 789999999999999999875 57999999999999999999999999999999999999999999999999999865
Q ss_pred cccccCCcccccCCCCccccccccccC-----CCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---CC
Q 011628 176 DQIRQDGLFHTFCGTPAYVAPEVLSRK-----GYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---RS 247 (481)
Q Consensus 176 ~~~~~~~~~~~~~gt~~y~APEvl~~~-----~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---~~ 247 (481)
+. .-+...+..|||.|||||++... .| ...+|+||||++..||..|.+|+-+..++....+|-.... .-
T Consensus 174 ds--T~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkr 250 (953)
T KOG0587|consen 174 DS--TVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKR 250 (953)
T ss_pred ec--ccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccc
Confidence 53 23345678999999999998543 34 3579999999999999999999999999877777765542 23
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
|...+.++.++|..||.+|-.+||+..++++|||+...
T Consensus 251 p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 251 PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 55678899999999999999999999999999999743
No 371
>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]
Probab=100.00 E-value=5.2e-41 Score=307.44 Aligned_cols=264 Identities=27% Similarity=0.449 Sum_probs=216.4
Q ss_pred CCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 011628 20 NQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT-- 97 (481)
Q Consensus 20 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-- 97 (481)
+.-...+.|+-..+||+|.||.||+|+...+|+.||+|++-.+. .+.++-....+|+.++..|+|+|++.++++|.+
T Consensus 11 P~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~ 89 (376)
T KOG0669|consen 11 PFCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKA 89 (376)
T ss_pred CceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhcc
Confidence 34445789999999999999999999999999999999875543 234556667899999999999999999988743
Q ss_pred ------CCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 98 ------KSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 98 ------~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
...+|+|+.+|+. +|+-++.. -+++..++.++++++.+||.|+|++.|+|||+||+|+||+.+|.+||+||
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecc
Confidence 2358999999976 88888865 47999999999999999999999999999999999999999999999999
Q ss_pred CCccccccccc--CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--CCC
Q 011628 170 GLSAVSDQIRQ--DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEF 245 (481)
Q Consensus 170 Gla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~ 245 (481)
|+++.+..... ...++..+-|.+|++||.+.+...++.+.|||+.|||+.+|.+|.+-+.+.+.......|.. |..
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 99976543222 22244556799999999999887778999999999999999999999988765444333321 111
Q ss_pred C--------------------CC-------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 246 R--------------------SP-------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 246 ~--------------------~~-------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
. .| -.-++++.+|+.++|..||.+|++++++++|.||.+.
T Consensus 249 tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred CcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 0 00 0124578899999999999999999999999999864
No 372
>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]
Probab=100.00 E-value=2.4e-39 Score=333.43 Aligned_cols=241 Identities=38% Similarity=0.602 Sum_probs=196.8
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC------
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS------ 99 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~------ 99 (481)
+-|..-+.||+||||.||+++++++|+.||||.++..... .-.+..-+|+++|++++|||||+++++-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 6688899999999999999999999999999999875422 23566779999999999999999998865543
Q ss_pred EEEEEEeccCCCchHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC--C--CEEEEecCC
Q 011628 100 KIYFVMEYVRGGELFNKVAK----GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN--G--DLKVSDFGL 171 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~----~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~--g--~lkl~DFGl 171 (481)
...+|||||.||+|+..+++ .+++|.+.+.++..+..|+.|||++||+||||||.||++-.. | ..||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 56899999999999999975 479999999999999999999999999999999999998543 3 369999999
Q ss_pred cccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-----hHHHHHHHHhh----
Q 011628 172 SAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-----NIMVMYKKIYK---- 242 (481)
Q Consensus 172 a~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-----~~~~~~~~i~~---- 242 (481)
|+-.+. +....+.+||+.|.+||++...++++..+|.||+||++|++.||.+||... +...++..+.+
T Consensus 171 Arel~d---~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDD---NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCC---CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 986543 447788999999999999986455577899999999999999999999432 11223332221
Q ss_pred ----------C------CCCCCCCCCHH----HHHHHHHhcccCcCCCC
Q 011628 243 ----------G------EFRSPRWFSPD----LIRLLTKLLDTNPDKRI 271 (481)
Q Consensus 243 ----------~------~~~~~~~~s~~----~~~li~~~L~~dP~~Rp 271 (481)
| .++.|..+++. +..++..+|..+|.+|.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 22334445554 45678889999999998
No 373
>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.8e-38 Score=318.61 Aligned_cols=247 Identities=28% Similarity=0.440 Sum_probs=196.3
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-KIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~l 103 (481)
.+.|.-.+.||+|+||.||+|.- .+|..||||.+....... ...+.+|+.++.+++|||+|+++|+|.+.+ ..+|
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 46777789999999999999986 455899999876654321 345899999999999999999999999998 5999
Q ss_pred EEeccCCCchHHHHHc--C-CCCHHHHHHHHHHHHHHHHHHHHcC---ceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 104 VMEYVRGGELFNKVAK--G-RLKEDLARKYFQQLISAVGFCHARG---VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~--~-~l~e~~~~~~~~ql~~al~yLH~~g---i~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
|+||++.|+|.+.+.. + .+++....+|+.+++.||+|||... |+||||||+|||||++.+.||+|||+|+....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999975 3 7899999999999999999999853 99999999999999999999999999965332
Q ss_pred cccCCccccc-CCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch------HHH-HHHHHhhCC-----
Q 011628 178 IRQDGLFHTF-CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN------IMV-MYKKIYKGE----- 244 (481)
Q Consensus 178 ~~~~~~~~~~-~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~------~~~-~~~~i~~~~----- 244 (481)
. .....+. .||.+|+|||++..... +.|+||||+||+|.||++|+.|.+... ... ....+..+.
T Consensus 230 ~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 230 G--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred c--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 1 2222222 89999999999976444 779999999999999999998887432 111 112222221
Q ss_pred -CCCC-CCCC--HH---HHHHHHHhcccCcCCCCCHhHHHh
Q 011628 245 -FRSP-RWFS--PD---LIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 245 -~~~~-~~~s--~~---~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.... ..++ .. +..+..+|++.+|..||++.|+++
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 1111 2233 22 556888999999999999999754
No 374
>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]
Probab=100.00 E-value=9.1e-40 Score=315.36 Aligned_cols=252 Identities=32% Similarity=0.510 Sum_probs=205.3
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCC----cceEEEEE
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR--HPN----IVQLFEVM 95 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~--Hpn----Iv~l~~~~ 95 (481)
..+.+||++..++|+|+||+|-.+.+.+++..||||+++.-. .+.+..+-|+.+++++. -|+ +|.+.++|
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 356789999999999999999999999999999999996433 23455667999999994 333 77888889
Q ss_pred EeCCEEEEEEeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc------------
Q 011628 96 ATKSKIYFVMEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE------------ 160 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~------------ 160 (481)
.-.++++||+|.+ |.++++++.++ +++.+.++.+.+||+.+++|||+.+++|-||||||||+.+
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999988 67999999863 6999999999999999999999999999999999999832
Q ss_pred --------CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCch
Q 011628 161 --------NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQN 232 (481)
Q Consensus 161 --------~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 232 (481)
+..++|+|||.|+...+. -.+.+.|..|+|||++.+.++ +.++||||+||||+||.+|..-|...+
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCC
Confidence 235899999999864331 256678999999999999999 678999999999999999999997543
Q ss_pred H---HHHHHHHhhC------------------CCCCCCC----------------------CC---HHHHHHHHHhcccC
Q 011628 233 I---MVMYKKIYKG------------------EFRSPRW----------------------FS---PDLIRLLTKLLDTN 266 (481)
Q Consensus 233 ~---~~~~~~i~~~------------------~~~~~~~----------------------~s---~~~~~li~~~L~~d 266 (481)
. ..+...|... .+..|.. -+ .++.+||++||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 2 1233333221 1110100 01 23789999999999
Q ss_pred cCCCCCHhHHHhCccccc
Q 011628 267 PDKRITIPEIMENRWFRK 284 (481)
Q Consensus 267 P~~Rps~~eil~h~~f~~ 284 (481)
|.+|+|+.|+|.||||..
T Consensus 394 P~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 394 PARRITLREALSHPFFAR 411 (415)
T ss_pred ccccccHHHHhcCHHhhc
Confidence 999999999999999965
No 375
>PLN03225 Serine/threonine-protein kinase SNT7; Provisional
Probab=100.00 E-value=9e-38 Score=334.01 Aligned_cols=253 Identities=20% Similarity=0.322 Sum_probs=178.2
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEE-----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKS----GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEV----- 94 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~----- 94 (481)
-.++|++++.||+|+||.||+|++..+ +..||+|.+...... +....| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 467999999999999999999999888 999999987643211 111111 1122222223222211
Q ss_pred -EEeCCEEEEEEeccCCCchHHHHHcCCC---------------------CHHHHHHHHHHHHHHHHHHHHcCceecCCC
Q 011628 95 -MATKSKIYFVMEYVRGGELFNKVAKGRL---------------------KEDLARKYFQQLISAVGFCHARGVYHRDLK 152 (481)
Q Consensus 95 -~~~~~~~~lv~Ey~~gg~L~~~i~~~~l---------------------~e~~~~~~~~ql~~al~yLH~~gi~HrDLK 152 (481)
......+++|+||+.+++|.+++....+ .+..+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456679999999999999998865321 134467899999999999999999999999
Q ss_pred CCcEEEcc-CCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCC---------------------CCcch
Q 011628 153 PENLLLDE-NGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYD---------------------AAKVD 210 (481)
Q Consensus 153 p~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~---------------------~~~~D 210 (481)
|+|||++. ++.+||+|||+|+..... ........+|++.|+|||++....+. +.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 579999999999754321 12233457899999999976432211 23569
Q ss_pred HHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCC---------------------CCCCCCCHHHHHHHHHhcccCcCC
Q 011628 211 IWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEF---------------------RSPRWFSPDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 211 iwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~---------------------~~~~~~s~~~~~li~~~L~~dP~~ 269 (481)
|||+||+||+|+++..|++.... .....+..... ......+....+||.+||++||.+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 99999999999998877654321 11111111110 001112234568999999999999
Q ss_pred CCCHhHHHhCcccccC
Q 011628 270 RITIPEIMENRWFRKG 285 (481)
Q Consensus 270 Rps~~eil~h~~f~~~ 285 (481)
|||+.++|+||||+..
T Consensus 441 R~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 441 RISAKAALAHPYFDRE 456 (566)
T ss_pred CCCHHHHhCCcCcCCC
Confidence 9999999999999753
No 376
>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.3e-39 Score=313.18 Aligned_cols=263 Identities=28% Similarity=0.462 Sum_probs=220.6
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEE-e
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK----SGLVAHIKREISILRRVRHPNIVQLFEVMA-T 97 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~ 97 (481)
.+.+||-++++||+|||+.||+|.+....+.||+|+-...+.+. .++.+..-||..|.+.|.||.||++|+++. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 46789999999999999999999999999999999976554332 346677889999999999999999999995 5
Q ss_pred CCEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHc--CceecCCCCCcEEEcc---CCCEEEEecCC
Q 011628 98 KSKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHAR--GVYHRDLKPENLLLDE---NGDLKVSDFGL 171 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~--gi~HrDLKp~NILl~~---~g~lkl~DFGl 171 (481)
.+.+|-|+|||+|.+|.-+++. ..++|.+++.|+.||+.||.||.+. .|+|-||||.|||+-. -|.+||+|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 5678999999999999888876 4689999999999999999999976 6999999999999954 36799999999
Q ss_pred cccccccccCC-----cccccCCCCccccccccc-c--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---HHHHHH
Q 011628 172 SAVSDQIRQDG-----LFHTFCGTPAYVAPEVLS-R--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---VMYKKI 240 (481)
Q Consensus 172 a~~~~~~~~~~-----~~~~~~gt~~y~APEvl~-~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i 240 (481)
+++.+....+. +..-..||.+|++||.+. + .+-.+.|+||||+|||+|.++.|+.||...... ..+.-|
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI 699 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI 699 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence 99876543321 234468999999999863 2 344477999999999999999999999875432 223344
Q ss_pred hhC---CCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 241 YKG---EFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 241 ~~~---~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+. .++..+.+++++++||++||+.--++|+.+.++-.||||...
T Consensus 700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 443 355566799999999999999999999999999999999653
No 377
>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]
Probab=100.00 E-value=4.7e-39 Score=296.72 Aligned_cols=250 Identities=24% Similarity=0.407 Sum_probs=205.6
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILR-RVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
.+-+..||.|+||+|++..++.+|+..|||.|+.... ....+++..|..... .-++||||++||....++..||.||
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 3345689999999999999999999999999987654 234567778887554 4479999999999999999999999
Q ss_pred ccCCCchHHHH------HcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 107 YVRGGELFNKV------AKGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 107 y~~gg~L~~~i------~~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+++- +|..+. ++.+++|+..-.+....+.||.||-. ..|+|||+||+|||++..|.+||||||++......
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 9964 443322 34679999999999999999999985 48999999999999999999999999998643221
Q ss_pred cCCcccccCCCCcccccccccc--CCCCCCcchHHHHHHHHHHHhcCCCCCCCchH-HHHHHHHhhCCCCC---C---CC
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSR--KGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI-MVMYKKIYKGEFRS---P---RW 250 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~--~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~~---~---~~ 250 (481)
-..+.-.|...|||||.+.. .+|+ .++|+||||++|||+.||..||..-+. .+....+..|.++. + -.
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 11233578899999999854 3564 689999999999999999999988654 46666677776553 2 23
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
++..+..+|..||.+|-..||...+++++||++.
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRM 332 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcchhhhhcCchhhh
Confidence 7889999999999999999999999999999864
No 378
>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain. Phosphotransferases. Serine or threonine-specific kinase subfamily.
Probab=100.00 E-value=1.4e-36 Score=288.60 Aligned_cols=239 Identities=50% Similarity=0.839 Sum_probs=206.6
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHH
Q 011628 38 TFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV 117 (481)
Q Consensus 38 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i 117 (481)
+||.||+|.+..+|+.+|+|++........ .+.+.+|+..+++++|+||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999988999999999976543321 577889999999999999999999999999999999999999999999
Q ss_pred HcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccc
Q 011628 118 AKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAP 196 (481)
Q Consensus 118 ~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~AP 196 (481)
... .++...+..++.|++.++.|||+.|++|+||+|.||+++.++.++|+|||.+....... ......++..|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 764 48999999999999999999999999999999999999999999999999987654321 33456788999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHhhCCCCCCCC---CCHHHHHHHHHhcccCcCCCCC
Q 011628 197 EVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIYKGEFRSPRW---FSPDLIRLLTKLLDTNPDKRIT 272 (481)
Q Consensus 197 Evl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~~~~~~~~~~---~s~~~~~li~~~L~~dP~~Rps 272 (481)
|.+.+..+ +.++||||||+++|+|++|..||.. .+.......+..+....... ++.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 99976666 4589999999999999999999988 55555555555554433222 7889999999999999999999
Q ss_pred HhHHHhCccc
Q 011628 273 IPEIMENRWF 282 (481)
Q Consensus 273 ~~eil~h~~f 282 (481)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
No 379
>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.2e-37 Score=318.39 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=219.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-SGE--SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~--~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 101 (481)
.++..+.++||+|+||+|+.|.+.. +|+ .||||.+....... ...+|.+|+.+|.+|+|||++++||+..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 4677888999999999999999875 333 58999998765432 56889999999999999999999999987 678
Q ss_pred EEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 102 YFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
.+|+|++++|+|.+.+.+ +.|.......|+.||+.|+.||.+++.|||||...|+|+.....+||+||||.+-.+..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 899999999999999976 46888999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCcc-cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHH
Q 011628 179 RQDGLF-HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDL 255 (481)
Q Consensus 179 ~~~~~~-~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~ 255 (481)
...... ....-...|+|||.++...+ +.++|+|++||++|||++ |+.||.+.+...+.++|-.++ ++-|..+|.++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedI 344 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDI 344 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHH
Confidence 221111 11223457999999988877 678999999999999998 899999999999999987664 67789999999
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.++++.||..+|.+|||+..|.+.-+.+
T Consensus 345 Y~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 345 YQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHhccCCccccccHHHHHHhHHHH
Confidence 9999999999999999999997654433
No 380
>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]
Probab=100.00 E-value=4.3e-37 Score=310.82 Aligned_cols=242 Identities=27% Similarity=0.471 Sum_probs=206.5
Q ss_pred EEeEecccCceEEEEEEEcCC--C--cEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKS--G--ESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~--~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+.+.||.|-||.||.|..... | -.||||..+.+.. .+..+.+..|..+|+.++|||||+++|++.+. ..||||
T Consensus 393 l~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm 469 (974)
T KOG4257|consen 393 LKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM 469 (974)
T ss_pred HHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence 357899999999999997532 3 3589998876543 33467899999999999999999999999875 489999
Q ss_pred eccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 106 EYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 106 Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
|+++-|+|..+++. ..++......|..||+.||.|||+..++||||...|||+.....+||+|||+++..... ..
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~---~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD---AY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcccc---ch
Confidence 99999999999975 46899999999999999999999999999999999999999999999999999865432 22
Q ss_pred ccccCC--CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 011628 184 FHTFCG--TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLL 259 (481)
Q Consensus 184 ~~~~~g--t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li 259 (481)
++...| ...|||||.++-..+ +.++|||-|||.+||++. |..||.+-...+..-.+-+|+ +++|+.+++.+..|+
T Consensus 547 YkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 547 YKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred hhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHH
Confidence 232233 456999999987776 567999999999999987 999999877666666777774 789999999999999
Q ss_pred HHhcccCcCCCCCHhHHHh
Q 011628 260 TKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 260 ~~~L~~dP~~Rps~~eil~ 278 (481)
.+||+.+|.+||++.+|..
T Consensus 626 skcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHhccCcccCCcHHHHHH
Confidence 9999999999999877754
No 381
>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]
Probab=100.00 E-value=1.2e-37 Score=281.80 Aligned_cols=249 Identities=29% Similarity=0.541 Sum_probs=203.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--EE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKS--KI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~ 101 (481)
.++|++.+++|+|.|+.||.|++..+++.++||++++-+ .+.++||+.||+.|. ||||++++++..++. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 679999999999999999999999999999999986543 367899999999997 999999999987653 57
Q ss_pred EEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCccccccccc
Q 011628 102 YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~~~~~ 180 (481)
.+++||+...+...+... ++.-.++.|+.||+.||.|||++||+|||+||.|+++|.. ..++|+|+|+|.+....
T Consensus 111 aLiFE~v~n~Dfk~ly~t--l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~-- 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYPT--LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG-- 186 (338)
T ss_pred hhHhhhhccccHHHHhhh--hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC--
Confidence 799999998776666543 7888999999999999999999999999999999999976 46999999999876432
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-chHHHHHHHHh-------------h----
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-QNIMVMYKKIY-------------K---- 242 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~~~~~~~~~i~-------------~---- 242 (481)
...+..+.+..|--||.+.........-|+|||||+|..|+..+-||-. .+......+|. +
T Consensus 187 -~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 187 -KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred -ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 2345567889999999997766666779999999999999999999832 21111111111 1
Q ss_pred ---------CCCCCCCC-----------CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 243 ---------GEFRSPRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 243 ---------~~~~~~~~-----------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+...-.+| .++++.+|+.++|..|-.+|+|+.|++.||||..
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 01111111 5789999999999999999999999999999964
No 382
>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-37 Score=292.72 Aligned_cols=255 Identities=28% Similarity=0.463 Sum_probs=213.6
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS---- 99 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~---- 99 (481)
...||.-++.+|.|+- .|..|-+.-+++.||+|....... .....++..+|..++..++|+||++++.++....
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 4678999999999998 888899988999999999877643 3345577889999999999999999999996544
Q ss_pred --EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 100 --KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 --~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..|+||||+.. +|.+.+. -.++-..+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+..+.
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 57999999965 8888776 4478889999999999999999999999999999999999999999999999985433
Q ss_pred cccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC-------------
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE------------- 244 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~------------- 244 (481)
. -..+.++.|..|.|||++.+.+| ...+||||+||++.||++|..-|.+.+....+.++....
T Consensus 171 ~---~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~ 246 (369)
T KOG0665|consen 171 D---FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP 246 (369)
T ss_pred c---cccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence 2 24567889999999999999997 578999999999999999999999887766666654310
Q ss_pred --------------CCC----CCC-----------CCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCc
Q 011628 245 --------------FRS----PRW-----------FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGF 286 (481)
Q Consensus 245 --------------~~~----~~~-----------~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~ 286 (481)
+.. |.. -+..+++|+.+||..||++|+|++++|+|||++-++
T Consensus 247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~ 317 (369)
T KOG0665|consen 247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWY 317 (369)
T ss_pred HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeec
Confidence 000 110 123489999999999999999999999999997553
No 383
>PLN03224 probable serine/threonine protein kinase; Provisional
Probab=100.00 E-value=8.2e-36 Score=312.11 Aligned_cols=260 Identities=18% Similarity=0.301 Sum_probs=188.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEc----------------CCCcEEEEEEeecccccc-hhH----------HHHHHHHH
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNV----------------KSGESVAIKVIDKEKILK-SGL----------VAHIKREI 77 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~~~~vAvK~i~~~~~~~-~~~----------~~~~~~Ei 77 (481)
.++|++.++||+|+||+||+|... ..++.||||.+....... .++ .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 245679999986542110 001 11223477
Q ss_pred HHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCchHHHHHc--C----------------------
Q 011628 78 SILRRVRHPNI-----VQLFEVMAT--------KSKIYFVMEYVRGGELFNKVAK--G---------------------- 120 (481)
Q Consensus 78 ~il~~l~HpnI-----v~l~~~~~~--------~~~~~lv~Ey~~gg~L~~~i~~--~---------------------- 120 (481)
.++.+++|.++ +++++++.. ....|+||||+++++|.+++.. +
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766554 566666643 3568999999999999888753 1
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCcccccccc
Q 011628 121 -RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVL 199 (481)
Q Consensus 121 -~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl 199 (481)
.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........ .......+|+.|+|||++
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeChhhh
Confidence 134567889999999999999999999999999999999999999999999865322111 111123458999999997
Q ss_pred ccCC--------------------CC-CCcchHHHHHHHHHHHhcCCC-CCCCchH-----------HHHHHHHhhCC--
Q 011628 200 SRKG--------------------YD-AAKVDIWSCGVILFVLMAGYL-PFQDQNI-----------MVMYKKIYKGE-- 244 (481)
Q Consensus 200 ~~~~--------------------~~-~~~~DiwSlGvil~elltg~~-Pf~~~~~-----------~~~~~~i~~~~-- 244 (481)
.... |. ..+.|+||+||++|+|++|.+ ||.+... ...+..+....
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~ 462 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYD 462 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCC
Confidence 5322 11 124799999999999999876 7754221 11122222223
Q ss_pred CCCCCCCCHHHHHHHHHhcccCc---CCCCCHhHHHhCcccccC
Q 011628 245 FRSPRWFSPDLIRLLTKLLDTNP---DKRITIPEIMENRWFRKG 285 (481)
Q Consensus 245 ~~~~~~~s~~~~~li~~~L~~dP---~~Rps~~eil~h~~f~~~ 285 (481)
+......++..++|+.+||..+| .+|+|++|+|+||||...
T Consensus 463 ~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 463 FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 23334578999999999999866 689999999999999653
No 384
>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]
Probab=100.00 E-value=1.6e-36 Score=306.24 Aligned_cols=241 Identities=26% Similarity=0.502 Sum_probs=212.2
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
..-++||.|-||.||.|.+++-.-.||||.++.+.. .+..+..|..+|+.++|||+|+++++|..+.-+|||+|||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345789999999999999999889999999876542 3567889999999999999999999999999999999999
Q ss_pred CCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 109 RGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 109 ~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
..|+|.++++. ..++.-....++.||.+|++||..+++|||||...|+|+.++..+||+|||++++... ..++
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DTYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Ccee
Confidence 99999999986 2467777888999999999999999999999999999999999999999999997543 2233
Q ss_pred ccCC---CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 011628 186 TFCG---TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLIRLLT 260 (481)
Q Consensus 186 ~~~g---t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~~li~ 260 (481)
...| ...|.|||-+....+ +.|+|||+|||+|||+.| |--||.+-+...+|..+-++ .+.-|..+++.+.+|++
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 3333 456999999977666 679999999999999998 99999999999998888776 36678999999999999
Q ss_pred HhcccCcCCCCCHhHHHh
Q 011628 261 KLLDTNPDKRITIPEIME 278 (481)
Q Consensus 261 ~~L~~dP~~Rps~~eil~ 278 (481)
.||+++|.+||++.||-+
T Consensus 501 aCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred HHhcCCcccCccHHHHHH
Confidence 999999999999998844
No 385
>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]
Probab=100.00 E-value=1.9e-37 Score=307.99 Aligned_cols=254 Identities=30% Similarity=0.518 Sum_probs=211.6
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCcceEEEE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH------PNIVQLFEV 94 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H------pnIv~l~~~ 94 (481)
+..+.+||++....|+|-|++|..|.+...|+.||||+|....+ +.+.=.+|++||++|+. -|+++++..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 46678999999999999999999999999999999999986543 44555689999999963 479999999
Q ss_pred EEeCCEEEEEEeccCCCchHHHHHc-C---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEec
Q 011628 95 MATKSKIYFVMEYVRGGELFNKVAK-G---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDF 169 (481)
Q Consensus 95 ~~~~~~~~lv~Ey~~gg~L~~~i~~-~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DF 169 (481)
|...+++|||+|-+. ..|.+.+.+ | ++....++.|++||..||..|-..||+|.||||.|||+++.. .+|||||
T Consensus 503 F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred hhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccC
Confidence 999999999999885 489999876 3 588899999999999999999999999999999999999875 5899999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhh--CCCCC
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYK--GEFRS 247 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~--~~~~~ 247 (481)
|.|..... ...+.+.-+..|.|||++.+.+|+ ...|+||+||+||||.||+..|++.+...++..... |.++.
T Consensus 582 GSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~ 656 (752)
T KOG0670|consen 582 GSASFASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPN 656 (752)
T ss_pred cccccccc----ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcH
Confidence 99876432 334556678889999999999995 679999999999999999999998765555443322 21110
Q ss_pred ----------------------------------------C-----------CCCC-------HHHHHHHHHhcccCcCC
Q 011628 248 ----------------------------------------P-----------RWFS-------PDLIRLLTKLLDTNPDK 269 (481)
Q Consensus 248 ----------------------------------------~-----------~~~s-------~~~~~li~~~L~~dP~~ 269 (481)
| +.++ ..+++|+.+||..||++
T Consensus 657 KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~K 736 (752)
T KOG0670|consen 657 KMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEK 736 (752)
T ss_pred HHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhh
Confidence 0 0011 13789999999999999
Q ss_pred CCCHhHHHhCccccc
Q 011628 270 RITIPEIMENRWFRK 284 (481)
Q Consensus 270 Rps~~eil~h~~f~~ 284 (481)
|.|+.|+|+||||+.
T Consensus 737 Rit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 737 RITVNQALKHPFITE 751 (752)
T ss_pred cCCHHHHhcCCcccC
Confidence 999999999999964
No 386
>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]
Probab=100.00 E-value=9.1e-37 Score=315.68 Aligned_cols=250 Identities=26% Similarity=0.436 Sum_probs=220.6
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGE---SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~---~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
..-.|.++||.|-||.|+.|+.+..|+ .||||.++... .+.....|..|..||-+++||||+++-|+.....-++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 445889999999999999999887664 69999997654 3445678999999999999999999999999999999
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||+|||+.|+|..+++. |+++.-+..-+++.|+.|++||-+.|.+||||...|||++.+-..|++|||+++......
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 99999999999999975 789999999999999999999999999999999999999999999999999999764422
Q ss_pred CCcccccCC--CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhC-CCCCCCCCCHHHH
Q 011628 181 DGLFHTFCG--TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKG-EFRSPRWFSPDLI 256 (481)
Q Consensus 181 ~~~~~~~~g--t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~-~~~~~~~~s~~~~ 256 (481)
+..+.+..| ..+|.|||.+....+ +.++||||+||+|||.++ |..||-+.+..+..+.|..| .++.|-.++..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 333344333 467999999988877 567999999999999877 99999999988999888877 4777888999999
Q ss_pred HHHHHhcccCcCCCCCHhHHHhC
Q 011628 257 RLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 257 ~li~~~L~~dP~~Rps~~eil~h 279 (481)
+|+..||++|-.+||.+.||+.+
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999873
No 387
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=100.00 E-value=2.1e-37 Score=315.76 Aligned_cols=255 Identities=32% Similarity=0.514 Sum_probs=224.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.++|++++.+|.|+||.||+|+++.+++..|+|+++.+... ...-+.+|+-+++.++||||+.+++.+......|++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 57899999999999999999999999999999999876532 345677899999999999999999999999999999
Q ss_pred EeccCCCchHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCc
Q 011628 105 MEYVRGGELFNKVA-KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGL 183 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~-~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~ 183 (481)
||||.||+|++.-. .|.++|.++....+..+.|++|||++|-+|||||-.|||+++.|.+|++|||.+......- ..
T Consensus 91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~K 168 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AK 168 (829)
T ss_pred EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhh--hh
Confidence 99999999999876 4899999999999999999999999999999999999999999999999999987544321 22
Q ss_pred ccccCCCCcccccccc---ccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCC-----CCCCCHHH
Q 011628 184 FHTFCGTPAYVAPEVL---SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRS-----PRWFSPDL 255 (481)
Q Consensus 184 ~~~~~gt~~y~APEvl---~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~-----~~~~s~~~ 255 (481)
.....|||+|||||+. +..+| ..++|||++|+...|+-.-++|--+..++.......+..+.. +...++.+
T Consensus 169 rksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 3567999999999985 33455 578999999999999999999988888877776666655544 33468889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+|++.+|.++|++|||++.+|.|||....
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 999999999999999999999999998765
No 388
>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]
Probab=100.00 E-value=6.5e-36 Score=300.75 Aligned_cols=250 Identities=20% Similarity=0.328 Sum_probs=206.2
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
-.+..+.++||+|-||.|.++.- ..+.+||||.++.+. ..+..+.+.+|+++|.+|+||||++++++|..++.++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 35678899999999999999985 446999999998764 334568899999999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccC
Q 011628 105 MEYVRGGELFNKVAKGR---LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~~---l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~ 181 (481)
+||++.|+|.+++.... .......+++.||++|++||.+.+++||||.+.|+|++.++++||+|||+++-.-.....
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999999998752 244566779999999999999999999999999999999999999999999832111111
Q ss_pred CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc--CCCCCCCchHHHHHHHH---hhC-----CCCCCCCC
Q 011628 182 GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA--GYLPFQDQNIMVMYKKI---YKG-----EFRSPRWF 251 (481)
Q Consensus 182 ~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt--g~~Pf~~~~~~~~~~~i---~~~-----~~~~~~~~ 251 (481)
..-...+-...|||||.+....+ +.++|+|++|+++||+++ ...||.+.+........ ... -+..|.-+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 11122344678999999877776 678999999999999764 89999887765554433 222 13457789
Q ss_pred CHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 252 SPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 252 s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+..+.+++.+||..+-++|||++++-.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 999999999999999999999999854
No 389
>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]
Probab=100.00 E-value=4.9e-36 Score=301.39 Aligned_cols=202 Identities=34% Similarity=0.578 Sum_probs=183.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHH-----HHHHHHHHHhCC---CCCcceEEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH-----IKREISILRRVR---HPNIVQLFEVMA 96 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~-----~~~Ei~il~~l~---HpnIv~l~~~~~ 96 (481)
...|..++.||+|+||+|++|.++++...|+||.|.++++....+++. +-.||+||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 567999999999999999999999999999999999988765544432 457999999997 999999999999
Q ss_pred eCCEEEEEEeccC-CCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 97 TKSKIYFVMEYVR-GGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 97 ~~~~~~lv~Ey~~-gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
+++.+||+||-.. |.+||++|+. .+++|.++..+|+|++.|+++||++||+|||||-||+.++.+|-+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 9999999999764 4599999986 5799999999999999999999999999999999999999999999999999875
Q ss_pred ccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCC
Q 011628 175 SDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQD 230 (481)
Q Consensus 175 ~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 230 (481)
. ..+.+....||..|.|||++.+..|-+.+-|||+||++||.++....||..
T Consensus 720 ~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 720 T----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred h----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 3 456678889999999999999999999999999999999999999999853
No 390
>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=3.8e-37 Score=284.85 Aligned_cols=257 Identities=28% Similarity=0.489 Sum_probs=209.3
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----E
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS-----K 100 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~-----~ 100 (481)
.+.+-.+-||-|+||+||.+.+..+|+.||+|.+..-. ..-...+++.+|+.++..++|.|++..+++..... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 45566789999999999999999999999999985432 22234477889999999999999999998876654 3
Q ss_pred EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccc
Q 011628 101 IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIR 179 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~ 179 (481)
+|+++|.+.. +|...|.. ..++.+.+.-+.+||++||+|||+.||.||||||.|+|++.|..+||||||+++......
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 6788888854 78887765 679999999999999999999999999999999999999999999999999999765432
Q ss_pred cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh------------------
Q 011628 180 QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY------------------ 241 (481)
Q Consensus 180 ~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~------------------ 241 (481)
.. ..+..+-|.+|+|||++.+...++...||||.|||+.||+..+..|...++.+....|.
T Consensus 211 ~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 211 RL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 22 22334568899999999998877889999999999999999999998777655544432
Q ss_pred -----hCCCCCCC-----------CCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 242 -----KGEFRSPR-----------WFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 242 -----~~~~~~~~-----------~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
.+..+.|+ .-..+...++.++|.+||++|++.++.+.|++..++
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 12222222 123357889999999999999999999999998654
No 391
>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]
Probab=100.00 E-value=3.7e-36 Score=313.90 Aligned_cols=252 Identities=25% Similarity=0.422 Sum_probs=201.8
Q ss_pred EeEecccCceE-EEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 011628 31 GKLLGHGTFAK-VYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 31 ~~~LG~G~fg~-Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
-+.+|.|+-|+ ||+|.. .|+.||||.+-.+ ....+.||+..++..+ |||||++|+.-.+....||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 36789999985 899987 7889999987543 3456789999999994 999999999999999999999999
Q ss_pred CCCchHHHHHcC-C----CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc---CC--CEEEEecCCccccccc
Q 011628 109 RGGELFNKVAKG-R----LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE---NG--DLKVSDFGLSAVSDQI 178 (481)
Q Consensus 109 ~gg~L~~~i~~~-~----l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~---~g--~lkl~DFGla~~~~~~ 178 (481)
.. +|.++++.. . ...-..+..+.|+++||++||+.+|+||||||.||||+. ++ +++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 75 999999863 1 111445889999999999999999999999999999986 34 5899999999865432
Q ss_pred c-cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcC-CCCCCCchHHHHHHHHhhCCCCCC---CCCCH
Q 011628 179 R-QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQNIMVMYKKIYKGEFRSP---RWFSP 253 (481)
Q Consensus 179 ~-~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~~~~~~~~~i~~~~~~~~---~~~s~ 253 (481)
. .-....+..||-+|+|||++..... +.++||||+||++|+.++| .+||.+.-.. ..+|..+....- +.-..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~ 741 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDC 741 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchHHh--hhhhhcCccceeeeccCchH
Confidence 1 2223556789999999999987665 4579999999999998885 9999876432 235555554321 11112
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHHhCcccccCccccceeec
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFKHIKFYIE 294 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~~~~~~~~ 294 (481)
++.+||.+|+.++|..||++.++|.||+|....++..|..+
T Consensus 742 eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~d 782 (903)
T KOG1027|consen 742 EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRD 782 (903)
T ss_pred HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHh
Confidence 89999999999999999999999999999987776666543
No 392
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional
Probab=100.00 E-value=7.2e-35 Score=332.82 Aligned_cols=237 Identities=23% Similarity=0.388 Sum_probs=187.8
Q ss_pred CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 011628 26 GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 26 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~ 105 (481)
..|...+.||+|+||.||+|++..++..||||.+...... ..+|+.++++++|||||++++++.+....|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 4566678999999999999999889999999998643311 124688999999999999999999999999999
Q ss_pred eccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH---HcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCC
Q 011628 106 EYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH---ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDG 182 (481)
Q Consensus 106 Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH---~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~ 182 (481)
||++||+|.+++.. +++..+.+++.|++.|++||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 763 Ey~~~g~L~~~l~~--l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----- 834 (968)
T PLN00113 763 EYIEGKNLSEVLRN--LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----- 834 (968)
T ss_pred eCCCCCcHHHHHhc--CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence 99999999999964 889999999999999999999 6699999999999999999888876 665543211
Q ss_pred cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHH-hh---------CCCCC-
Q 011628 183 LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKI-YK---------GEFRS- 247 (481)
Q Consensus 183 ~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i-~~---------~~~~~- 247 (481)
.....||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.... ...+.+. .. .....
T Consensus 835 -~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 835 -DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred -CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 123468899999999987777 5789999999999999999999854211 1111111 10 00000
Q ss_pred ---CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 248 ---PRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 248 ---~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
+.....++.+++.+||+.||++|||+.|+++.
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00112246789999999999999999999874
No 393
>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=4.1e-34 Score=283.11 Aligned_cols=131 Identities=30% Similarity=0.549 Sum_probs=115.0
Q ss_pred Ccc-CCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CC---CcceEEE
Q 011628 23 PLL-GRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-----HP---NIVQLFE 93 (481)
Q Consensus 23 ~~~-~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----Hp---nIv~l~~ 93 (481)
++. +||.+.++||.|-|++||+|.+..+.+.||+|+.+... .+.+....||.+|++++ |+ +||++++
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 454 89999999999999999999999999999999987654 45566778999999984 33 5999999
Q ss_pred EEEe----CCEEEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEE
Q 011628 94 VMAT----KSKIYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLL 158 (481)
Q Consensus 94 ~~~~----~~~~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl 158 (481)
.|.. +.++++|+|++ |-.|..+|.. .+++...+++|++|++.||.|||.. ||||-||||+|||+
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 9854 56899999999 6688888875 5799999999999999999999965 99999999999999
No 394
>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]
Probab=100.00 E-value=6.1e-34 Score=279.40 Aligned_cols=250 Identities=26% Similarity=0.469 Sum_probs=195.6
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEEEEEEeC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV--RHPNIVQLFEVMATK 98 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~ 98 (481)
+..+.....+.+.||+|.||.||+|++ .|+.||||++.... -....||.+|.+.. +|+||+.+++.-...
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~ 277 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKD 277 (513)
T ss_pred HHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence 455678899999999999999999998 68999999996542 13456788877654 899999998775332
Q ss_pred ----CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc--------CceecCCCCCcEEEccCCCEEE
Q 011628 99 ----SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR--------GVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 99 ----~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~--------gi~HrDLKp~NILl~~~g~lkl 166 (481)
.++|||++|.+.|+|+|++....++.+...+++..+++||+|||.. .|+|||||..|||+..+|..-|
T Consensus 278 ~gs~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 278 NGSWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred CCceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 4799999999999999999999999999999999999999999953 4999999999999999999999
Q ss_pred EecCCccccccccc--CCcccccCCCCccccccccccC----CCCC-CcchHHHHHHHHHHHhcC----------CCCCC
Q 011628 167 SDFGLSAVSDQIRQ--DGLFHTFCGTPAYVAPEVLSRK----GYDA-AKVDIWSCGVILFVLMAG----------YLPFQ 229 (481)
Q Consensus 167 ~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~----~~~~-~~~DiwSlGvil~elltg----------~~Pf~ 229 (481)
+|+|||-....... +-..+..+||.+|||||++... .+.+ ..+||||||.++||++.. ++||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 99999976443221 2233567999999999998542 1222 259999999999999742 68885
Q ss_pred C-----chHHHHHHHHhhCC--CCC-CCCCCHH----HHHHHHHhcccCcCCCCCHhHHHh
Q 011628 230 D-----QNIMVMYKKIYKGE--FRS-PRWFSPD----LIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 230 ~-----~~~~~~~~~i~~~~--~~~-~~~~s~~----~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+ ++.+++.+-+.-.+ +.. +.|-|.+ +-.+++.||..||.-|.|+--|.+
T Consensus 438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred cCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 4 34445544443333 333 3454443 456889999999999999866643
No 395
>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=3.9e-33 Score=300.98 Aligned_cols=248 Identities=25% Similarity=0.465 Sum_probs=208.1
Q ss_pred CeeEEeEecccCceEEEEEEEcC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVK-------SGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATK 98 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~-------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~ 98 (481)
+..+.+.||+|+||+|++|.-.. ....||||........ ...+.+..|+.+|+.+ .||||+.+.+++...
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 33567799999999999997431 1457999998765432 4567899999999999 599999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcCC-----------------CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGR-----------------LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~-----------------l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~ 161 (481)
..+++|+|||..|+|.++++..+ ++......++.||+.|++||++..++||||-..|||+..+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKN 454 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCC
Confidence 99999999999999999998766 8899999999999999999999999999999999999999
Q ss_pred CCEEEEecCCcccccccccCCcccccCC--CCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCch-HHHHH
Q 011628 162 GDLKVSDFGLSAVSDQIRQDGLFHTFCG--TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQN-IMVMY 237 (481)
Q Consensus 162 g~lkl~DFGla~~~~~~~~~~~~~~~~g--t~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~-~~~~~ 237 (481)
..+||+|||+|+......... .....| ...|||||.+....| +.++||||+||+|||+++ |..||.+-. ...++
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~ 532 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELL 532 (609)
T ss_pred CEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHH
Confidence 999999999998432211110 011222 345999999988655 779999999999999998 999999854 45556
Q ss_pred HHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 238 KKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 238 ~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
..+..|. ...|..+++++.++++.||+.+|++||++.++.+
T Consensus 533 ~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 533 EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 6777775 5779999999999999999999999999999875
No 396
>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]
Probab=100.00 E-value=8.1e-34 Score=253.47 Aligned_cols=212 Identities=26% Similarity=0.471 Sum_probs=175.6
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 103 (481)
.+...-+..||+|+||.|-+.++..+|...|+|.+...- .....++..+|+.+..+. .+|.+|.+|+.+.....+||
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 345566789999999999999999999999999997643 234567788899877666 69999999999999999999
Q ss_pred EEeccCCCchHHHH----Hc-CCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 104 VMEYVRGGELFNKV----AK-GRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 104 v~Ey~~gg~L~~~i----~~-~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
.||.+.. +|..+- .+ +.++|..+-+++..++.||.|||++ .|+|||+||+|||++.+|++|+||||++.....
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9999964 664443 33 4799999999999999999999987 899999999999999999999999999975432
Q ss_pred cccCCcccc-cCCCCccccccccc----cCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-hHHHHHHHHhhCC
Q 011628 178 IRQDGLFHT-FCGTPAYVAPEVLS----RKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NIMVMYKKIYKGE 244 (481)
Q Consensus 178 ~~~~~~~~~-~~gt~~y~APEvl~----~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~~~~~~~i~~~~ 244 (481)
....+ ..|...|||||.+. ..+| +-++||||||++++||.+++.||+.- ++-++.+++....
T Consensus 202 ----SiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 202 ----SIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred ----hhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence 22233 56888999999974 3456 57899999999999999999999764 5566777776654
No 397
>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.5e-33 Score=278.60 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=195.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcceEEEEEEeCC---
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV--RHPNIVQLFEVMATKS--- 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l--~HpnIv~l~~~~~~~~--- 99 (481)
....++.++||+|.||.||+|+. +++.||||++.... ...+..|-.|.+.. .|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 45577889999999999999986 67999999996543 34455666666554 7999999998866555
Q ss_pred -EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---------CceecCCCCCcEEEccCCCEEEEec
Q 011628 100 -KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR---------GVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 100 -~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~---------gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.++||+||.+.|+|.+++....+++....+++..+++||+|||+- .|+|||||..||||..|+..-|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 899999999999999999999999999999999999999999962 5999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCC-----CcchHHHHHHHHHHHhcCC------------CCCC---
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA-----AKVDIWSCGVILFVLMAGY------------LPFQ--- 229 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~-----~~~DiwSlGvil~elltg~------------~Pf~--- 229 (481)
|+|..+......+-...-+||.+|||||++.+.--.. .+.||||+|.+||||++.. +||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9998877655566666789999999999986532211 3589999999999999752 3443
Q ss_pred --CchHHHHHHHHhhC--CCCCCCC-----CCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 230 --DQNIMVMYKKIYKG--EFRSPRW-----FSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 230 --~~~~~~~~~~i~~~--~~~~~~~-----~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+...++...+... ++.+|.. --..+++.+.-||+.||+.|.|+.=+.+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 22344444444433 3333332 1234789999999999999999765544
No 398
>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]
Probab=100.00 E-value=1.1e-33 Score=293.73 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=213.8
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGE----SVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 102 (481)
..+..++||+|+||+||+|.+...|+ +||||++...... .....+.+|+-+|..+.|||++++++++.... +.
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~--~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP--KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc--hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34557899999999999999876655 5899988765433 33567889999999999999999999998766 88
Q ss_pred EEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 103 FVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
||++|+++|.|.++++. +.+.......|..||++|+.|||.++++||||-..|+|+..-..+||.|||+++.......
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 99999999999999875 6789999999999999999999999999999999999999999999999999987655333
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRL 258 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~l 258 (481)
.-......-.+.|||-|.+....| +.++||||+||++||++| |..|+.+....++-..+..|+ ++.|+.++.++..+
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~ 932 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMV 932 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHH
Confidence 322233333567999999988777 678999999999999998 999999998888877777764 78899999999999
Q ss_pred HHHhcccCcCCCCCHhHHHh
Q 011628 259 LTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~ 278 (481)
+.+||..|++.||+++++..
T Consensus 933 mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 933 MVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHHhccCcccCccHHHHHH
Confidence 99999999999999988765
No 399
>cd00180 PKc Catalytic domain of Protein Kinases. Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which
Probab=100.00 E-value=1.8e-31 Score=246.98 Aligned_cols=212 Identities=47% Similarity=0.825 Sum_probs=186.3
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCch
Q 011628 34 LGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGEL 113 (481)
Q Consensus 34 LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L 113 (481)
||+|++|.||++.+..+++.+++|++....... ....+.+|+..++.+.|++|+++++++......++++||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654321 346788999999999999999999999999999999999999999
Q ss_pred HHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-CCCEEEEecCCcccccccccCCcccccCCC
Q 011628 114 FNKVAKG--RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAVSDQIRQDGLFHTFCGT 190 (481)
Q Consensus 114 ~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~~~~~~~~~~~~~~~gt 190 (481)
.+++... .++...++.++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999864 7999999999999999999999999999999999999999 89999999999875433211 12345678
Q ss_pred CccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 191 PAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 191 ~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
..|++||.+......+.++|+|++|+++++| ..+.+++.+|++.||.+|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987652446789999999999999 678899999999999999
Q ss_pred CCHhHHHhCc
Q 011628 271 ITIPEIMENR 280 (481)
Q Consensus 271 ps~~eil~h~ 280 (481)
|++.++++|+
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999874
No 400
>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]
Probab=100.00 E-value=1.5e-33 Score=275.82 Aligned_cols=255 Identities=30% Similarity=0.522 Sum_probs=203.5
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVK---SGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
.+...|.+.++||+|+|++||+|.+.. ..+.||+|.+..... ..++..|+++|..+. +.||+++.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 346789999999999999999999887 788999999876432 355889999999995 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~~ 177 (481)
+...+|+||.+..+..++... ++..+++.|++.++.||.++|.+||+||||||.|+|.+.. +.-.|+|||+|...+.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999999888888765 6788999999999999999999999999999999999864 6789999999972111
Q ss_pred cc-------------------------------cCCcc-----------cccCCCCccccccccccCCCCCCcchHHHHH
Q 011628 178 IR-------------------------------QDGLF-----------HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCG 215 (481)
Q Consensus 178 ~~-------------------------------~~~~~-----------~~~~gt~~y~APEvl~~~~~~~~~~DiwSlG 215 (481)
.. ..+.. -...||++|+|||++...+-.++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 00000 1246999999999998888778899999999
Q ss_pred HHHHHHhcCCCCCCCch-----HHHHH---------------------H--------------------HHhhCCC---C
Q 011628 216 VILFVLMAGYLPFQDQN-----IMVMY---------------------K--------------------KIYKGEF---R 246 (481)
Q Consensus 216 vil~elltg~~Pf~~~~-----~~~~~---------------------~--------------------~i~~~~~---~ 246 (481)
||+..++++..||-... ..++. . .+.+.+. .
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999983210 00000 0 0000000 0
Q ss_pred ---CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 247 ---SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 247 ---~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
....++..+.+|+.+||+.||.+|+|+++.|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 01124557899999999999999999999999999973
No 401
>smart00221 STYKc Protein kinase; unclassified specificity. Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.
Probab=99.98 E-value=5.1e-31 Score=248.30 Aligned_cols=218 Identities=44% Similarity=0.719 Sum_probs=186.3
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
|.+.+.||.|++|.||+|.+..+++.+|+|.+...... ...+.+.+|+..++.++|+|++++++.+......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67899999999999999999888999999999765432 2467888999999999999999999999999999999999
Q ss_pred cCCCchHHHHHcC-C-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccc
Q 011628 108 VRGGELFNKVAKG-R-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFH 185 (481)
Q Consensus 108 ~~gg~L~~~i~~~-~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~ 185 (481)
+.+++|.+++... . +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence 9999999999764 4 8999999999999999999999999999999999999999999999999987654322 11234
Q ss_pred ccCCCCcccccccc-ccCCCCCCcchHHHHHHHHHHHhcCCCCCCC-c-hHHHHHHHHhhCCCCCCC
Q 011628 186 TFCGTPAYVAPEVL-SRKGYDAAKVDIWSCGVILFVLMAGYLPFQD-Q-NIMVMYKKIYKGEFRSPR 249 (481)
Q Consensus 186 ~~~gt~~y~APEvl-~~~~~~~~~~DiwSlGvil~elltg~~Pf~~-~-~~~~~~~~i~~~~~~~~~ 249 (481)
...++..|++||.+ ....+ +.++|+|+||+++++|++|+.||.. . +...+.+.+..+.....+
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 45788899999998 44445 4589999999999999999999988 4 445777777777654443
No 402
>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]
Probab=99.98 E-value=9.5e-33 Score=255.68 Aligned_cols=256 Identities=29% Similarity=0.440 Sum_probs=204.4
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE-EEeC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEV-MATK 98 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~-~~~~ 98 (481)
.-.+.+.|.|.+.||+|-||++.+++++.+++.+++|.+..... ..+.+.+|..---.| .|.||+.-|++ |++.
T Consensus 19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~ 94 (378)
T KOG1345|consen 19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTS 94 (378)
T ss_pred ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcC
Confidence 34567899999999999999999999999999999999987653 346677888766666 48999998876 5677
Q ss_pred CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc--CCCEEEEecCCccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE--NGDLKVSDFGLSAVSD 176 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~--~g~lkl~DFGla~~~~ 176 (481)
+.+.+++||++.|+|..-+...++.|....+++.|+++|++|+|+++++|||||.+||||.. ..++||||||+++..+
T Consensus 95 d~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 95 DAYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ceEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC
Confidence 78889999999999999999888999999999999999999999999999999999999954 3479999999987533
Q ss_pred ccccCCcccccCCCCccccccccccCCC----CCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCC-CCC
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGY----DAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGE-FRS 247 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~----~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~-~~~ 247 (481)
. ..+..--+..|.+||++..... ..+.+|+|.||+++|.+++|.+||..... -..+.++.++. ...
T Consensus 175 ~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~ 249 (378)
T KOG1345|consen 175 T-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPAL 249 (378)
T ss_pred c-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccC
Confidence 2 2222334567999998643221 12458999999999999999999985432 23445555543 233
Q ss_pred C---CCCCHHHHHHHHHhcccCcCCC---CCHhHHHhCcccccC
Q 011628 248 P---RWFSPDLIRLLTKLLDTNPDKR---ITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ~---~~~s~~~~~li~~~L~~dP~~R---ps~~eil~h~~f~~~ 285 (481)
| ..+|+.+..+.++-|.++|++| .++.......|....
T Consensus 250 P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~ 293 (378)
T KOG1345|consen 250 PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL 293 (378)
T ss_pred chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence 3 3478999999999999999999 566666777887554
No 403
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.97 E-value=1.7e-32 Score=293.01 Aligned_cols=261 Identities=31% Similarity=0.521 Sum_probs=212.9
Q ss_pred ccCCe-eEEeEecccCceEEEEEEEcCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 24 LLGRY-EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKE---KILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 24 ~~~~y-~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
+..+| .....+|.|++|.|+.+......+.++.|..... ..........+..|+.+-..++|||++.....+....
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 45667 6689999999999998888777777777765421 1122233344788999999999999988777666666
Q ss_pred EEEEEEeccCCCchHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKG-RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI 178 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~-~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~ 178 (481)
..+-.||||++ +|+.++... .+...++..+++||+.||.|+|+.||.|||+||+|+++..+|.+||+|||.+..+...
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 66666999999 999999875 8999999999999999999999999999999999999999999999999999876654
Q ss_pred ccC--CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHH---------HHHhhCCCCC
Q 011628 179 RQD--GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMY---------KKIYKGEFRS 247 (481)
Q Consensus 179 ~~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~---------~~i~~~~~~~ 247 (481)
... ......+|+..|+|||++.+..|+....||||+|++++.|.+|+.||......... .++..+..+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 444 45567899999999999999999999999999999999999999999765433211 1111122222
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
...++...+.+|.+||++||.+|+|+++|++++||+..
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i 591 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI 591 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence 33467788999999999999999999999999999864
No 404
>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]
Probab=99.97 E-value=4.1e-30 Score=248.52 Aligned_cols=251 Identities=21% Similarity=0.299 Sum_probs=209.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEE-eC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS-----GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMA-TK 98 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-~~ 98 (481)
..|+++..++-+|+||.||.|++.+. .+.|-+|.++... .+-.+..+..|...+..++|||+..+.++.. +.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 46788889999999999999987643 2346667664332 2234566788999999999999999999875 45
Q ss_pred CEEEEEEeccCCCchHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 99 SKIYFVMEYVRGGELFNKVAK---------GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~---------~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
...++++.+..-|+|..++.. ..++..+...++.|++.|++|||++||+|.||...|++||+.-.+||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 678899999999999999872 13677788899999999999999999999999999999999999999999
Q ss_pred CCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHHhhCC-CCC
Q 011628 170 GLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKIYKGE-FRS 247 (481)
Q Consensus 170 Gla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i~~~~-~~~ 247 (481)
.+++-........+-..-.....||+||.+.+..| +..+|+|||||+||||+| |..||.+-++.+++..+.+|. +..
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 99986444333222233345678999999998888 567999999999999998 999999999999999998884 667
Q ss_pred CCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 248 PRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 248 ~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
|-.+|+++..++..||...|++||+.+|+..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 8889999999999999999999999999865
No 405
>PLN00181 protein SPA1-RELATED; Provisional
Probab=99.97 E-value=7.9e-31 Score=292.94 Aligned_cols=198 Identities=15% Similarity=0.204 Sum_probs=146.3
Q ss_pred CCC-CCcceEEEEE-------EeCCEEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCC
Q 011628 83 VRH-PNIVQLFEVM-------ATKSKIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLK 152 (481)
Q Consensus 83 l~H-pnIv~l~~~~-------~~~~~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLK 152 (481)
++| +||+++++.+ .....++.++||+ +++|++++.. +.+++.++..+++||+.||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 445 5777777776 2234577888887 5699999975 459999999999999999999999999999999
Q ss_pred CCcEEEccC-------------------CCEEEEecCCccccccccc--------------CCcccccCCCCcccccccc
Q 011628 153 PENLLLDEN-------------------GDLKVSDFGLSAVSDQIRQ--------------DGLFHTFCGTPAYVAPEVL 199 (481)
Q Consensus 153 p~NILl~~~-------------------g~lkl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~APEvl 199 (481)
|+||||+.. +.+|++|||+++....... .......+||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 4456666666653211000 0001124689999999999
Q ss_pred ccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 200 SRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-SPRWFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 200 ~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.+..| +.++|||||||+||||++|..|+..... ....+.....+ .+....+...+++.+||+++|.+|||+.|+++
T Consensus 188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88887 6789999999999999999998765332 11112111111 11112456789999999999999999999999
Q ss_pred Cccccc
Q 011628 279 NRWFRK 284 (481)
Q Consensus 279 h~~f~~ 284 (481)
||||.+
T Consensus 265 h~~~~~ 270 (793)
T PLN00181 265 SEFINE 270 (793)
T ss_pred chhhhh
Confidence 999975
No 406
>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]
Probab=99.96 E-value=4.7e-27 Score=230.57 Aligned_cols=254 Identities=37% Similarity=0.593 Sum_probs=211.7
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP-NIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lv~E 106 (481)
|++.+.||.|+||.||++.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999986 88999999877654444567889999999999988 79999999988888999999
Q ss_pred ccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-CEEEEecCCcccccccccC
Q 011628 107 YVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQIRQD 181 (481)
Q Consensus 107 y~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~~~~~ 181 (481)
|+.++++.+.+... .+++.....++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999877764 699999999999999999999999999999999999999998 6999999998754332221
Q ss_pred C----cccccCCCCccccccccccC--CCCCCcchHHHHHHHHHHHhcCCCCCCCchH----HHHHHHHhhCCCC-CCCC
Q 011628 182 G----LFHTFCGTPAYVAPEVLSRK--GYDAAKVDIWSCGVILFVLMAGYLPFQDQNI----MVMYKKIYKGEFR-SPRW 250 (481)
Q Consensus 182 ~----~~~~~~gt~~y~APEvl~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~-~~~~ 250 (481)
. .....+||..|+|||.+.+. .+.....|+||+|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 34678999999999999874 4556789999999999999999999887763 4555555444433 2222
Q ss_pred CC--------HHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 251 FS--------PDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 251 ~s--------~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
.. ..+.+++.+++..+|..|.+..+...++|...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 22 46899999999999999999999988866544
No 407
>PRK09188 serine/threonine protein kinase; Provisional
Probab=99.96 E-value=3.4e-28 Score=244.81 Aligned_cols=171 Identities=24% Similarity=0.261 Sum_probs=136.1
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCcce-EEEEEE
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKI--LKSGLVAHIKREISILRRVRHPNIVQ-LFEVMA 96 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~-l~~~~~ 96 (481)
-.++.++|++.+.||+|+||+||+|++.. +++.||||++..... ........+.+|+.+|+.++|+||+. +++.
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 34678999999999999999999999876 678889998753311 12234567899999999999999985 4432
Q ss_pred eCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCcEEEccCCCEEEEecCCcccc
Q 011628 97 TKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDL-KPENLLLDENGDLKVSDFGLSAVS 175 (481)
Q Consensus 97 ~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDL-Kp~NILl~~~g~lkl~DFGla~~~ 175 (481)
...|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+..
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 458999999999999732 21 11 1578999999999999999999999 999999999999999999999865
Q ss_pred cccccCCc------ccccCCCCcccccccccc
Q 011628 176 DQIRQDGL------FHTFCGTPAYVAPEVLSR 201 (481)
Q Consensus 176 ~~~~~~~~------~~~~~gt~~y~APEvl~~ 201 (481)
........ ....++++.|+|||.+..
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 44332221 246688999999999854
No 408
>smart00750 KIND kinase non-catalytic C-lobe domain. It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features
Probab=99.95 E-value=2.2e-28 Score=223.13 Aligned_cols=158 Identities=21% Similarity=0.262 Sum_probs=128.6
Q ss_pred CchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccC
Q 011628 111 GELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFC 188 (481)
Q Consensus 111 g~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~ 188 (481)
|+|.+++.. +.+++..++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 689999974 46999999999999999999999999 999999999999999 9998764331 236
Q ss_pred CCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH-HHHHHHhhCCCC-------CCCCCCH--HHHHH
Q 011628 189 GTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM-VMYKKIYKGEFR-------SPRWFSP--DLIRL 258 (481)
Q Consensus 189 gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~~i~~~~~~-------~~~~~s~--~~~~l 258 (481)
||+.|+|||++.+..| +.++||||+||++|+|++|..||...... .....+..+... .+..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 8999999999988877 57899999999999999999999765432 333333322111 1222333 69999
Q ss_pred HHHhcccCcCCCCCHhHHHhCccccc
Q 011628 259 LTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 259 i~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
|.+||..||.+|||+.++++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999753
No 409
>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]
Probab=99.95 E-value=1.2e-28 Score=252.56 Aligned_cols=239 Identities=35% Similarity=0.606 Sum_probs=207.3
Q ss_pred EecccCceEEEEEEE---cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 011628 33 LLGHGTFAKVYHARN---VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~---~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~ 108 (481)
++|+|+||.|++++. .+.|..+|+|+..+......... .-+.|-.++..++ ||.+++++..+.++.+.|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998763 24678899999877654433222 4556888888887 999999999999999999999999
Q ss_pred CCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCccccc
Q 011628 109 RGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTF 187 (481)
Q Consensus 109 ~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~ 187 (481)
.||+|+..+.+ ..+.+.....+...++-+++++|+.||+|||+|++||+++.+|++++.|||+++..-... ..
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh------hc
Confidence 99999999876 468888899999999999999999999999999999999999999999999998643211 22
Q ss_pred CCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCc
Q 011628 188 CGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNP 267 (481)
Q Consensus 188 ~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP 267 (481)
|||..|||||+++ ++ ...+|.||+|+++|+|++|..||.. +....|.+.++..|..++..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999997 45 3469999999999999999999998 677788888999999999999999999999999
Q ss_pred CCCCC-----HhHHHhCcccccC
Q 011628 268 DKRIT-----IPEIMENRWFRKG 285 (481)
Q Consensus 268 ~~Rps-----~~eil~h~~f~~~ 285 (481)
.+|.- +.|+++|+||+..
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhccCcchhHHHhccchheee
Confidence 99975 6899999999764
No 410
>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=1.9e-25 Score=224.01 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=193.7
Q ss_pred CeeEEeEecccCceEEEEEEEcCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSG-ESVAIKVIDKEKILKSGLVAHIKREISILRRVRH----PNIVQLFEVM-ATKSK 100 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~-~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H----pnIv~l~~~~-~~~~~ 100 (481)
+|++.+.||+|+||.||++.+..++ ..+|+|+......... ..++.|+.++..+.. +++..+++.. .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 6789998766532221 157789999998873 6899999999 57888
Q ss_pred EEEEEeccCCCchHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-----CCEEEEecCCc
Q 011628 101 IYFVMEYVRGGELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-----GDLKVSDFGLS 172 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-----g~lkl~DFGla 172 (481)
-|+||+.+ |.+|.++... +.++...+..++.|++.+|+++|+.|++||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 7799998753 579999999999999999999999999999999999999865 35999999999
Q ss_pred ccccccccCC-------c-ccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH---HHHHHHh
Q 011628 173 AVSDQIRQDG-------L-FHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM---VMYKKIY 241 (481)
Q Consensus 173 ~~~~~~~~~~-------~-~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~ 241 (481)
+........+ . .....||..|+++....+... +.+.|+||++.++.+|+.|.+||...... ..+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8322111111 1 123459999999999888776 67899999999999999999999775532 2222222
Q ss_pred hCCCC--CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 242 KGEFR--SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 242 ~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
..... .....+..+..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22211 223345677777777777899999998887664
No 411
>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.94 E-value=2.8e-25 Score=211.46 Aligned_cols=247 Identities=19% Similarity=0.307 Sum_probs=198.0
Q ss_pred CCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 011628 21 QSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKS 99 (481)
Q Consensus 21 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~ 99 (481)
...+.-.|+++++||+|+||+.+.|.+.-+++.||||.-.... ...+++.|....+.|. .++|...|.+..++.
T Consensus 23 ~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~ 97 (449)
T KOG1165|consen 23 VLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGK 97 (449)
T ss_pred ceEecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccc
Confidence 3456779999999999999999999999999999999754332 2456888999999995 799999999988888
Q ss_pred EEEEEEeccCCCchHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC-----CEEEEecCCc
Q 011628 100 KIYFVMEYVRGGELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG-----DLKVSDFGLS 172 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g-----~lkl~DFGla 172 (481)
.-.||||++ |-+|.|+..- ++|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .+.|+|||+|
T Consensus 98 ~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 98 YNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 888999998 7799998874 5799999999999999999999999999999999999997644 4899999999
Q ss_pred ccccccccC-----CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc---hHHHHHHHHhhCC
Q 011628 173 AVSDQIRQD-----GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ---NIMVMYKKIYKGE 244 (481)
Q Consensus 173 ~~~~~~~~~-----~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~ 244 (481)
+.+...... +...+..||..||+--...+... +.+.|+-|||-+++.+|-|.+||.+. +..+-|.+|-...
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 865432221 12345689999999887777665 67899999999999999999999874 4456677775433
Q ss_pred CCC-----CCCCCHHHHHHHHHhcccCcCCCCCHh
Q 011628 245 FRS-----PRWFSPDLIRLLTKLLDTNPDKRITIP 274 (481)
Q Consensus 245 ~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ 274 (481)
..- ...+|.++...++-.-..+-.+-|..+
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 221 344677776666666555556666644
No 412
>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]
Probab=99.93 E-value=4.5e-25 Score=201.72 Aligned_cols=249 Identities=22% Similarity=0.333 Sum_probs=199.0
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMAT 97 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~ 97 (481)
...-...++|++++.||+|+||.+|+|....+|+.||||+-.... . ..++..|..+.+.|+ ...|..+..+..+
T Consensus 8 ~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e 82 (341)
T KOG1163|consen 8 LEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-K----HPQLLYESKVYRILQGGVGIPHIRHYGTE 82 (341)
T ss_pred hhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-C----CcchhHHHHHHHHhccCCCCchhhhhccc
Confidence 344456899999999999999999999999999999999865432 2 234668999999997 4778888888888
Q ss_pred CCEEEEEEeccCCCchHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC---CCEEEEecCCc
Q 011628 98 KSKIYFVMEYVRGGELFNKVA--KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN---GDLKVSDFGLS 172 (481)
Q Consensus 98 ~~~~~lv~Ey~~gg~L~~~i~--~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~---g~lkl~DFGla 172 (481)
...-.+||+.. |-+|.++.. ...++...+.-++-|++.-++|+|.++++||||||+|.|+.-+ ..+.++|||+|
T Consensus 83 ~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 83 KDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred cccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 88899999998 779999886 3679999999999999999999999999999999999999754 45899999999
Q ss_pred ccccccccCC-----cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchH---HHHHHHHhhCC
Q 011628 173 AVSDQIRQDG-----LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNI---MVMYKKIYKGE 244 (481)
Q Consensus 173 ~~~~~~~~~~-----~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~ 244 (481)
+.+....... .-....||..|.+--...+... +.+.|+-|+|.+|..+.-|.+||.+... ..-+.+|..-.
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 8754433221 1234579999998776655444 5679999999999999999999998644 35566665554
Q ss_pred CCC-----CCCCCHHHHHHHHHhcccCcCCCCCHh
Q 011628 245 FRS-----PRWFSPDLIRLLTKLLDTNPDKRITIP 274 (481)
Q Consensus 245 ~~~-----~~~~s~~~~~li~~~L~~dP~~Rps~~ 274 (481)
... ...+|.++...+.-|-..--++-|...
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 433 455788999999988776666667643
No 413
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.93 E-value=7.2e-26 Score=242.46 Aligned_cols=225 Identities=32% Similarity=0.620 Sum_probs=179.1
Q ss_pred CCCCCccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 011628 19 QNQSPLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATK 98 (481)
Q Consensus 19 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 98 (481)
....+...+|+.+++|..|+||.||+++++.+.+.+|+| +++++.. .|- |+.....|.+|
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--------lRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------LRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--------hhc--cccccCCccee---------
Confidence 366677889999999999999999999999999999995 4443321 111 33333344444
Q ss_pred CEEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
|+-..+++. +.++.+. +.+++|||+.||+|||+||+|++|+.=|++|++|||+++....
T Consensus 136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 455556654 5566544 8899999999999999999999999999999999999875321
Q ss_pred cccC----C---------cccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC
Q 011628 178 IRQD----G---------LFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE 244 (481)
Q Consensus 178 ~~~~----~---------~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~ 244 (481)
.... + .-...||||.|+||||+...+| +.++|.|++|+|+|+++-|..||.++++++++.......
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 1111 0 0134699999999999999999 678999999999999999999999999999999988876
Q ss_pred CCCCC---CCCHHHHHHHHHhcccCcCCCC---CHhHHHhCccccc
Q 011628 245 FRSPR---WFSPDLIRLLTKLLDTNPDKRI---TIPEIMENRWFRK 284 (481)
Q Consensus 245 ~~~~~---~~s~~~~~li~~~L~~dP~~Rp---s~~eil~h~~f~~ 284 (481)
...|. -++++++++|.++|+.+|..|. .+-++.+|+||+.
T Consensus 275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 54443 3788999999999999999996 5778999999974
No 414
>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]
Probab=99.92 E-value=6.6e-26 Score=242.43 Aligned_cols=259 Identities=31% Similarity=0.536 Sum_probs=220.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 102 (481)
...|.+.+.||+|+|+.|-++.+.. +...+|+|.+.... .......++..|..+.+.++ |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 5568999999999999999988744 45567888776554 33456677888999999998 999999999999999999
Q ss_pred EEEeccCCCchHHHH-HcC--CCCHHHHHHHHHHHHHHHHHHH-HcCceecCCCCCcEEEccCC-CEEEEecCCcccccc
Q 011628 103 FVMEYVRGGELFNKV-AKG--RLKEDLARKYFQQLISAVGFCH-ARGVYHRDLKPENLLLDENG-DLKVSDFGLSAVSDQ 177 (481)
Q Consensus 103 lv~Ey~~gg~L~~~i-~~~--~l~e~~~~~~~~ql~~al~yLH-~~gi~HrDLKp~NILl~~~g-~lkl~DFGla~~~~~ 177 (481)
++++|..|+++++.+ ... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ +++++|||+|+.+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 553 6888999999999999999999 99999999999999999999 999999999998766
Q ss_pred -cccCCcccccCC-CCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHH-HHHHhhC--C--CCCCCC
Q 011628 178 -IRQDGLFHTFCG-TPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVM-YKKIYKG--E--FRSPRW 250 (481)
Q Consensus 178 -~~~~~~~~~~~g-t~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-~~~i~~~--~--~~~~~~ 250 (481)
.+........+| ++.|+|||...+..|.+...|+||+|+++..+++|..||........ +...... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 555666778899 99999999998888888899999999999999999999987654321 1222221 1 233455
Q ss_pred CCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 251 FSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 251 ~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
++....+++.++|..+|..|.+++++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 7888999999999999999999999999999976
No 415
>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional
Probab=99.92 E-value=1.1e-24 Score=205.06 Aligned_cols=175 Identities=18% Similarity=0.209 Sum_probs=137.7
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhCCCCCcceEEEEEE
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH------IKREISILRRVRHPNIVQLFEVMA 96 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~HpnIv~l~~~~~ 96 (481)
.+.++|++.+.||.|+||.||++.. ++..+|||++.......+..... +.+|+..+.++.||+|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4578999999999999999999755 57789999998765544444444 579999999999999999998865
Q ss_pred eC--------CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEe
Q 011628 97 TK--------SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSD 168 (481)
Q Consensus 97 ~~--------~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~D 168 (481)
.. ...+++|||++|.+|.+... +++ ....+++.++..||++|++|||+||+||+++.+| ++|+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 43 35789999999999988732 333 3466999999999999999999999999999988 99999
Q ss_pred cCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHh
Q 011628 169 FGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLM 222 (481)
Q Consensus 169 FGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ell 222 (481)
||.+......... ..++....|+ .++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a~--------------d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK--------------DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH--------------HHHHHHhHhc-ccccccceeEeehHHH
Confidence 9987643211110 1133445565 6899999999877553
No 416
>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c
Probab=99.91 E-value=3.2e-24 Score=198.62 Aligned_cols=141 Identities=24% Similarity=0.336 Sum_probs=113.2
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----------------------HHHHHHHHHHHHHhCCCCC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG-----------------------LVAHIKREISILRRVRHPN 87 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~Hpn 87 (481)
...||+|+||.||+|.+. +|+.||||+++........ ......+|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 8999999999765321111 0123456999999998888
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCchHHH-HHcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCcEEEccCCCEE
Q 011628 88 IVQLFEVMATKSKIYFVMEYVRGGELFNK-VAKGRLKEDLARKYFQQLISAVGFC-HARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 88 Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~-i~~~~l~e~~~~~~~~ql~~al~yL-H~~gi~HrDLKp~NILl~~~g~lk 165 (481)
+.....+... ..+|||||++|+++... +..+.+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 7554433322 23899999999887655 4557899999999999999999999 799999999999999998 57899
Q ss_pred EEecCCcccc
Q 011628 166 VSDFGLSAVS 175 (481)
Q Consensus 166 l~DFGla~~~ 175 (481)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998743
No 417
>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A.
Probab=99.90 E-value=1.1e-23 Score=203.97 Aligned_cols=234 Identities=24% Similarity=0.348 Sum_probs=154.3
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC----------CCcceEEEEEE
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH----------PNIVQLFEVMA 96 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H----------pnIv~l~~~~~ 96 (481)
.+..++.||.|+++.||.+.+.+||+.+|+|++...........+++++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45778999999999999999999999999999876653334456777777766555432 23333333322
Q ss_pred e---------C---C-----EEEEEEeccCCCchHHHHHc----CCC----CHHHHHHHHHHHHHHHHHHHHcCceecCC
Q 011628 97 T---------K---S-----KIYFVMEYVRGGELFNKVAK----GRL----KEDLARKYFQQLISAVGFCHARGVYHRDL 151 (481)
Q Consensus 97 ~---------~---~-----~~~lv~Ey~~gg~L~~~i~~----~~l----~e~~~~~~~~ql~~al~yLH~~gi~HrDL 151 (481)
- . + +.+++|+-+. ++|.+++.- ... .......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 1 1 2367788774 588777542 222 22233456689999999999999999999
Q ss_pred CCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCC-------CCCCcchHHHHHHHHHHHhcC
Q 011628 152 KPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKG-------YDAAKVDIWSCGVILFVLMAG 224 (481)
Q Consensus 152 Kp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~-------~~~~~~DiwSlGvil~elltg 224 (481)
+|+|++++.+|.++|+||+.....+... .....+..|.+||...... ..+.+.|.|+||+++|.|.+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999998765433321 1133457799999864421 125679999999999999999
Q ss_pred CCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCC
Q 011628 225 YLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKR 270 (481)
Q Consensus 225 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 270 (481)
.+||........... .+.....+|..++.||..+|++||.+|
T Consensus 247 ~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 999986643211110 333344789999999999999999988
No 418
>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro
Probab=99.90 E-value=3e-23 Score=192.34 Aligned_cols=142 Identities=23% Similarity=0.325 Sum_probs=115.6
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhCCCC
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----------------------GLVAHIKREISILRRVRHP 86 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----------------------~~~~~~~~Ei~il~~l~Hp 86 (481)
+...||+|+||+||+|.+. +|+.||||+++....... .......+|...+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 899999999986531100 0122346899999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHH-HHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCE
Q 011628 87 NIVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 87 nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~-~i~~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~l 164 (481)
+|.....+.... .|+||||++|+++.. .+..+++++..+..++.|++.++.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 986555544333 489999999986544 3556778999999999999999999999 9999999999999999 8899
Q ss_pred EEEecCCcccc
Q 011628 165 KVSDFGLSAVS 175 (481)
Q Consensus 165 kl~DFGla~~~ 175 (481)
+|+|||++...
T Consensus 157 ~liDFG~a~~~ 167 (190)
T cd05145 157 YIIDVSQAVEL 167 (190)
T ss_pred EEEEcccceec
Confidence 99999998754
No 419
>PRK12274 serine/threonine protein kinase; Provisional
Probab=99.88 E-value=2.3e-22 Score=185.60 Aligned_cols=191 Identities=19% Similarity=0.257 Sum_probs=142.6
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh-HHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG-LVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~E 106 (481)
-+...|++|+||+||.+.. .+.+++.+.+......... ....+.+|+++|++|. |++|++++++ ...|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4578899999999998765 7788888877654432111 1225789999999995 5889999886 44699999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCC-CCCcEEEccCCCEEEEecCCcccccccccC-Cc-
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDL-KPENLLLDENGDLKVSDFGLSAVSDQIRQD-GL- 183 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDL-Kp~NILl~~~g~lkl~DFGla~~~~~~~~~-~~- 183 (481)
|+.|.+|.+....+ ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|......... ..
T Consensus 79 yI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 79 YLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred eecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99999997654322 1357899999999999999999999 799999999999999999999854432210 00
Q ss_pred ---------ccccCCCCccccccccccCCCCC-CcchHHHHHHHHHHHhcCCCCCCCc
Q 011628 184 ---------FHTFCGTPAYVAPEVLSRKGYDA-AKVDIWSCGVILFVLMAGYLPFQDQ 231 (481)
Q Consensus 184 ---------~~~~~gt~~y~APEvl~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~ 231 (481)
......++.|++|+...-..-.+ ...+.++.|+-+|.++|+.+|+-+.
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 01223678888988643322112 3578888999999999999887543
No 420
>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]
Probab=99.88 E-value=2e-23 Score=224.00 Aligned_cols=241 Identities=24% Similarity=0.351 Sum_probs=182.4
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEK-ILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 103 (481)
...|...+.||++.|=+|.+|++. .|. |+||++-+.. ...-.-..+..+|++ ...++|||.+++.-+.......|+
T Consensus 22 ~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAyl 98 (1431)
T KOG1240|consen 22 SVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYL 98 (1431)
T ss_pred ccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHH
Confidence 347899999999999999999873 344 9999986654 111122334445666 666789999999888888888899
Q ss_pred EEeccCCCchHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc--cccc
Q 011628 104 VMEYVRGGELFNKVAKGR-LKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD--QIRQ 180 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~-l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~--~~~~ 180 (481)
|-+|... +|+|.+..++ +..-+.+.|+.||+.||.-||..||+|+|||.|||||+.-+.+.|+||...+..- ...+
T Consensus 99 vRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 9999965 9999998765 5667788889999999999999999999999999999999999999998654210 1011
Q ss_pred CC---cccccCCCCccccccccccCC----------CCCCcchHHHHHHHHHHHhc-CCCCCCCch-----------HHH
Q 011628 181 DG---LFHTFCGTPAYVAPEVLSRKG----------YDAAKVDIWSCGVILFVLMA-GYLPFQDQN-----------IMV 235 (481)
Q Consensus 181 ~~---~~~~~~gt~~y~APEvl~~~~----------~~~~~~DiwSlGvil~ellt-g~~Pf~~~~-----------~~~ 235 (481)
.. .+.+...-..|+|||.+.... .-+++-||||+||++.||++ |++||.-.. +..
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~ 257 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQ 257 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHH
Confidence 11 123344456799999875422 12457899999999999988 799985322 122
Q ss_pred HHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 236 MYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 236 ~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
...+| -+..+++||..|++.||.+|.++++.|+.
T Consensus 258 ~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 258 LLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 22222 14468999999999999999999999984
No 421
>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]
Probab=99.88 E-value=1.1e-22 Score=197.70 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=176.3
Q ss_pred CccCCeeEEeEecccCceEEEEEEEcCCC-----------------------------------cEEEEEEeecccccc-
Q 011628 23 PLLGRYEIGKLLGHGTFAKVYHARNVKSG-----------------------------------ESVAIKVIDKEKILK- 66 (481)
Q Consensus 23 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~~-----------------------------------~~vAvK~i~~~~~~~- 66 (481)
.-.++|+|++.||+|.-+.||.|+...+| -+.|||.+-.-....
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 34788999999999999999999854311 124566553221111
Q ss_pred -hhHHHHHHHHHH------H--------HHh--------CCCCCcceEEEEEEe--------------------------
Q 011628 67 -SGLVAHIKREIS------I--------LRR--------VRHPNIVQLFEVMAT-------------------------- 97 (481)
Q Consensus 67 -~~~~~~~~~Ei~------i--------l~~--------l~HpnIv~l~~~~~~-------------------------- 97 (481)
....+..-+|.. . .+. -+|||||++...|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 112222223321 0 111 259999999876533
Q ss_pred -CCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEc--cCC--CEEEEecCCc
Q 011628 98 -KSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLD--ENG--DLKVSDFGLS 172 (481)
Q Consensus 98 -~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~--~~g--~lkl~DFGla 172 (481)
+..+|+||...+. +|..++-....+-...+-++.|+++|+.|||++||.|||+|.+|||+. +++ .+.|+|||.+
T Consensus 314 ~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 314 EPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 3457999987754 899999877788888999999999999999999999999999999984 333 4899999965
Q ss_pred cccccc----ccCCcccccCCCCccccccccccCCC-----CCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHh-h
Q 011628 173 AVSDQI----RQDGLFHTFCGTPAYVAPEVLSRKGY-----DAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIY-K 242 (481)
Q Consensus 173 ~~~~~~----~~~~~~~~~~gt~~y~APEvl~~~~~-----~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~-~ 242 (481)
--.+.. ..........|.-.-||||+....+- +-.|+|.|++|.+.||++....||.....+.+-..-+ .
T Consensus 393 LAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe 472 (598)
T KOG4158|consen 393 LADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQE 472 (598)
T ss_pred eeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhh
Confidence 321110 01111223467788999999754321 1247999999999999999999998855443222222 2
Q ss_pred CC-CCCCCCCCHHHHHHHHHhcccCcCCCCCH
Q 011628 243 GE-FRSPRWFSPDLIRLLTKLLDTNPDKRITI 273 (481)
Q Consensus 243 ~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~ 273 (481)
.+ +..|+.+++.+++++..+|+.||++|++.
T Consensus 473 ~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 473 SQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred hhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 22 45688899999999999999999999984
No 422
>PRK10345 hypothetical protein; Provisional
Probab=99.88 E-value=9.2e-22 Score=184.25 Aligned_cols=134 Identities=20% Similarity=0.279 Sum_probs=109.5
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-----RHPNIVQLFEVMATKS---KIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~~ 102 (481)
.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||+++|+++.+.. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 57899999999995 6667666 6999876432 2346789999999999 5799999999998874 434
Q ss_pred -EEEec--cCCCchHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHHcCceecCCCCCcEEEccC----CCEEEEecCCc
Q 011628 103 -FVMEY--VRGGELFNKVAKGRLKEDLARKYFQQLISAV-GFCHARGVYHRDLKPENLLLDEN----GDLKVSDFGLS 172 (481)
Q Consensus 103 -lv~Ey--~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al-~yLH~~gi~HrDLKp~NILl~~~----g~lkl~DFGla 172 (481)
+|+|| +.+|+|.+++.++.++++ ..++.|++.++ +|||+++|+||||||+|||++.. +.++|+||+.+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 558999999988777776 36688888887 99999999999999999999743 37999995533
No 423
>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]
Probab=99.87 E-value=1.7e-22 Score=187.74 Aligned_cols=241 Identities=21% Similarity=0.372 Sum_probs=196.8
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
++...+..+|.+.-.|..|+|++ .|..+++|++...... ......+..|.-.++.+.||||+.+++.|.++.++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 55667788899999999999998 4566788888765432 23446688899999999999999999999999999999
Q ss_pred EeccCCCchHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC--ceecCCCCCcEEEccCCCEEEE--ecCCcccccc
Q 011628 105 MEYVRGGELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARG--VYHRDLKPENLLLDENGDLKVS--DFGLSAVSDQ 177 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~g--i~HrDLKp~NILl~~~g~lkl~--DFGla~~~~~ 177 (481)
..|++.|+|+..+..+ -.+..++.+++.++++|++|||+.. |----|....+++|++-..+|+ |--++- +
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf---q 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF---Q 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---e
Confidence 9999999999999874 3788899999999999999999874 3344588899999998776654 322211 1
Q ss_pred cccCCcccccCCCCccccccccccCCCCC--CcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhC--CCCCCCCCCH
Q 011628 178 IRQDGLFHTFCGTPAYVAPEVLSRKGYDA--AKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKG--EFRSPRWFSP 253 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~APEvl~~~~~~~--~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~~~~~s~ 253 (481)
.. ...-+|.||+||.+..++.+. ..+|+|||.+++|||.|...||.+-.+++.-.+|.-. ...+|+.+++
T Consensus 343 -e~-----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 343 -EV-----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred -cc-----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 11 123478999999998776543 3699999999999999999999999988877776543 3567999999
Q ss_pred HHHHHHHHhcccCcCCCCCHhHHH
Q 011628 254 DLIRLLTKLLDTNPDKRITIPEIM 277 (481)
Q Consensus 254 ~~~~li~~~L~~dP~~Rps~~eil 277 (481)
....|+.-|++.||.+||.++.|+
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999988764
No 424
>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]
Probab=99.85 E-value=7.2e-21 Score=208.04 Aligned_cols=235 Identities=23% Similarity=0.370 Sum_probs=181.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR---HPNIVQLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~ 101 (481)
..+|.|-+.||+|+||+||.|.... |+.||+|+-.....++-... .+++.+|+ -+.|+.++..+.-.+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~------~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYIC------LQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeeh------HHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 5789999999999999999999865 99999999877665432222 23334443 34566666666667778
Q ss_pred EEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------CCCEEEEecCCcc
Q 011628 102 YFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-------NGDLKVSDFGLSA 173 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-------~g~lkl~DFGla~ 173 (481)
++|+||.+.|+|.++++. +.+++..+..+..|++.-|++||..+|||+||||+|.||.. +--++|+|||-|-
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 999999999999999986 57999999999999999999999999999999999999953 2348999999987
Q ss_pred cccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCCCC-----CC
Q 011628 174 VSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGEFR-----SP 248 (481)
Q Consensus 174 ~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~-----~~ 248 (481)
-.........+...++|-.+-.+|+..+.++ +..+|.|.+..+++.||.|+.- +..+|... .+
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y~-----------q~~~g~~~~~~~~~~ 917 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKYM-----------EVKNGSSWMVKTNFP 917 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHHH-----------HhcCCcceeccccch
Confidence 6555455556778899999999999999998 6889999999999999998532 13333211 23
Q ss_pred CCCCHH-HHHHHHHhcccCcCCCCCHhHHHh
Q 011628 249 RWFSPD-LIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 249 ~~~s~~-~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
+.+..+ ..+++..+|+.|-..=|...+|..
T Consensus 918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~ 948 (974)
T KOG1166|consen 918 RYWKRDMWNKFFDLLLNPDCDTLPNLQELRT 948 (974)
T ss_pred hhhhHHHHHHHHHHHhCcCcccchhHHHHHH
Confidence 333333 456888999855555555555543
No 425
>smart00090 RIO RIO-like kinase.
Probab=99.85 E-value=7.2e-21 Score=182.16 Aligned_cols=143 Identities=21% Similarity=0.277 Sum_probs=115.0
Q ss_pred CeeEEeEecccCceEEEEEE-EcCCCcEEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 011628 27 RYEIGKLLGHGTFAKVYHAR-NVKSGESVAIKVIDKEKILK---------------------SGLVAHIKREISILRRVR 84 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~-~~~~~~~vAvK~i~~~~~~~---------------------~~~~~~~~~Ei~il~~l~ 84 (481)
-|++.+.||+|+||.||+|. +..+|+.||+|+++...... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 66799999999997543110 001234678999999997
Q ss_pred CCC--cceEEEEEEeCCEEEEEEeccCCCchHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHcC-ceecCCCCCcEEEcc
Q 011628 85 HPN--IVQLFEVMATKSKIYFVMEYVRGGELFNKV-AKGRLKEDLARKYFQQLISAVGFCHARG-VYHRDLKPENLLLDE 160 (481)
Q Consensus 85 Hpn--Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i-~~~~l~e~~~~~~~~ql~~al~yLH~~g-i~HrDLKp~NILl~~ 160 (481)
+.+ +.++++. ...++||||+.|++|.... ....+.+..+..++.|++.++.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3344432 2358999999998887765 3455677778899999999999999999 99999999999999
Q ss_pred CCCEEEEecCCccc
Q 011628 161 NGDLKVSDFGLSAV 174 (481)
Q Consensus 161 ~g~lkl~DFGla~~ 174 (481)
++.++|+|||.+..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998864
No 426
>PRK14879 serine/threonine protein kinase; Provisional
Probab=99.83 E-value=2e-19 Score=169.03 Aligned_cols=137 Identities=24% Similarity=0.366 Sum_probs=116.2
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG-----LVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
+.||+|++|.||+|++ +|..|++|+.......... ....+.+|+.++..+.|++|.....++......+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 7788999987543322111 22457789999999999999887777777788899999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999876422 7889999999999999999999999999999999 78999999998864
No 427
>TIGR03724 arch_bud32 Kae1-associated kinase Bud32. Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.
Probab=99.80 E-value=5.8e-19 Score=164.43 Aligned_cols=133 Identities=23% Similarity=0.333 Sum_probs=109.4
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-----GLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey 107 (481)
.||+|+||.||+|.. +|..|++|+......... ....++.+|+.+++.+.|+++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 678899998654322111 1235678999999999988766655556666778999999
Q ss_pred cCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 108 VRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 108 ~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
++|++|.+.+..... .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999998765321 8899999999999999999999999999999 88999999998865
No 428
>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom
Probab=99.80 E-value=4e-19 Score=165.66 Aligned_cols=139 Identities=20% Similarity=0.321 Sum_probs=110.4
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch-------------------hHHHHHHHHHHHHHhCCCCC-
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS-------------------GLVAHIKREISILRRVRHPN- 87 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~-------------------~~~~~~~~Ei~il~~l~Hpn- 87 (481)
|.+.+.||+|+||.||+|.+ .+|+.||||++........ .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88899999999999999987 4899999999865431000 01123678999999998874
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 011628 88 -IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 88 -Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
+...++ ....+++|||++|++|...... .....++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2345899999999998765431 346678899999999999999999999999999999999999
Q ss_pred EecCCccccc
Q 011628 167 SDFGLSAVSD 176 (481)
Q Consensus 167 ~DFGla~~~~ 176 (481)
+|||++....
T Consensus 167 iDfg~~~~~~ 176 (198)
T cd05144 167 IDWPQMVSTD 176 (198)
T ss_pred EECCccccCC
Confidence 9999986443
No 429
>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]
Probab=99.78 E-value=7e-19 Score=180.87 Aligned_cols=199 Identities=24% Similarity=0.420 Sum_probs=156.4
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCc-eecCCCCCcE
Q 011628 80 LRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLISAVGFCHARGV-YHRDLKPENL 156 (481)
Q Consensus 80 l~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~al~yLH~~gi-~HrDLKp~NI 156 (481)
|+.+.|.|+.++++.+..+...++|.+||.-|+|++.+... .++.--...++++|+.|+.|+|.-.| +|+.+++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 45788999999999999999999999999999999999875 45666667788999999999998766 9999999999
Q ss_pred EEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCC------CCCcchHHHHHHHHHHHhcCCCCCCC
Q 011628 157 LLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGY------DAAKVDIWSCGVILFVLMAGYLPFQD 230 (481)
Q Consensus 157 Ll~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~------~~~~~DiwSlGvil~elltg~~Pf~~ 230 (481)
+++....+||+|||+..+..........+...-...|.|||.+..... .+.+.||||+|++++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876532111111122223456999999876421 35679999999999999999999976
Q ss_pred ch----HHHHHHHHhh-CCCCC-CC-----CCCHHHHHHHHHhcccCcCCCCCHhHHHh
Q 011628 231 QN----IMVMYKKIYK-GEFRS-PR-----WFSPDLIRLLTKLLDTNPDKRITIPEIME 278 (481)
Q Consensus 231 ~~----~~~~~~~i~~-~~~~~-~~-----~~s~~~~~li~~~L~~dP~~Rps~~eil~ 278 (481)
.. +.++..++.+ +.... |. .+++++..++..||..+|..||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 32 3445555555 32211 21 24557899999999999999999998865
No 430
>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated
Probab=99.78 E-value=1.8e-18 Score=185.22 Aligned_cols=140 Identities=21% Similarity=0.274 Sum_probs=113.9
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK-----SGLVAHIKREISILRRVRHPNIVQLFEVMATKS 99 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 99 (481)
...|...+.||+|+||+||+|.+. +..+++|+........ ......+.+|+.+++.++|++|+..+.+.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 345567899999999999999874 3445555433221111 112356789999999999999998887777777
Q ss_pred EEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 100 KIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
..++||||++|++|.+.+. ....++.|++.+|.|||++|++||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8899999999999999875 457799999999999999999999999999999 678999999999875
No 431
>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]
Probab=99.78 E-value=7.5e-20 Score=184.88 Aligned_cols=248 Identities=25% Similarity=0.367 Sum_probs=172.0
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEE-------E
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFE-------V 94 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~-------~ 94 (481)
.+.+.+-+..+..+++.+...+-..+ .+.++-+..+.+.. .......+++-.+....|.+..-+.+ .
T Consensus 243 ~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 243 SGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhh
Confidence 45667777778888887776654333 33444444433321 22333455666665555444333222 1
Q ss_pred EE-----eCCEEEEEEeccCCCchHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 011628 95 MA-----TKSKIYFVMEYVRGGELFNKVAKG----RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 95 ~~-----~~~~~~lv~Ey~~gg~L~~~i~~~----~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lk 165 (481)
.. ....+||.|++|.-.+|.+++... ..+......++.|+..|++| +|.+|||+||.||+...+..+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 11 123589999999999999999742 46777889999999999999 9999999999999999999999
Q ss_pred EEecCCcccccccc----cCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc-CCCCCCCchHHHHHHHH
Q 011628 166 VSDFGLSAVSDQIR----QDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA-GYLPFQDQNIMVMYKKI 240 (481)
Q Consensus 166 l~DFGla~~~~~~~----~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~i 240 (481)
|.|||+........ .........||..||+||.+.+..| +.++||||||+||+||+. -..+|.. ......+
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~ 472 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQFER---IATLTDI 472 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhh
Confidence 99999987543322 1112345689999999999999888 689999999999999997 2333322 2233344
Q ss_pred hhCCCCCCCCC-CHHHHHHHHHhcccCcCCCCCHhHHHhCccc
Q 011628 241 YKGEFRSPRWF-SPDLIRLLTKLLDTNPDKRITIPEIMENRWF 282 (481)
Q Consensus 241 ~~~~~~~~~~~-s~~~~~li~~~L~~dP~~Rps~~eil~h~~f 282 (481)
..+.++.-.+. .|.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 473 r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 44544421111 2445689999999999999977776666664
No 432
>cd05119 RIO RIO kinase family, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct
Probab=99.76 E-value=4.1e-18 Score=156.97 Aligned_cols=139 Identities=22% Similarity=0.365 Sum_probs=101.9
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHH---------------------HHHHHHHHHHhCCCCC-
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVA---------------------HIKREISILRRVRHPN- 87 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~Hpn- 87 (481)
+++.||+|+||+||+|.+. +++.||||++............ ....|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999975 8999999998764322111111 1145677777765443
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCchHH-HHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCE
Q 011628 88 -IVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDL 164 (481)
Q Consensus 88 -Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~-~i~~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~l 164 (481)
+.++++. ...+++|||++|+.+.. .+...... ..++.++.|++.++.++|+ +||+||||||+||+++ ++.+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4555543 23589999999964432 12221111 6788999999999999999 9999999999999999 8999
Q ss_pred EEEecCCcccc
Q 011628 165 KVSDFGLSAVS 175 (481)
Q Consensus 165 kl~DFGla~~~ 175 (481)
+|+|||.+...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999998643
No 433
>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed
Probab=99.75 E-value=1.9e-17 Score=158.86 Aligned_cols=138 Identities=17% Similarity=0.330 Sum_probs=107.0
Q ss_pred EeEec-ccCceEEEEEEEcCCCcEEEEEEeecccc----c------chhHHHHHHHHHHHHHhCCCCCc--ceEEEEEEe
Q 011628 31 GKLLG-HGTFAKVYHARNVKSGESVAIKVIDKEKI----L------KSGLVAHIKREISILRRVRHPNI--VQLFEVMAT 97 (481)
Q Consensus 31 ~~~LG-~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~------~~~~~~~~~~Ei~il~~l~HpnI--v~l~~~~~~ 97 (481)
+..|| .||.|+||.+.. .+..++||.+..... . .......+.+|+.++..|.|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 35576 777788888765 478899998864321 0 11223567899999999998885 667666433
Q ss_pred C-C---EEEEEEeccCC-CchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 98 K-S---KIYFVMEYVRG-GELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 98 ~-~---~~~lv~Ey~~g-g~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
. . ..++||||++| .+|.+++..+.+++.. +.|++.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 23599999998 6899998877777653 578999999999999999999999999999999999999987
Q ss_pred cc
Q 011628 173 AV 174 (481)
Q Consensus 173 ~~ 174 (481)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
No 434
>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family. The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves
Probab=99.68 E-value=2.9e-16 Score=137.96 Aligned_cols=132 Identities=23% Similarity=0.317 Sum_probs=112.9
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH--PNIVQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lv~Ey 107 (481)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.+.| +++.+++......+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999973 47899999865432 3567889999999976 5899999988888899999999
Q ss_pred cCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 108 VRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR---GVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 108 ~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~---gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
+.|+.+... +......++.+++.++.++|.. +++|+|++|+||+++..+.++++|||.++.
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 5566778899999999999984 799999999999999989999999998864
No 435
>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]
Probab=99.68 E-value=1.5e-17 Score=179.16 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=209.7
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
.+.+.+.+-+-+|+++.++.+.-..+|...++|+............+.+.++-.++-...+|-+++..--+......+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 56788888999999999999998888888888876544332222233344444444444567777665555667789999
Q ss_pred EeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccc-----
Q 011628 105 MEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQI----- 178 (481)
Q Consensus 105 ~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~----- 178 (481)
++|+.|++|...+.. +..+++.++.++..+..+++|||+..+.|||++|.|+|...+|..+++|||........
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999999999987 56889999999999999999999999999999999999999999999999843221111
Q ss_pred -----c-----------------cC--CcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHH
Q 011628 179 -----R-----------------QD--GLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIM 234 (481)
Q Consensus 179 -----~-----------------~~--~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 234 (481)
. .. ..-....||+.|.+||.+.+... +..+|+|+.|+++++.++|..||....+.
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 0 00 11234578999999999988877 45799999999999999999999999999
Q ss_pred HHHHHHhhCCCCC---CCCCCHHHHHHHHHhcccCcCCCCCHh---HHHhCcccccC
Q 011628 235 VMYKKIYKGEFRS---PRWFSPDLIRLLTKLLDTNPDKRITIP---EIMENRWFRKG 285 (481)
Q Consensus 235 ~~~~~i~~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~---eil~h~~f~~~ 285 (481)
..+..|.++..+. |...++.+++++.++|..+|.+|..+. ++..|+||+..
T Consensus 1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence 9999999887655 445789999999999999999999877 88999999753
No 436
>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs). Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.
Probab=99.64 E-value=1.8e-16 Score=116.36 Aligned_cols=57 Identities=65% Similarity=0.969 Sum_probs=47.5
Q ss_pred CCCccchhhhccCCCCCCCCCcccCc-----cccceecCCCHHHHHHHHHHHHHHcCcEEEE
Q 011628 340 PASLNAFDLISFSPGFDLSGLFEEGG-----EGARFVSGAPVSKIITKLEEIAKVVSFTVRK 396 (481)
Q Consensus 340 ~~~~~~~~~~~~~~~~~l~~~~~~~~-----~~~~f~~~~~~~~~~~~l~~~~~~~~~~~~~ 396 (481)
|..+|||||||+|+|||||+||+... +.+||+|+.|+++|+++||++|+.+||+|+|
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence 66899999999999999999998643 4799999999999999999999999999976
No 437
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.60 E-value=6.1e-16 Score=159.41 Aligned_cols=256 Identities=20% Similarity=0.226 Sum_probs=194.8
Q ss_pred ccCCeeEEeEecc--cCceEEEEEEE--cCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 011628 24 LLGRYEIGKLLGH--GTFAKVYHARN--VKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATK 98 (481)
Q Consensus 24 ~~~~y~i~~~LG~--G~fg~Vy~a~~--~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~ 98 (481)
+...+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+.... ......+=.+|+...+.++ |+|.++.+..++..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccC
Confidence 4567788899999 99999999998 88999999998543221 1111222346888878785 99999999999999
Q ss_pred CEEEEEEeccCCCchHHHHHc-C-CCCHHHHHHHHHHHHH----HHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCC
Q 011628 99 SKIYFVMEYVRGGELFNKVAK-G-RLKEDLARKYFQQLIS----AVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGL 171 (481)
Q Consensus 99 ~~~~lv~Ey~~gg~L~~~i~~-~-~l~e~~~~~~~~ql~~----al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGl 171 (481)
+..|+-+|+|. .+|..+... . -+++..++..+.+... ||.++|+.+++|-|+||.||++..+ ...+++|||+
T Consensus 191 ~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 191 GILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred Ccceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcce
Confidence 99999999996 678777765 4 4899999999999999 9999999999999999999999999 8899999998
Q ss_pred cccccccccCCcc---cccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCc-hH-HHHHHHHhhCCCC
Q 011628 172 SAVSDQIRQDGLF---HTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQ-NI-MVMYKKIYKGEFR 246 (481)
Q Consensus 172 a~~~~~~~~~~~~---~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~-~~-~~~~~~i~~~~~~ 246 (481)
........-.... ...-|...|++||..++.. +...|||++|.++.+-.++..+.... +. -....+++ -...
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e 346 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLE 346 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchh
Confidence 8755432211111 2235778899999986543 56799999999999988876554332 11 11111111 1112
Q ss_pred CCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 247 SPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 247 ~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
+....+.++...+..|++.+|-.|++...+++|+++..
T Consensus 347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 23334667778999999999999999999999999864
No 438
>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase. This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.
Probab=99.59 E-value=7.5e-15 Score=152.74 Aligned_cols=142 Identities=23% Similarity=0.314 Sum_probs=98.1
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccc-------------------------------hhHHH------HHH
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK-------------------------------SGLVA------HIK 74 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------------------------------~~~~~------~~~ 74 (481)
+.||.|++|+||+|+. .+|+.||||+.++.-... .++.. ++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999986 589999999986532100 00111 234
Q ss_pred HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcC--CCCHHHHHHHHHHHHH-HHHHHHHcCc
Q 011628 75 REISILRRVR-----HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKG--RLKEDLARKYFQQLIS-AVGFCHARGV 146 (481)
Q Consensus 75 ~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~--~l~e~~~~~~~~ql~~-al~yLH~~gi 146 (481)
+|...+.++. ++++.-..-+....+..++||||++|++|.+..... ... ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 4555555552 343322211222234569999999999998876432 222 3445566665 4678999999
Q ss_pred eecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 147 YHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 147 ~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
+|+|+||.||+++.+|.++++|||++...+.
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999876543
No 439
>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed
Probab=99.58 E-value=1.3e-15 Score=160.54 Aligned_cols=146 Identities=23% Similarity=0.379 Sum_probs=101.3
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--------------------------c-----hhHHHH
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--------------------------K-----SGLVAH 72 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--------------------------~-----~~~~~~ 72 (481)
+...|+. +.||+|++|+||.|+.+.+|+.||||++++.... + .++.+.
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3556777 8999999999999999878999999999754210 0 022233
Q ss_pred HHH------HHHHHHhCC----CCCcceEEEEEEe-CCEEEEEEeccCCCchHHH--HHc-C----CCCHHHHHHHHHHH
Q 011628 73 IKR------EISILRRVR----HPNIVQLFEVMAT-KSKIYFVMEYVRGGELFNK--VAK-G----RLKEDLARKYFQQL 134 (481)
Q Consensus 73 ~~~------Ei~il~~l~----HpnIv~l~~~~~~-~~~~~lv~Ey~~gg~L~~~--i~~-~----~l~e~~~~~~~~ql 134 (481)
+.+ |...+.++. +.+.+.+-.++.+ .+..++||||+.|+.+.+. +.. + .+.+..+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 333 443343332 3333443334322 4557899999999999774 333 3 24455556666666
Q ss_pred HHHHHHHHHcCceecCCCCCcEEEccCC----CEEEEecCCcccccc
Q 011628 135 ISAVGFCHARGVYHRDLKPENLLLDENG----DLKVSDFGLSAVSDQ 177 (481)
Q Consensus 135 ~~al~yLH~~gi~HrDLKp~NILl~~~g----~lkl~DFGla~~~~~ 177 (481)
+ ..|++|+|+||.||+++.+| .++++|||++...+.
T Consensus 277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5 58999999999999999988 999999999876543
No 440
>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain. The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.
Probab=99.49 E-value=4.4e-13 Score=123.70 Aligned_cols=139 Identities=19% Similarity=0.246 Sum_probs=103.5
Q ss_pred EeEecccCceEEEEEEEcC------CCcEEEEEEeecccc-------------------cchhHHHH----HHHHHHHHH
Q 011628 31 GKLLGHGTFAKVYHARNVK------SGESVAIKVIDKEKI-------------------LKSGLVAH----IKREISILR 81 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~-------------------~~~~~~~~----~~~Ei~il~ 81 (481)
...||.|.-+.||.|.... .+..+|||+.+.... .+.+.... .++|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998643 357999998853211 00111222 348999999
Q ss_pred hCCC--CCcceEEEEEEeCCEEEEEEeccCCCchHH-HHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCcEE
Q 011628 82 RVRH--PNIVQLFEVMATKSKIYFVMEYVRGGELFN-KVAKGRLKEDLARKYFQQLISAVGFC-HARGVYHRDLKPENLL 157 (481)
Q Consensus 82 ~l~H--pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~-~i~~~~l~e~~~~~~~~ql~~al~yL-H~~gi~HrDLKp~NIL 157 (481)
++.. -++..++.+ ..-+|||||+.+..+.. .+....++++.+..++.|++.++..| |+.|++|+||+|.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9963 456666654 45689999998765532 34444566777888899999999998 8999999999999999
Q ss_pred EccCCCEEEEecCCccc
Q 011628 158 LDENGDLKVSDFGLSAV 174 (481)
Q Consensus 158 l~~~g~lkl~DFGla~~ 174 (481)
++ ++.+.|+|||.+-.
T Consensus 158 ~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 158 WH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EE-CCcEEEEECCCcee
Confidence 97 57899999998754
No 441
>KOG1243 consensus Protein kinase [General function prediction only]
Probab=99.49 E-value=4.9e-13 Score=139.36 Aligned_cols=171 Identities=20% Similarity=0.380 Sum_probs=131.9
Q ss_pred EEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCC
Q 011628 44 HARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLK 123 (481)
Q Consensus 44 ~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~ 123 (481)
.|..+.++.+|.|.+.+.... .....+++-++-|+.++||||+++++.+++.+.+|||+|.+. -|...+.. +.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--hH
Confidence 455667899999999877653 345667888999999999999999999999999999999986 45555554 23
Q ss_pred HHHHHHHHHHHHHHHHHHH-HcCceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccC
Q 011628 124 EDLARKYFQQLISAVGFCH-ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRK 202 (481)
Q Consensus 124 e~~~~~~~~ql~~al~yLH-~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~ 202 (481)
......-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++........ ......---.|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 6667777899999999998 56899999999999999999999999998765443221 11111222336667665333
Q ss_pred CCCCCcchHHHHHHHHHHHhcCCC
Q 011628 203 GYDAAKVDIWSCGVILFVLMAGYL 226 (481)
Q Consensus 203 ~~~~~~~DiwSlGvil~elltg~~ 226 (481)
.+ ..|.|.|||++++++.|..
T Consensus 181 ~~---s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 EW---SIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred cc---chhhhhHHHHHHHHhCccc
Confidence 32 3799999999999999933
No 442
>cd05151 ChoK Choline Kinase (ChoK). The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph
Probab=99.45 E-value=3.3e-13 Score=121.95 Aligned_cols=127 Identities=19% Similarity=0.294 Sum_probs=97.2
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEEeccC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV-QLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lv~Ey~~ 109 (481)
.+.|+.|.++.||+++. .++.|++|+...... ....+.+|+.+++.+.+.+++ +++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999986 478899999765431 112356899999998765544 4554433 33589999999
Q ss_pred CCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCc-----eecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 110 GGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGV-----YHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 110 gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi-----~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
|.++.+. ......++.+++.++..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887653 11123467899999999999985 9999999999999 6789999999875
No 443
>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]
Probab=99.42 E-value=1.3e-13 Score=142.32 Aligned_cols=252 Identities=19% Similarity=0.185 Sum_probs=190.1
Q ss_pred CCccCCeeEEeEecccCceEEEEEEEc-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 011628 22 SPLLGRYEIGKLLGHGTFAKVYHARNV-KSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEVMATKS 99 (481)
Q Consensus 22 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~ 99 (481)
....++|.++..||.|.|+.|+..... .++..|++|.....-....+.+. -..|+.+...+ .|.++++++..+....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccc
Confidence 345778999999999999999987755 57889999988665433322222 23577777777 4999999999999888
Q ss_pred EEEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccC-CCEEEEecCCcccccc
Q 011628 100 KIYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDEN-GDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 100 ~~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~-g~lkl~DFGla~~~~~ 177 (481)
..|+-.|||+++++...+.- ..+.+...+++..|++.++.++|+..++|+|+||+||++..+ +..++.|||..+...-
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~ 419 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF 419 (524)
T ss_pred cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce
Confidence 99999999999987766642 468899999999999999999999999999999999999886 7889999998764211
Q ss_pred cccCCcccccCCCCccc-cccccccCCCCCCcchHHHHHHHHHHHhcCCC-CCCCchHHHHHHHHhhCCCCCCCCCCHHH
Q 011628 178 IRQDGLFHTFCGTPAYV-APEVLSRKGYDAAKVDIWSCGVILFVLMAGYL-PFQDQNIMVMYKKIYKGEFRSPRWFSPDL 255 (481)
Q Consensus 178 ~~~~~~~~~~~gt~~y~-APEvl~~~~~~~~~~DiwSlGvil~elltg~~-Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~ 255 (481)
.. ....+..++. .+|++........++|++|||..+++.+++.. ++.+. ....+..+..+.....+..+
T Consensus 420 --~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~~ 490 (524)
T KOG0601|consen 420 --SS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQL 490 (524)
T ss_pred --ec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHhh
Confidence 00 1112233344 24554443333678999999999999998753 33332 23345556666655566889
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
..+.+.++.+++..|+.+.++..|.=|.
T Consensus 491 q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 491 QVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred hhhhhhhcCCccccchhhhhhcccchhh
Confidence 9999999999999999999988876553
No 444
>KOG1266 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.35 E-value=1.1e-12 Score=125.90 Aligned_cols=202 Identities=17% Similarity=0.260 Sum_probs=140.6
Q ss_pred HHHHhCCCCCcceEEEEEEeC-----CEEEEEEeccCCCchHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHc--C
Q 011628 78 SILRRVRHPNIVQLFEVMATK-----SKIYFVMEYVRGGELFNKVAK-----GRLKEDLARKYFQQLISAVGFCHAR--G 145 (481)
Q Consensus 78 ~il~~l~HpnIv~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~i~~-----~~l~e~~~~~~~~ql~~al~yLH~~--g 145 (481)
..+-++-|.|||+++.++.+. ....+++||++.|+|.+++++ ..+......+|.-||++||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 334445699999999988654 457899999999999999875 2588889999999999999999987 5
Q ss_pred ceecCCCCCcEEEccCCCEEEEecCCccccccccc--CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhc
Q 011628 146 VYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMA 223 (481)
Q Consensus 146 i~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~ellt 223 (481)
|+|+++...-|++..+|-+|+.--.....-..... ........+-++|.|||.=..... ..++|||++|....+|..
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAI 277 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHH
Confidence 99999999999999999888753221111000000 001112346788999997544444 346999999999999988
Q ss_pred CCCC-CCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 224 GYLP-FQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 224 g~~P-f~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
+..- -...........+.+.-+.. -.+--+.++.+||+..|..||++.+++.||.+-
T Consensus 278 lEiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred heeccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence 7544 22222111111111111110 122245789999999999999999999999763
No 445
>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]
Probab=99.32 E-value=2.7e-11 Score=108.60 Aligned_cols=134 Identities=23% Similarity=0.337 Sum_probs=103.4
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhH-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGL-----VAHIKREISILRRVRHPNIVQLFEVMATKSKIYFVME 106 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~E 106 (481)
..+++|+-+.+|.+.. -|..+++|.-.+.....++. ..+-.+|..++.++.--.|.-.+=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4578999999999966 34557777644333322222 2445689999999976666655556667777889999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
|++|-.|.+.+... ...+++.+-.-+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999898775 245677777888899999999999999999997765 99999999875
No 446
>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]
Probab=99.24 E-value=1.7e-10 Score=103.13 Aligned_cols=144 Identities=24% Similarity=0.293 Sum_probs=109.9
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG-----LVAHIKREISILRRVRHPNIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~-----~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 104 (481)
....|-+|+-+.|+.+.+ .|+.+.||.-.......+. ...+.++|+.++.++.--.|.-..=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567888999999999987 7888888865433322221 235678899999999766666555566666667889
Q ss_pred EeccCC-CchHHHHHc--CCCCHHH-HHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC---EEEEecCCcccc
Q 011628 105 MEYVRG-GELFNKVAK--GRLKEDL-ARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD---LKVSDFGLSAVS 175 (481)
Q Consensus 105 ~Ey~~g-g~L~~~i~~--~~l~e~~-~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~---lkl~DFGla~~~ 175 (481)
|||++| .++.+++.. ..-.++. ...+++++-+.+.-||.++|+|+||..+||++..+|. +.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999988 467777764 2223333 3789999999999999999999999999999987764 589999998653
No 447
>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins. This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain
Probab=99.24 E-value=5.3e-11 Score=112.12 Aligned_cols=140 Identities=19% Similarity=0.312 Sum_probs=107.0
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEe
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH--PNIVQLFEVMATK---SKIYFVME 106 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lv~E 106 (481)
+.||.|..+.||++... +|+.+++|+....... .....+.+|+.+++.+.+ .++.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 56899999999999873 3688999997654321 123457899999999975 3457777776654 26789999
Q ss_pred ccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 011628 107 YVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA------------------------------------------- 143 (481)
Q Consensus 107 y~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~------------------------------------------- 143 (481)
|++|.++.+.+..+.++++....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988776543456777777777777777777773
Q ss_pred -------------cCceecCCCCCcEEEcc--CCCEEEEecCCccc
Q 011628 144 -------------RGVYHRDLKPENLLLDE--NGDLKVSDFGLSAV 174 (481)
Q Consensus 144 -------------~gi~HrDLKp~NILl~~--~g~lkl~DFGla~~ 174 (481)
..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23689999999999998 56689999998764
No 448
>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]
Probab=99.16 E-value=1.3e-09 Score=110.94 Aligned_cols=211 Identities=18% Similarity=0.276 Sum_probs=157.9
Q ss_pred CceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeccCCC-c
Q 011628 38 TFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIVQLFEVMAT----KSKIYFVMEYVRGG-E 112 (481)
Q Consensus 38 ~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lv~Ey~~gg-~ 112 (481)
--.+.|++....+|..|++|.++-.+.... .....-+++++++.|+|+|++.+++.+ ...+++|++|.++. +
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 345789999989999999999955443322 223345788999999999999999874 34689999999874 7
Q ss_pred hHHHHH----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccc
Q 011628 113 LFNKVA----------------KGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSD 176 (481)
Q Consensus 113 L~~~i~----------------~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~ 176 (481)
|.++-- ..+.+|+.+|.|+.||..||.++|+.|..-+-|.|.+||++.+.+++|+..|+..+..
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 766541 1237889999999999999999999999999999999999999999998877665432
Q ss_pred ccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCC-CCCchHHHH-HHHHhhCCCCCCCCCCHH
Q 011628 177 QIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLP-FQDQNIMVM-YKKIYKGEFRSPRWFSPD 254 (481)
Q Consensus 177 ~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~P-f~~~~~~~~-~~~i~~~~~~~~~~~s~~ 254 (481)
... . |-+.+ -.+-|.=-||.+++.|.+|..- |........ ...|. ..+|.+
T Consensus 445 ~d~--------------~--~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-------~~yS~D 497 (655)
T KOG3741|consen 445 EDP--------------T--EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-------TTYSTD 497 (655)
T ss_pred CCC--------------C--cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------hhhhHH
Confidence 211 1 11221 1358999999999999998543 333333322 22222 346889
Q ss_pred HHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 255 LIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 255 ~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
++++|.-+...+++. -++.+++.+
T Consensus 498 ~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 498 LRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHHhcCccc-ccHHHHHHH
Confidence 999999999999987 688888875
No 449
>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.
Probab=99.11 E-value=8.1e-10 Score=101.56 Aligned_cols=127 Identities=24% Similarity=0.409 Sum_probs=85.2
Q ss_pred EEEEEEEcCCCcEEEEEEeecccc-----------------------cchhHHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 011628 41 KVYHARNVKSGESVAIKVIDKEKI-----------------------LKSGLVAHIKREISILRRVRHP--NIVQLFEVM 95 (481)
Q Consensus 41 ~Vy~a~~~~~~~~vAvK~i~~~~~-----------------------~~~~~~~~~~~Ei~il~~l~Hp--nIv~l~~~~ 95 (481)
.||.|.. .+|..+|||+...... ...-.....++|...|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899987 5788999998853211 0111235578999999999865 456666442
Q ss_pred EeCCEEEEEEeccC--CCchHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 96 ATKSKIYFVMEYVR--GGELFNKVAKGRLKEDLARKYFQQLISAVGF-CHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 96 ~~~~~~~lv~Ey~~--gg~L~~~i~~~~l~e~~~~~~~~ql~~al~y-LH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
. -.|||||+. |..+..+. ...++.+....++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||.+
T Consensus 80 --~--~~ivME~I~~~G~~~~~l~-~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 80 --R--NVIVMEYIGEDGVPLPRLK-DVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp --T--TEEEEE--EETTEEGGCHH-HCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred --C--CEEEEEecCCCccchhhHH-hccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 2 379999999 65565443 3333355677788888886555 579999999999999999887 9999999987
Q ss_pred cc
Q 011628 173 AV 174 (481)
Q Consensus 173 ~~ 174 (481)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 53
No 450
>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional
Probab=99.06 E-value=5.1e-09 Score=101.87 Aligned_cols=129 Identities=18% Similarity=0.171 Sum_probs=94.4
Q ss_pred EEEEEEEcCCCcEEEEEEeecccccchhHHH----------HHHHHHHHHHhCCCCCc--ceEEEEEEe-----CCEEEE
Q 011628 41 KVYHARNVKSGESVAIKVIDKEKILKSGLVA----------HIKREISILRRVRHPNI--VQLFEVMAT-----KSKIYF 103 (481)
Q Consensus 41 ~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~----------~~~~Ei~il~~l~HpnI--v~l~~~~~~-----~~~~~l 103 (481)
.|+.... .|+.|.||........ ...+ .+.+|+..+.+|..-+| ..+..+... ...-++
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~--~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWG--EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHH--HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 4555543 6788999976432210 1111 36789999988854333 333444432 235789
Q ss_pred EEeccCCC-chHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEcc-------CCCEEEEecCCc
Q 011628 104 VMEYVRGG-ELFNKVAK---GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDE-------NGDLKVSDFGLS 172 (481)
Q Consensus 104 v~Ey~~gg-~L~~~i~~---~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~-------~g~lkl~DFGla 172 (481)
|||+++|. +|.+++.. ...++.....++.+++..+.-||.+||+|+|+++.|||++. ++.+.++||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999986 78888753 45677788899999999999999999999999999999985 467999999977
Q ss_pred c
Q 011628 173 A 173 (481)
Q Consensus 173 ~ 173 (481)
.
T Consensus 193 ~ 193 (268)
T PRK15123 193 Q 193 (268)
T ss_pred c
Confidence 5
No 451
>KOG2137 consensus Protein kinase [Signal transduction mechanisms]
Probab=99.01 E-value=2.5e-10 Score=119.88 Aligned_cols=152 Identities=20% Similarity=0.374 Sum_probs=111.7
Q ss_pred HHHHHHHHHHHc-CceecCCCCCcEEEccCCCEEEEecCCccccccccc--CCccc-----ccCCCCccccccccccCCC
Q 011628 133 QLISAVGFCHAR-GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ--DGLFH-----TFCGTPAYVAPEVLSRKGY 204 (481)
Q Consensus 133 ql~~al~yLH~~-gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~--~~~~~-----~~~gt~~y~APEvl~~~~~ 204 (481)
+.+.|+.|+|.. +++|+.|.|++|.++.+|..||+.|+++........ -..+. ...-...|.|||++.+. .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~-~ 185 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT-T 185 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc-c
Confidence 444899999965 899999999999999999999999998754322111 00011 11234569999999874 4
Q ss_pred CCCcchHHHHHHHHHHHh-cCCCCCCCchHHHHHHHHh-h---CCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhC
Q 011628 205 DAAKVDIWSCGVILFVLM-AGYLPFQDQNIMVMYKKIY-K---GEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMEN 279 (481)
Q Consensus 205 ~~~~~DiwSlGvil~ell-tg~~Pf~~~~~~~~~~~i~-~---~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h 279 (481)
.+.++|+||+||++|.+. .|..-+...+....+..-. . +.+.....+++++++=+.++|..++..||++.+++..
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI 265 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence 477899999999999999 4555555443222222111 1 1234456789999999999999999999999999999
Q ss_pred cccccC
Q 011628 280 RWFRKG 285 (481)
Q Consensus 280 ~~f~~~ 285 (481)
|||...
T Consensus 266 ~ff~D~ 271 (700)
T KOG2137|consen 266 PFFSDP 271 (700)
T ss_pred cccCCc
Confidence 999865
No 452
>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]
Probab=98.97 E-value=3.2e-09 Score=100.82 Aligned_cols=136 Identities=26% Similarity=0.360 Sum_probs=100.8
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc-----------------cc--hhHHHHHHHHHHHHHhCCCC--
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-----------------LK--SGLVAHIKREISILRRVRHP-- 86 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----------------~~--~~~~~~~~~Ei~il~~l~Hp-- 86 (481)
+.++..||-|.-+.||.|.+ ..|.++|||.-+.... .. .-.....++|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 46789999999999999997 4799999997532110 00 11234567999999999754
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEE
Q 011628 87 NIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKV 166 (481)
Q Consensus 87 nIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl 166 (481)
.+.+.+++ +.-.+||||++|-.|...-. +.+.+..++..|+.-+.-+-..||+|+|+.+-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~----~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL----DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC----cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 66666654 45689999999977765431 34444555566666555555899999999999999999999999
Q ss_pred EecCCc
Q 011628 167 SDFGLS 172 (481)
Q Consensus 167 ~DFGla 172 (481)
+||--+
T Consensus 244 IDwPQ~ 249 (304)
T COG0478 244 IDWPQA 249 (304)
T ss_pred EeCccc
Confidence 999644
No 453
>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]
Probab=98.95 E-value=1.5e-08 Score=100.97 Aligned_cols=231 Identities=19% Similarity=0.247 Sum_probs=152.2
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcceEEEE------EEeC-CE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRV-RHPNIVQLFEV------MATK-SK 100 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~------~~~~-~~ 100 (481)
.+++.||+|+-+.+|-.-. -...+.|+........ .. +.+..|... .||-+-.=+.+ .... ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~---~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAA---QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecch---hhchhheeecCCCchH---HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 4578899999999996532 2334678887654321 11 122333333 46644331111 1122 23
Q ss_pred EEEEEeccCCCchHH-HHHc----C---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 101 IYFVMEYVRGGELFN-KVAK----G---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~-~i~~----~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
+-+.|..++|..--. +... . ...++-+.+..+.|+.+..-||..|..-+|+.++|+|+.+++.+.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778999998864322 2221 1 2667888999999999999999999999999999999999999999986543
Q ss_pred ccccccccCCcccccCCCCccccccccc-----cCCCCCCcchHHHHHHHHHHHhcC-CCCCCCc-------hHHHHHHH
Q 011628 173 AVSDQIRQDGLFHTFCGTPAYVAPEVLS-----RKGYDAAKVDIWSCGVILFVLMAG-YLPFQDQ-------NIMVMYKK 239 (481)
Q Consensus 173 ~~~~~~~~~~~~~~~~gt~~y~APEvl~-----~~~~~~~~~DiwSlGvil~elltg-~~Pf~~~-------~~~~~~~~ 239 (481)
.+. ..+......+|.+.|.+||.-. +.+. +...|.|.||+++|+++.| ++||.+- ++.+ ..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 332 2334455678999999999754 2222 3469999999999999886 9999753 1211 11
Q ss_pred HhhC-----------CCCCC---C--CCCHHHHHHHHHhccc--CcCCCCCHh
Q 011628 240 IYKG-----------EFRSP---R--WFSPDLIRLLTKLLDT--NPDKRITIP 274 (481)
Q Consensus 240 i~~~-----------~~~~~---~--~~s~~~~~li~~~L~~--dP~~Rps~~ 274 (481)
|..+ ..+.| + -++++++.|..+|+.. ++.-|||++
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 2111 11111 1 2678899999999865 467899854
No 454
>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane
Probab=98.74 E-value=8.8e-08 Score=89.82 Aligned_cols=104 Identities=23% Similarity=0.407 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhCCCCC--cceEEEEEEeC----CEEEEEEeccCCC-chHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Q 011628 71 AHIKREISILRRVRHPN--IVQLFEVMATK----SKIYFVMEYVRGG-ELFNKVAK-GRLKEDLARKYFQQLISAVGFCH 142 (481)
Q Consensus 71 ~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~----~~~~lv~Ey~~gg-~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH 142 (481)
....+|+..+..|..-+ +.+++.+.... ...++|+|+++|. +|.+++.. ...+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 45778998888885433 34555555442 2458999999985 79998876 34777788999999999999999
Q ss_pred HcCceecCCCCCcEEEccCC---CEEEEecCCccc
Q 011628 143 ARGVYHRDLKPENLLLDENG---DLKVSDFGLSAV 174 (481)
Q Consensus 143 ~~gi~HrDLKp~NILl~~~g---~lkl~DFGla~~ 174 (481)
++||+|+|++|.|||++.++ .+.++||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999987 899999987653
No 455
>PRK09902 hypothetical protein; Provisional
Probab=98.71 E-value=2.7e-07 Score=85.74 Aligned_cols=137 Identities=12% Similarity=0.145 Sum_probs=99.3
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhCCCCC--cceEEEE--EEeC--CEEEEEE
Q 011628 35 GHGTFAKVYHARNVKSGESVAIKVIDKEKILK---SGLVAHIKREISILRRVRHPN--IVQLFEV--MATK--SKIYFVM 105 (481)
Q Consensus 35 G~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~--~~~~--~~~~lv~ 105 (481)
|+||-+.|+.... .|+.+-+|.-...-... +.-...+.+|+..++.|..-+ +.++... ...+ -.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5688889998765 45578888764211000 112356889999999986332 3343311 1112 2467999
Q ss_pred eccCCC-chHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCC--EEEEecCCcc
Q 011628 106 EYVRGG-ELFNKVAKG---RLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGD--LKVSDFGLSA 173 (481)
Q Consensus 106 Ey~~gg-~L~~~i~~~---~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~--lkl~DFGla~ 173 (481)
|-+.|- +|.+++... +.++.....++.+++..+.-||+.|+.|+|+-+.|||++.+|. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 988764 898888764 4577788899999999999999999999999999999987777 9999997654
No 456
>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY). The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process
Probab=98.71 E-value=2.1e-07 Score=86.76 Aligned_cols=140 Identities=21% Similarity=0.286 Sum_probs=95.1
Q ss_pred ccCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhCC---CCCcceEEEE
Q 011628 24 LLGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAH------IKREISILRRVR---HPNIVQLFEV 94 (481)
Q Consensus 24 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~------~~~Ei~il~~l~---HpnIv~l~~~ 94 (481)
+.++|.+.+.+-......|.+..- +|+.+++|....+....+..... ..+++..+..+. --....++-+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 467899999999888888887754 77899999987654332222222 233444444442 2233333333
Q ss_pred EE-----eCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEec
Q 011628 95 MA-----TKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDF 169 (481)
Q Consensus 95 ~~-----~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DF 169 (481)
.. -....+++|||++|..|.+... +++ .+...+.+++.-+|+.|++|+|.+|.|++++.+ .++++||
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 22 2234568999999988776542 233 244567788999999999999999999999865 4999999
Q ss_pred CCcc
Q 011628 170 GLSA 173 (481)
Q Consensus 170 Gla~ 173 (481)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8654
No 457
>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]
Probab=98.65 E-value=4.4e-07 Score=85.53 Aligned_cols=138 Identities=19% Similarity=0.254 Sum_probs=98.6
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchh---------------------HHHHHHHHHHHHHhCC--CCC
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSG---------------------LVAHIKREISILRRVR--HPN 87 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~---------------------~~~~~~~Ei~il~~l~--Hpn 87 (481)
.-.|+.|.-+.||+|.. .++..+|+|++......... ......+|+..|+++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34667788889999985 67899999998644321111 1123467888888884 444
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCc-hHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCceecCCCCCcEEEccCCCEE
Q 011628 88 IVQLFEVMATKSKIYFVMEYVRGGE-LFNKVAKGRLKEDLARKYFQQLISAVGFCHA-RGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 88 Iv~l~~~~~~~~~~~lv~Ey~~gg~-L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~-~gi~HrDLKp~NILl~~~g~lk 165 (481)
+.+.+.+.. -.|||||+.... -.-.+..-++..+++..+..+++..+.-|-. .|++|+||+.-|||+. ++.+.
T Consensus 132 vP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 132 VPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 555555543 378999996642 1222333334455889999999999988766 8999999999999999 88999
Q ss_pred EEecCCccc
Q 011628 166 VSDFGLSAV 174 (481)
Q Consensus 166 l~DFGla~~ 174 (481)
|+|||-|..
T Consensus 207 iID~~QaV~ 215 (268)
T COG1718 207 IIDVSQAVT 215 (268)
T ss_pred EEECccccc
Confidence 999997754
No 458
>COG0661 AarF Predicted unusual protein kinase [General function prediction only]
Probab=98.62 E-value=2.2e-07 Score=97.93 Aligned_cols=138 Identities=25% Similarity=0.378 Sum_probs=92.9
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccc---------------------------cc----hhHHHH------HH
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI---------------------------LK----SGLVAH------IK 74 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---------------------------~~----~~~~~~------~~ 74 (481)
+-|+.++-|+||.|+. .+|+.||||+.++.-. .- .++.+. +.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 6789999999999997 4699999999864210 00 011112 33
Q ss_pred HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCchHHHH--HcCCCCH-----HHHHHHHHHHHHHHHHHH
Q 011628 75 REISILRRVR-----HPNIVQLFEVMATKSKIYFVMEYVRGGELFNKV--AKGRLKE-----DLARKYFQQLISAVGFCH 142 (481)
Q Consensus 75 ~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i--~~~~l~e-----~~~~~~~~ql~~al~yLH 142 (481)
+|...+.++. .|++.-..-+++-.+.-.++|||++|..+.+.. ...+++. ..+..++.|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f~~q~~------- 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL------- 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHHHHHHH-------
Confidence 4555555552 344433333334455668999999999887774 4444553 23333333333
Q ss_pred HcCceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 143 ~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
..|++|.|.+|.||+++.+|.+.+.|||+....+.
T Consensus 283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 48999999999999999999999999999875443
No 459
>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]
Probab=98.62 E-value=2.5e-09 Score=111.28 Aligned_cols=239 Identities=18% Similarity=0.160 Sum_probs=165.1
Q ss_pred cCCeeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEE
Q 011628 25 LGRYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN-IVQLFEVMATKSKIYF 103 (481)
Q Consensus 25 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~l 103 (481)
...|...+-+++|+++++++.+...+...+ .+.+... ..+.-++++|.+++||| .++.++-+..++..++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 455677888999999999999876655444 6666433 23456899999999999 7888888888889999
Q ss_pred EEeccCCC-chHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEEEEecCCccccccccc
Q 011628 104 VMEYVRGG-ELFNKVAK--GRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQ 180 (481)
Q Consensus 104 v~Ey~~gg-~L~~~i~~--~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~ 180 (481)
.|+++.++ +....... -.+.+-+.....+.-+.+++++|+---+||| ||+..+ +..+..||+.........
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 99999988 22222111 1233334445556667889999998778999 777665 678999999876543322
Q ss_pred CCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCCCchHHHHHHHHhhCC--CCC---CCCCCHHH
Q 011628 181 DGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQDQNIMVMYKKIYKGE--FRS---PRWFSPDL 255 (481)
Q Consensus 181 ~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~--~~~---~~~~s~~~ 255 (481)
...+..+++.++|||+.....++ ...|.|++|+--.++.-|.+|-..+. .....+-.+. +.. -.|-+..-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~ 460 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFH 460 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccc
Confidence 34567899999999999888885 46999999987777877777754311 0000111110 000 01111112
Q ss_pred HHHHHHhcccCcCCCCCHhHHHhCcccc
Q 011628 256 IRLLTKLLDTNPDKRITIPEIMENRWFR 283 (481)
Q Consensus 256 ~~li~~~L~~dP~~Rps~~eil~h~~f~ 283 (481)
.++...|+..-|..|+.....+.|.+|.
T Consensus 461 ~~~~~~~~~g~P~~pkv~mgacfsKvfn 488 (829)
T KOG0576|consen 461 RDFPAPCLNGLPPTPKVHMGACFSKVFN 488 (829)
T ss_pred cCCcccccCCCCCCCcchhhHHHHHHhc
Confidence 2477889999999999988888877764
No 460
>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172. This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.
Probab=98.54 E-value=1.2e-06 Score=83.36 Aligned_cols=133 Identities=17% Similarity=0.174 Sum_probs=85.3
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeccC
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEVMATKSKIYFVMEYVR 109 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lv~Ey~~ 109 (481)
..||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-+ +.+.+.+....+...++||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25567899876432 1244688999999996443 4677888888888899999999
Q ss_pred CCc-hH--------------HHH-------HcC---CCCHHH-HHHHHHHH----------HHH-HHHHHH----cCcee
Q 011628 110 GGE-LF--------------NKV-------AKG---RLKEDL-ARKYFQQL----------ISA-VGFCHA----RGVYH 148 (481)
Q Consensus 110 gg~-L~--------------~~i-------~~~---~l~e~~-~~~~~~ql----------~~a-l~yLH~----~gi~H 148 (481)
|.+ +. ..+ ..- ..+... ...+..++ ... ..+|.+ ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 11 111 110 011111 11111111 111 122221 24789
Q ss_pred cCCCCCcEEEccCCCEEEEecCCccc
Q 011628 149 RDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 149 rDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
+|+.|.||++++++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999988 99999998764
No 461
>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily.; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....
Probab=98.53 E-value=1.5e-06 Score=82.09 Aligned_cols=136 Identities=21% Similarity=0.334 Sum_probs=82.1
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEEE---EeCCEEEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEVM---ATKSKIYFVM 105 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~~---~~~~~~~lv~ 105 (481)
++.|+.|..+.||++.... ..+++|+.... .....+.+|..+++.+.... +.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4689999999999998743 58999997544 23466778999998885333 45666543 2334689999
Q ss_pred eccCCCchHH----------------HHH---cC--C---CCHHH------HHHH---------------HHHHHH-HHH
Q 011628 106 EYVRGGELFN----------------KVA---KG--R---LKEDL------ARKY---------------FQQLIS-AVG 139 (481)
Q Consensus 106 Ey~~gg~L~~----------------~i~---~~--~---l~e~~------~~~~---------------~~ql~~-al~ 139 (481)
++++|..+.. .+. .- . +.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987766 111 10 0 01000 0000 011222 233
Q ss_pred HHH-------HcCceecCCCCCcEEEc-cCCCEEEEecCCcc
Q 011628 140 FCH-------ARGVYHRDLKPENLLLD-ENGDLKVSDFGLSA 173 (481)
Q Consensus 140 yLH-------~~gi~HrDLKp~NILl~-~~g~lkl~DFGla~ 173 (481)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 333 24599999999999999 56667899998765
No 462
>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]
Probab=98.45 E-value=2.1e-06 Score=95.35 Aligned_cols=202 Identities=19% Similarity=0.241 Sum_probs=142.2
Q ss_pred HHHHHHHHHHhCCCCCcceEEEEEEeCCE----EEEEEeccCCCchHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCc
Q 011628 72 HIKREISILRRVRHPNIVQLFEVMATKSK----IYFVMEYVRGGELFNKVAK-GRLKEDLARKYFQQLISAVGFCHARGV 146 (481)
Q Consensus 72 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~----~~lv~Ey~~gg~L~~~i~~-~~l~e~~~~~~~~ql~~al~yLH~~gi 146 (481)
...-|+..+....|+|++.++.+...... ..+..++|.+-++...+.. +.++.+..+.+..+++.|+.|+|+...
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 34457778888899999999988755432 3455789999999999987 789999999999999999999999965
Q ss_pred eecCCCCC---cEEEccCCCEEEE--ecCCcccccccccCCcccccCCCCccccccccccCCCCC-CcchHHHHHHHHHH
Q 011628 147 YHRDLKPE---NLLLDENGDLKVS--DFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDA-AKVDIWSCGVILFV 220 (481)
Q Consensus 147 ~HrDLKp~---NILl~~~g~lkl~--DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~-~~~DiwSlGvil~e 220 (481)
.|.-+... +--.+..+.+.++ ||+.+........ .....-+..+.|||......+.. ...|+|.+|..+..
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~ 384 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQ 384 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHhh
Confidence 55544444 3344555666666 8887765433222 12234456688888876655432 23699999999999
Q ss_pred HhcCCCCCCCchHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccC
Q 011628 221 LMAGYLPFQDQNIMVMYKKIYKGEFRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKG 285 (481)
Q Consensus 221 lltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~ 285 (481)
+..|..+-...... ..+. +........+.+.+|+.-++++|+++.+++.|+|.+-.
T Consensus 385 ~~~~~~i~~~~~~~---~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 385 LSQGEDISEKSAVP---VSLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hhhcCcccccccch---hhhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 98875442211110 0000 11112267889999999999999999999999997643
No 463
>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2
Probab=98.38 E-value=1.4e-05 Score=73.75 Aligned_cols=129 Identities=21% Similarity=0.293 Sum_probs=92.9
Q ss_pred cCCeeEEeEecccCc-eEEEEEEEcCCCcEEEEEEeeccc----------ccc--------hhHHHHHHHHHHHHHhCC-
Q 011628 25 LGRYEIGKLLGHGTF-AKVYHARNVKSGESVAIKVIDKEK----------ILK--------SGLVAHIKREISILRRVR- 84 (481)
Q Consensus 25 ~~~y~i~~~LG~G~f-g~Vy~a~~~~~~~~vAvK~i~~~~----------~~~--------~~~~~~~~~Ei~il~~l~- 84 (481)
..+++.++.||.|+- |.||+++- .|+.+|+|++..-. ... .....-+..|.+...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 378999999999999 99999986 78899999932100 000 022345667777777664
Q ss_pred --CCCc--ceEEEEEEeC------------------CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 011628 85 --HPNI--VQLFEVMATK------------------SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCH 142 (481)
Q Consensus 85 --HpnI--v~l~~~~~~~------------------~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH 142 (481)
+.++ |++||+..-. ...-||-||++... .....-+.+|.+-+..+|
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRDIPQMLRDLKILH 181 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhHHHHHHHHHHHHH
Confidence 5566 8999987322 12357788776543 223344667888888999
Q ss_pred HcCceecCCCCCcEEEccCCCEEEEecCCc
Q 011628 143 ARGVYHRDLKPENLLLDENGDLKVSDFGLS 172 (481)
Q Consensus 143 ~~gi~HrDLKp~NILl~~~g~lkl~DFGla 172 (481)
..||+-+|+++.|.. .-||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEecccC
Confidence 999999999999987 4589999864
No 464
>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH). The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio
Probab=98.33 E-value=5.4e-06 Score=79.62 Aligned_cols=133 Identities=16% Similarity=0.154 Sum_probs=82.7
Q ss_pred ecccCc-eEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 011628 34 LGHGTF-AKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNIVQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 34 LG~G~f-g~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
|-.|.. +.||+... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 334444 78999865 34678899875432 234668999998884 444667787777767789999999997
Q ss_pred chHHHH----------------Hc-CCCCH-----H-HHHHHHHH-----------------------HHHHHHHHH---
Q 011628 112 ELFNKV----------------AK-GRLKE-----D-LARKYFQQ-----------------------LISAVGFCH--- 142 (481)
Q Consensus 112 ~L~~~i----------------~~-~~l~e-----~-~~~~~~~q-----------------------l~~al~yLH--- 142 (481)
+|.... .. ..++. . .......+ +...+..|-
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 664321 10 01110 0 00000000 111112221
Q ss_pred ----HcCceecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 143 ----ARGVYHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 143 ----~~gi~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
...++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 23489999999999999987788999997753
No 465
>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]
Probab=98.30 E-value=5.2e-06 Score=74.35 Aligned_cols=133 Identities=25% Similarity=0.362 Sum_probs=97.4
Q ss_pred cCCee--EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEE
Q 011628 25 LGRYE--IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV-QLFEVMATKSKI 101 (481)
Q Consensus 25 ~~~y~--i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~ 101 (481)
.+.|. ..+.||+|.+|.||++.+ .|..+|+|+-..+. ....+..|.+++..+.-.++- ++|.+.. .
T Consensus 19 ~~~~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~ 87 (201)
T COG2112 19 EGKYELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE----D 87 (201)
T ss_pred ccchhhhhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech----h
Confidence 34454 468899999999999987 67799999876543 346688999999999877765 3444433 3
Q ss_pred EEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCC-CCcEEEccCCCEEEEecCCccc
Q 011628 102 YFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLK-PENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLK-p~NILl~~~g~lkl~DFGla~~ 174 (481)
++.|||+.|-.|.+....+ -++-...+++..--|-..||-|..|. |...++..++.+.|+||.-|++
T Consensus 88 ~i~me~i~G~~L~~~~~~~------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIGG------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhhcCcchhhhhhcc------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 4559999998887765433 13344455666555677899999986 6666666666999999998874
No 466
>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP. PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].
Probab=98.27 E-value=2.3e-05 Score=72.69 Aligned_cols=130 Identities=20% Similarity=0.336 Sum_probs=96.9
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccc-------------cchhHHHHHHHHHHHHHhCC------CCCcceEE
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI-------------LKSGLVAHIKREISILRRVR------HPNIVQLF 92 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-------------~~~~~~~~~~~Ei~il~~l~------HpnIv~l~ 92 (481)
..||+|+.=.||.- .......||+...... ......++..+|+.-...+. +.+|.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999999952 3456678999977650 01112455677887777766 78899999
Q ss_pred EEEEeCCEEEEEEeccCCC------chHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCC----
Q 011628 93 EVMATKSKIYFVMEYVRGG------ELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENG---- 162 (481)
Q Consensus 93 ~~~~~~~~~~lv~Ey~~gg------~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g---- 162 (481)
|+.++....-+|+|.+.+. +|.+++..+.+++ ...+ .+-.-..||-+++|+.+|++|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~ 159 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEF 159 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCce
Confidence 9999999999999987642 6889998887777 3333 334445688899999999999999997543
Q ss_pred CEEEEe
Q 011628 163 DLKVSD 168 (481)
Q Consensus 163 ~lkl~D 168 (481)
.+.|+|
T Consensus 160 ~lvlID 165 (199)
T PF10707_consen 160 RLVLID 165 (199)
T ss_pred EEEEEe
Confidence 477777
No 467
>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]
Probab=98.24 E-value=8.2e-06 Score=85.96 Aligned_cols=140 Identities=21% Similarity=0.295 Sum_probs=88.9
Q ss_pred eEecccCceEEEEEEEcCCCcEEEEEEeecccccc----------------------------hhHHHHH------HHHH
Q 011628 32 KLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK----------------------------SGLVAHI------KREI 77 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~----------------------------~~~~~~~------~~Ei 77 (481)
+.||.-+.|+||+|+-+ +|+.||||+-++.-... .++.+.+ .+|.
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 68999999999999975 59999999976431100 1111222 2333
Q ss_pred HHHH----hCCCCC------cceEEEEEEeCCEEEEEEeccCCCchHHH--HHcCCCCHHHHHHHHHHHHHHHHHHHHcC
Q 011628 78 SILR----RVRHPN------IVQLFEVMATKSKIYFVMEYVRGGELFNK--VAKGRLKEDLARKYFQQLISAVGFCHARG 145 (481)
Q Consensus 78 ~il~----~l~Hpn------Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~--i~~~~l~e~~~~~~~~ql~~al~yLH~~g 145 (481)
+... .+.|-+ |.++|..+ .+...|+|||++|..+.|. +.+.+++...+...+.+.. ++.+=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 3333 333545 33433322 3456899999999876544 5555566554333222221 12333579
Q ss_pred ceecCCCCCcEEEcc----CCCEEEEecCCccccc
Q 011628 146 VYHRDLKPENLLLDE----NGDLKVSDFGLSAVSD 176 (481)
Q Consensus 146 i~HrDLKp~NILl~~----~g~lkl~DFGla~~~~ 176 (481)
++|+|=+|.||++.. ++.+.+-|||+.....
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999994 5679999999986543
No 468
>PLN02876 acyl-CoA dehydrogenase
Probab=98.20 E-value=1.7e-05 Score=89.44 Aligned_cols=146 Identities=18% Similarity=0.409 Sum_probs=92.8
Q ss_pred EEeEecccCceEEEEEEEcCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKSG--ESVAIKVIDKEKILKSGLVAHIKREISILRRVR-HPNI--VQLFEVMATK---SKI 101 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~--~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~ 101 (481)
-.+.|+.|.+..+|+......+ ..+++|+........ ....+.+|+.+++.+. |+++ .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998764332 467788765432221 1245789999999995 6765 7777777654 467
Q ss_pred EEEEeccCCCchHH--------------------HHHc-CCCC----------------HHHHHHHHHH-----------
Q 011628 102 YFVMEYVRGGELFN--------------------KVAK-GRLK----------------EDLARKYFQQ----------- 133 (481)
Q Consensus 102 ~lv~Ey~~gg~L~~--------------------~i~~-~~l~----------------e~~~~~~~~q----------- 133 (481)
|+||||++|..+.+ .+.. ..++ ...+..|..|
T Consensus 120 flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~ 199 (822)
T PLN02876 120 FYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPP 199 (822)
T ss_pred eEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCC
Confidence 89999999864321 1110 0000 1122222222
Q ss_pred ----HHHHHHHHHH-----------cCceecCCCCCcEEEccC-CC-EEEEecCCcccccc
Q 011628 134 ----LISAVGFCHA-----------RGVYHRDLKPENLLLDEN-GD-LKVSDFGLSAVSDQ 177 (481)
Q Consensus 134 ----l~~al~yLH~-----------~gi~HrDLKp~NILl~~~-g~-lkl~DFGla~~~~~ 177 (481)
+...+.+|.. ..++|+|++|.|||++.+ +. .-|.||++++..+.
T Consensus 200 ~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~GdP 260 (822)
T PLN02876 200 RNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGNQ 260 (822)
T ss_pred CChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCCh
Confidence 2223456632 249999999999999853 34 57999999876443
No 469
>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]
Probab=98.16 E-value=1.6e-07 Score=105.84 Aligned_cols=208 Identities=16% Similarity=0.079 Sum_probs=148.6
Q ss_pred HHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCCCchHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHc--
Q 011628 74 KREISILRRVRHPNIVQLFEVMAT--KSKIYFVMEYVRGGELFNKVAKG-----RLKEDLARKYFQQLISAVGFCHAR-- 144 (481)
Q Consensus 74 ~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lv~Ey~~gg~L~~~i~~~-----~l~e~~~~~~~~ql~~al~yLH~~-- 144 (481)
..|..-++...|+++...+.-... ....|..++|+.+|.+++.|-+| .+.+..+....++.+.+..-+|++
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344455566789998876655433 34578999999999999999764 245555566666668888887765
Q ss_pred ---CceecCCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHH
Q 011628 145 ---GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVL 221 (481)
Q Consensus 145 ---gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~el 221 (481)
-.+|++||+-|.+|..+.++|+.++|+.++... .........+++.|++|++.+.-.+ +.++|+|..|+-+|+.
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHH
Confidence 278999999999999999999999999984322 1223445678999999999887777 4569999999999999
Q ss_pred hcCCCCCCCchHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcccCcCCCCCHhHHHhCccccc
Q 011628 222 MAGYLPFQDQNIMVMYKKIYKGE-FRSPRWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRK 284 (481)
Q Consensus 222 ltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~ 284 (481)
..|..+|-.-....+...+.++. ...+...|.++-.....+|-..-..||.-..++..+.|.-
T Consensus 1434 s~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1434 SDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred hcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 99988875444333333333333 2334444555555666666666678898888877766643
No 470
>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members. The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista
Probab=97.91 E-value=6.4e-05 Score=71.85 Aligned_cols=72 Identities=10% Similarity=0.214 Sum_probs=45.1
Q ss_pred eEecccCce-EEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEE
Q 011628 32 KLLGHGTFA-KVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHP---NIVQLFEVMATK---SKIYFV 104 (481)
Q Consensus 32 ~~LG~G~fg-~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hp---nIv~l~~~~~~~---~~~~lv 104 (481)
+.|+.|+.. .||.. +..+++|+..... ....+.+|..+++.+... -+.++++..... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 457767766 58875 2346788754321 234688999999888532 244444443332 245889
Q ss_pred EeccCCCch
Q 011628 105 MEYVRGGEL 113 (481)
Q Consensus 105 ~Ey~~gg~L 113 (481)
|++++|.++
T Consensus 73 ~~~i~G~~l 81 (235)
T cd05155 73 YRWLEGETA 81 (235)
T ss_pred EEeecCCCC
Confidence 999999665
No 471
>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C). Proteins in this uncharacterised family are described as transmembrane proteins.
Probab=97.84 E-value=6.9e-05 Score=69.13 Aligned_cols=96 Identities=22% Similarity=0.289 Sum_probs=79.9
Q ss_pred HHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCCchHH----HHHcCCCCHHHHHHHHHHHHHHHHHHHH---cCc
Q 011628 75 REISILRRVRH-PNIVQLFEVMATKSKIYFVMEYVRGGELFN----KVAKGRLKEDLARKYFQQLISAVGFCHA---RGV 146 (481)
Q Consensus 75 ~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~----~i~~~~l~e~~~~~~~~ql~~al~yLH~---~gi 146 (481)
.|.-+++.+.+ +++.+++|.|.. +++.||...+++.. +.+-...++....+++.|++..+++++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58889999976 699999999854 77999998877652 2222346899999999999999999987 358
Q ss_pred eecCCCCCcEEEccCCCEEEEecCCccc
Q 011628 147 YHRDLKPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 147 ~HrDLKp~NILl~~~g~lkl~DFGla~~ 174 (481)
.-.|++|+|+-++++|++|++|...+..
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcch
Confidence 8899999999999999999999987654
No 472
>PRK09550 mtnK methylthioribose kinase; Reviewed
Probab=97.81 E-value=0.00046 Score=70.89 Aligned_cols=80 Identities=15% Similarity=0.202 Sum_probs=54.5
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeeccccc--c--hhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL--K--SGLVAHIKREISILRRVR---HPNIVQLFEVMATKSKIYF 103 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~--~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 103 (481)
.+.||.|.+..||++.....++.|+||.-...-.. . .-...+...|...|+.+. ..++.+++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46799999999999998543368999985421100 1 113456677888888863 3456777766 4455789
Q ss_pred EEeccCCCc
Q 011628 104 VMEYVRGGE 112 (481)
Q Consensus 104 v~Ey~~gg~ 112 (481)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
No 473
>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo
Probab=97.79 E-value=0.00034 Score=66.60 Aligned_cols=75 Identities=19% Similarity=0.340 Sum_probs=48.9
Q ss_pred EeEecccCceEEEEEEEcC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecc
Q 011628 31 GKLLGHGTFAKVYHARNVK-SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYFVMEYV 108 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~ 108 (481)
.+.|..|-...+|+..... .++.|++|+...... ......+|+.+++.+...++ .+++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4567788888999987532 357899997754321 11234579999999864444 44444332 2 3799999
Q ss_pred CCCch
Q 011628 109 RGGEL 113 (481)
Q Consensus 109 ~gg~L 113 (481)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 99654
No 474
>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]
Probab=97.75 E-value=0.00031 Score=69.94 Aligned_cols=141 Identities=26% Similarity=0.356 Sum_probs=100.4
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccc----------------------cchhHH-HHHHHHHHHHHhCCC
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKI----------------------LKSGLV-AHIKREISILRRVRH 85 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----------------------~~~~~~-~~~~~Ei~il~~l~H 85 (481)
+|-..|.-|.-+.||+|.. .+|..+|||+++-.-. ....++ -...+|+.-|++++.
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4456777899999999985 6788899998752210 011122 235678999999876
Q ss_pred CCcceEEEEEEeCCEEEEEEeccCCCc-hHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HHcCceecCCCCCcEEEccCCC
Q 011628 86 PNIVQLFEVMATKSKIYFVMEYVRGGE-LFNKVAKGRLKEDLARKYFQQLISAVGFC-HARGVYHRDLKPENLLLDENGD 163 (481)
Q Consensus 86 pnIv~l~~~~~~~~~~~lv~Ey~~gg~-L~~~i~~~~l~e~~~~~~~~ql~~al~yL-H~~gi~HrDLKp~NILl~~~g~ 163 (481)
..|...--+... .-.|||+|+.+.. -.-.+..-.++...+..+.+|++.-+.-| |..+++|.||.--|+|+ .+|.
T Consensus 226 aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred cCCCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCE
Confidence 665433222222 3478999996422 23345555788889999999999988776 56799999999999998 5578
Q ss_pred EEEEecCCcc
Q 011628 164 LKVSDFGLSA 173 (481)
Q Consensus 164 lkl~DFGla~ 173 (481)
+.|+|.+-|-
T Consensus 303 lyiIDVSQSV 312 (520)
T KOG2270|consen 303 LYIIDVSQSV 312 (520)
T ss_pred EEEEEccccc
Confidence 9999998664
No 475
>TIGR02721 ycfN_thiK thiamine kinase. Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.
Probab=97.70 E-value=0.00015 Score=70.12 Aligned_cols=132 Identities=17% Similarity=0.221 Sum_probs=78.6
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYFVMEYVRGG 111 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey~~gg 111 (481)
.+..|-...+|+.. .+++.+++|+...... ...-...+|..+++.+...++ .+++... . -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 35667788999886 3567888997644321 111134679999999864433 3444433 2 26899999986
Q ss_pred chHH--------------HHH---cCC-----CC-HHHHHHHHHHHH---------HHHHHHHH--------cCceecCC
Q 011628 112 ELFN--------------KVA---KGR-----LK-EDLARKYFQQLI---------SAVGFCHA--------RGVYHRDL 151 (481)
Q Consensus 112 ~L~~--------------~i~---~~~-----l~-e~~~~~~~~ql~---------~al~yLH~--------~gi~HrDL 151 (481)
.+.. .+. .-+ ++ ...+..+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 5421 111 111 11 122233332221 11222211 24899999
Q ss_pred CCCcEEEccCCCEEEEecCCccc
Q 011628 152 KPENLLLDENGDLKVSDFGLSAV 174 (481)
Q Consensus 152 Kp~NILl~~~g~lkl~DFGla~~ 174 (481)
.|.||+++.++ +.|+||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998864
No 476
>cd05153 HomoserineK_II Homoserine Kinase, type II. Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.
Probab=97.70 E-value=0.00023 Score=70.34 Aligned_cols=135 Identities=17% Similarity=0.191 Sum_probs=82.3
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEV------MATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 102 (481)
.+.|..|....+|+... ++..+++|+.... . ...+..|+.+++.+.+.+ +.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56777888889999864 4457889987541 1 244667888888885332 4444331 23345678
Q ss_pred EEEeccCCCchHH-----------HH---Hc--CCCC--------HHHHHH------------HHHHHHHHHHHHHH---
Q 011628 103 FVMEYVRGGELFN-----------KV---AK--GRLK--------EDLARK------------YFQQLISAVGFCHA--- 143 (481)
Q Consensus 103 lv~Ey~~gg~L~~-----------~i---~~--~~l~--------e~~~~~------------~~~ql~~al~yLH~--- 143 (481)
++++|++|..+.. .+ .. ..+. ...... ....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999965421 11 10 0010 000000 11112233444443
Q ss_pred ----cCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 144 ----RGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 144 ----~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
.+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999988777899998764
No 477
>PRK10593 hypothetical protein; Provisional
Probab=97.69 E-value=0.0008 Score=66.78 Aligned_cols=78 Identities=12% Similarity=0.119 Sum_probs=55.1
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEEE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH---PNIVQLFEVMAT---KSKIY 102 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~~ 102 (481)
.-.+.||.|..+.||.... .+..+.+|..+... . ...+.+|...++.+.- -.+.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~--~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYD--SQGNPMPLMARSFS--T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEc--CCCCEEEEEecccc--c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3457899999999999864 23356778743211 1 1357789999998853 357788887754 36689
Q ss_pred EEEeccCCCch
Q 011628 103 FVMEYVRGGEL 113 (481)
Q Consensus 103 lv~Ey~~gg~L 113 (481)
+|||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
No 478
>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.
Probab=97.65 E-value=0.0001 Score=51.39 Aligned_cols=42 Identities=26% Similarity=0.468 Sum_probs=35.6
Q ss_pred ccEEEEEEEEEEc-CceEEEEeEecCCCchhHHHHhhhcccccc
Q 011628 412 GPLTIATEIFELT-PKLVVVEVKKKGGDKGEYEEFCNKELKPGL 454 (481)
Q Consensus 412 ~~l~~~~~v~~~~-~~~~lVe~~~~~Gd~le~~~~~~~~l~~~l 454 (481)
..+.+.+||+++. ++++.|+|+|.+||...|+++|.+ |-..|
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~-il~~l 45 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSK-ILNEL 45 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHH-HHHHT
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHH-HHHHc
Confidence 3588999999997 899999999999999999999998 65444
No 479
>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]
Probab=97.60 E-value=5.5e-05 Score=74.00 Aligned_cols=134 Identities=16% Similarity=0.269 Sum_probs=95.5
Q ss_pred CeeEEeEecccCceEEEEEEEcCCCcEEEEEEeeccccc-----------------chhHH--HHHHHHHHHHHhCC-CC
Q 011628 27 RYEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL-----------------KSGLV--AHIKREISILRRVR-HP 86 (481)
Q Consensus 27 ~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-----------------~~~~~--~~~~~Ei~il~~l~-Hp 86 (481)
=|.++++||-|.-+.||.+-+ ..|++.++|.-+..... ..-.. -...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367889999999999999987 57889999964322110 01111 23467999999885 33
Q ss_pred C-cceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceecCCCCCcEEEccCCCEE
Q 011628 87 N-IVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHRDLKPENLLLDENGDLK 165 (481)
Q Consensus 87 n-Iv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~HrDLKp~NILl~~~g~lk 165 (481)
. +.+.+++ +..++|||++.|..|.+.-.- ..+..+...++.-+--|-.+|+||+|..--||++++++.++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-----~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-----EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec-----CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 2 3444433 456899999999777654321 12334555666666778899999999999999999999999
Q ss_pred EEecC
Q 011628 166 VSDFG 170 (481)
Q Consensus 166 l~DFG 170 (481)
++||-
T Consensus 243 vIDFP 247 (465)
T KOG2268|consen 243 VIDFP 247 (465)
T ss_pred Eeech
Confidence 99995
No 480
>TIGR00938 thrB_alt homoserine kinase, Neisseria type. Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.
Probab=97.52 E-value=0.00098 Score=66.38 Aligned_cols=136 Identities=18% Similarity=0.203 Sum_probs=79.9
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFEV------MATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 102 (481)
.+.++.|....+|++.. . +..+++|+..... . ...+..|+.+++.|...+ +.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-C-CCcEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677787789998864 3 3467789875432 1 123456777777774222 3444331 12245678
Q ss_pred EEEeccCCCchH-----------HHH---Hc--CCCCH-------HHHH----------------HHHHHHHHHHHHHHH
Q 011628 103 FVMEYVRGGELF-----------NKV---AK--GRLKE-------DLAR----------------KYFQQLISAVGFCHA 143 (481)
Q Consensus 103 lv~Ey~~gg~L~-----------~~i---~~--~~l~e-------~~~~----------------~~~~ql~~al~yLH~ 143 (481)
+++||++|.++. ..+ .. ..++. ...+ .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999985431 111 11 01100 0000 001112334555532
Q ss_pred -------cCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 144 -------RGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 144 -------~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999998877899999764
No 481
>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]
Probab=97.43 E-value=0.0012 Score=65.63 Aligned_cols=146 Identities=16% Similarity=0.273 Sum_probs=86.0
Q ss_pred eeEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEE
Q 011628 28 YEIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRH--PNIVQLFEVMATKS--KIYF 103 (481)
Q Consensus 28 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H--pnIv~l~~~~~~~~--~~~l 103 (481)
..+.+.+..|.--.+|.... +++.+++. ... ............+|..+++.+.- .-+.+.+++|.++. ..|.
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence 34455554444444555544 37888888 332 12222345667889999988853 22344556665555 6799
Q ss_pred EEeccCCCchHHHHHcCCC---------------------------------CHHHHHHHHHHH--------------HH
Q 011628 104 VMEYVRGGELFNKVAKGRL---------------------------------KEDLARKYFQQL--------------IS 136 (481)
Q Consensus 104 v~Ey~~gg~L~~~i~~~~l---------------------------------~e~~~~~~~~ql--------------~~ 136 (481)
||+|++|..+.+....... ...+...+..+. ..
T Consensus 103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~ 182 (321)
T COG3173 103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR 182 (321)
T ss_pred EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence 9999999432211111000 011111111111 12
Q ss_pred HHHHHHHc--------CceecCCCCCcEEEccCCCEEEEecCCcccccc
Q 011628 137 AVGFCHAR--------GVYHRDLKPENLLLDENGDLKVSDFGLSAVSDQ 177 (481)
Q Consensus 137 al~yLH~~--------gi~HrDLKp~NILl~~~g~lkl~DFGla~~~~~ 177 (481)
-..|++.+ .++|+|+++.|++++.++-+-|.||+++.+.+.
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 23444432 489999999999999999999999999986544
No 482
>PRK05231 homoserine kinase; Provisional
Probab=97.43 E-value=0.0021 Score=64.33 Aligned_cols=135 Identities=13% Similarity=0.192 Sum_probs=74.3
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLFE------VMATKSKIY 102 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~~------~~~~~~~~~ 102 (481)
.+.|+.|....+|.... . +..+++|++. .. . ...+..|+.+++.|...+ +.+++. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~-~~--~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFE-RL--T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe-C-CCcEEEEEec-cC--C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 35567787789999875 2 3468899875 21 1 122334566665553212 333332 122356689
Q ss_pred EEEeccCCCchH-----------HHHH---c--CCC--------CH----HHHHH-----------HHHHHH-HHHHHHH
Q 011628 103 FVMEYVRGGELF-----------NKVA---K--GRL--------KE----DLARK-----------YFQQLI-SAVGFCH 142 (481)
Q Consensus 103 lv~Ey~~gg~L~-----------~~i~---~--~~l--------~e----~~~~~-----------~~~ql~-~al~yLH 142 (481)
+++||++|..+. ..+. . ..+ .. ..... .+.+.+ ..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999996431 1111 0 011 00 00000 111111 1122222
Q ss_pred -------HcCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 143 -------ARGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 143 -------~~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
..|++|+|++|.|||++.+...-|+||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2389999999999999866556899999775
No 483
>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes. The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer
Probab=97.40 E-value=0.0013 Score=65.18 Aligned_cols=75 Identities=17% Similarity=0.303 Sum_probs=48.4
Q ss_pred EeEecccCceEEEEEEEcC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVK------SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYF 103 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l 103 (481)
++.|..|--..||+..... +++.+++|+..... .......+|..+++.+...++ .+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3456667777899887532 25789999975532 112345689999988864333 345555432 35
Q ss_pred EEeccCCCch
Q 011628 104 VMEYVRGGEL 113 (481)
Q Consensus 104 v~Ey~~gg~L 113 (481)
|+||++|..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 8999998655
No 484
>PLN02756 S-methyl-5-thioribose kinase
Probab=97.15 E-value=0.0055 Score=62.92 Aligned_cols=85 Identities=19% Similarity=0.090 Sum_probs=55.6
Q ss_pred EEeEecccCceEEEEEEEcCCCcEEEEEEeecccccch----hHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKS----GLVAHIKREISILRRVR---HPNIVQLFEVMATKSKIY 102 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~----~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~ 102 (481)
-.+.||.|.-..||+..+ .++.++||.-........ ....+...|...|+.+. ..++.+++.++.+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 367889999999999886 345689997652221111 12344556777777664 2477888887774 457
Q ss_pred EEEeccCCC--chHHHHH
Q 011628 103 FVMEYVRGG--ELFNKVA 118 (481)
Q Consensus 103 lv~Ey~~gg--~L~~~i~ 118 (481)
++|||++++ .+.+.+.
T Consensus 112 lvME~L~~~~~ilr~~Ll 129 (418)
T PLN02756 112 IGMRYLEPPHIILRKGLI 129 (418)
T ss_pred EEEeecCCcceehhhhhc
Confidence 889999872 3444333
No 485
>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]
Probab=96.98 E-value=0.0026 Score=65.97 Aligned_cols=163 Identities=24% Similarity=0.296 Sum_probs=104.8
Q ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCceec
Q 011628 71 AHIKREISILRRVRHPNIVQLFEVMATK-SKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHARGVYHR 149 (481)
Q Consensus 71 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~gi~Hr 149 (481)
.++.-..++++.+.|+|...++++.... ....+|||++ +.+|.+.+..+.+...... .+|+.|-
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s~~--------------~~~~~~~ 91 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDESLL--------------AHGVLHL 91 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhhhc--------------cccccee
Confidence 4456678899999999999998887543 3578899999 5589998876542211111 2222221
Q ss_pred CCCCCcEEEccCCCEEEEecCCcccccccccCCcccccCCCCccccccccccCCCCCCcchHHHHHHHHHHHhcCCCCCC
Q 011628 150 DLKPENLLLDENGDLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLSRKGYDAAKVDIWSCGVILFVLMAGYLPFQ 229 (481)
Q Consensus 150 DLKp~NILl~~~g~lkl~DFGla~~~~~~~~~~~~~~~~gt~~y~APEvl~~~~~~~~~~DiwSlGvil~elltg~~Pf~ 229 (481)
| .++.+| -+.. .| |-.+ ++|+||||+|.++.++.-|..-|.
T Consensus 92 -----~-------~~~~td-~~~t------------------~~--~~~~------~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 92 -----N-------IIYITD-HFLT------------------KY--PSPI------GPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----h-------hhhccc-cccc------------------cC--CCCC------CcchhhhhHHHHHHHHHHhhHHHH
Confidence 1 223333 0100 00 1111 248999999999999999987776
Q ss_pred CchHHHHHHHHhhCCCCCC------------CCCCHHHHHHHHHhcccCcCCCCCHhHHHhCcccccCcc
Q 011628 230 DQNIMVMYKKIYKGEFRSP------------RWFSPDLIRLLTKLLDTNPDKRITIPEIMENRWFRKGFK 287 (481)
Q Consensus 230 ~~~~~~~~~~i~~~~~~~~------------~~~s~~~~~li~~~L~~dP~~Rps~~eil~h~~f~~~~~ 287 (481)
.....+....+.+-..... -.++.....+..+|+-..|..||...++.+++-|...+.
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 6554444444433211111 113555788999999999999999999999999887643
No 486
>TIGR01767 MTRK 5-methylthioribose kinase. This enzyme is involved in the methionine salvage pathway in certain bacteria.
Probab=96.91 E-value=0.0079 Score=60.74 Aligned_cols=86 Identities=17% Similarity=0.165 Sum_probs=52.8
Q ss_pred EecccCceEEEEEEEcCCCcEEEEEEeeccccc----chhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEE
Q 011628 33 LLGHGTFAKVYHARNVKSGESVAIKVIDKEKIL----KSGLVAHIKREISILRRVR--HP-NIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 33 ~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lv~ 105 (481)
.||.|.-..||++.+...++.|+||.-...-.. -.-...+..-|...|+... .| .+.++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997543468999965321110 0112355667888887764 35 34555443 445567999
Q ss_pred eccCCC-chHHHHHcC
Q 011628 106 EYVRGG-ELFNKVAKG 120 (481)
Q Consensus 106 Ey~~gg-~L~~~i~~~ 120 (481)
|+++.. .|...+.+|
T Consensus 80 EdL~~~~ilR~~Li~g 95 (370)
T TIGR01767 80 EDLSHHKIARKGLIEG 95 (370)
T ss_pred hhCccchHHHHHHHcC
Confidence 999654 343444333
No 487
>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported
Probab=96.81 E-value=0.0083 Score=58.84 Aligned_cols=31 Identities=29% Similarity=0.501 Sum_probs=26.0
Q ss_pred CceecCCCCCcEEEccCCC-EEEEecCCcccc
Q 011628 145 GVYHRDLKPENLLLDENGD-LKVSDFGLSAVS 175 (481)
Q Consensus 145 gi~HrDLKp~NILl~~~g~-lkl~DFGla~~~ 175 (481)
.++|+|++|.|||++.+++ .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 469999988653
No 488
>TIGR02906 spore_CotS spore coat protein, CotS family. Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.
Probab=96.60 E-value=0.022 Score=56.56 Aligned_cols=29 Identities=34% Similarity=0.629 Sum_probs=25.4
Q ss_pred cCceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 144 RGVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 144 ~gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
.+++|+|+++.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999998654
No 489
>PLN02236 choline kinase
Probab=96.57 E-value=0.021 Score=57.92 Aligned_cols=136 Identities=15% Similarity=0.227 Sum_probs=81.2
Q ss_pred EeEecccCceEEEEEEEcC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVK----SGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNIV-QLFEVMATKSKIYFVM 105 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~----~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lv~ 105 (481)
.+.|-.|-.-.+|++.... +++.|++|+..... ...+. ..+|..+++.+..-++- ++++.+..+ .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEE
Confidence 4455557788999986432 34689999876542 12222 36799999999654443 555655332 579
Q ss_pred eccCCCchHH--------------HHH---cCCC-------CHHHHHHHHHHHH-----------------HHHHHH---
Q 011628 106 EYVRGGELFN--------------KVA---KGRL-------KEDLARKYFQQLI-----------------SAVGFC--- 141 (481)
Q Consensus 106 Ey~~gg~L~~--------------~i~---~~~l-------~e~~~~~~~~ql~-----------------~al~yL--- 141 (481)
||++|.+|.. .+. ...+ ..+.+..+..++. ..+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 9998766521 111 1111 1223333332221 111122
Q ss_pred -H----HcCceecCCCCCcEEEcc-CCCEEEEecCCccc
Q 011628 142 -H----ARGVYHRDLKPENLLLDE-NGDLKVSDFGLSAV 174 (481)
Q Consensus 142 -H----~~gi~HrDLKp~NILl~~-~g~lkl~DFGla~~ 174 (481)
. ...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 225899999999999986 46799999988764
No 490
>PLN02421 phosphotransferase, alcohol group as acceptor/kinase
Probab=96.36 E-value=0.032 Score=56.20 Aligned_cols=135 Identities=16% Similarity=0.254 Sum_probs=78.4
Q ss_pred eEecccCceEEEEEEEcCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEec
Q 011628 32 KLLGHGTFAKVYHARNVKS---GESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIYFVMEY 107 (481)
Q Consensus 32 ~~LG~G~fg~Vy~a~~~~~---~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lv~Ey 107 (481)
+.|..|=--.+|+...... +..|.+|+...... ..-...+|..+++.+..-++ .++++++. .+ +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence 4444466677888865332 34789998754321 12224579999999975555 35555553 22 48999
Q ss_pred cCCCchHH--------------HHH---cCCC-------CHHHHHHHHHHHH----------------------HHHHHH
Q 011628 108 VRGGELFN--------------KVA---KGRL-------KEDLARKYFQQLI----------------------SAVGFC 141 (481)
Q Consensus 108 ~~gg~L~~--------------~i~---~~~l-------~e~~~~~~~~ql~----------------------~al~yL 141 (481)
++|..|.. .+. ...+ ....+.+|+.++- .-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 98765411 111 1111 1223333333321 112111
Q ss_pred H----Hc----CceecCCCCCcEEEcc-CCCEEEEecCCccc
Q 011628 142 H----AR----GVYHRDLKPENLLLDE-NGDLKVSDFGLSAV 174 (481)
Q Consensus 142 H----~~----gi~HrDLKp~NILl~~-~g~lkl~DFGla~~ 174 (481)
. +. -.+|.|+.+.|||+++ ++.++++||..|..
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 11 2799999999999975 57899999998764
No 491
>PRK12396 5-methylribose kinase; Reviewed
Probab=96.20 E-value=0.03 Score=57.29 Aligned_cols=88 Identities=17% Similarity=0.186 Sum_probs=55.9
Q ss_pred EeEecccCceEEEEEEEcCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 011628 31 GKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILK---SGLVAHIKREISILRRVR--HP-NIVQLFEVMATKSKIYFV 104 (481)
Q Consensus 31 ~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lv 104 (481)
.+.||.|.-.-||++.+...++.|+||--...-... .-...+..-|..+|+... .| .+.++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678899999999999984345789999643211110 123466677888888774 45 45555543 44556789
Q ss_pred EeccCCC-chHHHHHcC
Q 011628 105 MEYVRGG-ELFNKVAKG 120 (481)
Q Consensus 105 ~Ey~~gg-~L~~~i~~~ 120 (481)
||+++.. .|.+.+..|
T Consensus 112 MEdL~~~~ilR~~Li~G 128 (409)
T PRK12396 112 MEDLSDHTILRTALINH 128 (409)
T ss_pred HHhCcccHHHHHHHHcC
Confidence 9999653 244444333
No 492
>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2.7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....
Probab=96.13 E-value=0.022 Score=53.36 Aligned_cols=30 Identities=33% Similarity=0.707 Sum_probs=21.6
Q ss_pred CceecCCCCCcEEE-ccCCCEEEEecCCccc
Q 011628 145 GVYHRDLKPENLLL-DENGDLKVSDFGLSAV 174 (481)
Q Consensus 145 gi~HrDLKp~NILl-~~~g~lkl~DFGla~~ 174 (481)
.++|+|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998864
No 493
>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]
Probab=96.02 E-value=0.02 Score=58.09 Aligned_cols=61 Identities=26% Similarity=0.273 Sum_probs=48.1
Q ss_pred EEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHH-HHHcCceecCCCCCcEEEccC
Q 011628 101 IYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGF-CHARGVYHRDLKPENLLLDEN 161 (481)
Q Consensus 101 ~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~y-LH~~gi~HrDLKp~NILl~~~ 161 (481)
..++-+|..|.++..++.....+|....+++.-.+.|+-- +--.+.+|.|++|.||++--+
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred ceeeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4567778999999999987777887777777777777643 345689999999999999544
No 494
>TIGR02904 spore_ysxE spore coat protein YsxE. Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.
Probab=95.94 E-value=0.15 Score=50.78 Aligned_cols=29 Identities=21% Similarity=0.235 Sum_probs=27.0
Q ss_pred CceecCCCCCcEEEccCCCEEEEecCCcc
Q 011628 145 GVYHRDLKPENLLLDENGDLKVSDFGLSA 173 (481)
Q Consensus 145 gi~HrDLKp~NILl~~~g~lkl~DFGla~ 173 (481)
+++|+|+.+.|+|++.++.+.++||..++
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998765
No 495
>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]
Probab=95.61 E-value=0.034 Score=55.75 Aligned_cols=87 Identities=21% Similarity=0.308 Sum_probs=60.9
Q ss_pred CCCCCcceEEEEE-EeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc-CceecCCCCCcEEEcc
Q 011628 83 VRHPNIVQLFEVM-ATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHAR-GVYHRDLKPENLLLDE 160 (481)
Q Consensus 83 l~HpnIv~l~~~~-~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~~-gi~HrDLKp~NILl~~ 160 (481)
..-++..+.+-+- .+....|++|++- |+.+. .+.. ...+++..++++.+.-++-+..+ ..-|||+...||||+
T Consensus 282 ~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is-~ik~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId- 356 (488)
T COG5072 282 CGSVFLETLKVVSLDETLYLYLHFKDH-GTPIS-IIKA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID- 356 (488)
T ss_pred ccchhhhcceEEecCCceEEEEEEecC-Cceee-eeec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-
Confidence 3344555544443 3334567777775 33332 2211 35677888898888877777765 689999999999999
Q ss_pred CCCEEEEecCCccc
Q 011628 161 NGDLKVSDFGLSAV 174 (481)
Q Consensus 161 ~g~lkl~DFGla~~ 174 (481)
+|++.|+||-+++.
T Consensus 357 ~GnvtLIDfklsRl 370 (488)
T COG5072 357 EGNVTLIDFKLSRL 370 (488)
T ss_pred cCceEEEEeeeeec
Confidence 99999999999984
No 496
>PTZ00384 choline kinase; Provisional
Probab=95.56 E-value=0.11 Score=53.49 Aligned_cols=76 Identities=21% Similarity=0.308 Sum_probs=46.2
Q ss_pred EEeEecccCceEEEEEEEcCC-CcE-----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 011628 30 IGKLLGHGTFAKVYHARNVKS-GES-----VAIKVIDKEKILKSGLVAHIKREISILRRVRHPNI-VQLFEVMATKSKIY 102 (481)
Q Consensus 30 i~~~LG~G~fg~Vy~a~~~~~-~~~-----vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~ 102 (481)
..+.|..|--..+|++..... +.. |.+++... ..+..-.-.+|+.+++.+...++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345565688889999875332 122 44443211 11222234579999999976555 455555542 6
Q ss_pred EEEeccCCCch
Q 011628 103 FVMEYVRGGEL 113 (481)
Q Consensus 103 lv~Ey~~gg~L 113 (481)
++.||++|.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 89999999765
No 497
>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []. Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.
Probab=95.47 E-value=0.25 Score=48.68 Aligned_cols=75 Identities=13% Similarity=0.205 Sum_probs=47.4
Q ss_pred eEEeEecccCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEE
Q 011628 29 EIGKLLGHGTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVR---HPNIVQLFEVMATKSKIYFVM 105 (481)
Q Consensus 29 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lv~ 105 (481)
+-.+.+|.|....+|... .+++.+-||+-.... ...+..|..-|+.|. --.+.+++.+....+..|++|
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 346788999999999887 678899999876321 133567888777773 345778888888777789999
Q ss_pred eccCCC
Q 011628 106 EYVRGG 111 (481)
Q Consensus 106 Ey~~gg 111 (481)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
No 498
>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length. The function of this family is unknown.
Probab=95.19 E-value=0.072 Score=49.93 Aligned_cols=83 Identities=19% Similarity=0.201 Sum_probs=57.8
Q ss_pred HHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCchHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH--cCceec
Q 011628 72 HIKREISILRRVRHPNIVQLFEVMATKSKIYFVMEYVRGGELFNKVAKGRLKEDLARKYFQQLISAVGFCHA--RGVYHR 149 (481)
Q Consensus 72 ~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~Ey~~gg~L~~~i~~~~l~e~~~~~~~~ql~~al~yLH~--~gi~Hr 149 (481)
.++.+.+++.+++ .|+++..- ..-.+-+++|+|-... . .-..++.-=+.+|.-.|+ .+.+|+
T Consensus 104 ~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-----------i-~~~N~i~agi~~L~~fH~~~~~~lHG 167 (308)
T PF07387_consen 104 LYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-----------I-NFSNFITAGIKDLMDFHSENQHCLHG 167 (308)
T ss_pred hhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-----------c-chhHHHHHhHHHHHHhhccCCCeecC
Confidence 3567888888775 68887732 4456779999995311 1 011111122456777784 379999
Q ss_pred CCCCCcEEEccCCCEEEEecC
Q 011628 150 DLKPENLLLDENGDLKVSDFG 170 (481)
Q Consensus 150 DLKp~NILl~~~g~lkl~DFG 170 (481)
|..|+||+-|..|.+||.|=+
T Consensus 168 D~np~NiM~D~~G~lKlVDP~ 188 (308)
T PF07387_consen 168 DCNPDNIMCDKFGYLKLVDPV 188 (308)
T ss_pred CCChhheeecCCCCEEecChh
Confidence 999999999999999999976
No 499
>PRK11768 serine/threonine protein kinase; Provisional
Probab=95.06 E-value=0.57 Score=47.02 Aligned_cols=71 Identities=15% Similarity=0.180 Sum_probs=42.8
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--cceEE---E--EEEeCCEEEEEEeccC
Q 011628 37 GTFAKVYHARNVKSGESVAIKVIDKEKILKSGLVAHIKREISILRRVRHPN--IVQLF---E--VMATKSKIYFVMEYVR 109 (481)
Q Consensus 37 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn--Iv~l~---~--~~~~~~~~~lv~Ey~~ 109 (481)
+.-..||.... .++..+++|+.+.... ....+..|+..+..|.... ++... + +..-++..+.++++++
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~ 110 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG 110 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence 34457898864 4577899998864331 1344667888777773211 22211 1 1223567888999998
Q ss_pred CCc
Q 011628 110 GGE 112 (481)
Q Consensus 110 gg~ 112 (481)
|..
T Consensus 111 G~~ 113 (325)
T PRK11768 111 GRA 113 (325)
T ss_pred CCC
Confidence 853
No 500
>PRK06148 hypothetical protein; Provisional
Probab=94.54 E-value=0.53 Score=54.64 Aligned_cols=31 Identities=29% Similarity=0.472 Sum_probs=26.3
Q ss_pred cCceecCCCCCcEEEccCC--CEE-EEecCCccc
Q 011628 144 RGVYHRDLKPENLLLDENG--DLK-VSDFGLSAV 174 (481)
Q Consensus 144 ~gi~HrDLKp~NILl~~~g--~lk-l~DFGla~~ 174 (481)
++++|+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998753
Done!